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Foreword

Whether we have been providing professional consulting services for many years, as I have, or we are
relative newcomers to the field of consulting services, the current state of the healthcare environment
certainly can tend to make us all feel a bit bewildered. The ongoing technological, economic, and political changes that are happening require all of us to arm ourselves with the knowledge and skills necessary
to address these changes. Bob Cimasi’s new, comprehensive, reference work is an essential tool if we
are to be able to provide useful specialized advice to our clients.
This Guide, containing 18 chapters of up-to-date specialized information concerning every aspect of
healthcare Professional Practices, is a monumental collection of detailed, useful information for CPAs,
Business Valuators, Attorneys, Financial Planners, Health Care Executives, Administrators, and even for
Physicians and Surgeons. It covers the waterfront of the types of entities providing healthcare services
with specific attention to each medical and dental specialty.
In examining this vast range of entities and professionals, this Guide does not confine its presentations to highlights only. Rather, it delves deeply and precisely into the finer points of problems and
opportunities confronting each of the specialized healthcare professional practice entities. A recurring
theme throughout the book is to consider the delivery of healthcare professional services within the context of what Bob Cimasi terms “the four pillars of the healthcare industry, i.e., regulatory, reimbursement, competition, and technology.”
As a CPA, business appraiser, and consultant who has practiced for 56 years, I believe that this
monumental book should be in the library of every CPA firm, business valuation firm, legal firm, financial planner, and consultant who hopes to continue to serve clients in the healthcare field competently
in these rapidly changing times. As I have learned as the father of a long-time practicing critical-care
internist and hospitalist, I believe that the book also is a must for the libraries of professional physicians, surgeons, dentists, and administrators who are on the every-day firing lines trying to survive the
sea of change in their respective professions. And before closing, I want to say some words about the
author, Bob Cimasi. I have known Bob for many years, first as a participant in professional seminars
and conferences in which he has been a presenter, and later on a more direct professional and personal
basis. Throughout these years, I have been impressed with both his technical knowledge, and even more
importantly, the unselfish and tireless sharing of his time, talent, and accumulated knowledge with his
professional colleagues in the accounting, business valuation, and consulting professions. There are few
people in the world that I have known who are of his caliber! This Guide confirms again what many of
us know. Bob Cimasi is truly one-of-a-kind dedicated professional whose writings are worth reading.
Richard D. Thorsen, CPA/ABV, CMEA, CVA
May 2010
Past Member, Board of Directors and Vice President of the American Institute of CPAs (AICPA)
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Preface
“Tho’ much is taken, much abides.” (Ulysses) Lord Alfred Tennyson, 1833

I was born in 1950, the fourth child in our family, and the first born in a hospital—my older brothers and
sisters having been delivered in my grandmother’s bed. In the small, upstate New York farming community where I was raised, doctor house calls were not unusual. When an injury or sudden illness required
a response by emergency services, the dispatcher would sound the community sirens, signaling the volunteer firemen on duty to radio ahead from their emergency vehicle to the small, four-bed, rural hospital,
which would then alert one of the three physicians in the community to rush to the hospital to provide
emergency care. When our neighbors developed musculoskeletal conditions from working on the farms
or in small manufacturing plants and machine shops, they would visit the town chiropractor who would
perform manipulation and prescribe vitamins and various homeopathic remedies. The local dentist’s services were in great demand with the prefluorination, widespread incidence of juvenile tooth decay. This
was a time in U.S. history when Marcus Welby was not only a regular family television drama but was
also a reasonable characterization of how healthcare services were perceived to be delivered by professional practices throughout much of the country.
During the sixty year period since 1950, the U.S. population has doubled from just more than 150
million to an estimated 300 million in 2010,1 and the average life expectancy has increased from approximately 68 years to 78 years.2 With the record number of births of the “baby boomer” generation
from the late 1940s through the early 1960s, the proportion of the U.S. population over the age of 65
increased from 8.1 percent in 1950 to an estimated 13.2 percent in 2010.3 This demographic shift is
expected to continue, with the proportion of Americans over 65 expected to reach 20 percent of the total
population by 2050—an estimated 360 percent increase over a single century.4
This increased life expectancy, and the subsequent “graying” of the U.S. population, with the accompanying rise in the incidence and prevalence of the diseases, conditions, and injuries for which
the elderly are more at risk, is expected to continue driving demand for healthcare services, as well as
a dynamic evolution in the demand for, the supply of, and the very nature of healthcare professional
practices.5
Although age-related population trends are one of the key contributors to the changing demand for
health services, other changes in the U.S. demographic and economic climate have significant bearing as
well. The accelerated population shift from rural to urban areas during the last sixty years also may have
influenced the increased incidence and prevalence of disease. Although the urbanization of the United
1

2
3

4
5

“Current Population Reports,” Series P-25, Nos. 311, 917, 1095, National Population Estimates, U.S. Department of Commerce, Economics and Statistics Administration, Bureau
of the Census, April 11, 2000, http://www.census.gov/population/estimates/nation/popclockest.txt (accessed 03/26/2010); “Current Population Reports: Population Projections
of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050,” Series P25-1130, U.S. Department of Commerce, Economics and Statistics Administration, Bureau of
the Census, 1996, p. 1. “Table 1. Projections of the Population and Components of Change for the United States: 2010 to 2050 (NP2008-T1),” by U.S. Department of Commerce,
Economics and Statistics Administration, Bureau of the Census, Population Division, August 14, 2008.
“United States Life Tables, 2003,” by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics,
National Vital Statistics Report, Volume 54, Number 14, (April 19, 2006), p. 34; “International Data Base,” United States Census Bureau, March 19, 2010, http://www.census.gov/
ipc/www/idb/country.php (accessed 03/26/2010).
“Chapter 2—Age and Sex Composition,” in “Demographic Trends in the 20th Century: Census 2000 Special Reports,” by Frank Hobbs and Nicole Stoops, U.S. Department of
Commerce, Economics and Statistics Administration, United States Census 2000, November 2002, CENSR-4, p. 56; “Table 3: Projections of the Population by Age, Race, and
Hispanic Origin for the United States: 1995–2050—Principal Alternative Series,” in “Current Population Reports: Population Projections of the United States by Age, Sex, Race,
and Hispanic Origin: 1995 to 2050,” Series P25-1130, U.S. Department of Commerce, Economics and Statistics Administration, Bureau of the Census, 1996, p. 90.
Ibid.
“The Impact of the Aging Population on the Health Workforce in the United States,” by the National Center for Health Workforce Analysis, Bureau of Health Professions Health
Resources and Services Administration, December 2005, p. 10; “Health, United States, 2008, With Special Feature on the Health of Young Adults,” U.S. Department of Health and
Human Services, National Center for Disease Statistics, March 2009, http://www.cdc.gov/nchs/data/hus/hus08.pdf#120 (accessed 09/11/2009), p. 4.
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States was already under way in 1950, this shift continued to reshape the population distribution, with
the urban population increasing from 64 percent of the U.S. population in 1950, to almost 80 percent in
2010.6
Additionally, the shift from an agrarian into an industrialized society, and once again into a servicedriven economy, has affected the American lifestyle and related health trends.7 The waning of family
farms and rise of industrialized agriculture resulted in a shift in the U.S. diet. High-calorie commodities
laden with fats, oils, and sugars, were mass produced at the expense of farming affordable, fresh, and
nutritious produce.8 With this increased availability, and, consequently, the consumption of high caloricenergy, came a decrease in energy expended, arising from the sedentary, high stress, and extended work
day practices characteristic of many service industry sectors (for example, finance, legal, insurance and
real estate, retail trade, and public utilities). The emergence and proliferation of automobile transportation, decreased emphasis on the family unit, and sedentary recreational habits led to a decrease in physical activity. These factors further fueled the impact of the fast food industry and processed food consumption on the health of the U.S. population, now plagued by chronic diseases for which obesity and
poor diet are often major co-morbidities.9
The increased demand driven by these changes and other economic and demographic variables may
have, in part, fueled the increase in healthcare expenditures from 5 percent of GDP in 1950, to more
than 17 percent in 2010.10 Increased spending also may be a consequence of the surge in technological
and other medical advances in the healthcare industry, promulgated at the close of World War II and
encouraged by the increase in federal and state funding for healthcare expenditures.11 Since the adoption
of Medicare in 1965, public (government) payors have come to fund more than half of all healthcare
expenditures.12
Also, among the driving forces of U.S. healthcare industry trends that impact professional practices
are the supply and distribution of various types and multiple levels of healthcare professionals who work
within a dynamic framework of myriad competing interests in order to meet the growing needs of an
aging and, in many ways, less healthy population. As a result of technological and medical advances,
specialized medicine flourished across the healthcare workforce, growing as a significant trend in the
1950s.13 In response to the past and present surge in demand, the physician population has increased
from 219,997 in 1950 to 954,224 in 2009, and the number of physicians per 100,000 individuals has
increased from 142.2 to 316.4.
Despite these growing workforce trends, it is expected that, with a disproportionate number of physicians retiring, an inadequate supply medical graduates, and the expected continuing growth in demand,
the present shortage in supply of physician manpower will continue to worsen.14 As a result, there has
6

7
8
9
10
11
12
13
14

“Table 1. Urban and Rural population: 1900–1990,” by the U.S. Department of Commerce, Economics and Statistics Administration, Bureau of the Census, October 1995,
http://www.census.gov/population/censusdata/urpop0090.txt (accessed 03/26/2010); U.S. Census Bureau 2010 Census Planning Data Base, U.S. Department of Commerce,
Economics and Statistics Administration, Bureau of the Census, 2010, http://www.census.gov/procur/www/2010communications /tract%20level%20pdb%20with%20census%
202000%20data%2001-19-07.pdf (accessed 03/26/2010).
“Obesity and the Economy: From Crisis to Opportunity,” by Davis S. Ludwig, MD, PhD and Harold A. Pollack PhD, the Journal of the American Medical Association, Volume 301,
Number 5, (February 4, 2009), p. 533; “The Role of Services in the Modern U.S. Economy,” by Douglas B. Cleveland, Office of Service Industries, January 1999.
Ibid.
Ibid.
“Health Care Expenditures in the OECD,” by the National Bureau of Economic Research, 2006, http://www.nber.org/aginghealth/winter06/w11833.html (accessed 03/26/2010); .
“Plunkett’s Health Care Industry Trends and Statistics 2008 (Summary),” By Jack W. Plunkett, Plunkett Research Ltd., 2007, p. 3.
“Chapter 6—Health Care Personnel,” and “Chapter 7—Financing Healthcare” in “Health Care USA: Understanding its Organization and Delivery,” by Harry A. Sultz and Kristina
M. Young, Jones and Bartlett Publishers, Sixth Edition (2009), p.196, 234–235.
“Chapter 7—Financing Healthcare” in “Health Care USA: Understanding its Organization and Delivery,” by Harry A. Sultz and Kristina M. Young, Jones and Bartlett Publishers,
Sixth Edition (2009), p. 231.
“Physician Characteristics and Distribution in the US 2010 Edition” American Medical Association, 2010, p. 458; “Table 201—Total and Active Physicians (MDs) and Physicianto Population Ratios, Selected Years: 1950-2000,” in “Health Resources Statistics, 1965,” by the U.S. Department of Health, Education, and Welfare, National Center for Health
Statistics, PHS Pub. No. 1509, 1966.
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been a further increase in diversification of the healthcare workforce, comprised of more than 13 million individuals, with fewer than one million being physicians.15 The diversification, specialization, and
collaboration of physician and nonphysician practitioners has increased, expanded, and enhanced to
meet the compounding demand. This Guide addresses not just physician medical practices but discusses
a comprehensive array of professional practice types, as well as the various practitioners that comprise
the healthcare workforce, including allied health professionals, mid-level providers, and technicians and
paraprofessionals, as well as complementary and alternative medical practitioners.
Although professional practice enterprises currently account for $447 billion of a $2.26 trillion
healthcare market (19.8 percent), recent efforts at regulatory and reimbursement reform suggest that
healthcare professional practices may be facing an unprecedented dramatic transition.16 The evolution
and increasing complexity of healthcare reimbursement, regulatory, competitive, and technological environments has made it more difficult for professionals to maintain revenue yield while avoiding running
afoul of regulatory edicts.
A notable element of these challenges is an industry transition reflected in the recent increase in the
number of hospital-employed physicians, and the dwindling of physician-ownership of private, independent practices. A growing number of young physicians, plagued by medical school debt and intent upon
achieving a more comfortable work-life balance, are opting out of private, independent practice and
pursing salaried employment by hospitals and health systems.
These trends have made it increasingly difficult for older independent practitioners to recruit junior
partners, a struggle which, paired with the burden of rising costs, has led many physician-owners to sell
their practices to hospitals and enter into salaried employment arrangements as well. This shift further
away from the independent practice of medicine as a “cottage industry” in the United States may be
viewed by patients as both a blessing and a burden of the changing healthcare delivery system. On one
hand, the trend away from small, physician- or provider-owned, independent private practices holds the
promise of improved quality and cost efficiency for the delivery of better and integrated medical care.
Alternately, the “corporatization” of healthcare professional practices may result in a weakening of the
independent physician- or provider-patient relationship, an intimacy and level of trust that was long a
characteristic of the cottage industry healthcare delivery system of old.17 Given these trends in healthcare
professional practices, it may not be far-fetched to believe that “Marcus Welby is dead!” (see chapter 2
of Professional Practices).
These dramatic and ongoing changes, as well as the sheer size and complexity of the healthcare
delivery system, have provided new opportunities in healthcare consultancy. Responding to the expanding market in the current era of reform, many financial and management consulting firms have extended
their service line to include healthcare advisory services. Accounting firms, which traditionally have
served as primary business and financial advisors for their clients, also have steadily increased the scope
of their healthcare professional practice advisory services.
The persistent volatility of the healthcare industry landscape can be difficult to navigate. To be effective in offering services to healthcare professional practice clients, consulting professionals should
possess an understanding of the history and background of professional practice enterprises, as well as
the market mechanisms at work in the current healthcare environment—in particular, how those forces
15 Ibid.
16 “Plunkett’s Health Care Industry Trends and Statistics 2008 (Summary),” By Jack W. Plunkett, Plunkett Research Ltd., 2007, p. 44.
17 “More Doctors Giving Up Private Practices,” by Gardiner Harris, New York Times, March 25, 2010; “The Social Transformation of American Medicine,” by Paul Starr, Basic Books
Inc. 1982, p. ix.
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interact to shape the future direction of professional practices in the healthcare delivery system under
pending legislative reform.
Although consultancy for healthcare professional practices may present an attractive business development opportunity for consultants, it is not an area that lends itself to ad hoc, generic advisory services.
In light of the increasingly complex, diverse, and ever-changing scope and volume of information that
contributes to a comprehensive understanding of the healthcare industry, consulting professionals who
possess a more general background and expertise and pursue providing services to healthcare professional practices may endeavor to become better informed to avoid being viewed, in some regard, as
jacks of all trades and masters of none.
This three book set is designed to serve as a reference guide for those seeking a more in-depth
knowledge of the healthcare marketplace; a working and applied understanding of the forces that affect
the industry within which healthcare providers operate; and a primer regarding how consulting services
may be offered to these enterprises specifically, healthcare professional practices, in an ever-changing
reimbursement, regulatory, competitive, and technological healthcare environment. Such industry-specific knowledge should serve as a catalyst for these consulting professionals to better serve their existing
clients and expand their services for potential new engagements.
This Guide may also prove useful to the licensed healthcare professionals who own independent
practices, as well as their professional advisors, managers, and administrators. Providing these stakeholders with in-depth background information and a context within which to view professional practice
enterprises as part of a dynamic healthcare marketplace may enhance their ability to assist their organizations in surviving and thriving in the future.
With the first publication of this Guide, we earnestly solicit reader comments, criticisms, and suggestions for improvements in future editions.
Sincerely,
Robert James Cimasi, MHA, ASA, CBA, AVA, CM&AA
HEALTH CAPITAL CONSULTANTS
Saint Louis, Missouri
November, 2010
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Introduction
These papers, advocating a more active participation in public
affairs by physicians than has been the custom in this country, are
reprinted with the belief that such broader activity on the part of
my colleagues will help to free the State from many present evils.
A good doctor must be educated, honest, sensible and brave.
Nothing more is needed in its citizens to make a state great.
John B. Roberts, 1908
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The Four Pillars of the Healthcare Industry
When developing an understanding of the forces and stakeholders that have the potential to drive healthcare markets, it is useful to examine professional practice enterprises as they relate to the “four pillars”
of the healthcare industry: reimbursement, regulatory, competition, and technology (see the following
figure I-1). These four elements shape the professional practice and provider dynamic, while serving as
a framework for analyzing the viability, efficiency, efficacy, and productivity of healthcare enterprises.
The four pillars, discussed briefly in this introduction, will be further addressed in subsequent chapters
devoted to each of these four topics.

Figure I-1: Four Pillars of Healthcare Enterprises

Technology

Competition

Regulatory

Reimbursement

Economic Value

Healthcare Enterprises

Reimbursement
Chapter 2, Reimbursement Environment provides an overview of current and future trends in healthcare
reimbursement. With healthcare reform on the horizon, it is vital for providers to maintain an applied
understanding of healthcare payment sources (for example, Medicare, Medicaid, State Children’s Health
Insurance Program, etc.), revenue and billing procedures (for example, the resource-based relative value
scale payment system, relative value units and their components, Current Procedural Terminology
codes, etc.), and payment plans (for example, fee-for-service plans, performance-based payment plans,
and consumer driven health plans).
As healthcare expenditures rise, proponents of reform advocate for both a reduction in service costs
and increases in quality of care. To achieve these goals, the industry variously has moved toward managed care, pay-for-performance programs, gainsharing arrangements, and patient-centered models of
medical practice (for example, boutique medicine, the medical home model, etc.). In addition, reimbursement for physician services has become a highly contested issue; repeated annual congressional
overrides of reductions to physician payment rates for services under the sustainable growth rate system
have created a large gap in current healthcare spending and target (sustainable) expenditures. To combat
2
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these rising costs, for example, the high expenditures for imaging services, billing codes have, during
the past decade, been “bundled.” Bundling has been utilized to reduce the overall payment for certain
interrelated services by billing for them under one, combined code, rather than under independent codes.
The emergence of bundled codes, among other trends, is evidence of the rapidly changing reimbursement environment within the U.S. healthcare delivery system.

Regulatory
The U.S. healthcare industry is governed by a network of ever-changing state and federal regulations,
relating to both physician and nonphysician professionals. Chapter 3, Regulatory Environment contains
a detailed overview of the general provisions that apply to the various practitioners and providers in the
healthcare industry.
Various key regulatory issues may influence the healthcare climate. For example, in recent years,
there has been increased government scrutiny of regulatory violations of fraud and abuse laws, particularly as the violations relate to acquisition and compensation transactions between hospitals and
physicians. Failure to comply with valuation standards for physician and executive compensation arrangements (for example, fair market value and commercial reasonableness) may result in liability under
the False Claims Act, the antikickback statute, and the Stark law. Chapter 3, Regulatory Environment
includes a discussion of these concepts and regulations along with the definitions, applications, implications, and trends of additional federal and state healthcare laws and regulations (for example, Certificate
of Need programs).

Competition
Additionally, rapid changes in the healthcare competitive market may be attributed to the ever-increasing
demand for care from the aging baby boomer population and to the continuous development of new
technologies, the latter which may enhance the quality and efficiency of the healthcare delivery system.
In recent years, there has been a rapid growth in the number of limited-service providers, or “niche
providers,” such as specialty and surgical hospitals (for example, orthopedic and heart hospitals), which
are sometimes referred to as “focused factories.”1 As a result of this trend toward specialization, concern has been raised that the medical care offered by niche providers may have a negative impact on the
profitability of general acute care hospitals, which traditionally have provided specialty and primary care
to patients. Similarly, there has been a movement toward increasing the scope and volume of mid-level
provider-issued care, resulting in additional market competition for physicians.
The changing demographics of the patient population (that is, the baby boomer population) and the
physician workforce also may have a lasting impact on the healthcare competitive environment. There
has been an increase in concern related to the shortage of physician manpower and the limited number of
available residency slots that restrict physician entry into the healthcare market. Among the most notable
concerns is the perceived shortage of primary care physicians; with many medical students opting for
careers in higher-paying medical specialties, primary care physicians are pressed more than ever to meet
patient demand for services. Additionally, women and minorities make up a much higher percentage
of the physician workforce than they have in the past (in most specialties), effectively diversifying the
traditionally Caucasian male physician demographic. Although they provide patients with more choices
for care, they also are presenting challenges related to the demands of achieving a practice—lifestyle
balance.
3
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These issues and numerous others, such as healthcare and insurance reform, shape the unique and
dynamic healthcare competitive environment. Chapter 4, Impact of Competitive Forces includes a more
detailed examination of these issues within the context of Porter’s five forces of competition.

Technology
Significant technological advances during the past few decades have had a notable impact on the U.S.
healthcare delivery system. Electronic health record technologies gradually have been integrated into
medical records maintenance systems, replacing traditional paper files. Similarly, Computerized physician order entry has streamlined the process of ordering prescriptions and minimized error caused by
handwritten orders. Although these new electronic approaches to healthcare delivery are saving employers money, physician unwillingness to adopt these new technologies has impeded their widespread
emergence into the healthcare market. Regardless, new and improved management technology is slowly
becoming an important facet of the healthcare industry.
Progress in clinical technology also has flourished in recent years, including highly controversial
practices such as stem cell research. However, one of the various genres of medical services that may
have drawn the most attention is imaging; services that utilize the technology, such as the various types
of magnetic resonance imaging, computed tomography (for example, positron emission tomographycomputed tomography, single photon emission computed tomography, and picture archiving and communications systems), and teleradiology services, have become a staple in modern diagnostic radiology
practice.
Oncologists and surgeons also have seen major advancements in the treatment and detection of
cancer and in minimally invasive or noninvasive surgery, respectively. For oncologists, radiation therapy methods are improving continuously, and their use of innovative alternative and supporting technologies, such as image-guided radiation therapy, which is used during intensity-modulated radiation
therapy; gamma knives; and stereotactic radiosurgery, is increasing. The use of robotics has become a
rapidly advancing trend, and surgeons with robotics experience are sought after for their skills. Robotic
technologies have been used for urologic, gynecologic, and cardiothoracic procedures, among others.
Although expensive, robotic technology minimizes the degree of invasiveness, shortens recovery time,
and improves patient outcomes.
These advancements in medical technology have helped to revolutionize modern medicine. The
cost of implementing and maintaining these new devices and procedures, however, may counterbalance
efforts to control healthcare expenditures. The future of healthcare may well depend on a compromise
between the advancement of medical technological capabilities and the cost of supporting those technologies that allows practitioners to provide the best quality care possible. Chapter 5, Technology Development includes a more detailed discussion of the impact of technology on healthcare practices.

Structure of this Guide
This Guide serves as a resource for consulting professionals who provide services to professional practices and related healthcare providers. It is divided into three books:
1. An Era of Reform, consisting of six chapters, begins with an abridged history of healthcare, from
the origins of medicine to the transformation of modern healthcare in the twentieth and twentyfirst centuries (chapter 1). The next several chapters (chapters 2–5) provide a more comprehensive look at the reimbursement, regulatory, competitive, and technological environments as they
4
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apply to healthcare practice. The last chapter (chapter 6) provides an overview of the healthcare
environment and related healthcare reform bills, at the time of the submission of this Guide.
2. Professional Practices, consisting of eight chapters, discusses the myriad of practice structures
(chapter 1), medical specialties, and professionals seen in healthcare to date. This discussion
includes emerging models of healthcare enterprises, physicians, mid-level providers, technicians
and paraprofessionals, allied health professionals, alternative medicine practitioners, and a new
paradigm for professional practices (chapters 2–8, respectively), as well as information regarding
the scope of subspecialties, types of providers, and practitioners of each service type.
3. Consulting With Professional Practices, consisting of four chapters, provides a descriptive
overview for consultants advising professional practice clients on matters related to healthcare
consulting (chapter 1); benchmarking strategies related to healthcare and valuation (chapter 2);
compensation and income distribution (chapter 3); and financial valuation of healthcare enterprises, assets, and services (chapter 4). The information provided in these chapters should supply
the reader with the tools necessary to translate healthcare consulting theory into practice.
It should be noted that the second and third books of this Guide focus on the professional practice
component of the U.S. healthcare delivery system and do not directly address other healthcare sectors,
including inpatient (for example, hospitals), outpatient and ambulatory (for example, ambulatory surgery
centers and diagnostic imaging centers), long term care (for example, nursing homes and hospice), and
home health sectors. However, many of the concepts and much of the content in the second and third
books of this Guide may be applicable to consulting projects in these other healthcare sectors, as well.

Reader Tools: Sidebars, Tables, and Figures
To enhance the utility of this Guide as a navigable source for readers of various backgrounds, certain
tools have been developed and appear throughout:
1. Sidebars. These supplemental features have been integrated into the content of each chapter and
have been grouped as follows:
a. Key terms. Key terms are important words used in text that may need to be defined for the
reader. This tool can be found at the beginning of each chapter and serves to identify those
terms that appear within the text of corresponding chapters as well as in the glossary at the
end of this book. Key terms may be discussed, or, at least, mentioned in multiple chapters.
b. Key concepts. Similar to key terms, key concepts are the important concepts mentioned in
text that may require further elaboration or emphasis and a list of key concepts can be found
at the beginning of each chapter. This tool serves a bimodal role, to further stress important
ideas discussed in the chapter and to further discuss ideas that may have only been mentioned
in passing.
c. Key sources. This feature points to significant sources, both used within this Guide and fundamental to the chapter content. These sources serve as chapter-specific bibliographies, and,
therefore, may be found in multiple chapters. Key sources can be found at the end of each
chapter.
d. Associations. A brief list of topic-relevant associations provides the reader with contact
information for associations referenced within a chapter. A list of related associations can be
found at the end of each chapter.
5
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e. Factoids. These are brief, related facts of interest either mentioned in text or supplemental to
a topic discussed in a particular chapter that help build a contextual framework for the reader
that may aid in explaining the material. You will find factoids located close to the content
that they address within each chapter.
2. Tables. Tables are used to display benchmark data, to demonstrate numerical trends, and to draw
comparisons. They are referenced in text, but they may be used to display extra information not
discussed in the content of the chapter.
3. Figures. Pictorial and graphical depictions have been used to complement the text and enhance
the reader’s comprehension of the material. These figures are referenced and discussed in text.

Professional Practice Taxonomy
Healthcare reform is driven by complex, polar, and potentially conflicting market factors, such as increased spending; a growing and graying demographic; workforce shortages and inefficiencies; problematic chronic and acute health indicators; and shortcomings in the delivery of efficient, quality care.
The subsequent chapters detail these issues, their implications, and the reform initiatives proposed to
delicately counterbalance the U.S. healthcare delivery system on the nation’s scale of justice. However,
before delving into the complexities of healthcare reimbursement, regulation, competition, and technology, the dynamic healthcare provider workforce should be addressed.
Provider versatility has been growing and changing to complement an evolving healthcare industry. The diverse healthcare workforce is instrumental to improving efficacy, quality of care, financial
efficiency, patient satisfaction, workforce productivity, and professional satisfaction.3 In order to capitalize on this potential, institutions adopt models that strategically allocate physician and nonphysician
manpower resources on the basis of scope and skill set—ensuring that the right care is provided by the
right provider at the right time and place.”4 Implementation models are characterized by (1) the site of
service (for example, hospital, clinic, or community), (2) the guidelines that regulate provider practice
and compensation within an intraprofessional care model, (3) the system by which scope of practice is
defined for each provider classification, (4) the degree to which providers are liable for their professional
actions, and (5) the degree to which they model efficacy and efficiency.5
2

The intraprofessional care models that have been implemented most successfully stem from several provider taxonomies, which were intended to mirror the complex relationships within the existing
healthcare workforce. The most influential provider taxonomies (detailed in tables I-1[A-D] and I-2)
are each based on a different system of classification that focuses on a portion of the industry dynamic
and include those developed by (1) the Human Resources and Services Administration, which utilizes
a four-tiered hierarchal system and aggregates specific occupations based on the degree of training and
type of services provided (table I-1A); (2) the American Medical Association, which classifies professionals based on the specialized area of medical practice under which they provide their services (table
I-1B); and (3) the Centers for Medicare and Medicaid Services, which categorizes professionals based
on how they bill these professionals for services (table I-1C). Although these taxonomies are based on
key structural considerations, they each neglect certain industry facets, and discrepancies arise due to
the limitations that this unilateral rationale presents. The models used to enhance the delivery of intraprofessional care face similar limitations, as institutions typically focus on only one, highly customized
model, foregoing a more industrywide perspective by neglecting models that represent the other industry
sectors.6
6
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Alternately, multiple models can be synthesized to represent an industrywide, intrapersonal dynamic.7 Elements from three models, the physician extender model, the triage model, and the parallel
model, were used to derive the taxonomical system for classifying healthcare professionals that is utilized in this Guide (detailed in tables I-1D and I-2).
Traditionally, all nonphysician clinicians are referred to as “allied health professionals.”8 However,
advances in technology and capability paired with the change in healthcare demand during the course
of medical history have rendered this system of classification far too rudimentary for the diversity that
the workforce now holds. As the healthcare industry continues to change and market demand for primary, preventative, and rehabilitative care increases, the varying degrees of responsibility, expertise,
and autonomy afforded to the increasingly diverse nonphysician healthcare workforce is reassessed and
the scope of practice continues to expand.9 By creating a taxonomy based on these three representative
models, allied health professionals may be partitioned into appropriate substrata of nonphysician providers, because they would function within the ideal intraprofessional workforce dynamic.
Under the physician extender model, the scope of nonphysician professional practice lies entirely
within the scope of physician practice.10 These physician extenders (hereinafter “technicians and paraprofessionals”) supplement physician care, either as highly technical or technological support or as manpower support.11 Specifically, one subset of the professionals defined within this model is trained in a
highly specialized technical or technological field and provides services that physicians rely upon but are
incapable of providing independently. The other subset of professionals, physician extenders, provides
routine medical and administrative services to relieve physicians of a portion of their workload, allowing
them to focus on more difficult and complex tasks. From an official standpoint, these professionals may
or may not be licensed or certified (depending on which subset of the provider population they belong to
or which role they tend to fill most appropriately).
The original rationale behind the classification of “mid-level providers,” as defined for the purposes
of this Guide, derives from the triage model.12 Under this model, nonphysician professionals are trained
to provide a specific subset of physician services, and they traditionally serve as a source of physician
relief by providing triage care and enhancing patient throughput.13 Historically, these providers could
only practice under direct or indirect supervision of a physician.14 As demand increased, namely for the
provision primary care services, the autonomy of mid-level providers increased.15 To date, these professionals are relied upon for the provision of specialized services that are incident to physician services
but also exercise a certain measure of independence, because they can autonomously provide a specific
scope of services in lieu of physicians.16 The services which mid-level providers are authorized to provide in lieu of physicians typically are limited to a portion of primary care practice healthcare services,
and, consistent with the triage model, complex cases are handed off to physicians, because they may fall
outside that predetermined scope of service.17
The parallel model lies on the opposite end of the spectrum. Under this model, the scope of the allied health professional practice is separate, distinct, and, essentially, parallel to the scope of physician
practice.18 These allied health professionals are nonphysician practioners who practice independently
and offer services that, despite some overlap with physician care, are largely outside the scope of physician practices.19 Although allied health professionals (as defined in this Guide) and physicians sometimes may compete due to shared patient populations and practice objectives, the specific services they
provide typically have distinct differences.

7
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Table I-1A: Healthcare Professional Practices Provider Taxonomies

Organization: Bureau of Labor Statistics  Classification System: A six-digit hierarchal structure resulting in four levels of aggregation
(categories): Category 1=Major Group, Category 2=Minor Group, Category 3=Broad Occupation, Category 4=Detailed Occupation.

Category

Definition

Healthcare Practitioners and
Technical Occupations

Major Occupational Group A—Professional occupations
concerns with the study, application, and/or administration
of medical practices or theories. Some occupations are concerned with interpreting, informing, expressing, or promoting
ideas, products, etc. by written, artistic, sound, or physical
medium. This category also includes technical occupations,
involved in carrying out technical and technological functions
in health. May perform research, development, testing, and
related activities. May operate technical equipment and
systems.

Subcategories
Health Diagnosing Occupations
Chiropractors
Dentists
Dentists, General

Prosthodontists

Oral and Maxillofacial Surgeons

Dentists, All Other Specialties

Orthodontists
Optometrists
Physicians and Surgeons
Podiatrists
Veterinarians
Health Assessment and Treating Occupations
Dietitians and Nutritionists
Pharmacists
Physician Assistants
Therapists
Occupational Therapist

Respiratory Therapists

Physical Therapist

Speech-Language Pathologist

Radiation Therapists

Exercise Physiologists

Recreational Therapists

Therapists, All Other
Registered Nurses
Nurse Anesthetists
Nurse Midwives
Nurse Practitioners

Miscellaneous Health Diagnosing/Treating Practitioners
Health Technologists and Technicians
Clinical Laboratory Technologists/Technicians
Medical and Clinical Laboratory
Technologists

Medical and Clinical Laboratory
Technicians

Dental Hygienists
Diagnostic Related Technologists and Technicians
Cardiovascular Technologists
and Technicians

Radiologic Technologists

Diagnostic Medical
Sonographers

Magnetic Resonance Imaging
Technologists

Nuclear Medicine Technologists

8
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Table I-1A: Healthcare Professional Practices Provider Taxonomies (continued)

Organization: Bureau of Labor Statistics  Classification System: A six-digit hierarchal structure resulting in four levels of aggregation
(categories): Category 1=Major Group, Category 2=Minor Group, Category 3=Broad Occupation, Category 4=Detailed Occupation.

Category

Definition

Healthcare Practitioners
and Technical Occupations
(continued)

Subcategories
Emergency Medical Technicians/Paramedics
Health Practitioner Support Technologists/Technicians
Dietetic Technicians

Surgical Technicians

Pharmacy Technicians

Veterinary Technicians

Psychiatric Technicians

Ophthalmic Medical Technicians

Respiratory Technicians
Licensed Practical and Licensed Vocational Nurses
Medical Records and Health Information Technicians
Opticians, Dispensing
Miscellaneous Health Technologists/Technicians
Orthotists and Prosthetists

Other

Hearing Aid Specialists
Other Healthcare Practitioners/Technical Occupations
Occupational Health and Safety Specialists/Technicians
Occupational Health and Safety
Specialists

Occupational Health and Safety
Technicians

Miscellaneous Health Practitioners/Technical Workers
Athletic Trainers
Healthcare Support
Occupations

Major Occupational Group K - Occupations concerned with
other health care services for children and adults, mainly
cater to the provision of support services.

Other

Nursing, Psychiatric, and Home Health Aides
Home Health Aides

Nursing Assistants

Psychiatric Aides

Orderlies

Occupational Therapy/Physical Therapist Assistants/Aides
Occupational Therapy
Occupational Therapy Assistants

Occupational Therapy Aides

Physical Therapy
Physical Therapy Assistants

Physical Therapy Aides

Other Healthcare Support Occupations
Massage Therapists
Miscellaneous Healthcare Support Occupations
Dental Assistants

Medical Equipment Preparers

Medical Assistants
Notes:
* “Chapter 6. Occupation and Industry Classification Systems,” in “Nursing Aides, Home Health Aides, and Related Health Care Occupations—National and Local Workforce
Shortages and Associated Data Needs” by the U.S. Department of Health and Human Services, Health Resources and Services Administration, 2009, http://bhpr.hrsa.gov/
healthworkforce/reports/nursing/nurseaides/chap6.htm.
** “2010 Standard Occupational Classification,” by the Bureau of Labor Statistics, January 2009, p. 16-19.
† “MOG—Level Definitions,” in “Occupational Classification System Manual,” by the U.S. Bureau of Labor Statistics, National Compensation Survey, http://www.bls.gov/ncs/
ocs/ocsm/comMOGADEF.htm#mogaanchor (accessed 01/04/09).
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Table I-1B: Healthcare Professional Practices Provider Taxonomies
Organization: Centers for Medicare and Medicaid   Classification System: Based on System for Billing for Services

Category

Definition

Physician

As stated in Section 1861(r) SSA to include the
professionals listed here

Subcategories
N/A
MDs*

Doctor of Optometry*

DOs*

Chiropractor*

Doctor of Dental Surgery/
Dental Medicine*

Interns and Residents*

Doctor of Podiatric Medicine*
Allied Health Providers

As stated in 42USC sec. 295p to include those professionals who: (A) who has received a certificate,
an associate’s degree, a bachelor’s degree, a master’s degree, a doctoral degree, or post baccalaureate training, in a science relating to health care;
(B) who shares in the responsibility for the delivery
of health care services or related services, including: (i) services relating to the identification, evaluation, and prevention of disease and disorders; (ii)
dietary and nutrition services; (iii) health promotion
services; (iv) rehabilitation services; or (v) health
systems management services; and (C) who has
not received a degree of doctor of medicine, a
degree of doctor of osteopathy, a degree of doctor
of dentistry or an equivalent degree, a degree of
doctor of veterinary medicine or an equivalent
degree, a degree of doctor of optometry or an
equivalent degree, a degree of doctor of podiatric
medicine or an equivalent degree, a degree of
bachelor of science in pharmacy or an equivalent
degree, a degree of doctor of pharmacy or an
equivalent degree, a graduate degree in public
health or an equivalent degree, a degree of doctor
of chiropractic or an equivalent degree, a graduate
degree in health administration or an equivalent
degree, a doctoral degree in clinical psychology or
an equivalent degree, or a degree in social work or
an equivalent degree or a degree in counseling or
an equivalent degree.

Mid-Level Provider—also known as: Non-Physician
Practitioner/Physician Extender—Health professionals
who may deliver covered Medicare services if the services
are incident to a physician’s service or if there is
specific authorization in the law
Physician Assistant/Advanced Practice Nurses
Physician Assistant*,**,†

Certified Registered Nurse
Anesthetists*,**,†

Nurse Practitioners*,**,†

Certified Nurse Midwives*,**,†
Other

Qualified Clinical Psychologists*,**,†

Respiratory Therapy Workers††,‡,‡‡,§

Clinical Social Workers*,**,†

Speech Pathologist/Audiologists††,‡,‡‡,§

Dieticians/Dietetic
Technicians*,**,†,††,‡,‡‡,§

Dietetic Assistants††,‡,‡‡,§

Dental Hygienists/Assts/Lab
Techs††,‡,‡‡,§

Genetic Assistants††,‡,‡‡,§

EMT/Paramedic††,‡,‡‡,§

Operating Room Technicians††,‡,‡‡,§

Health Information Admin/
Tech††,‡,‡‡,§

Ophthalmic/Optometric Medical
Assistants††,‡,‡‡,§

Occupational Therapists††,‡,‡‡,§

Medical Transcriptionists††,‡,‡‡,§

Orthotists and Prosthetists††,‡,‡‡,§

Vocational Rehab Counselors††,‡,‡‡,§

Physical Therapists††,‡,‡‡,§

Other Rehabilitation Workers††,‡,‡‡,§

Radiologic Service Workers††,‡,‡‡,§

Other Social and Mental Health
Workers††,‡,‡‡,§

Notes:
* “Physicians” in “The Public Health and Welfare,” United States Code Title 42 1395x(r).
** “Ratio of Physician to Physician Extenders (Resolution 303, I-97),” by Kay K. Hanley, MD, December 1998, CMS Report 10-1-98.
† “ ‘Incident to’ Services,” MLN Matters, SE0441.
†† “Definitions, Federal Health Insurance for the Aged and Disabled, Center for Medicare and Medicaid Services, Department of Health and Human Services” 42 CFR 405.400.
‡ “Chapter 6A: Definitions, General Provisions, Health Professions Education, Public Health Service, The Public Health and Welfare,” United States Code Title 42 p.295.
‡‡ “Civil Remedies Decision CR1961,” by the Departmental Appeals Board, Department of Health and Human Services, June 16, 2009, p. 3.
§ “Interdisciplinary, Community-Based Linkages, Title VII, Part D, Public Health Service Act,” by the Advisory Committee on Interdisciplinary, Community-Based Linkages, 2006,
Fifth Annual report to the Secretary of the U.S. Department of Health and Human Services and to the Congress.
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Table I-1C: Healthcare Professional Practices Provider Taxonomies
Organization: American Medical Association  Classification System: As utilized in the Health Care Careers Directory 2009-2010

Category

Definition

Physician

There are two types of physicians: MD—Doctor
of Medicine—and DO-Doctor of Osteopathic
medicine … Both MDs and DOs may legally use
all accepted methods of treatment, including
drugs and surgery.

Subcategories
N/A
MDs

DOs*

*

Optometry

Optometrist*,**

Complementary and
Alternative Medicine

Chiropractic*,**

Dentistry

Dentist*,**

Pharmacy

Pharmacist*,**

Podiatry

Veterinary Medicine

N/A

“Specialize in diagnosing and treating disorders,
diseases, and injuries of the foot, ankle, and lower
leg”

Podiatrist

Provide healthcare professional and support
services for the care of pets, livestock, and zoo,
sporting, and laboratory animals

Veterinarian

Nursing

*,**

N/A
*,**

Registered Nurses*,**

Licensed Vocational Nurses**

Licensed Practical Nurses**
Mid-Level Provider - also known as: Non-Physician Practitioner/
Physician Extender - Health professionals who may deliver covered Medicare services if the
services are incident to a physician’s service or if there is specific authorization in the law
Advanced Practice Nurses
Nurse Practitioners

Certified Nurse Midwives†,††,‡

†,††,‡

Certified Registered Nurse Anesthetists†,††,‡
Psychology

Clinical Psychologists
Clinical Psychologists

†,††,‡

Allied Health
Professional

“Participate in the delivery of health care, diagnostic, and rehabilitation services, therapeutic
treatments, or related services,” and excludes
“the MODVOPP professions: medicine (allopathic),
osteopathic medicine, dentistry, veterinary medicine, optometry, podiatry, and pharmacy—as well
as chiropractic, clinical psychology, any level of
nursing education, and graduate degrees in public
health or health administration.”

Physician Assistant
Physician Assistant

Dieticians/Dietetic Technicians†,††,‡

†,††,‡

Clinical Social Workers

†,††,‡

Dietetics
Dietitian/Nutritionist

Dietetic Technician*,**

*,**

Dentistry and Related Fields
Dentist

Dental Hygienist*,**

Dental Assistant*,**

Dental Lab Technician*,**

*,**

Communication Sciences
Audiologist*,**

Speech-Language Pathologist*,**
Complementary and Alternative Medicine

Massage Therapist

*,**

Counseling
Counselor

Rehabilitation Counselor*,**

*,**

Genetic Counselor*,**
Expressive/Creative Art Therapies
Art Therapist

*,**

Music Therapist*,**

Dance/Movement Therapist*,**
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Table I-1C: Healthcare Professional Practices Provider Taxonomies (continued)
Organization: American Medical Association  Classification System: As utilized in the Health Care Careers Directory 2009-2010

Category
Allied Health
Professional
(continued)

Definition

Subcategories
Health Information and Communication
Cancer Registrar

Medical Coder*,**

*,**

Health Information Administrator

Medical Librarian*,**

Health Information Technician*,**

Medical Transcriptionist*,**

*,**

Laboratory Science
Blood Bank Technology-Specialist*,**

Clinical Laboratory Technician/
Medical Laboratory Technician*,**

Clinical Assistant*,**

Cytogenetic Technologist*,**

Clinical Laboratory Scientist/Medical
Technologist*,**

Cytotechnologist*,**
Medical Imaging

Diagnostic Molecular Sonographer*,**

Magnetic Resonance Technologist*,**

Histotechnician

Medical Dosimetrist*,**

*,**

Histotechnologist

Nuclear Medicine Technologist*,**

Pathologists’ Assistant*,**

Radiation Therapist*,**

*,**

Phlebotomist

Radiographer*,**

*,**

Diagnostic Medical Sonographer

Registered Radiologist Assistant*,**

*,**

Vision-Related Professions
Ophthalmic Assistant/Technician/
Technologist*,**

Orthoptist*,**

Ophthalmic Dispensing Optician*,**

Teacher of the Visually Impaired*,**

Optometrist

Vision Rehabilitation Therapist*,**

*,**

Orientation and Mobility Specialist*,**
Therapy and Rehabilitation
Occupational Therapist*,**

Physical Therapist Assistant*,**

Occupational Therapy Assistant

Therapeutic Recreation Specialist*,**

*,**

Physical Therapist

*,**

Other
Anesthesiologist Assistant*,**

Nursing Aides, Orderlies, Attendants*,**

Anesthesia Technologist/Technician*,**

Occupational Health and Safety Technician*,**

Athletic Trainer

Orthotists and Prosthetists*,**

*,**

Cardiovascular Technician/Technologist

Orthotics and Prosthetics Technicians*,**

*,**

Electroneurodiagnostic Technologist*,**
Emergency Medical Technician-Paramedic

Perfusionist*,**
*,**

Pharmacy Technician*,**

Exercise Science (Personal Fitness Trainer,
Exercise Physiologist, and Exercise Science
Professional)*,**

Polysomnographic Technologist*,**

Home Health, Personal Care, and Psychiatric
Aides*,**

Psychiatric Aides/Technicians*,**

Kinesiotherapist*,**

Respiratory Therapist*,**

Medical Assistant

Respiratory Therapy Technicians*,**

*,**

Medical Equipment Preparer

Surgical Assistant*,**

Medical Illustrator*,**

Surgical Technologist*,**

*,**

Notes:
* “Health Care Careers Directory 2009-2010,” by the American Medical Association, p. iii-iv.
** “Coming Together, Moving Apart: A History of the Term Allied Health in Education, Accreditation, and Practice,” by Fred G. Donini-Lenhoff, MA, Journal of Allied Health, Spring 2008, Volume 37,
Number 1, p. 46-49
†	“Physicians” in “The Public Health and Welfare,” United States Code Title 42 1395x(r).
†† “Ratio of Physician to Physician Extenders (Resolution 303,I-97),” by Kay K. Hanley, MD, December 1998, CMS Report 10-I-98.
‡ “‘Incident to’ Services,” MLN Matters, SE0441.

13

V1-00-Introduction.indd 13

9/28/10 3:12 PM

Th e A dvi ser ’ s Gu i de to Hea lthca re

Table I-1D: Healthcare Professional Practices Provider Taxonomies
Organization: Health Capital Consultants  Classification System: N/A

Category

Definition

Physicians

Doctors of allopathic or osteopathic medicine. Both allopathic
and osteopathic physicians may specialize in many of the
same areas, though the process required to achieve specialization certifications occasionally differs between the two
forms of medicine.

Allied Health Professionals

Midlevel Providers

Non-physician providers of health services who provide
primary healthcare services. Allied health professionals may
work with physicians, mid-level providers, paraprofessionals
and technicians, but they are professionally licensed to work
autonomously in the provision of services.
Non-physician providers who may or may not provide healthcare services independently of a superior licensed provider.
Depending on state licensing criteria, mid-level provides (e.g.
nurse practitioners, physicians’ assistants, dental hygienists)
may work independently in the provision of services, or may
need to be supervised by a licensed physician or allied health
professional.

Subcategories
N/A
MDs

DOs

N/A
Dentists

Psychologists

Optometrists

Podiatrists

Chiropractors
Clinical Service Providers
Therapists
Physical

Audiologists/Speech

Occupational
Physician Assistants
Physician Assistant
Registered Nurses
Registered Nurses
APRNS
Certified Registered Nurse
Anesthetists

Dieticians & Nutritionists

Nurse Practitioners

Nurse Midwives

Technical Service Providers

Technicians &
Paraprofessionals

Non-physician providers who may never provide healthcare
services independently of a supervising licensed provider.
This category of provider is divided between licensed and
unlicensed paraprofessionals.

Dental Hygientists

Opticians

Dental Assistants

Dental Assistants
Assistants

Social and Human Service
Assistants

Physical Therapist Assistants

Anesthesiologists Assistants

Dental Assistants

Occupational Therapist
Assistants

Medical Assistants
Aides

Personal Care Aides

Psychiatric Aides

Home Health Aides

Physical Therapist Aides

Nursing Aides, Orderlies,
Attendants

Pharmacy Aides
Therapists

Radiation Therapists

Respiratory Therapists
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Table I-1D: Healthcare Professional Practices Provider Taxonomies (continued)
Organization: Health Capital Consultants  Classification System: N/A

Category

Definition

Subcategories
Technologists

Technicians &
Paraprofessionals
(continued)

Medical and Clinical
Laboratory Technologists

Nuclear Medicine

Cardiovascular

Surgical

Radiologic
Technicians
Cardiovascular

Psychiatric

Medical and Clinical Laboratory

Respiratory Therapy

Radiologic

Medical Records and Health
Information

Emergency Medical

Occupational Health and
Safety

Dietetic

Orthotics and Prosthetics

Pharmacy
Nurses
Licensed Vocational Nurses

Licensed Practical Nurses
Other

Medical Dosimetrist

Medical Equipment Preparers

Diagnostic Medical
Sonographers

Medical Transcriptionists

Athletic Trainers
Alternative Medicine
Providers

Providers who may or may not be physicians, but who practice
forms of therapy and treatment outside the mainstream
practice of medicine, e.g. homeopathic medicine. Alternative
medicine practitioners may provide primary or secondary care,
and are generally licensed to work independently of supervision by another licensed provider.

Whole Medical Systems
Eastern Whole Medical Systems
Traditional Chinese Medicine

Ayurvedic Medicine

Western Whole Medical Systems
Homeopathic

Naturopathic
Mind-Body Medicine

Aromatherapy

Mental Healing

Cognitive Behavioral Theory

Expressive/Creative Arts
Therapy

Meditation & Prayer
Biologically Based Practices
Dietary Supplements

Herbal Remedies

Manipulative & Body-Based Practices
Massage Therapy

Chiropractic Medicine
Energy Medicine

Biofield Therapy

Reiki

Bioelectromagnetic-Based
Therapy

Therapeutic Touch

15

V1-00-Introduction.indd 15

9/28/10 3:12 PM

Th e A dvi ser ’ s Gu i de to Hea lthca re

Table I-2: 	Healthcare Professional Practices Provider Taxonomies Comparison Chart
Profession

Health Capital
Consultants

BLS1, 2, 3

CMS4, 5, 6, 7, 8, 9, 10, 11, 12

AMA11, 12, 13, 14, 15

Chiropractors

Allied Health

Health Diagnosing Occupations

Physician

Complementary and
Alternative Medicine

Dentists

Allied Health

Health Diagnosing Occupations

Physician

Dentistry and Related Fields

Psychologists

Allied Health

Social Scientists and Urban Planners

Mid-Level Provider*

Mid-Level Provider*

Podiatrists

Allied Health

Health Diagnosing Occupations

Physician

Podiatrists

Optometrists

Allied Health

Health Diagnosing Occupations

Physician

Optometry

Aromatherapy

Alternative Medicine

Other Health Diagnosing/Treating
Practitioners

Auxiliary personnel—not covered
for therapy services

Allied Health

Ayuredic Medicine

Alternative Medicine

Miscellaneous Health Diagnosing/
Treating Practitioners

Auxiliary personnel—not covered
for therapy services

Allied Health

Bioelectromagnetic-Based
Therapy

Alternative Medicine

Other Health Diagnosing/Treating
Practitioners

Complementary and Alternative
Medicine

Allied Health

Biofield Therapy

Alternative Medicine

Other Health Diagnosing/Treating
Practitioners

Complementary and Alternative
Medicine

Allied Health

Cognitive Behavioral Theory

Alternative Medicine

Other Health Diagnosing/Treating
Practitioners

Auxiliary personnel—not covered
for therapy services

Allied Health

Dietary Supplements

Alternative Medicine

Other Health Diagnosing/Treating
Practitioners

Auxiliary personnel—not covered
for medical services

Allied Health

Expressive Creative Arts
Therapy

Alternative Medicine

Other Health Diagnosing/Treating
Practitioners

Complementary and Alternative
Medicine

Allied Health

Herbal Remedies

Alternative Medicine

Other Health Diagnosing/Treating
Practitioners

Auxiliary personnel—not covered
for medical services

Allied Health

Homeopathic

Alternative Medicine

Miscellaneous Health Diagnosing/
Treating Practitioners

Auxiliary personnel—not covered
for medical services

Allied Health

Massage Therapy

Alternative Medicine

Other Health Diagnosing/Treating
Practitioners

Auxiliary personnel—not covered
for therapy services

Allied Health

Meditation & Prayer

Alternative Medicine

Other Health Diagnosing/Treating
Practitioners

Complementary and Alternative
Medicine

Allied Health

Mental Healing

Alternative Medicine

Other Health Diagnosing/Treating
Practitioners

Auxiliary personnel—not covered
for medical services

Allied Health

Naturopathic

Alternative Medicine

Miscellaneous Health Diagnosing/
Treating Practitioners

Auxiliary personnel—not covered
for medical services

Allied Health

Reiki

Alternative Medicine

Other Health Diagnosing/Treating
Practitioners

Auxiliary personnel—not covered
for medical services

Allied Health

Therapeutic Touch

Alternative Medicine

Other Health Diagnosing/Treating
Practitioners

Complementary and Alternative
Medicine

Allied Health

Traditional Chinese
Medicine

Alternative Medicine

Other Health Diagnosing/Treating
Practitioners

Auxiliary personnel—not covered
for medical services

Allied Health

Prosthetists & Orthotists

Mid-Level

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

(continued)
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Table I-2: 	Healthcare Professional Practices Provider Taxonomies Comparison Chart (continued)
Profession

Health Capital
Consultants

BLS1, 2, 3

CMS4, 5, 6, 7, 8, 9, 10, 11, 12

AMA11, 12, 13, 14, 15

Audiologists/SpeechLanguage Pathologists

Mid-Level

Health Assessment and Treating
Occupations

Allied Health—Professionals/
Qualified Auxiliary Therapy
Personnel

Allied Health

Dental Hygienists

Mid-Level

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Dieticians & Nutritionists

Mid-Level

Health Assessment and Treating
Occupations

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Certified Registered Nurse
Anesthetists

Mid-Level

Health Assessment and Treating
Occupations

Mid-Level Provider*

Mid-Level Provider*

Nurse Midwives

Mid-Level

Health Assessment and Treating
Occupations

Mid-Level Provider*

Mid-Level Provider*

Nurse Practitioners

Mid-Level

Health Assessment and Treating
Occupations

Mid-Level Provider*

Mid-Level Provider*

Physician Assistants

Mid-Level

Health Assessment and Treating
Occupations

Mid-Level Provider*

Mid-Level Provider*

Registered Nurses

Mid-Level

Health Assessment and Treating
Occupations

Allied Health—Professionals/
Qualified Auxiliary Personnel

Nursing

Pharmacists

Mid-Level

Health Assessment and Treating
Occupations

Pharmacists

Pharmacy

Occupational Therapists

Mid-Level

Health Assessment and Treating
Occupations

Allied Health—Professionals/
Qualified Auxiliary Therapy
Personnel

Allied Health

Physical Therapists

Mid-Level

Health Assessment and Treating
Occupations

Allied Health—Professionals/
Qualified Auxiliary Therapy
Personnel

Allied Health

Opticians

Mid-Level

Health Assessment and Treating
Occupations

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

DOs

Physician

Health Diagnosing Occupations

Physician

Physician

MDs

Physician

Health Diagnosing Occupations

Physician

Physician

Anesthesiologists Assistants

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Athletic Trainers

Technicians and
Paraprofessionals

Other Healthcare Practitioners/
Technical Occupations

Allied Health—Auxiliary
Personnel—not covered for therapy
services

Allied Health

Cardiovascular Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Cardiovascular
Technologists

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Emergency Medical
Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Home Health Aides

Technicians and
Paraprofessionals

Nursing, Psychiatric, and Home
Health Aides

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health
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Table I-2: 	Healthcare Professional Practices Provider Taxonomies Comparison Chart (continued)
Profession

Health Capital
Consultants

BLS1, 2, 3

CMS4, 5, 6, 7, 8, 9, 10, 11, 12

AMA11, 12, 13, 14, 15

Medical Assistants

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Medical Equipment
Preparers

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Nursing Aides, Orderlies,
Attendants

Technicians and
Paraprofessionals

Nursing, Psychiatric, and Home
Health Aides

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Occupational Health and
Safety Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Orthotics and Prosthetics
Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Personal Care Aides

Technicians and
Paraprofessionals

Nursing, Psychiatric, and Home
Health Aides

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Psychiatric Aides

Technicians and
Paraprofessionals

Nursing, Psychiatric, and Home
Health Aides

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Psychiatric Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Respiratory Therapists

Technicians and
Paraprofessionals

Health Assessment and Treating
Occupations

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Respiratory Therapy
Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Surgical Technologists

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Social and Human Service
Assistants

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Clinical Social Workers are MidLevel Providers*; others are Allied
Health—Professionals/Qualified
Auxiliary Personnel

Allied Health

Dental Assistants

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Dietetic Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Medical Records and Health
Information Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Medical Transcriptionists

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Medical and Clinical
Laboratory Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Medical and Clinical
Laboratory Technologists

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Diagnostic Medical
Sonographers

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Medical Dosimetrist

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health
(continued)
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Table I-2: 	Healthcare Professional Practices Provider Taxonomies Comparison Chart (continued)
Profession

Health Capital
Consultants

BLS1, 2, 3

CMS4, 5, 6, 7, 8, 9, 10, 11, 12

AMA11, 12, 13, 14, 15

Nuclear Medicine
Technologists

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Radiation Therapists

Technicians and
Paraprofessionals

Health Assessment and Treating
Occupations

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Radiologic Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Radiologic Technologists

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Licensed Practical Nurses

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Nursing

Licensed Vocational Nurses

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Nursing

Pharmacy Aides

Technicians and
Paraprofessionals

Other Healthcare Support
Occupations

Allied Health—Professionals/
Qualified Auxiliary Personnel

Pharmacy

Pharmacy Technicians

Technicians and
Paraprofessionals

Health Technologists and
Technicians

Allied Health—Professionals/
Qualified Auxiliary Personnel

Pharmacy

Occupational Therapist
Assistants

Technicians and
Paraprofessionals

Occupational Therapy/Physical
Therapist Assistants/Aides

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Physical Therapist Aides

Technicians and
Paraprofessionals

Occupational Therapy/Physical
Therapist Assistants/Aids

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Physical Therapist
Assistants

Technicians and
Paraprofessionals

Occupational Therapy/Physical
Therapist Assistants/Aids

Allied Health—Professionals/
Qualified Auxiliary Personnel

Allied Health

Notes				
1 “Chapter 6. Occupation and Industry Classification Systems,” in “Nursing Aides, Home Health Aides, and Related Health Care Occupations—National and Local Workforce
Shortages and Associated Data Needs” by the “U.S. Department of Health and Human Services, Health Resources and Services Administration, 2009, http://bhpr.hrsa.gov/
healthworkforce/reports/nursing/nurseaides/chapt6.htm.”
2 “2010 Standard Occupational Classification,” by the Bureau of Labor Statistics, January 2009, p. 16-19.
3 “MOG—Level Definitions,” in “Occupational Classification System Manual,” by the U.S. Bureau of Labor Statistics, National Compensation Survey, http://www.bls.gov/ncs/ocs/
ocsm/comMOGADEF.htm#mogaanchor (accessed 01/04/09).
4 “Definitions, Federal Health Insurance for the Aged and Disabled, Center for Medicare and Medicaid services, Department of Health and Human Services” 42 CFR 405.400.
5 “Chapter 6A: Definitions, General Provisions, Health Professions Education, Public Health Service, The Public Health and Welfare,” United States Code Title 42 295p.
6 “CR1961,” by the Departmental Appeals Board, Civil Remedies Division, Department of Health and Human Services, June 16, 2009, p. 3.
7 “Interdisciplinary, Community-Based Linkages, Title VII, Part D, Public Health Service Act,” by the Advisory Committee on Interdisciplinary, Community-Based Linkages, 2005,
Fifth Annual report to the Secretary of the U.S. Department of Health and Human Services and to the Congress.
8 “Chapter 15—Covered Medical and Other Health Services,” in: “Medicare Benefit Policy Manual,” Centers for Medicare and Medicaid Services, Rev. 109, August 7, 2009.
9 “Chapter 5—Definitions,” in “Medicare General Information, Eligibility, and Entitlement,” Centers for Medicare and Medicaid Services, Rev. 58, March 6, 2009.
10 “Medicare National Coverage Determinations,” by the Department of Health and Human Services, Centers for Medicare and Medicaid, Transmittal 2 (Pub. 100-03), October 17,
2003.
11 “Physicians” in “The Public Health and Welfare,” United States Code Title 42 1395x(r).
12 “Incident to’ Services,” MLN Matters, SE0441.
13 “Health Care Careers Directory 2009–2010,” by the American Medical Association, p. iii-iv.
14 “Coming Together, Moving Apart: A History of the Term Allied Health in Education, Accreditation, and Practice,” by Fred G. Donini-Lenhoff, MA, Journal of Allied Health, Spring
2008, Volume 37, Number 1, p. 46–49.
15 “Ratio of Physician to Physician Extenders (Resolution 303,I-97),” by Kay K. Hanley, MD, December 1998, CMS Report 10-I-98.
* also known as: Non-Physician Practitioner/Physician Extender.
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This Guide distinguishes among five general types of health professionals. The trifurcation of nonphysician practitioners in mainstream medicine, as described previously, serves as the rationale behind
allied health professionals, mid-level providers, and technicians and paraprofessionals, as they are
defined herein. In addition to the physician and nonphysician professionals who practice conventional
medicine, a class of professionals exists that provides complementary and alternative medical services
that, to date, is treated as a parallel (sometimes intertwined) but unconventional subset of the healthcare
workforce. In brief, the five taxonomical categories of professional providers, as they are discussed in
this Guide, are defined as:
1. Physicians—Doctors of allopathic or osteopathic medicine. Both allopathic and osteopathic physicians may specialize in many of the same areas, though the process required to achieve specialization certifications occasionally differs between the two forms of medicine.
2. Allied health professionals—Nonphysician providers of health services who provide primary
healthcare services. Allied health professionals may work with physicians, mid-level providers, and paraprofessionals and technicians, but they are professionally licensed to work autonomously in the provision of services. This Guide discusses five distinct allied health professions:
dentists, optometrists, chiropractors, psychologists, and podiatrists.
3. Mid-level providers—Nonphysician providers who may or may not provide healthcare services
independently of a superior licensed provider but are, by in large, moving into increasingly
autonomous practice types. These professionals typically provide primary care services in lieu
of physicians. Depending on state licensing criteria, mid-level providers (such as nurse practitioners, physicians’ assistants, and dental hygienists) may work independently in the provision of
services. Mid-level providers are further divided between clinical service providers and technical
service providers.
4. Technicians and paraprofessionals—Nonphysician providers who may never provide healthcare services independently of a supervising licensed provider. These individuals either serve to
alleviate a manpower deficit or to contribute to the technological sophistication, efficiency, and
quality of physician services; in either case, their scope of practice is contingent upon the scope
of their physician’s practice and nonexistent otherwise. On the basis of these two types of physician extenders, this category of provider is divided between licensed and unlicensed technicians
and paraprofessionals.
5. Alternative medicine practitioners—Providers who may or may not be physicians but who practice forms of therapy and treatment outside the mainstream practice of medicine, for example,
homeopathic medicine. Alternative medicine practitioners may provide primary or secondary
care, and they generally are licensed to work independently of supervision by another licensed
provider.
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1

Historical
Development
The history of medicine is, in fact, the history of humanity itself,
with its ups and downs, its brave aspirations after truth and
finality, its pathetic failures. The subject may be treated variously
as a pageant, an array of books, a procession of characters, a
succession of theories, an exposition of human ineptitudes, or as
the very bone and marrow of cultural history. As Matthew Arnold
said of the Act Sanctorum, ‘All human life is there.’
Fielding Garrison, 1913

KEY TERMS
- Allopathic Medicine
- Chiropractic
- Corpus
- Customary Prevailing
and Reasonable
- Diagnostic Related
Groups
- Eclectic Medicine
- Health Maintenance
Organization
- Homeopathic Medicine
- Industrial Hygiene
- Legal Medicine
- Medicaid
- Medicare

- Medicare Part A
- Medicare Part B
- Naturopathic Medicine
- Osteopathic
- Pasteurization
- Physiotherapy
- Preferred Provider
Organization (PPO)
- Prospective Payment
System
- Public Health
- Resource Based
Relative Value System
- Studia Generalia
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Key Concept

Definition

Citation

Assyro-Babylonian Medicine

Established in 4 BC by the people of southern Mesopotamia; regarded medicine as an abstraction to be treated
with priestly reverence.

“Chapter III: Antiquity,” in “The Greatest Benefit to
Mankind: A Medical History of Humanity,” by Roy Porter,
HarperCollins Publishers Ltd., p. 46–47. “A History of
Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947,
p. 32.

The Rod and Serpent in AssyroBabylonian Medicine

First seen as the symbol attributed to the Babylonian lord
of physicians, Ninazu, and his son. The serpent represented the healing god, Sachan.

“The Rod and Serpent of Asklepios. Symbol of Medicine,”
by J. Schouten. (Pp. 260+ix; illustrated. 65s.) London:
Elsevier, 1967.

Galenic Medicine

Based on the findings of Claudius Galen and his followers.
Pioneered the fields of anatomy and physiology, methods
of animal dissection, and an understanding of the circulation of blood. Although this generation of medicine was
significant to developments in scientific inquiry, false
assumptions about animal-to-human anatomic translation
and hematology served in the medical world’s disfavor as
time progressed.

“Chapter 3: The Reawakening,” in “Doctors: The Illustrated
History of Medical Practices,” by Sherwin B. Nuland,
Random House Inc., 1988, p. 71; “The Western Medical
Tradition 800 BC to AD 1800,” by Lawrence I. Conrad, et.
al., Cambridge University Press, 1995, p. 225.

The Rod and Serpent in Galenic
Medicine

Reappeared in depictions of the Greek god of healing,
Asklepios, in which he is seen holding a staff with a snake
coiled around it.

“The Rod and Serpent of Asklepios. Symbol of Medicine,”
by J. Schouten. (Pp. 260+ix; illustrated. 65s.) London:
Elsevier, 1967.

Types of Roman Universities

(1) community-funded, (2) state-funded, and (3) ecclesiastically funded.

“A History of Medicine,” by Arturo Castiglioni, Alfred A.
Knopf, Inc., 1947 p. 325.

The Rod and Serpent in Roman
Civilization

Reappeared in depictions of the Roman god of healing,
Asclepius, in which he is seen holding a staff with a snake
coiled around it.

“The Rod and Serpent of Asklepios. Symbol of Medicine,”
by J. Schouten. (Pp. 260+ix; illustrated. 65s.) London:
Elsevier, 1967.

Greco-Arabian Medicine

The solution to shortcomings of the medical education of
the Middle Ages; involved incorporation of Arabian medical
texts, as introduced by scholars and physicians who infused Arabian medicine, with the scholarship of philosophy,
and attempted to compromise their differences.

“Chapter IV: Medicine and Faith,” in “The Greatest Benefit
to Mankind: A Medical History of Humanity,” by Roy Porter,
HarperCollins Publishers Ltd., p. 98–9; “A History of
Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947,
p. 325–29.

The Rod and Serpent Today

Used as the modern symbol for medicine.

“The Rod and Serpent of Asklepios. Symbol of Medicine,”
by J. Schouten. (Pp. 260+ix; illustrated. 65s.) London:
Elsevier, 1967.

Reason for a Resource-Based
Relative Value Scale

Was intended to bring medical practice more in line with a
prospective payment system in which payments are made
based on set fees for types of procedures or diagnosis.
Medicare payments are based on the relative value assigned to each procedure’s work, practice expense, and
malpractice costs with payment adjusted by a geographic
and a universal conversion factor. Every physician uses the
same payment schedule under the Medicare program.

“A Guide to Consulting Services for Emerging Healthcare
Organizations” by Robert James Cimasi, CBI, CBC, John
Wiley and Sons, Inc., p. 24–25.

Overview
Modern medicine is the product of continuous (if sometimes sporadic) advances in scientific, sociopolitical, and philosophic thought throughout many centuries. Paul Starr1 addresses this evolution of medical
thought and practice in his book, The Social Transformation of American Medicine, examining “first, the
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rise of professional sovereignty; and second, the transformation of medicine into an industry and the
growing, though still unsettled, role of corporations and the state.”2 This chapter describes the chronological progression of medicine in accordance with this bimodal transformation, specifically, the centuries of
progress in healthcare practitioner and professional practice credibility.

Origins of Medicine
The original concept of the practice of medicine derived from the concern for human pain. From this
source, a sequence of facts, ideas, and discoveries resulted in the development and evolution of medical
thought, knowledge, study, and practice.3 Without an understanding of the basic origins and principles
of medicine, one can neither understand the modern practice of medicine nor anticipate developments
related to healthcare professional practice.
Because it deals with the vital interests of both individuals and societies—with
life and death, and with so much that matters in between—medicine has
long had an unusually complex and intimate relationship to social and cultural
developments at large . . . In other words, medical history involves social and
economic as well as biologic content and presents one of the central themes in
human experience. After all, what is more basic in the life of any people than life
itself? Richard Harrison Shryock, 1966
The original concept of medicine derived from the concern for human pain.
“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947 p. 3–12.

Medicine and Religion and Astrology
The Mediterranean region gave rise to civilizations that heavily influenced the advance of human knowledge, innovation, and society.4 The region endured five thousand years of war, politics, development,
and demise, fostering not only the origin and intensive development of art and science but also the birth
of monotheistic religion.5 Therefore, the evolution of medicine is inherently linked to the civilizations
that rose and fell in the Fertile Crescent, as well as the religions and spiritualities on which these societies relied.6 In 4 BC, the people of southern Mesopotamia attempted to establish a systematic medical
concept. The outcome of their effort became known as Assyro-Babylonian Medicine.7
For the Sumerians, Babylonians, and Assyrians, medicine was a highly revered abstraction treated
with magical and priestly reverence.8 These civilizations intently studied astronomy, and the assumed
relationships between physiology and celestial findings led to the development of medical concepts.9 As
astronomy evolved to include stories, divinities, and beliefs, the concepts developed into religious systems.10 The reliance on divine healing became a concept of medical practice: the Assyrians relied on the
healing god, Nabu, and the Babylonians turned to the lord of magicians, Marduk, and the god of medicine, Ea, to sustain and restore health.11 Further, the Babylonian caste of physicians was led by Ninurta,
a god who served as their chief. Ninazu, the lord of physicians, and his son, Ningischzida, are known
most notably for their symbol, the rod and serpent (the serpent representing the healing god Sachan).12
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Sumerian, Assyrian, and Babylonian civilizations intently studied astronomy,
and medical concepts developed as a result of the assumed relationships
between physiology and celestial findings.
“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947 p. 31–44.

The Greek god of healing,
Asklepios, also was depicted
holding a staff with a snake coiled
around it, similar to the symbol
attributed to the Babylonian gods
Ninazu and Ningischzida.13 (Aesculapios, his Roman counterpart,
carried a rod as well.) This singleserpent symbol image in Greek
and Roman cultures was attributed to their healing and medical
deities, and it serves as a modern symbol of medicine in most
countries. Note, however, that the
United States uses both the singleserpent symbol, Asklepian, and the
double-serpent symbol, Caduceus,
to represent medicine.14

Askleopios (left) and Caduceus (right). Source: History of the American Medical Writer’s
Association Part 5” By Cynthia Haggard, Clarifying, April 8, 2009, http://clarifying.wordpress.com/2009/04/08/history-of-the-american-medical-writers-association-part-5/ (Accessed 2/17/10).; “Physician Payment Reform, a California Lesson?” By Steve Sweetman,
Healthcare Updates from Steve Sweetman: Regional Contracts Director for The Scooter
Store, September 15, 2009, http://stevesweetman.wordpress.com/2009/09/15/physicianpayment-reform-a-california-lesson/ (Accessed 2/17/10).

The people of Israel, dating
back to 1500 BC, recognized the
practice of medical healing as attributed to “the one God.”15 This idea was reaffirmed through the traditions of Christianity, which emerged from a disease-plagued society.16 Jesus Christ’s depiction as a
“healer” translated not only into spiritual salvation but also into his divine ability to miraculously heal
physical ailments.17 Christianity centers on “a different valuation of human life, a fraternal concept of
equality and charity which imposed on all the faithful the most severe sacrifices in order to lessen the
suffering of others.”18 This concept influenced attitudes toward medicine in areas where people were simultaneously adopting religion and fighting widespread disease. Intellectuals collaborated almost exclusively on religious issues with underlying ethical implications, and medicine was commonly among the
most pressing issues discussed.19 Despite stages of resistance, the church ultimately acknowledged the
importance of medicine, namely when it recognized Claudius Galen (see Galenic Medicine) as a canonical authority.20
Box 1-1 summarizes key early religious figures, places, and medical concepts.
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Box 1-1: Early Medical Figures, Places, and Concepts

Deities and Religious Figures*,**,†
Nabu

Mesopotamia

Assyrian god of healing

Marduk

Mesopotamia

Babylonian lord of magicians

Ea

Mesopotamia

Babylonian god of medicine

Ninurta

Mesopotamia

Babylonian god who led the caste of physicians

Ninazu

Mesopotamia

Babylonian lord of the physicians, represented by rod and serpent symbol

Ningischzida

Mesopotamia

Son of Ninazu, also represented by rod and serpent symbol

Askleopios

Greece

Greek god of healing

Aesculapios

Rome, Italy

Roman god of healing

Buddah (Siddhattha Gotama)

Kapilavastu, Nepal

A spiritual leader and the founder of Buddhism

Jesus Christ

Nazareth, Israel

Son of God, thought to have a divine ability to heal physical ailments

Places§
Fertile Crescent

Western Asia, including the
fertile regions of present-day
Iraq and Syria

Medicine rooted in both religious and empirical treatments evolved from the
Mesopotamian civilization

Medical Concepts and Symbols*,§§,‡
Rod and Serpent

Representation of the healing god Sachan in Babylonia

Asklepian

The staff of Asklepios around which a serpent or serpents are wrapped to symbolize medicine

Caduceus

Double serpent winding around a staff; a symbol for medicine

Vedas

A collection of doctrinal Ayurvedic medical texts

Ayurvedic Sages

Educated by the medical deity prior to transcription of the Vedas

Palatine Archiaters

Court physicians

*
**

“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
“Rod and Serpent,” by Edwin Clarke, Book Review of “The Rod and Serpent of Asklepios. Symbol of Medicine,” by J. Schouten. (Pp. 260+ix; illustrated. 65s.) London: Elsevier,
1967, in the British Medical Journal, Vol. 3, No. 5561, Aug. 5, 1967.
† “The Western Medical Tradition 800 BC to AD 1800,” by Lawrence I. Conrad, et. al., Cambridge University Press, 1995.
§ “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter, HarperCollins Publishers Ltd.
§§ “The Symbol of Modern Medicine: Why One Snake Is More Than Two,” By Robert A. Wilcox and Emma M. Whitham, Annals of Internal Medicine, Vol. 138, No. 8, Apr. 15, 2003.
‡ “A History of Medicine,” by Louis N. Magner, Marcel Dekker, Inc., 1992.

Philosophy and Science of Medicine
Following from ancient tradition, religion shaped the way early Greeks perceived medicine.21 The dawn
of Greek philosophy influenced the origins of a much more scientific approach to medicine, spurring a
pursuit for cures through “critical thought based on observation and experience.”22 Philosophers of both
Western (for example, Thales of Miletus, Plato, Aristotle, Anaximander, and Anaximenes) and Eastern
(for example, Zoroaster, Confucius, Buddha, and Pythagoras) origins contributed to a mathematical,
cosmic, and physiological concept of nature and the biologic system.23
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Ancient philosophers, including Thales of Miletus, Plato, Aristotle,
Anaximander, Anaximenes, Zoroaster, Confucius, Buddha, and Pythagoras,
contributed to a mathematical, cosmic, and physiological concept of nature
and the biologic system.
“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947 p. 129–41.

Similar to their Western counterparts, the people of the Orient viewed medicine as inherently intertwined in religious tradition. Buddhism and Hinduism were instrumental to ancient Chinese and Indian
medicine.24 Although both Eastern and Western medical traditions stemmed from the similar religious
origins and progressed into parallel eras of proliferative philosophy, they diverged as a result of the
differing roles that religion would play in the centuries that followed. Hinduism has a profound impact
on Indian medicine (known as Ayurvedic Medicine) as does Buddhism on traditional Chinese medicine
(see chapter 7 of Professional Practices).25 In fact, it is believed that the Vedas, a collection of doctrinal
Ayurvedic medical texts, is inspired by the teachings of the Hindu divinity Dhanvantari.26 According to
Indian tradition, the medical deity transcribed the Vedas only after educating many Ayurvedic sages.27
Unlike Eastern medicine, and despite centuries of ecclesiastic resistance, philosophic (and later, scientific) foundations for Western medicine formed, solidified, and, over time, replaced religion as drivers of
medical practice.
Box 1-2 outlines the key philosophers and locations in the history of early medicine.

Hippocrates
“A physician who is a lover of wisdom is the equal to a god.” Hippocrates

During its “golden age,” Greece prospered in countless social aspects, wisdom, knowledge, development, beauty, literature, and culture. “[I]t seemed as if an impulse to grandeur and glory and a striving for liberty and beauty pervaded all Greece.”28 Among the unmatched intellectuals of this era was
Hippocrates, recognized as “the wisest and the greatest practitioner of his art.”29 Born in 460 BC, Hippocrates served as both a priestly and empirical authority of medicine, and he authored the Corpus with
his students, which includes works on medical specialties and pathologies, the practice of medicine, and
medical ethics.30 Several influential philosophers and intellectuals in the area of medicine (for example,
Galen and Erotius) published commentaries on Hippocrates and his teachings.31 Additionally, many of
his contemporaries, including Plato, praised his efforts as an author and inspirer of important medical
texts.32
Hippocrates served as both a priestly and empirical authority of medicine
during the golden age of Greece; he was responsible for compiling the
Oath of Hippocrates, as well as writing and inspiring works that
became part of the Corpus.
“Chapter III: Antiquity,” in “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter,
HarperCollins Publishers Ltd., p. 56;“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc.,
1947, p. 148–49.
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Box 1-2: Early Philosophers and Key Locations for Medicine

Eastern Philosophers*,**
Name

Birth/Death

Location

Claim to Fame

Zoroaster

660–583 BC

Iran

Philosopher and religious reformer; founder of Zoroastrianism, or
Parsiism

Confucius

551–479 BC

State of Lu (present-day Shandong
province, China)

Most famous Chinese philosopher/teacher/political theorist

Western Philosophers§
Plato

428–347 BC

Greece

Renowned philosopher and author

Aristotle

384–322 BC

Greece

Student of Plato, renowned for knowledge of art, science, and
philosophy

Thales of Miletus

639–544 BC

Miletus (present-day Turkey)

The first philosopher in the Greek tradition

Anaximander

610–546 BC

Miletus (present-day Turkey)

Pupil of Thales, who focused on the cyclical rhythm of generation and
corruption

Anaximenes

570–500 BC

Miletus (present-day Turkey)

Follower of Thales, who thought the essential substance of life was air

Pythagoras

580–489 BC

Croton, Italy

Founder of Italic School of Philosophy, who connected math, music, and
medicine

Places§§

*
**
§
§§

Place

Location

Role in Medical History

Fertile Crescent

Western Asia, including the fertile
regions of present-day Iraq and Syria

Medicine evolved from the Mesopotamian civilization

“Zoroaster: The Prophet of Ancient Iran” by A.V. Williams Jackson, Columbia University Press, 1919, p. 15.
“The Analects of Confucius” by Simon Leys, W.W. Norton & Company, Inc, 1997, p. xxi.
“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
“The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter, HarperCollins Publishers Ltd.

The first of Hippocrates’ ethical texts was the Oath of Hippocrates, “which covers the duty of the
physician to his teacher, his pupils, and his patients, clearly shows that a relationship existed between
Hippocratic medicine and priestly medicine; but it raises medicine to a height and human dignity that
assures it its own position as a science.”33 Figure 1-1 contains an excerpt from the classic Oath of
Hippocrates.
Medical students commonly take the Hippocratic Oath (or a modification thereof) is to demonstrate a
commitment to uphold ethical standards as they practice medicine.34 Although many attribute to Hippocrates the physician’s commitment to “first do no harm” (translated from the Latin phrase “primum
non nocere”), the true origins of the phrase are unknown and arguably not of Hippocratic origin.35 Box
1-3 outlines the three most influential figures and their works during this time period.
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Figure 1-1: Excerpt From the Classic Hippocratic Oath*
I swear by Apollo Physician and Asclepius and Hygieia and Panaceia and all the gods
and goddesses, making them my witnesses, that I will fulfill according to my ability
and judgment this oath and this covenant:
To hold him who has taught me this art as equal to my parents and to live my life in partnership
with him, and if he is in need of money to give him a share of mine, and to regard his offspring as
equal to my brothers in male lineage and to teach them this art—if they desire to learn it—without
fee and covenant; to give a share of precepts and oral instruction and all the other learning to my
sons and to the sons of him who has instructed me and to pupils who have signed the covenant and
have taken an oath according to the medical law, but no one else.
I will apply dietetic measures for the benefit of the sick according to my ability and judgment;
I will keep them from harm and injustice.
I will neither give a deadly drug to anybody who asked for it, nor will I make a suggestion to
this effect. Similarly I will not give to a woman an abortive remedy. In purity and holiness
I will guard my life and my art.
I will not use the knife, not even on sufferers from stone, but will withdraw in favor of
such men as are engaged in this work.
Whatever houses I may visit, I will come for the benefit of the sick, remaining free of all intentional
injustice, of all mischief and in particular of sexual relations with both female and male persons,
be they free or slaves.
What I may see or hear in the course of the treatment or even outside of the treatment in regard to
the life of men, which on no account one must spread abroad, I will keep to myself, holding such
things shameful to be spoken about.
* “Hippocratic Oath” Johns Hopkins University, http://guides.library.jhu.edu/content.php?pid=23699&sid=190555 (Accessed 9/10/09).

Box 1-3: Influential Figures During the Time of Hippocrates*

Name

*

Location

Claim to Fame

Hippocrates

Birth/Death
460–370 BC

Greece

Thought to be one of the wisest authorities on medicine at the time;
authored medical books on specialties and pathologies, the practice of
medicine, and ethics, including the Oath of Hippocrates, which is still
used today to swear in graduating medical students

Julius Caesar

100–44 BC

Rome, Italy

Granted Roman citizenship to physicians, elevating their social status

Claudius Galen

AD 138–201

Pergamon (Asia Minor)

A physician and author best known for his study of anatomy and
theories on the circulation of the blood, in his best known work, Ars
Parva

“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.

Professional Practice and Status of the Physician
The practice of medicine originated in Greece and spread slowly throughout the Roman Empire.36
People regarded medical practice as a trade of foreigners, and Greek physicians were regarded with
little, if any, respect.37 Many assumed the title of “physician” without the training, further contributing
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to the defamation of the profession.38 However, in 46 BC, Julius Caesar granted physicians the right to
Roman citizenship, an honor that elevated the reputation of physicians in Roman society.39 Soon thereafter, it became necessary to establish medical schools to repel the invasion of unqualified “pseudo-physicians” seeking easy profit in Rome.40 The number of medical schools approved by the Roman Empire
increased, the most celebrated of which could be found in Marseille, Lyon, Saragossa, Antioch, Athens,
and Alexandria.41 A medical licensure process was mandated, and both private and public libraries were
developed to preserve the valued tests and manuscripts.42 Court physicians, called “palatine archiaters,”
played an essential role in politics and legal affairs and designated celebrated physicians in the empire.43
As the practice of medicine became systemized, so did the social position of physicians.44 Although the
medical advances made by the Roman Empire were minimal, Rome was first to incorporate a system of
medicine that became an important part of its intricate system of laws.45
The Roman Empire was first to incorporate a system of legal medicine,
which was an important part of Rome’s intricate system of laws.
“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947 p. 233–35.

Galenic Medicine
Solidifying Hippocratic theories through dissection and experimentation helped reduce the mystery and
doubt that surrounded physicians and helped enhance the quality of medical care in the Roman Empire.46 The first influential strides in this direction were made by Galen of Pergamon in Asia Minor (AD
129–200), a student of Hippocrates, who published fifteen commentaries to Hippocrates’ work.47 He was
appointed physician of the gladiators, an honorable and sought after position.48 Galen quickly became
known as an extraordinary practitioner, writer, and student.49
A student of philosophy and medicine, Galen was a pioneer in the field of anatomy, translating his
findings from animal dissection to human application.50 His philosophical background drove many of
his hypotheses, chiefly those related to the physiological explanation for human blood circulation.51
Though Galenic medicine represented a huge step forward for evidence-based medicine, it also impeded
advances in anatomy and physiology due to its inherent flaws and blind adoption by the medical and
religious communities.52
Drawbacks of Galenic Medicine: findings based entirely on animal dissection
and false perceptions regarding the circulation of human blood.
“Chapter 3: The Reawakening,” in “Doctors: The Illustrated History of Medical Practices,” by Sherwin B. Nuland,
Random House Inc., 1988, p. 71; “The Western Medical Tradition 800 BC to AD 1800,” by Lawrence I. Conrad, et.
al., Cambridge University Press, 1995, p. 225; “A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc.,
1947 p. 218–19.

Rise of the Medical University
The oldest universities, though originating from the ancient Latin schools and persevering through the
Roman Empire, did not flourish until the end of the thirteenth century.53 As academia increased in sophistication, three kinds of universities emerged: community-funded, state-funded, and ecclesiastically
funded.54 Although some schools focused entirely on medicine, others (termed Studia Generalia) also
incorporated law, theology, and philosophy in their curricula.55
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The church’s influence on medical curricula often slowed the advance of anatomical and physiological understanding due to its resistance to findings of clinical and experimental research.56 The Christian
belief that disease was a consequence of sin left healing to the devices of nature.57 Through the translation of Arabian medical texts, scholars developed Greco-Arabian medicine, which confronted the shortcomings of medical education in the early Middle Ages.58 The physician Abu Ali al-Husayn Abdallah
ibn Sinna (known in the West as “Avicenna”) compiled the first comprehensive medical text in Arabic.59
His work, Kitab al-Qanun (The Canon of Medicine), synthesized the philosophies and teachings of
Hippocrates, Galen, Dioscorides, and Alexandrian physicians.60 His mastery of medical science became
legendary, and ibn Sinna became known as the “Galen of Islam.”61
Despite the barriers posed by the Inquisition, scholars, philosophers, and physicians, such as Pietro
d’Abano, infused Arabian medicine into the scholarship of philosophy while attempting to compromise
their differences.62 This movement gave rise to the University of Padua, which pioneered public dissections of human cadavers and gave rise to revolutionary work in dentistry and medieval medicine and
to publications, including Galen’s Ars Parva (a commentary of Torrigiani), and Aphorisms of Hippocrates.63 Greco-Arabian medicine also gave rise to the University of Bologna, the first literary collection of clinical cases, and the work of Ugo Borgognoni of Lucca, the latter of which set the foundation
of modern surgery.64 The University of Montpellier was the first institution to award a doctorate degree,
and at one point, Bologna and Montpellier had the most stringent dissection requirements.65 However,
the University of Montpellier lost its prominence when the popes retreated from Avignon and religious
warfare decimated the area.66

Renaissance: Revival of Anatomy and Physiology
Liberation from Galenic medicine and the scholasticisms encouraged by the church began with the work
of early Renaissance Anatomists in the late 1400s and early 1500s.67 Artist-anatomists such as Andrea
Verrochio and Leonardo da Vinci were pioneers in the field.68 Da Vinci performed dissections of human
carcasses and made drawings of his observations.69 He also refuted many of the statements made by his
Galenic predecessors; due to his objective perspective of anatomy, his work was not immediately recognized with the respect it deserved.70
Andreas Vesalius also refuted aspects of Galen’s work, claiming that Galen’s anatomical knowledge applied only to animals and was incredibly flawed when applied to humans.71 His discoveries in
anatomy, released in the mid-1500s, are medical landmarks.72 By contradicting Galen’s deductions from
animal dissection and philosophical conjecture, Vesalius was the first to describe the vasculature and
anatomy of the human heart.73 By daring to question the doctrinal teachings of their honored predecessors, these and other artists, anatomists, philosophers, and scientists heralded an era of enlightenment,
through which “the sluices of objective inquiry and experiment had been opened.”74 Box 1-4 indicates
the most influential figures and important locations in the history of healthcare during the Renaissance
and Inquisition.
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Box 1-4: I nfluential Figures and Important Places During the Time of the Renaissance and Inquisition*,**

Influential Figures
Name

Birth/Death

Location

Claim to Fame

Abu Ali al-Husayn (Abdallah
ibn Sinna or “Avicenna)

AD 980–1037

Bukhara, Persia

Compiled first comprehensive medical text in Arabic, Kitab al-Qanun
(The Canon of Medicine)

Pietro d’Abano

AD 1250–1315

Padua, Italy

Infused Arabian medicine into the scholarship of philosophy

Ugo Borgognoni of Lucca

Second half of the
twelfth century–1252

Bologna, Italy

A Bolognese surgeon during the Crusades, he simplified the treatment
of lesions of the extremities and fractures; none of his works exist
today, but he has been quoted by his son, Theodoric of Lucca
(AD 1205–1258)

Andrea Verrochio

AD 1435–1488

Florence, Italy

Painter and anatomist; teacher of Leonardo da Vinci; his students
examined cadavers

Leonardo da Vinci

AD 1452–1519

Florence, Italy

Greatest artist anatomist; revolutionized anatomy with his anatomical
sketches based on actual cadavers

Andreas Vesalius

1515–1564

Brussels, Belgium

First to describe vasculature and anatomy of the human heart; refuted
Galen’s theories of anatomy

Important Places

*
**

Place

Location

Role in Medical History

University of Padua

Padua, Italy

Pioneered public dissection of human cadavers

University of Bologna

Bologna, Italy

Held the first literary collection of clinical cases

University of Montpellier

Montpellier, France

Became the first institution to award doctorate degrees

“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
“The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter, HarperCollins Publishers Ltd.

Seventeenth Century: The Dawn of Scientific Liberty
Anatomical Advances
Countless influential figures significantly contributed to the overhaul of Galenic medicine, laying the
foundation for the modern school of medical thought. The work of da Vinci and Vesalius prompted advances in anatomy and physiology.75 Michael Servetus’s breakthroughs in pulmonary circulation, Fabrecius’s discovery of the valves in veins, and William Harvey’s revelations on the enigmatic circulation
of the blood gave mathematical, mechanical, and methodical meaning to the sciences of physiology and
pathological anatomy.76 These findings prompted a contagion of anatomical investigations like Adrien
Spigelius’s studies of the liver, Giulio Casseri’s inquiries of the anatomy of abdominal organs, and Antonio Maria Valsalva’s observation of the human ear.77
Antoni van Leeuwenhoek’s discovery of the microscope in the early 1670s triggered interest in the
molecular implications of human anatomy.78 Van Leeuwenhoek is credited with the discovery of red
blood corpuscles, the advanced study of vessel walls, and the estimation of blood’s velocity.79
The conceptualization of toxicology, knowledge of contagious diseases, and developments in surgery
were furthered by brilliant minds, including Marcello Malpighi, Jean-Baptiste van Helmont, and
Francois Mauriceau.80
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Progress in Hygiene
A series of devastating epidemics terrorized Europe from the fourteenth century through beginning of
the eighteenth century. During this period, Europeans suffered from scurvy, malaria, typhus, smallpox,
diphtheria, influenza, and, perhaps most notably, the various infestations of The Black Death.81 The
Black Death decimated Europe from 1320–1420, with mortality counts of barely less than two-thirds
the original population.82 The notable devastation endured through the seventeenth century, prompting
the focused study of the causes of disease, the results of which led to the emergence of epidemiology, as
well as, perhaps most important, the rise of modern hygiene.83 Giovanni Maria Lancisi, a renowned clinician and epidemiologist, responded to the influenza epidemic in Italy by proposing a series of hygiene
improvements, namely, the need to drain stagnant bodies of water and to purify the air in places where
disease ran rampant.84
The epidemic-related devastation of the seventeenth century, which saw
outbreaks of scurvy, malaria, typhus, the Bubonic plague, smallpox,
diphtheria, and influenza, prompted the dawn of epidemiology, and, more
important, modern hygiene.
“Chapter IX: The New Science,” in “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy
Porter, HarperCollins Publishers Ltd., p. 236–40;“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf,
Inc., 1947, p. 560–63.

Because disease was a significant problem in the military, sanitary measures and disease containment within the military became an area of significant focus.85 The first substantial investigations into
military hygiene were conducted by Florentine Orazio Monti and Antonio Porzio.86 Porzio made notable advances on the subject of epidemic avoidance in armies, demonstrating the detrimental effects of
intrabarrack contamination and, ultimately, civilian contamination.87
Bernardino Ramazzini of Capri became the father of industrial hygiene and authored the first
treatise on occupational disease: De morbis artificum.88 Ramazzini compiled research on the diseases
of miners and issued a report of his findings that resembled a modern occupational risk assessment.89
He also studied the harmful effects of metals on artisans, the risks associated with surgeon exposure to
mercurial inunctions, and the exposures to lead, antimony, and countless other toxins endured by chemists, pharmacists, gilders, painters, tinners, and colored-glass workers.90 Not only was Ramazzini the
first investigator of occupational disease, but he was also a remarkable general clinician, focusing on the
methodical investigation of disease toward the proper course of action.91
Bernardo Ramazzini of Capri became known as the father of industrial
hygiene; he authored the first treatise on occupational disease,
De morbis artificum.
“Chapter X: Enlightenment,” in “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter,
HarperCollins Publishers Ltd., p. 296; “A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc.,
1947, p. 564.
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Legislators began passing sanitation laws toward the end of the seventeenth century.92 When the
plague broke out in Rome, the city took measures to contain the disease by means of regulatory sanitary
controls.93 For example, the College of Physicians was asked to report all patients who had been treated
for certain diseases in the past six months.94 Physicians took appropriate measures to disinfect victims
of the plague, and the city gave physicians permits to euthanize and perform autopsies on any patients
dying of contamination.95 The executions caused uproar among civilians, which brought an end to these
measures for disease control.96 Nonetheless, they prompted more efforts toward military hygiene.97
From these advances in hygiene, preventative and sanitary control measures became areas of legislative
reform that developed throughout the eighteenth and nineteenth centuries.98
Beginning in the seventeenth century and continuing through the eighteenth
and nineteenth centuries, advances in hygiene, methods for arriving at
pathological conclusions, and preventative and sanitary control measures
became areas of legislative reform.
“Chapter XIII: Public Medicine,” in “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy
Porter, HarperCollins Publishers Ltd., p. 397–400, 405–7; “A History of Medicine,” by Arturo Castiglioni, Alfred A.
Knopf, Inc., 1947, p. 567.

Eighteenth Century: The Shift Toward the
“Science” of Medicine
The reformist attitudes of physicians and scientists initiated scientific progress in the eighteenth century.
They believed that health improvement was imperative “to human emancipation . . . from suffering,
want, and fear.”99 As the dark age of the ecclesiastic resistance to scientific advance culminated, advocates argued that medicine should be more philosophical and method-based.100 Although the eighteenth
century became known for Emmanuel Kant’s suggestion “that philosophy is the queen of all the sciences,” it is more renowned for landmark progress in the exact sciences.101 Countless discoveries in
chemistry, physics, biology, physiology, anatomy, and pathology yielded a single conclusion: without an
applied understanding of each of these areas of science, the practice of medicine is arbitrary.102 Box 1-5
outlines the most influential figures and a few key events in medical history during the seventeenth and
eighteenth centuries.
According to Emmanual Kant and his followers: “philosophy is the queen
of all sciences.”
“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947, p. 580–82.
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Box 1-5: Influential Figures and Important Events During the Seventeenth and Eighteenth Centuries

Influential Figures*,**,§
Name

Birth/Death

Location

Claim to Fame

Michael Servetus

1511–1553

Villanueva, Spain

Discovered pulmonary circulation

Hieronymus Fabricius ab
Aquapendente

1533–1619

Padua, Italy

The greatest comparative anatomist; published that veins contained
valves in his work, De venarum ostiolis (On the Valves and the Veins) in
1603

William Harvey

1578–1657

Folkeston, England

Premier name in the discovery of the modern theories of circulation

Adrian Spigelius

1567–1625

Brussels, Belgium

Studied the liver

Giulio Casseri

1552–1616

Padua, Italy

Studied abdominal organs

Antonio Maria Valsalva

1666–1723

Bologna, Italy

Studied the human ear

Antoni van Leeuwenhoek

1632–1723

Delft, Holland

Invented the microscope in the early 1670s, with which he is believed
to have discovered red blood corpuscles and advanced the study of
vessel walls

Marcello Malpighi

1628–1694

Crevallcore, Italy

Conceptualized toxicity

Jean-Baptiste van Helmont

1577–1644

Brussels, Belgium

Known for his knowledge of contagious diseases

Francois Mauriceau

1637–1709

Paris, France

A obstetric pioneer renowned for his contribution to surgical medicine

Giovanni Maria Lancisi

1654–1720

Rome, Italy

Renowned epidemiologist, who, in responding to an influenza epidemic,
improved public hygiene by draining stagnant bodies of water and
purifying the air in disease-ridden areas

Orazio Monti

1724–1787

Vienna, Austria

Conducted the first substantial investigations of military hygiene in his
book, Trattato della Consuetudine, con il Modo do Governare gli Eserciti
ed i Naviganti

Antonio Porzio

1637–1715

Vienna, Austria

Made advances in epidemic avoidance in armies, with his book De
Militum in Castris Sanitate Tuenda in 1865

Bernardino Ramazzini

1633–1714

Capri, Italy

Father of industrial hygiene

Emmanuel Kant

1724–1804

Königsberg, Prussia

Philosopher

Events*,§§
Name

Definition

Black Death

A plague that decimated two thirds of Europe’s population

De morbis artificum

First treatise on occupational disease written by Bernardino Ramazzini

College of Physicians	Physicians association; by the end of the seventeenth century, reported all patients treated for certain
diseases
*
**
§

“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
“The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter, HarperCollins Publishers Ltd.
“Memorie storico-culturali delle Accademie orcianesi”, by Franco Marini, Fondazione Cassa di Risparmio, www.fondazionecarifano.it/EventsDocs/2007/AccademieOrcianesi.
htm (accessed 03/15/10).
§§ “The Black Death and the Transformation of the West,” by David Herlihy, Harvard University Press, 1997.
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Nineteenth Century: The Practice of Medicine
Study of the Medical Sciences
The knowledge a man can use is the only knowledge which has life and growth
in it and converts itself into practical power. The rest hangs like dust about the
brain or dries like raindrops off the stones. (Froude) Sir William Osler, 1899

The nineteenth century saw an increase in the number of medical schools and efforts to teach the history of scientific advancement in a focused, discipline-centric manner, which heralded the concept of the
practice of medicine. The famed text, Practice, published in 1843 by Sir Thomas Watson, remained the
prominent treatise on general medicine for more than forty years.103 However, with Watson’s work becoming perceived as outdated, in 1981, Sir William Osler wrote his magnum opus—The Principles and
Practice of Medicine: Designed for the Use of Practitioners and Students of Medicine—while working
at Johns Hopkins School of Medicine.104 Osler’s text, first published in 1982, established him as a leading authority on medicine and sold hundreds of thousands of copies; multiple editions were published
throughout his life and posthumously.105

Impact of the Industrial Revolution on the
Practice of Medicine
Following a lull attributed to the French and American revolutions and unrest in central Europe, medical progress began gaining momentum.106 Urban and industrial growth spurred demand for sanitary
conditions.107 “Together with the great increase in material and cultural growth, a deeper sense of human dignity was penetrating even to the lowest classes.”108 However, in many countries, a “realistic
tendency and the pursuit of materialistic aims” shattered this idealism.109 Finally, medicine was regarded
as a necessary scientific field. Efforts to overcome “transcendental tendencies and further the progress
of the natural sciences” resulted in experimental investigation and observation of all forms of life.110
Scientists sought to understand complex biological issues that philosophical hypotheses previously
disregarded.111 As a result, various schools of thought emerged and advances in science fostered medical
specialization.112

Diversified Schools of Medicine
Allopathic Medicine
Since its inception as a mythical abstraction, medicine has transformed into a rational science. Through
expansion of logical thought, the study of social value systems113 medical knowledge, and technological
capabilities, allopathic (traditional) Western physicians adopted “a method of healing founded on a scientific basis”114 At the time of its establishment in 1847, the American Medical Association (AMA) was
largely comprised of allopathic physicians.115 The AMA recognized the potency of Western medicine
and understood that danger may result from inadequately regulated growth and expansion of biologically
based methodologies.116
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As the frontiers of scientific medicine extended, quackery found even broader fields of operation.
Scientific explorations into the mysteries of vitamins, hormones, and antibiotics not only provided
better medical care for the public, but also opened up new sources of gain for the unscrupulous.
While scientific research kindled the imagination of crafty promoters who sought easy ways to
riches, its failure to discover cures for various major ailments made the boastful claims of pretending healers all the more impressive.117

As such, the AMA served to scientifically and ethically appraise innovative medical developments,
as well as educational standards, and hoped to regain public support and trust.118

Alternative Medicine
Allopathic practitioners were skeptical of “cultist” or “sectarian” physicians who practiced unconventional forms of medicine, such as homeopathic, eclectic, naturopathic, chiropractic, and osteopathic
medicine.119 Allopathic sentiments toward alternative medical practices were distrustful and condemning, to say the least. Oliver Wendell Holmes, a prominent physician, attributed with coining the term
“anesthesia,” went as far as to call homeopathic practitioners, “a mingled mass of perverse ingenuity, of
tinsel erudition, of imbecile credulity, and of artful misrepresentation.”120 Though not as prominent as
allopathic medicine, practioners of alternative medicine exist today. To reduce public aversion and distrust, the alternative medicine field has developed education and training requirements, as well as regulation and licensing measures to legitimize its practices.121
Homeopathic therapies utilize medicine that would typically induce disease symptoms in healthy
individuals to treat individuals with that disease; homeopathy still exists as a school of medicine.122
Eclectics use herbal medicines and remedies to treat pathologic conditions.123 Among less threatening
therapies, eclectics are known primarily for their use of arsenic and mercury treatments.124 Naturopathic
physicians utilize natural elements like water, heat, and massage in their therapies.125 Chapter 7 of
Professional Practices contains more information about alternative medicine in the modern healthcare
industry.
The practice of chiropractic medicine has transformed from a form of alternative medicine into an
allied health profession. The origins of chiropractic medicine involved beliefs that vertebral alignment
would serve to remedy diseases; progress in science and medicine cultivated skepticism toward practitioners of this philosophy.126 Over time, a reduced focus on these abstract chiropractic practices reduced
skepticism from medical practitioners; although some chiropractors still employ questionable methods,
modern chiropractic practice is mainstream and widely accepted.127 See chapter 6 of Professional Practices for further discussion of chiropractic medicine as an allied health professional practice.
One of the two most reputed schools of medicine in the United States is osteopathic medicine.128 Andrew Taylor Still founded osteopathic medicine, treating patients by assessing not only their symptoms
but also their overall health and environment.129 He opened the American School of Osteopathy in 1892
in Kirksville, Missouri.130 By the 1960s, there were six schools for osteopathy, and, as of 1985, Doctors
of Osteopathic Medicine were certified in all specialties.131 Because osteopathic medicine contributes a
great deal to the modern practice of medicine, chapter 1 of Professional Practices addresses in detail the
similarities and differences between Doctors of Medicine and Doctors of Osteopathic Medicine.
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As of April 1985, Doctors of Osteopathy (D.O.) were certified
in all specialties.
“History of Osteopathy” In “An Osteopathic Approach to Diagnosis and Treatment,” by Eileen L. DiGiovanna and
Stanley Schiowitz, 1997, p. 1–3.

Diversified Roles of Medicine
The practice of medicine in the nineteenth century expanded from strictly clinical practice to include
legal medicine, public health, and medical research. Legal medicine involves the implementation of
medical expertise for legal and judicial purposes.132 In the later portion of the century, the scientific and
medical communities began to grapple with the social and economic implications of healthcare.133 As
such, medicine “assume[d] its role as a social science,” transforming itself from an elite and sophisticated trade134 The national prevalence of infectious disease resulted in an emphasis on community and
hygienic medicine.135
Public health is an area of science and medicine characterized by a “community health point of
view.”136 All public health research, policies, and programs stemmed from the same objective: to provide
“defen(s)e against disease as a social problem” by way of preventative medicine.137 Unfortunately, progress in prevention is difficult to quantify, and its value within the healthcare industry is not concrete.138
As a result, preventative care is dismissed as inferior, and public health has faced significant resistance
and alienation from the medical community.139
Lastly, growth in holistic medical research paired with paralleled growth in scientific knowledge facilitated the publication of substantial medical literature in serial journals, with the American Journal of
Medical Sciences entering print in 1838 and the New England Journal of Medicine and Surgery entering
print in 1812.140 This constant flow of new research findings and an increasing knowledge-base resulted
in the perpetual tendency toward specialization that continues to drive current trends in medicine.

Specialization of the Sciences
The nineteenth century saw the first significant period in technical progress that proved extremely important to the advance of both science and medicine.141 Through continued advances in chemistry and
physics, the disciplines of physiological and pathological chemistry emerged. A more intensive knowledge-base was established for biology, chemistry, anatomy, and physiology, which gave rise to fields
like biochemistry, cytology, genetics, endocrinology, anthropology, immunology, and microbiology.142
Through his investigations of fermentation and pathogenic bacteria, Louis Pasteur pioneered a
branch of microbiology now known as bacteriology.143 Pasteur’s work influenced both clinical and
laboratory medicine through his discovery of pasteurization, a process widely used today in the preservation of perishable products.144 Pasteurization involves the strategic application of heat to kill
microbes without injuring the quality of its media (for example, wine, beer, etc.).145 Through the discovery of pasteurization, the development of antirabic treatment, and his observations of anthrax, chicken
cholera, staphylococci, and streptococci, Pasteur became recognized as “one of the greatest and noblest
pioneers of civilization.”146 Pasteur improved healthcare and enhanced its economic benefits through his
contributions to the fields of clinical, hygienic, and social medicine.147
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Specialization of Medicine
Specialized forms of internal medicine emerged contemporaneously with developments in pathology
and microbiology.148 The nineteenth century marked the discovery of anesthesia and asepsis which
resulted in unmatched advances in the study of surgery.149 Surgical specialization fostered the inception of plastic surgery, neurosurgery, pathological (namely, cancer related) surgery, surgical procedures
in gynecology and obstetrics, and countless other areas.150 Similar scientific milestones enhanced both
diagnostic and therapeutic capabilities in various medical fields including obstetrics and gynecology,
pediatrics, otology, laryngology, rhinology, urology, dermatology, syphilology, orthopedics, dentistry,
neurology, and psychiatry.151

Specialty Diagnostics
Physicians in the nineteenth century were among the first to engage in the identification, classification,
and reporting of various pathologies and diseases.152 In order to conduct the necessary laboratory procedures, physicians had to possess a substantial amount of knowledge in a condensed area of medicine.153
As a result, the range of available specialties grew, became more focused, and ultimately led to more
specialized medical research.154 At the turn of the twentieth century, diagnostic medicine endured a
transformation, with Wilhelm Conrad Roentgen’s discovery of x-rays in 1895 that promulgated the rapid
advancement of quantum physics and Antoine Beclere’s implementation of the first x-ray machine in
1906.155 Soon after, these nuances in radiation diagnostics would leak into therapeutics, with discoveries
in radiation therapy (see chapter 5, Technology Development for an in depth discussion of radiation as a
diagnostic and therapeutic technology).156

Specialty Therapeutics: Pharmacology and Physiology
The practice of medicine has not always been about understanding a problem to arrive at its solution.
For much of history, diagnostic medicine was an enigma—frequently neglected, unequivocally lacking,
and often hypothetical.157 The treatment of diseases, however, always has been at the apex of the medical practice.158 Physician inquiry in specialized areas of medicine allowed for the expansion of diagnostic capabilities in the nineteenth century.159 Additionally, the nineteenth century brought with it the
unparalleled evolution of therapeutic technology.160 It was not until the 1800s that pharmacology gained
scientific credibility through animal and clinical trial investigations.161 Ancient forms of physiotherapy
slowly transformed over time, only to emerge in various specialized forms including hydrotherapy, massage, mechanotherapy, electrotherapy, and heat therapy.162 Box 1-6 summarizes the key people, places,
and events of the nineteenth century in medical history.
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Box 1-6: Influential Figures, Key Places, and Important Events During the Nineteenth Century

Influential Figures*,**,†,††,‡,‡‡
Name

Location

Claim to Fame

Sir Thomas Watson

Birth/Death
1792–1882

Devonshire, England

Authored Practice, a premier medical text published in 1843; it was the
prominent general medical treatise for forty years

Sir William Osler

1849–1919

Montreal, Canada

Authored The Principles and Practice of Medicine, a premier medical
text published in 1892, which solidified him as the leading authority on
medicine at the time for both students and practitioners

American Medical
Association

1847–Present

U.S.

A group of predominantly allopathic physicians that lobbies for
physicians rights and supremacy

Oliver Wendell Holmes

1809–1894

U.S.

Prominent physician who coined the term “anesthesia”

Andrew Taylor Still

1828–1917

U.S.

Founder of osteopathic medicine, the practice of treating patients based
on symptoms and overall health

Louis Pasteur

1822–1896

Paris, France

Pioneered bacteriology, a subfield of microbiology; also discovered
pasteurization

Wilhelm Conrad Roentgen

1845–1923

Germany

Discovered x-rays in 1895

Antoine Beclere

1856–1939

Paris, France

Implemented the first x-ray treatment of glandular tuberculosis

Places‡‡
Place

Location

Role in Medical History

American School of Osteopathy

Kirksville, MO, U.S.

First osteopathic school, founded by Andrew Taylor Still in 1892

Events*,**,‡,§,§§
Name

Definition

Anesthesia

A numbing agent

American Journal of Medical Science	Began printing in 1838 to help the spread of medical information
New England Journal of Medicine and Surgery	Began printing in 1812 and to facilitate the growth of medical knowledge
Fermentation	The enzymatic decomposition of an organic substance in the absence of oxygen; usually produces a gas
Pathogenic Bacteria	Bacteria that causes disease
Pasteurization	A process which preserves perishable products involving strategic application of heat to kill microbes
without injuring the media
Antirabic Treatment	A treatment for rabies developed at the Pasteur Institute
Anthrax	A fatal bacterial infection of warm-blooded animals
Chicken Cholera	A disease affecting poultry, Pasteur’s work with the disease led him to discover vaccinations
Staphylococci	A set of spherical bacteria
Streptococci	A set of spherical bacteria, which grow in chains and can cause serious diseases; used to make
Streptomycin, an antibiotic
Asepsis	The state of being free from disease-causing germs
X-ray	Discovered in 1895, promulgated the rapid advancement of quantum physics
*
**
†
††

“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
“The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter, HarperCollins Publishers Ltd.
“The Life of Sir William Osler,” by Harvey Cushing, Oxford, 1925.
“Our History, Illustrated Highlights,” the American Medical Association, 2009, www.ama-assn.org/ama/pub/about-ama/our-history/illustrated-highlights.shtml, (accessed
09/10/09).
‡ “Dr. Holmes at 200—The Spirit of Skepticism” by Charles S. Bryan, M.D., and Scott H. Podolsky, M.D., New England Journal of Medicine, Vol. 361, no. 9 (August 27, 2009),
p. 846.
‡‡ “An Osteopathic Approach to Diagnosis and Treatment,” by Eileen L. DiGiovanna and Stanley Schiowitz, 1997.
§ “Early History of X Rays,” by Alexi Assmus, Beamline Publication, Stanford University, Summer 1995.
§§ “Two Centuries of American Medicine,” by James Bordley III, MD and A. McGehee Harvey, MD, W.B. Saunders Company, 1976.

41

V1-A-Chapter 01.indd 41

9/28/10 3:16 PM

Th e A dvi ser ’ s Gu i de to Hea lthca re

Twentieth and Twenty-First Centuries: The
Transformation of Modern Healthcare
The twentieth century will be remembered chiefly, not as an age of political
conflicts and technical inventions, but as an age in which human society dared to
think of the health of the whole human race as a practical objective.
Arnold Toynbee, 1931

By the twentieth and twenty-first centuries, healthcare professionals had earned credibility, and continuing developments in modern medicine only fortified the perpetual growth of their medical authority.163
Starr noted:
The rise of the professionals was the outcome of a struggle for cultural authority as well as for
social mobility. It needs to be understood not only in terms of the knowledge and ambitions of
the medical profession, but also in the context of broader changes in the culture and society that
explains why Americans became willing to acknowledge and institutionalize their dependence
on the professions. The acceptance of professional authority was, in a sense America’s cultural
revolution.164

Technological Advances
With physicians developing expertise in exceedingly specialized areas of medicine, the expectation was
that they would administer care with the same level of expertise.165 As such, the demand for innovative
technologies increased to allow for the provision of services that advanced diagnoses required. Over
time, demand took a completely different form to account for more than just advances in diagnostics and
therapeutics, and, moreover, it grew at astronomical rates.166 To match a growing and shifting demand,
increased spending, demographic trends, and a pathologic shift (discussed further herein), existing technologies evolved to improve the quality and efficiency of services delivered.167
Accompanying the increase in spending, healthcare practitioners became viewed not only as healers
but also as businessmen. As the demand for increasingly expensive medical technology grew, the old
adage, “no Buck Rogers,” defined the cyclical relationship between technological demand and business
investment. Within that context, demand for more sophisticated management technologies to enhance
practice efficiency and reliability increased significantly.168 Chapter 5, Technology Development extensively addresses both management and clinical technology.

The Inception of Medicare and Medicaid Services
The economic devastation that plagued a war-torn middle- and working-class at the dawn of the Great
Depression gave rise to the concept of “health security” in the newly urbanized and industrialized United
States.169 Despite resistance from conservative stakeholders, that is, the AMA, the Progressive movement emerged in hopes of relinquishing “inequities and poverty in America.”170 President Franklin D.
Roosevelt (FDR) attempted to implement a national health insurance program, first, in 1935, through
the Social Security Bill, a part of The New Deal, and, again, through the National Health Act of 1939.171
Both attempts were in vain, and FDR’s sudden, tragic death in 1945 left health reform in the hands of
his successor, Harry S. Truman.172
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Truman was a zealous proponent of “universal, comprehensive coverage,” and actively sought enactment of a program for the entirety of his presidency.173 However, he faced opposition from the AMA,
perceived to be “the country’s richest and most influential post-World War II lobby.”174 His stance
on healthcare was viewed by the AMA and other conservative stakeholders as “socialistic” and “unAmerican.”175 Although his vehement support for health reform did not result in the implementation of
a national health program during his presidency, Truman did live to see the inception of a program that,
though not as ambitious as the ones he or FDR proposed, represented significant progress in the direction of change.176
In the 1960s, John F. Kennedy’s presidential campaign once again targeted the recession, unemployment, and stagnant economy introduced by World War II.177 Starr stated that, “[t]he triumph of the
liberal agenda in the mid-1960s brought a new generation of programs and policies in health care.”178
Starr also recognized that the need for an increase in “health manpower” would result in an expansion of
education programs and initiatives.179
President Lyndon B. Johnson, like President Kennedy, recognized the connection between bad
healthcare and poverty and lobbied for social programs to ensure the poor received healthcare coverage.180 Although Medicare had been a political issue since the late 1950s, it was not until the “Democratic sweep in 1964” that a Congressional majority passed the Medicare program and President Johnson signed the bill into law.181 The Medicare program of the 1960s was comprised of three layers: (1)
Medicare Part A, “the Democratic plan for a compulsory hospital insurance program under Social
Security;” (2) Medicare Part B, “the revised Republican program of government-subsidized voluntary
insurance to cover physicians’ bills;” and (3) Medicaid, “the expanded assistance to the states for medical care.”182 The introduction of the Medicare and Medicaid programs dramatically increased access to
care for indigent individuals and proved to be the first of many steps toward healthcare reform.183

Shift to Managed Care
Following the movement toward a prospective payment system (PPS) in the late 1980s, the U.S.
healthcare delivery system underwent fundamental changes that proved, in some ways, as significant as
the introduction of Medicare in the mid 1960s. The sea change in the U.S. healthcare delivery system
during those decades continues to present both challenges and opportunities for healthcare professional
providers and investors alike.184 As one of the largest payors of healthcare benefits, the government continues to attempt to control healthcare costs by developing reimbursement policies that serve as significant drivers of current trends in healthcare delivery.185
Although most professions saw an increase in compensation since the 1990s, physician compensation has been fairly stagnant.186 Physicians have invested in ancillary services providers not only in an
effort to counter reductions in professional fee reimbursement revenue but also to exercise control over
their practice environment and ability to provide technologically advanced, high-quality care to their
patients.187 The realignment of the Inpatient Prospective Payment System (IPPS) with the introduction of
severity adjusted diagnostic related groups (DRGs), as well as heightened initiatives aimed at restricting physician ownership of ancillary services and technical component revenue streams (most recently
through the Children’s Health and Medicare Protection provision removing the whole hospital exception
to the Stark law) have raised some investor concerns.188
The overall impact of this and other attacks on physician ownership appears to be aimed at consigning physicians to nothing more than “sharecroppers.” This perceived diminution of the professional
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standing and investor interest of physicians is further exacerbated by widespread acceptance among
even the most ardent proponents of physician independence, such as Arnold Relman, M.D., Harvard
professor and former editor of the New England Journal of Medicine, who, by neglecting to condone
physician ownership and advocating for a U.S. healthcare system where, “. . . most physicians would be
salaried employees of not-for-profit, prepaid group practices,” may have redefined his stance on physician “independence.”189
From the perspective of many, the inevitable outcome of these efforts at placing additional restrictions on physician independence will be to relegate these professionals and their practice of
medicine, to the status of, at best, the healthcare equivalent of sharecropping, and, at worst (per
Relman), the status of hired help.190

Historically, Medicare and Medicaid paid for hospital services using a cost plus method of reimbursement, in which hospitals received reimbursement in excess of all of their costs.191 In 1983, the federal government introduced a PPS in an effort to remedy the rising healthcare costs.192 Under this PPS,
hospitals are reimbursed an average, qualified, and predetermined fee for every recognized DRG.193 The
government has also developed a PPS for ambulatory surgery centers, home healthcare, hospital outpatient services, rehabilitation facilities, and skilled nursing facilities.194
In 1983, the federal government introduced a prospective payment system
(PPS) in an effort to remedy the rising healthcare costs.
“Assessing payment adequacy and updating payment in fee-for-service Medicare” in Report to the Congress:
Medicare Payment Policy, March 2005, p. 29–32.

In 1989, the resource based relative value system (RBRVS) was introduced as a mechanism to
control the costs of physicians’ services borne by the Medicare program.195 This new payment system,
based on estimates of resource costs incurred in an efficient medical practice, replaced the previous
customary prevailing and reasonable charge system.196 The five-year implementation and subsequent
updates to this system affected the reimbursement levels of various specialties unevenly with primary
care physicians generally faring well under the new system.197 The RBRVS was intended to bring medical practice more in line with a PPS in which payments are made based on set fees for types of procedures or diagnosis For more information about trends in reimbursement, see chapter 2, Reimbursement
Environment.198
In 1989, the resource-based relative value System (RBRVS) was
introduced as a mechanism to control the costs of physicians’
services borne by the Medicare program.
“A Guide to Consulting Services for Emerging Healthcare Organizations” by Robert James Cimasi, CBI, CBC,
John Wiley and Sons, Inc., p. 24–25.

Managed competition between larger, consolidated provider entities was an inevitable goal of the
shift to managed care and capitation from a fee-for-service medical system.199 The expeditious consolidation of healthcare entities, in both public and private sectors, into emerging healthcare organizations
within both private and public sectors is a result of the gradual transition into managed care through
regulatory action at both state and federal levels.200
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Health maintenance organizations and preferred provider organizations have sought to combine
the roles of insurance companies, utilization review organizations, and medical services providers in
order to offer prepaid medical plans to subscribers, forcing cost containment by integrating operational
and financial functions.201 The transition into managed care has reinforced the primary care physician’s
role as “gatekeeper.”202 As such, the value attributed to primary care physicians has increased, though
the trend toward specialization prevails.203
The inception of managed care, as well as the industry hype instigated by Starr’s romanticized call
for “corporatization,” promulgated the increased integration of healthcare organizations.204 However, the
industry did not see the desired improvements in quality and efficiency promised by managed care.205
Most organizations only consolidated in order to survive the backlash of managed care; in light of this
misalignment, increased integration has only furthered the fragmentation of healthcare delivery.206
Consolidation to date has, in some respects, deterred from managed care’s intended goal: the fluid and
comprehensive continuum of quality care. In all respects, however, organizational integration has merely
created a façade of increased consolidation in a healthcare system that remains, inherently, a “cottage industry.”207 Although managed care was, at one time, believed to be the Pied Piper of cottage healthcare,
transformation into postindustrial care is also contingent upon the standardization of care, accounting for
performance measures, and employed transparent reporting practices.208

Inpatient and Outpatient Market Trends
The Bureau of Health Professions predicted that between 2000 and 2020, the U.S. population would increase by 18 percent.209 Also, the number of people aged sixty-five and older is anticipated to account for
13 percent of the total world population in 2030.210 The market for outpatient services more than doubled
from 1987 to 2007 in order to offset trends in population demand.211 Continuing increases in healthcare
costs containment pressures should preserve growth in outpatient demand.
The Bureau of Health Professions predicted that, between 2000 and 2020,
the U.S. population would increase by 18 percent. Also, the number of
people aged sixty-five and older is anticipated to account for 13 percent of
the total world population by 2030.
“Trend Watch” American Hospital Association, 2002, p. 62.

It would be incorrect to assume that the expansion of outpatient care is the sole factor influencing
the healthcare market and competitive arena. Demand is bifurcated due to increased incidence of several chronic diseases paired with emerging infectious diseases that are resistant to existing therapies.212
Though not as drastic, inpatient demand has increased from 96 million visits in 1995 to 119 million
visits in 2006, with the percentage of inpatients older than sixty-five years of age nearly doubling from
1970 to 2006.213 An expected population increase by 2030 of 30 million people suggests that both outpatient and inpatient markets can expect positive trends in demand.214
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The Healthcare Manpower Shortage: A Barrier to
Managed Care
In 1980, the Graduate Medical Education National Advisory Committee projected a surplus of 70,000
physicians in the year 2000. As a result of this estimate, a cap on medical school enrollment was put
in place to control supply of physicians to the market.215 Due to “tightly controlled” managed care in
the 1990s, the projections of a physician surplus in the next decade were reaffirmed, and the number of
graduates per year remained unchanged for nearly twenty-five years.216 However, in 2006, foreseeing a
physician shortage, the Association of American Medical Colleges (AAMC) recommended a 30 percent
increase in U.S. medical school enrollment by 2015 in hopes of alleviating the shortage.217
The healthcare industry faces present and projected healthcare professional manpower shortages
due to the repercussions of previously capped medical school enrollment, the economic recession, and
the demographic shift.218 Based on the number of additional physicians needed to meet current market
demands, the projected 10 percent physician shortage is expected to double in the next decade.219 In November of 2008, the AAMC projected a physician shortage of 159,000 physicians by the year 2025.220
In 2000, thirty states experienced nursing shortages greater than 3 percent.221 In recent years, the average
age of registered nurses has increased steadily due to a six-fold decrease in nursing school enrollment
since 2002, higher average ages of recent graduating classes, and aging of the nursing population as
a whole.222 The U.S. Department of Health and Human Services anticipates 1 million unfilled nursing
positions by 2020.223
In November of 2008, the Association of American Medical Colleges (AAMC)
projected a physician shortage of 159,000 physicians by the year 2025.
“The Complexities of Physician Supply and Demand: Projections Through 2025,” by Michael J. Dill and Edward S.
Salsberg, Center for Workforce Studies, Association of American Medical Colleges, November 2008, p. 6.

The U.S. Department of Health and Human Services anticipates 1 million
unfilled nursing positions by 2020.
“Nursing, doctor numbers worsen,” By Gregory Lopes, The Washington Times, July 27, 2007, www.newser.com/
archive-science-health-news/1G1-166859372/nursing-doctor-numbers-worsenbusiness.html (accessed
April 10, 2009).

In addition to the shortage of physicians across all specialties, there is a growing shortage of physicians seeking to practice in primary care medicine.224
Possibly the largest factor contributing to the shortage is the disparity in pay, as specialists often earn
twice the pay of primary care physicians and work more predictable hours.225 Given that medical students graduate with a significant amount of debt (often more than $100,000), the reason for choosing a
more lucrative specialization is obvious.226
Old Medical Adage
“Primary care physicians (PCPs) believe they treat the conditions that patients have, while
specialists and surgeons believe their patients have the conditions they treat.”
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Because medical schools rely on funds from advanced specialties for their student training programs,
the programs tend to have a highly specialized emphasis.227 Additionally, training in primary care has
been hindered by cuts to training grants (Section 747, Title VII Public Health Service Act) that provide
medical students with exposure to primary care settings outside the academic medical center, often in
rural and medically underserved areas.228 Potential solutions to the shortage of primary care physicians
include providing more financial incentives to attract new graduates to the primary care practice, as well
as expanding exposure to primary care practices during medical school.229
Old Medical Adage
“Specialists and surgeons relegate the complaints of primary care
physicians as ‘the revenge of the C student.’ ”

Further, analysts project that allied health professionals will see a 1.6 to 2.5 million practitioner
shortage in coming years.230 Factors driving the allied health practioner shortage are similar to that of the
nursing shortage: allied health professionals earn more money working than they do teaching, resulting
in a lack of academic faculty.231 Additionally, underfunded educational institutions and community colleges do not inform waitlisted students about the availability of seats at other teaching institutions.232
Box 1-7 outlines several of the most important twentieth century figures and events as they relate to
the healthcare profession.
There is a projected shortage of 1.6 to 2.5 million allied health professionals.
“Workforce Shortage Crisis,” By George Lauer, Allied Health Professionals Week Highlights, January 27, 2007,
www.californiahealthline.org/Features/2009/Shortage-of-Allied-Health-Workers (accessed April 10, 2009).

The Healthcare Professional’s Duty to the State
The practice of medicine began as hypothetical thought and transformed over time into a scientific
industry in growing demand. Ultimately, a company’s success is a function of market control and profit.
However, market competition within the healthcare industry is ultimately driven by the ethical duties
unique to the medical profession. In addition to the duty to “primum non nocere”—first (or above all) do
no harm—healthcare professionals are also expected to exhibit “[q]ualities such as wisdom, compassion,
human concern, and service.”233 However, business objectives built around these ethical values may
conflict with the entrepreneurial objectives that take priority in most industries.234 Further, due to the
community-based nature of many healthcare services, industry trends are driven largely by public opinion on matters related to health status.235 As such, the healthcare professional’s ethical duties are rooted
deeply in community benefit.236 Healthcare delivery is subject to a unique sixth force of the competitive
equation: the requirement that community benefit maintain weighted significance in the decisions that
impact the provision of care.237
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Box 1-7: Influential Figures and Key Events During the Twentieth Century

Influential Figures*,**,†,††
Name

Birth/Death

Location

Claim to Fame

Franklin D. Roosevelt

1882–1945

Washington, D.C., U.S.

U.S. President from 1932–45, who attempted to implement a national
health insurance program in 1935 and again in 1939

Harry S. Truman

1884–1972

Washington, D.C., U.S.

U.S. President from 1945–53, who attempted to implement a national
health insurance program

John F. Kennedy

1917–63

Washington, D.C., U.S.

U.S. President from 1961–63, whose term was plagued by a recession,
unemployment, and a stagnant economy

Lyndon B. Johnson

1908–73

Washington, D.C., U.S.

U.S. President from 1963–69, who, with assistance from a democratic
sweep, passed Medicare parts A and B, and Medicaid

Paul Starr

1949–present

Princeton, N.J., U.S.

Renowned sociologist who won the Pulitzer Prize for his book, The
Social Transformation of American Medicine

Events‡
Name

Definition

Bureau of Health Professions	Part of the U.S. Department of Health and Human Services, deals with grants, studies, and designations of
the health workforce
*
**

“Harry S. Truman Versus the Medical Lobby,” by Monte M. Poen, University of Missouri Press, 1979.
“A Brief History: Universal Health Care Efforts in the U.S.,” by Karen S. Palmer, MPH, MS, Physicians for a National Health Program, Spring 2009, www.pnhp.org/facts/a_brief_
history_universal_health_care_efforts_in_the_us.php?page=all (accessed 02/17/2010)
† “The Social Transformation of American medicine,” by Paul Star, Basic Books Inc. 1982.
†† “Paul Starr: Biographical Sketch”, Princeton University, October 19, 2008, www.princeton.edu/~starr/starrbio.html (accessed 02/24/10)
‡ “Projected supply, demand, and shortages of registered nurses: 2000–2020,” By the United States Department of Health and Human Services, Health Resources and Services
Administration, Bureau of Health Professions, National Center for Health Workforce Analysis, July 2002, www.ahcancal.org/research_data/staffing/Documents/Registered_
Nurse_Supply_Demand.pdf (accessed 04/10/09).

According to the AMA’s 1908 publication, The Doctor’s Duty to the State:
The doctor’s highest duty is to be honest and to fight for honesty in his profession and the state...
He, as others, sees in history the same process exhibited in the remote effects of corporate and
governmental vice...To whom then shall the state look for preservation of its health, to whom
shall the state call for help in time of trouble, in whom shall the state place its hope for deliverance...The honest citizen; and the honest doctor is his best representative.238

Unfortunately, the public’s perception of healthcare providers gradually has eroded during the past
decade, with patients becoming increasingly distrustful of hospitals, doctors, and drug companies and
with a growing perception that there has been a lapse in attention to the healthcare professional’s highest
ethical duty.239 In the face of rapidly accelerating changes in the healthcare industry, it is an increasing
challenge for healthcare professionals to maintain their professional obligations as well as their financial
solvency. Notwithstanding this duality of objective, medical ethics remain a market driver that distinguishes healthcare from all other industries.
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The History You Don’t Know
The only thing new in the world is the history you don’t know. Harry S. Truman
(1974), in Plain Speaking: An Oral Biography of Harry S. Truman

Discussed in subsequent chapters of this Guide, and as mentioned in the introduction, the healthcare
industry’s four pillars, the reimbursement, regulatory, competitive, and technology environments, are
founded in the historical development of medicine and science. These historical foundations have played
a significant role in influencing the development of several other aspects of the healthcare delivery
system, for example, the organizational structure and emerging models of healthcare, and they also have
had an impact on the practice of the healthcare consulting, both of which are discussed in more detail in
subsequent books of this Guide: Professional Practices and Consulting with Professional Practices.

Key Sources

Key Source

Description

Citation

Hyperlink

The Social Transformation of
American Medicine

Paul Starr’s work discussing the
evolution of American Medicine.

“The Social Transformation of American
medicine,” by Paul Star, Basic Books Inc.
1982.

n/a

Oath of Hippocrates

An oath taken by physicians
that was originally written by
Hippocrates but has been revised
multiple times to date.

Original:
“The Hippocratic Oath: Text, Translation,
and Interpretation,” by Ludwig Edelstein.
Baltimore: Johns Hopkins Press, 1943.
Modern:
“The Hippocratic Oath and the Ethics of
Medicine,” by Steven H. Miles, Oxford
University Press, 2004.

Original:
http://guides.library.jhu.edu/
content.php?pid=23699&
sid=190555
Modern:
http://guides.library.jhu.edu/
content.php?pid=23699&
sid=190964

Centers for Medicare and
Medicaid

“The US federal agency which
administers Medicare, Medicaid,
and the Children’s Health
Insurance Program.”

“Mission, Vision & Goals,” Centers for
Medicare and Medicaid, July 17, 2009,
www.cms.hhs.gov/MissionVisionGoals/,
(accessed 09/09/09).

www.cms.hhs.gov

The Doctor’s Duty to the State

Roberts’ work discussing the
healthcare professional’s state
and federal responsibility to
community benefit.

“The Doctor’s Duty to the State,” by
Roberts, J. B. (1908), Chicago, IL:
American Medical Association.

n/a
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Associations

Type of
Association

Professional
Association

Description

Citation

Hyperlink

Contact
Information

National

American Medical
Association

“The American Medical
Association helps doctors help
patients by uniting physicians
nationwide to work on the most
important professional and public
health issues.”

“Our Mission,”
American Medical
Association, 2009,
www.ama-assn.
org/ama/pub/
about-ama/
our-mission.
shtml, (accessed
09/09/09).

www.ama-assn.org

American Medical
Association
515 N. State Street
Chicago, IL 60654
Phone: 800-621-8335
Fax: n/a
E-mail: n/a

National

Association of
American Medical
Colleges (AAMC)

The AAMC represents all 131
accredited U.S. and 17 accredited
Canadian medical schools;
approximately 400 major teaching
hospitals and health systems,
including 68 Department of Veterans
Affairs medical centers; and nearly
90 academic and scientific societies.
Through these institutions and
organizations, the AAMC represents
125,000 faculty members, 75,000
medical students, and 106,000
resident physicians.

“About the
AAMC,” the
Association of
American Medical
Colleges, 2009,
www.aamc.
org/about/start.
htm, (accessed
09/09/09).

www.aamc.org

Association of American
Medical Colleges
2450 N Street, NW
Washington, DC 200371126
Phone: 202-828-0400
Fax: 202-828-1125
E-mail: n/a
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Reimbursement
Environment
Trust not to the omnipotency of gold, or say not unto it, thou art
my confidence.
Thomas Browne, 1643
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Key Concept

Definition

Citation

Reimbursement

Payment for provider services made by patients and third-party payors. Unlike most
businesses, healthcare providers may have hundreds of different contracts with
payors, each with varying terms and rates for the same services.

Source: “Reimbursements” in “Medical Practice
Management System” by Linda Nadeau, Thomson
Delmar Learning, 2007, pg. 198; “Financial
Environment of Health Care Organizations” in
Essentials of Health Care Finance, Sixth Edition” by
William O. Cleverley and Andrew E. Cameron, Jones
and Bartlett Publishers, Inc., 2007, pg. 36–37.

Pay-for-Performance
(P4P)

A remuneration system in which part of the payment is dependent on performance as
measured against a defined set of criteria.Although a P4P system can be structured
in several ways, the common elements to all systems are (1) a set of targets or
objectives that define what will be evaluated; (2) measures and performance
standards for establishing the target criteria; and (3) rewards—typically financial
incentives—-that are at risk, including the amount and the method for allocating the
payments among those who meet or exceed the reward threshold.

“Pay-for-Performance in Health Care” by Jim Hahn,
Congressional Research Service, The Library of
Congress, November 2, 2006, p. CRS-2-4.

Medical Home

A patient-centered model of healthcare delivery and payment reform that focuses on
improving the quality of care and reducing costs through its emphasis on the role of
primary care.

“Medical Home Models: Improving Care and
Reducing Costs in Healthcare, White Paper Analysis of
HIN Monthly E-Survey Results on Trends Shaping the
Healthcare Industry” by Laura M. Greene, Healthcare
Intelligence Network, May 2009.

Resource Based
Relative Value System
(RBRVS)

The scale on which Medicare bases its standardized physician payment schedule.
The RBRVS determines payments based on the value of the resources necessary to
provide a particular service.

“Overview of the RBRVS,” American Medical
Association, www.ama-assn.org/ama/pub/physicianresources/solutions-managing-your-practice/
coding-billing-insurance/medicare/the-resourcebased-relative-value-scale/overview-of-rbrvs.shtml
(accessed October 5, 2009).

Relative Value Unit
(RVU)

The RBRVS assigns each procedure a relative value unit, or RVU. Three types of RVUs
exist: one for physician work (wRVU), one for practice expense (PE), and one for
malpractice costs. The three components of the RVU can be broken down as follows:
1. Work. The estimated value of the time, effort, expertise, and intensity of the
service, approximately 55 percent of the RVU value.
2. Practice expense. The estimated value of overhead and other expenses
necessary to run the practice, approximately 42 percent of the RVU value.
3. Professional Liability Insurance (PLI). The estimated value of malpractice cost
for the service—approximately 3 percent of RVU value.

“Gauging Emergency Physician Productivity: Are
RVUs the Answer,” by John Proctor, MD, MBA,
American College of Emergency Physicians, ACEP
Reimbursement Committee, www.acep. org/practres.
aspx?id=30306 (accessed April 1, 2009).

Healthcare Common
Procedure Coding
System (HCPCS)

A coding system that provides the payor information in regard to the procedures
performed in the treatment of patients. The system does not relay diagnosis
information. HCPCS codes are used by hospitals to report information on procedures
performed for outpatient services and by physicians to report information in
connection with the performance of procedures in both the inpatient and outpatient
settings. Two HCPCS levels exist: Level I codes are referred to as Current Procedural
Terminology (CPT) codes, and Level II codes are temporary codes used to represent
services, supplies, and procedures for which CPT codes do not yet exist.

“Billing and Coding for Health Services” in Essentials
of Health Care Finance, Sixth Edition, by William O.
Cleverley and Andrew E. Cameron, Jones and Bartlett
Publishers, Inc., 2007, pg. 18.

Current Procedural
Terminology (CPT)

A system developed by the American Medical Association that is used by providers to
report information to patients and insurers about services and procedures provided to
patients.

“CPT Coding” in “Understanding Health Insurance:
A Guide to Billing and Reimbursement, Ninth Edition”
by Michelle A. Green and JoAnn C. Rowell, Delmar
Cengage Learning, 2008, p. 191.

Diagnosis-Related
Group (DRG)

A way to categorize patients in hospitals based on the relative intensity of services
related to that diagnosis. Patients typically are classified based on their admitting
diagnosis, which is grouped with other diagnoses into a DRG so that the hospital can
identify groups of patients that require roughly the same amount of resources.

“Health Law: Cases Materials and Problems,” by
Barry R. Furrow, et al., Third ed., West Publishing
(1997), p. 845–46.

Workers’
Compensation

Laws that provide healthcare coverage and monetary payments to employees injured
at work or suffering from an occupational disease and monetary benefits for the
dependents of employees killed on the job. In addition, the laws limit the financial
liability of employers, and they nearly eliminate the financial liability of co-workers for
most accidents.

“Workers’ Compensation” in “Understanding Health
Insurance: A Guide to Billing and Reimbursement,
Ninth Edition” by Michelle A. Green and JoAnn C.
Rowell, Delmar Cengage Learning, 2008, p. 532.
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Key Concept

Definition

Citation

Indian Health Services
(IHS)

An agency located within the United States Department of Health and Human
Services. It provides healthcare services to approximately 1.9 million American
Indians and Alaska Natives, directly through tribal healthcare programs and indirectly
through purchases from private providers.

Indian Health Service Introduction” by Indian
Health Services, IHS.gov, June 2009, www.ihs.gov/
PublicInfo/PublicAffairs/Welcome_Info/IHSintro.asp,
(accessed August 10, 2009); “IHS Fact Sheets” by
Indian Health Service, IHS.gov, June 2009, http://
info.ihs.gov/QuickLook09.asp, (accessed August 10,
2009).

Commercial Insurers

Plans that are offered by life insurance companies, casualty insurance companies,
and companies that were formed for the sole purpose of offering health insurance.

“The Financial Environment” in “Healthcare
Finance: An Introduction to Accounting and Financial
Management, Third Edition” by Louis C. Gapenski,
Health Administration Press/Association of University
Programs in Health Administration, 2005, p. 35.

Fee Allowance
Schedule

A managed care reimbursement scheme by which the fees for procedures are
explicitly laid out and the physician agrees to accept those fees as full payment,
unless the discounted charges are less than the fee schedule in which case the plan
pays the lesser of the two.

“The Managed Health Care Handbook, Third Edition,”
by Peter R. Kongstvedt, Ernst & Young, 1996,
p. 140–41.

Relative Value Scale
(RVS)

The reimbursement scheme by which each procedure is assigned a relative value
which is multiplied by a negotiated factor (the multiplier), usually a discount, to arrive
at a payment.

“The Managed Health Care Handbook, Third Edition,”
by Peter R. Kongstvedt, Ernst & Young, 1996,
p. 140–41.

Performance Based
Fee-For-Service

A managed care reimbursement scheme using a scale that adjusts fees based on
individual medical specialties. In this approach, each specialty has a per-member-permonth budget (for example, $2 per member per month for OB/GYN), and actual costs
are measured against that budget. If costs exceed the budget, then fees are lowered
but only for that specialty and vice versa if costs are better than budget. This system
requires a highly sophisticated tracking system and a large enough patient base to
make the analysis statistically significant, which makes it well suited for independent
practice associations.

“The Managed Health Care Handbook, Third Edition,”
by Peter R. Kongstvedt, Ernst & Young, 1996, p. 181.

Retainer

A managed care reimbursement scheme that involves a set monthly payment amount
for each physician, reconciled at periodic intervals based on actual utilization, either
as a pre-negotiated discount on charges or on some other objective measure. This
ensures the availability of physicians to members and provides for the steady income
desired by physicians, while still allowing payment on the basis of actual utilization.

“The Managed Health Care Handbook, Third Edition,”
by Peter R. Kongstvedt, Ernst & Young, 1996, p. 186.

Hourly & Salary
Reimbursement

A way to pay physicians at an hourly rate or a salary for performing services. This
type of arrangement is common in emergency departments or other settings in which
a physician needs to be available for a defined period of time. This arrangement also
works when buying on-call coverage to back up an in-house physician.

“The Managed Health Care Handbook, Third Edition,”
by Peter R. Kongstvedt, Ernst & Young, 1996, p. 186.

Single Fee
Reimbursement

A scheme under which fees are paid for a procedure no matter how much time and
effort is required. Two applications of this method exist:
1. Case rates or flat rates. The same rate is paid for a procedure no matter what
choice of treatment used; for example, a physician is reimbursed the same
amount for delivering a baby regardless of whether it was a vaginal birth or
delivery by way of a cesarean section surgery.
2. Global fees. A flat rate encompassing more than a single type of service.
For example, a global fee for surgery may include all preoperative and
postoperative care as well as one or two follow-up office visits. A global fee
for obstetrics may include all prenatal and postnatal care.

“The Managed Health Care Handbook, Third Edition,”
by Peter R. Kongstvedt, Ernst & Young, 1996,
p. 186–87.

Bundled Case Rates
or Package Pricing

A form of reimbursement that combines institutional and professional charges into a
single payment; for example, a plan may negotiate a bundled case rate of $20,000 for
cardiac bypass surgery, which covers all staff for preoperative and postoperative care.
Usually outlier provisions exist for cases that become catastrophic.

“The Managed Health Care Handbook, Third Edition,”
by Peter R. Kongstvedt, Ernst & Young, 1996, p. 187.

Periodic Interim
Payments (PIPs) and
Cash Advances

A managed care reimbursement plan that advances the provider a set amount of
cash equivalent to a defined time period’s expected reimbursable charges. As claims
come in from a physician, the claims are subtracted from the PIP, which is routinely
replenished. In this way, the physician has a positive cash flow, as well as the use of
the plan’s money, interest free. This method may be employed in a plan with a heavy
POS enrollment.

“The Managed Health Care Handbook, Third Edition,”
by Peter R. Kongstvedt, Ernst & Young, 1996, p. 187.
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Overview
Healthcare reimbursement is the payment received by providers for the services they render to patients.
Most providers will be reimbursed for their services by patients and by third-party payors, including,
but not limited to, employers, insurance companies, and government agencies.1 Unlike most businesses,
which bill their customers based on a fixed-price per unit set by the business and multiplied by the quantity sold, healthcare providers may have hundreds of different contracts with payors, each with varying
terms and rates for the same services.2 These payments may take a variety of forms, including payment
at a fee set by the provider, a discounted fee negotiated by the parties, a fee schedule set by the payor, a
relative value scale that takes into consideration various costs incurred by the provider rendering the service in a particular geographic locale, capitation based on the number of individuals enrolled in a plan,
bundled payments which pay providers on a per-diem or per-case rate multiplied by the length of stay,
or a prospective payment system (PPS), which reimburses providers a set amount in accordance with a
patient’s diagnosis or treatment.3
In 2007, U.S. healthcare expenditures totaled $2.2 trillion, or 16.2 percent of the gross domestic
product (GDP).4 U.S. healthcare costs have exceeded general inflation for twenty years.5 To combat
these rising costs, private payors, state governments, and the federal government have implemented
PPSs, fee schedules, selective contracting agreements, and managed care principles, but these efforts
have had little success in slowing this continued growth.6 In addition, healthcare reform has taken center
stage in federal and state politics, with reform efforts aimed at reducing the cost of care and improving
healthcare by tying provider reimbursement to patient outcomes, allowing providers to receive a share
of the savings attributable to their cost-cutting efforts, increasing the coordination of care, increasing the
reliance on capitated payments, and bundling provider payments.
In 2007, the average healthcare expenditure per person was $7,421. Nearly
a third of the money spent in 2007, 31 percent, was used to pay for hospital
care. Another 25 percent was spent on dental services, home health, and
other professional services; durable medical equipment, over-the-counter
drugs, and other personal healthcare; and public health research, structure,
and equipment. Rounding out the expenditures, physician and clinical
services comprised 21 percent of the spending, prescription drugs 10
percent, program administration and net cost 7 percent, and nursing
home care 6 percent. In terms of payment sources, state and federal
government payors were responsible for 46 percent of these expenditures,
private insurance paid for 35 percent, patients covered 12 percent
out-of-pocket, and other private payors funded the remaining 7
percent of healthcare expenditures.
www.cms.hhs.gov/NationalHealthExpendData/downloads/PieChartSourcesExpenditures2007.pdf.

Healthcare Revenue Cycle
The revenue cycle describes the process by which a provider practice schedules patients, diagnoses conditions, documents diagnoses, bills payors, and collects billable charges from the payor and the patient
to recover revenue for the services provided.7 See figure 2-1 for a pictorial description of the revenue
cycle in healthcare.
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Elements of the Revenue Cycle
Figure 2-1: The Healthcare Revenue Cycle
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Step 1: Scheduling and Registration
The revenue cycle typically begins when a patient schedules his or her appointment.8 The importance
of a practice’s scheduling system should not be underestimated, as patient-physician relationships and
a healthy revenue cycle depend on it.9 Although a system that overbooks appointments may lead to a
stressful office environment that could negatively affect revenue, a steady flow of patients is what brings
in revenue to the practice.10 Therefore, to maximize revenue, when developing a scheduling system, private practices should give sufficient thought to the type of patients to be seen, their medical conditions,
provider tasks that need to be completed throughout the day (for example, chart review and dictation),
the provider’s scheduling preferences, and the likelihood of walk-ins and no-shows.11
A key element of the revenue cycle is an effective registration system that accurately collects patient
information. This is especially important when dealing with claims that are paid by third-party payors,
because erroneous or omitted information may delay reimbursement.12 To ensure revenue maximization, a patient’s demographic information should be verified every time the patient sees a provider.13 In
addition, staff should check the patient’s eligibility status and satisfy any pre-authorization requirements
before the patient receives services in order to avoid the denial of a claim.14

Volume Management
Volume management is critical to a successful practice, because the main objective of an appointment scheduling system is to have a continuous succession of patients each day.15 Too often, healthcare
practices use off-the-shelf software or appointment books, and they proceed to schedule patients in the
61

V1-B-Chapter 02.indd 61

9/28/10 3:17 PM

Th e A dvi ser ’ s Gu i de to Hea lthca re

predetermined time slots without considering whether this schedule realistically accommodates the
needs of the practice.16 To better manage patient volume, an appointment scheduling system should be
set according to the amount of time each provider prefers to spend per patient type and appointment
type, the maximum number of patients to schedule per day, and the amount of time required per appointment type for every provider in the practice.17 An appointment system based on these criteria will ensure
a workable schedule that maximizes patient satisfaction and physician efficiency.18

Step 2: Diagnostic and Procedural Coding
Accurate coding and documentation are necessary to ensure proper payment, as treatment information in
a patient’s medical record is used to trigger payment in the billing process.19 The proper education of the
provider and staff, and the regular review of coding procedures, can help ensure accuracy and the legitimate maximization of practice revenue.20
In the case of diagnostic services, providers typically bill for both a professional fee component and
a technical component (see the following section, Professional Component versus Ancillary Services
and Technical Component), or they may report a global diagnostic code, which is a combination of both
the professional fee and technical components.21 If reporting is done with a global diagnostic code, reimbursement is equal to the sum of the professional fee and technical components that could have been
billed separately for the services.22
Providers typically bill for a professional component (PC), technical
component (TC), or the global diagnostic code (PC + TC) when
billing for diagnostic services.
www.cms.hhs.gov/NationalHealthExpendData/downloads/PieChartSourcesExpenditures2007.pdf.

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) requires providers to
classify (1) diagnoses and (2) clinical procedures by using several coding systems (see chapter 3, Health
Insurance Portability and Accountability Act of 1996 (HIPPA)).23
The most commonly implemented coding systems include the International Classification of
Diseases, Ninth Revision (ICD-9), the Healthcare Common Procedure Coding System (HCPCS), for
classifying ancillary services and procedures, the imminent ICD-10, the Current Procedural Terminology (CPT-4) for physician procedures in both inpatient and outpatient settings, the Current Dental Terminology for dental procedures (to be implemented on October 1, 2013), and the National Drug Code
system.24 For diagnosis reporting, all healthcare providers, including both physician professional practices and other facilities (for example, hospitals), use the ICD-9, Clinical Modification (ICD-9-CM).The
ICD-9 Procedure Coding System (ICD-9-PCS) is used for procedure reporting for hospital inpatients.
Despite the fact that ICD-9 is used universally for classifying diagnoses, procedural reporting is not
as simple. Procedural coding depends on (1) whether the designated provider is a physician or a facility and, (2) in the circumstance of a facility provider, whether the procedure was performed within an
inpatient or outpatient system. Procedures and services submitted on a claim must be linked, by way of
appropriate CPT, HCPCS Level II, or ICD-9 codes, to the ICD-9-CM code that corresponds to the diagnostic reasoning behind the claim.25 Table 2-1 illustrates the coding systems used for services provided
by each provider type within each setting.26
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The most commonly implemented coding systems include: ICD-9, HCPCS,
ICD-10, CPT-4, Current Dental Technology, and the National Drug Codes.
“Overview: Transaction Code Sets Standards,” by Centers for Medicare and Medicaid, 04/26/2009, www.cms.hhs.
gov/TransactionCodeSetsStands/ (accessed September 15, 2009).

Table 2-1: HIPAA-Designated Coding*
Inpatient

Outpatient

Diagnosis

Procedure

Diagnosis

Procedure

Physician

ICD-9-CM

CPT

ICD-9-CM

CPT

Facility

ICD-9-CM

ICD-9-CM

ICD-9-CM

HCPCS (CPT and
HCPCS Level II)

*

“Billing and Coding for Health Services” In Essentials of Health Care Finance, Sixth Edition, By William O. Cleverley and Andrew E. Cameron, Jones and Bartlett Publishers,
Inc., 2007, p. 17.

International Classification of Diseases 9th Revision—Clinical Modification
The ICD-9 system has codes that supply a payor with information regarding both the patient diagnosis
and the procedures performed in treating the diagnosis.27 HIPAA requires all healthcare providers to
use the ICD-9 codes when reporting diagnosis information to payors.28 In addition, HIPAA requires that
hospitals use the ICD-9 procedural codes when reporting information to payors detailing the treatment
of hospital inpatients.29
Shift from ICD-9 to ICD-10 Coding
In early 2009, the United States Department of Health and Human Services (HHS) announced a final
rule that called for the replacement of the current ICD-9 code set used to report healthcare diagnoses and
procedures with the International Classification of Diseases, Tenth Revision (ICD-10) set by October 1,
2013.30 The adoption of the new system offers several benefits, including the facilitation of quality data
reporting, support for pay for performance payment methodologies, improved billing accuracy, and allowances for international comparison of the incidence and spread of disease.31
Differences between ICD-9 and ICD-10
Note the several major differences between the current ICD-9 code set and the new ICD-10 code set:
• Size. The ICD-9 code set contains 17,000 codes and parts of the code set are running out of space,
whereas the ICD-10 code set contains more than 155,000 codes and has ample room for the addition of new diagnoses and procedures.
• Specificity. The new ICD-10 code set provides for greater specificity when diagnosing conditions.
For example, under the new system, 1,170 codes describe angioplasty, whereas the ICD-9 code set
has only one.
• Basic information. It is anticipated that the ICD-10 system will improve the quality of care provided through the communication of basic information the ICD-9 code does not provide, such as
informing providers about which side of a patient’s body the condition occurred.32
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Financial Impact of the Shift
The switch to the ICD-10 code set will not be without costs. According to a 2008 study, physicians will
incur significant expenditures associated with the change in six key areas: employee education and training, business processes, billing documents, information technology systems, documentation, and disruptions in cash flow.33 Although the extent of these expenditures will vary by practice, the study estimates
that they will range from a little more than $83,000 for a “small” practice, consisting of three physicians
and two administrative employees, to slightly more than $2.7 million for a “large” practice, consisting of
100 providers, ten full time coders, and fifty-four medical records employees.34
Expenditures for the shift from ICD-9 to ICD-10 is estimated to
cost anywhere from $83,000 to $2.7 million, depending on the
size of the practice.
“The Impact of Implementing ICD-10 on Physician Practices and Clinical Laboratories: A Report to the ICD-10
Coalition” by Nachimson Advisors, LLC, Nachimsonadvisors.com, October 8, 2008, http://nachimsonadvisors.com/
Documents/ICD-10%20Impacts%20on%20Providers.pdf, (accessed October 7, 2009) p. 3–4, 6.

Healthcare Common Procedure Coding System (HCPCS)
The Healthcare Common Procedure Coding System (HCPCS) provides a payor information in regard
to the procedures performed in the treatment of patients.35 The system does not relay diagnosis information.36 Hospitals use HCPCS codes to report information on procedures performed for outpatient services; physicians use them to report information in connection with the performance of procedures in
both the inpatient and outpatient settings.37 There are two HCPCS levels: Level I codes are referred to as
Current Procedural Terminology (CPT) codes, and Level II codes are temporary codes used to represent
services, supplies, and procedures for which CPT codes do not yet exist.38

Current Procedural Terminology (CPT)
Current Procedural Terminology (CPT) is a system developed by the American Medical Association
(AMA) that providers use to report information to patients and to insurers about services and procedures
provided to patients.39 In response to the Medicare Prescription Drug, Improvement, and Modernization
Act of 2003 (MMA), the Centers for Medicare and Medicaid Services (CMS) adopted regulations that
require “new, revised, and deleted CPT codes be implemented” on the first day of January each year.40
Many times, multiple combinations of HCPCS and CPT codes apply to a particular procedure.41
Despite the many ways in which to code for a procedure, however, providers are not allowed to separate, or “unbundle,” codes for different components of a comprehensive procedure if a code exists for
the entire procedure.42 CMS developed the National Correct Coding Initiative (NCCI) in an effort to
prevent improper coding (for example, unbundling CPT codes in an effort to receive higher payments)
and standardize national coding procedures.43 The NCCI policy manual lists HCPCS and CPT codes
that cannot be reported together unless a NCCI-associated modifier is used in a clinically appropriate
manner.44 NCCI denies claims when certain pairs of codes are reported together because one of the two
codes may represent a component procedure to the procedure described by the other code, or because the
two described procedures cannot possibly be performed together.45 Additionally, some procedures that
are integral to more comprehensive procedures (for example, wound irrigation is essential to the comprehensive treatment of all wounds) do not have CPT codes at all, and, therefore, should not be reported
64

V1-B-Chapter 02.indd 64

9/28/10 3:17 PM

C hap ter 2 : R ei mbu r semen t E n vi ron men t

separately.46 For more information on the liability associated with improper coding see chapter 3, False
Claims Act (FCA).
Modifiers
Modifiers are two-digit codes added to five-digit CPT codes to clarify the services and procedures
performed.47 Modifiers may be added to CPT codes for a number of reasons, including that the procedure was performed more than once, performed by more than one physician, or discontinued because
of threats to a patient’s health.48 Both the AMA and CMS update the list of modifiers on a continuous
basis.49 The expansion of modifiers presents the potential for some of the same operational and financial
challenges as does the expansion of CPT codes.50 A provider’s costs may increase if billing time increases and the need for staff training arises.51 However, as with expansions to the CPT coding system,
an increase in the number of modifiers may lead to increased revenue, because the added modifiers may
lead to reimbursement for procedures and services not previously covered.52

Step 3: Documentation to Capture the Charge
Upon completion of the coding and documentation process, “the revenue cycle moves from the clinical
side to the business side.”53 Capturing the charge entails the transfer of a provider’s coding and documentation to the actual bill.54 Providers are tasked with recording the appropriate procedure and diagnosis codes on an encounter form, and their business staff is responsible for ensuring that the encounter
form is accurate before using it to bill patients and third-party insurers.55

Electronic Charge Capture
To improve charge capture and revenue generation, the more technologically advanced practices have
begun using personal digital assistants to capture charges.56 The electronic capture systems are then tied
into the practice’s practice management system, a computer system designed to collect registration and
insurance information, facilitate billing and collections, and perform other operational functions so that
charges can be downloaded and posted electronically.57 These systems help reduce errors that may occur
in the capture process, and they reduce the time between service and charge entry.58

Capturing Revenue for Office- and Hospital-Based Professional Practices
Office-based professional practices can capture inpatient charges in a variety of ways. Typically, if a
practice has not adopted an electronic charge capture system as described previously, it may rely on the
older method of charge capture which requires the physician to actually note every consult or procedure
he or she performs on a paper form.59 Other practices hire staff to review hospital charts onsite for all patients seen by the practice’s physicians.60 In addition, to capture charges when the office-based practice
is closed, some providers have set up a phone message system to which the physician can call, in order
to record the relevant patient information, and from which the staff performs the relevant billing actions
when the office reopens.61
Hospital-based professionals typically capture charges in much the same way as their office-based
counterparts, using either paper forms or electronic charge capture devices, although their bills are then
submitted to the hospital’s billing department.62
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Step 4: Patient and Insurance Billing
Once a provider has properly coded and documented the services provided, its staff must ensure the accuracy of the charge captures in order to facilitate accurate and timely billing of patients and third-party
insurers.63 Many providers implement practice management systems, process claims electronically, work
to maintain relationships with payors, develop internal information system processes, and develop other
steps to ensure the effectiveness of the billing process.64 Without an effective billing process, the revenue cycle will breakdown, money will be lost, and the full financial potential of the practice will not be
realized.65 Details on billing to particular payors are included in Current Reimbursement Environment.

Step 5: Account Follow-Up and Collections
Submitting claims to third-party payors and sending bills to patients are not always sufficient to ensure
timely payment, and follow-up on overdue accounts is often necessary to correct billing errors or to
encourage payment by those who refuse to pay or cannot pay in a timely manner.66 Thus, the revenue
cycle is complete with the successful performance of the account follow-up and collection process.67 A
practice’s past due accounts should be continually monitored, and when attempting to collect payment,
it should use frequent phone calls, e-mails, and collection letters and other forms of communication as
needed.68

Use of Lockboxes
Instead of handling the collection and processing of payments themselves, providers may decide to use a
lockbox service. For a fee, lockbox services open a provider’s mail, collect payments, and deposit payments into the provider’s account.69 A lockbox service is convenient in that it saves the practice the time
and resources of performing these procedures themselves. However, if the lockbox service is slow to
process the payments, a payor who has properly paid its bill may receive another statement from the provider requesting payment, thereby creating more work for the provider and frustration for the patient.70

Accounting for Bad Debt
Regardless of the amount of effort a provider puts into the collection process, some account balances
may never be collected. In these instances, providers will likely write the “balance off the accounts
receivable as bad debt.”71 At this time, the provider must then decide whether to send the account to an
outside collection agency, which will attempt to recover the balance for a fee, or give up all attempts at
recovery because it may cost more to further pursue payment than to receive the outstanding amount.72

Changing Nature of the Revenue Cycle
Experts predict that competitive pressure, as well as newly adopted and pending revenue cycle management regulations, will force providers to assess their revenue cycle management systems, resulting in
system upgrades and the purchase of new systems over the next several years.73 Providers with older
revenue cycle management systems may need to upgrade these systems in order to improve patient
satisfaction and convenience and to allow providers to more efficiently manage their revenue cycles.74
Patient satisfaction, convenience, and increased efficiency will result from, among other things, the
patient’s ability to pre-register, schedule, and pay for their services by way of their provider’s website.75
Similarly, providers will benefit from new systems that improve efficiency by way of checking the
payor’s rules to ensure that the services to be performed are covered by the payor, automatically creating
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bills from the electronic medical record, bypassing clearinghouses and submitting claims directly to payors, enabling providers to receive electronic funds transferred directly from the payor to the provider’s
bank, and allowing providers to integrate their financial and clinical data.76

Current Reimbursement Environment
Public Payors
As the baby boomer generation becomes eligible for Medicare, public payor spending is expected to
grow at a greater rate than private payor spending, surmounting 50 percent of total national health
expenditures by 2016.77 This prevalence of public payors in the healthcare marketplace typically tends
to set the benchmark for private reimbursement rates.78 Among these influential public payors are Medicare, Medicaid, State Children’s Health Insurance Program (SCHIP), TRICARE, Civilian Health and
Medical Program of the Department of Veteran Affairs (CHAMPVA), workers’ compensation, and
Indian Health Services (IHS).

Medicare
Overview
Medicare was created in 1965 as Title XVIII of the Social Security Act.79 The program, originally
known as the Health Insurance for the Aged and Disabled Act, is an entitlement program available to
individuals over the age of sixty-five.80 During the 1970s, benefits were extended to include the disabled
and individuals with end-stage renal disease (ESRD).81 Medicare is divided into four parts: (1) Part A,
which covers inpatient hospital care; (2) Part B, which covers outpatient visits; (3) Part C, which people
can choose as a managed care replacement of Part A and B; and (4) Part D, created under the MMA and
implemented in 2006, which covers prescription drug benefits.82 Individuals may enroll in coverage for
Parts A and B, in which they pay a premium only for Part B, or they may elect to enroll in Medicare
Advantage (MA), also known as Medicare Part C, managed care plan that will cover both inpatient and
outpatient services. Individuals may or may not decide to enroll in Part D.83
Medicare reimburses providers using a combination of fee-for-service (FFS), managed care arrangements, and payments from health savings accounts (HSA).84 Medicare does not process or pay
claims directly, rather it contracts with insurance companies to perform these services for them.85
Fiscal intermediaries are insurance companies that handle claims for hospitals, skilled nursing facilities,
intermediate care facilities, long-term care facilities, and home health agencies.86 By contrast, carriers
process claims for physicians, providers, and suppliers.87 In addition, private companies provide medical
and hospital coverage to enrollees of MA (Part C).88
Medicare reimburses for services provided to enrollees of Medicare Part A and Medicare Part B.
Medicare Part A provides insurance coverage for inpatient care in acute care hospitals, critical access
hospitals, and skilled nursing facilities, and Medicare Part B covers a portion of the costs associated with
the beneficiary’s physician services, outpatient hospital care, and other services not covered by Part A.89
Under federal law, all providers and suppliers must submit claims if they provide a Medicare-covered
service to a beneficiary enrolled in Medicare Part B90 (see chapter 3, False Claims Act (FCA)).
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Medicare should be billed as the primary payor when:
• An employee has chose not to enroll in, or has recently dropped, his or her coverage in a group
health plan;
• An employee is not yet eligible for group health plan coverage or has depleted his or her benefits
under the plan;
• The insurance plan only covers the self-employed;
• The insurance plan is an individual plan and was not obtained through a group;
• The patient has coverage through TRICARE;
• The patient is younger than sixty-five, is covered by Medicare due to a disability or ESRD, and
does not have employer-sponsored health insurance;
• The patient is younger than sixty-five, has ESRD, and is covered by an employer sponsored health
insurance plan, but the patient has been eligible for Medicare for more than thirty months;
• The patient has left a company through which they were covered under a group health plan and has
coverage under federal Consolidated Omnibus Budget Reconciliation Act); or
• The patient has both Medicare and Medicaid.91
Medicare administrative contractors are required to pay clean claims, that is, those with the requisite data needed to process and pay the claim, within thirty days from receipt, and must pay interest
on those clean claims paid after thirty days.92 Federal regulation also mandates that MA organizations
pay 95 percent of clean claims submitted by nonparticipating providers in thirty days and pay interest
on clean claims that are not paid prior to this deadline.93 In addition, MA organizations must include a
prompt payment provision in their contracts with participating providers, although the organization and
the participating provider are free to agree upon its terms.94 Typically, if an electronic claim is submitted,
providers can receive Medicare reimbursement in fourteen days.95
As mentioned previously, Medicare pays for services provided by physicians, allied health professionals, nurse practitioners, and other paraprofessionals, with few exceptions.96 In particular, Medicare
makes certain distinctions for reimbursement based on the site of service of particular allied health
practices. For more information on reimbursement of nonphysician providers, refer generally to topics
covered in Professional Practices, chapters 4 and 5, and specifically to the following sections in those
chapters: Dental Reimbursement, Optometric Reimbursement, Chiropractic Reimbursement, Psychology
Reimbursement, and Podiatry Reimbursement.
A unique aspect of the Medicare reimbursement system is the participating physician program,
which originated with the 1984 Deficit Reduction Act.97 Under the program, Medicare and physicians
enter into participating provider (PAR) agreements by which the providers agree to accept the reimbursement amount set by the Medicare physician fee schedule (MPFS), as payment in full for every
claim.98 The physician may bill the patient for the patient’s share of the co-insurance and the patient’s
deductible, but it cannot balance bill the patient, that is, attempt to collect the difference between its
usual fee and Medicare’s lower allowed charge.99
Like any other third-party payor system, Medicare beneficiaries may be subject to premiums, deductibles, and co-insurance, all of which vary according to their coverage, income, and services sought.100
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Reimbursement and Billing
Facility-Based Reimbursement Rates
Medicare reimburses providers at different rates depending on whether payments are being made under
Part A or Part B (that is, inpatient or outpatient), and reimburses outpatient procedures at different rates
based on the site of service. For reimbursement under Part A, hospitals are reimbursed under the Inpatient Prospective Payment System (IPPS) using diagnosis-related groups (DRGs) that classify patients
based on the average per discharge cost of caring for their diagnosis.101 Each DRG is assigned a relative
rate based on its average cost, which is then multiplied by the input-price level of each market to determine the payment rate for the DRG.102 In certain cases, these payments are increased for hospitals with
academic medical centers or for hospitals that serve a disproportionate amount of low-income patients,
although payments are reduced for some transfer cases. Finally, additional reimbursement may be paid
in cases of patients who represent particularly expensive outliers.103
For reimbursement under Part B, hospital outpatient departments (HOPD), ambulatory surgery
centers (ASCs), and physician offices are all reimbursed under distinct payment systems.104 When physicians provide services and perform procedures in their offices, they are reimbursed under the MPFS
for their professional services. When procedures are provided in hospitals or ASCs, however, they are
reimbursed under both the MPFS (for the physician services) and the hospital Outpatient Prospective
Payment System (OPPS), which reimburses for the cost of facilities, equipment, supplies, and hospital
staff for services provided in a HOPD or ASC.105 OPPS payments are classified by service groups called
Ambulatory Payment Classifications (APC), each of which includes services that are clinically similar to
one another and require similar resources.106 Each APC has a relative weight that reflects the median cost
of services in that group.107
For most services performed in an ASC, payment is made under a revised ASC payment system
that began implementation in 2008. The revised system bases ASC payment rates on the APC relative
weights for similar services and extends payment to more surgical services in ASCs.108 The new payment system aligns ASC reimbursement rates at a percentage of the OPPS rates.109 Due to the need to
ensure budget neutrality between the old ASC payment system and the revised system, the reimbursement rate for ASC procedures was set at 65 percent of the HOPD rate in 2008.110 CMS cut this rate to 59
percent of the HOPD rate in 2009 and only increased the conversion factor for payments to ASCs by 1.2
percent for 2010, despite an increase of 2.1 percent for HOPDs for the same year.111 However, CMS significantly expanded Medicare reimbursement for procedures performed in ASCs to any procedure that
does not pose a significant safety risk and that would not require longer than a twenty-four-hour stay.112
Few procedures performed in ASCs exist that are not reimbursed at the OPPS percentage. Of these,
services performed in ASCs that are generally performed in physician offices at least 50 percent of the
time constitute “new, office-based procedures,” which CMS began paying for in ASCs in 2008.113 In an
effort to prevent physicians from moving their practices out of their offices and into ASCs, CMS determined that it would reimburse for these services performed in an ASC at a rate that is the lower of the
ASC rates (that is, the percentage of the OPPS rate) or the practice expense portion of the MPFS payment rate that would apply to the procedure if it had been performed in a physician’s office.114 Based on
the same objective of discouraging shifting procedures to ASCs, CMS also excludes from the revised
ASC payment rates reimbursement for separately payable radiology services, instead applying the same
reimbursement policy as for office-based procedures.115 CMS also decided to reimburse for drugs provided in ASCs at the OPPS rate, rather than the ASC revised rate, under the same theory.116
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Appendix A, found at the end of this chapter, shows historic changes in Medicare payments charged
in the industry segments discussed in this section.
Physician Reimbursement and Billing: The Resource Based Relative Value
Scale (RBRVS)
Medicare reimbursement is based on a standardized physician payment schedule based on a resourcebased relative value scale (RBRVS), which determines payments based on the value of the resources
necessary to provide a particular service.117
History and Background
The RBRVS was introduced in 1988 as a mechanism to control the cost of physicians’ services borne
by the Medicare program. William C. Hsiao from the Harvard School of Public Health developed it
from the results of a 1988 study that was conducted in order to address the growing inequity between
reimbursement rates for procedural services and those for cognitive clinical services, as well as the rapid
increase in Medicare spending.118 The system also was intended to bring medical practice payment more
in line with a PPS, whereby reimbursement is based on a predetermined, fixed amount, and away from a
purely FFS system.119 The RBRVS system was implemented in 1992, and it is updated annually by the
CMS.120
The RBRVS was created by William C. Hsiao in 1988 in order to (1) address
the growing inequity of reimbursement rates for procedural services
for cognitive clinical services and (2) address the rapid increases
in Medicare spending.
“Resource-based Relative Value Units: A Primer for Academic Family Physicians,” by Sarah E. Johnson, MD, and
Warren P. Newton, MD, MPH, Family Medicine, March 2002, p. 172–73.

Hsiao’s Research
Dr. Hsiao’s research consisted of examining components of providing care, such as physician work,
practice costs, and the opportunity costs associated with training.121 Through a series of surveys, the
Hsiao study determined the relative value of the service-specific work component by establishing ways
of quantifying work, including the time spent before, during, and after a procedure, as well as measuring the intensity of the work.122 By conducting interviews with physicians, Hsiao and his team were able
to develop a common scale describing and quantifying the resource costs needed to provide physician
services across all fields of medicine.123
Transition from Customary Prevailing and Reasonable (CPR) to Prospective Payment System with
Resource-Based Relative Value Scale
The Omnibus Reconciliation Acts of 1989 and 1990 implemented a new fixed-fee schedule for Medicare
services.124 The MPFS became effective January 1, 1992, and replaced the previous customary prevailing and reasonable (CPR) charge system with the RBRVS, which is based on estimates of resource
costs incurred in an efficient medical practice.125 CPR payments were based on fees charged by providers by specialty within particular regions of the country, whereas the RBRVS fee schedule is a list of
predetermined payments for healthcare services provided to patients.126 The RBRVS was intended to
place greater emphasis on time spent with a patient when assessing health, diagnosing conditions, and
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listening to complaints, thereby distributing Medicare payments more equitably among physicians who
traditionally had seen higher payments to specialists and lower payments to family practitioners.127
Utilizing Relative Value Units (RVU) When Determining Fees and Costs
The MPFS constitutes a list of payment rates for different services based on their particular HCPCS
codes.128 The MPFS bases its payments on a single cross-specialty RBRVS with payment determined by
a procedure’s relative value units (RVUs).129
There are three RVU components: one for physician work, one for practice expense, and one for
malpractice costs. These components can be broken down as follows:
1. Work. The estimated value of the time, effort, expertise, and intensity of the service—
approximately 55 percent of the RVU value.
2. Practice expense. The estimated value of overhead and other expenses necessary to run the
practice—approximately 42 percent of the RVU value.
3. Professional liability insurance. The estimated value of malpractice cost for the service—
approximately 3 percent of RVU value.130
These RVU components, as well as total RVU, are often adjusted using modifiers. Local geographic
differences are accounted for by multiplying each RVU component by its corresponding geographic
practice cost index (GPCI). By multiplying total RVU (the sum of geographically adjusted components)
by a conversion factor (CF), the dollar amount of governmental reimbursement may be determined.131
The formula for calculating the Medicare physician reimbursement amount for a specific procedure
and location is as follows: 132
Payment = [(wRVU * GPCI work) + (RVU PE * GPCI PE) +
(RVU malpractice * GPCI malpractice)] * CF

RVUs are updated annually by committees from the AMA. Committees listen to testimony from
practitioners and update the RVU modifiers as necessary.133 The three RVU components, GPCI, and CF
are discussed further in the following sections.
Work Component
The work RVU component represents a physician’s contribution of time and effort to the completion of
a procedure. For example, a colonoscopy will have a higher work RVU than an intermediate office visit
because the colonoscopy requires more time and skill.134 The higher the value of the code, the more skill,
time, and work it takes to complete.
Practice Expense Component
The practice expense RVU component is based on numerous expenses that are incurred as a cost of providing the service or overhead of the practice, including the costs associated with office space, supplies,
equipment, and nonadministrative staff.135 The practice expense RVU component is calculated using a
bottom-up methodology in which direct costs (for example, costs than can be assigned, such as the cost
of supplies) are calculated and indirect costs (for example, costs that cannot be assigned but are the costs
of owning a practice, such as the cost of having a waiting room) are allocated.136
The practice expense RVU component may be a different type of RVU depending on whether
services were provided in a facility setting (for example, a hospital), or in a nonfacility setting (for
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example, a freestanding center) because of differences in the cost of operation.137 The formula discussed
previously can therefore be rewritten as:
2009 Facility Payment Amount =
Payment = [(Work RVU * Work GPCI) + (Facility PE RVU * PE GPCI) +
(MP RVU * MP GPCI)] * [Conversion Factor adjusted for budget neutrality]
2009 Nonfacility Payment Amount =
Payment = [(Work RVU * Work GPCI) + (Nonfacility PE RVU * PE GPCI) +
(MP RVU * MP GPCI)] * [Conversion Factor adjusted for budget neutrality]138

Services that are billed by a nonfacility receive a higher practice expense RVU component than
services billed by a facility because the practice expenses are higher for a physician office than for a
hospital.139 When a service is billed by a nonfacility, the practice expense RVU component compensates
the physician’s practice for the costs of owning and operating a practice, but when a service is billed by
the facility, costs associated with clinical personnel, equipment, and supplies are incurred by the facility,
not the practice.140 This makes the practice expense RVU component lower.141 The 2009 practice expense RVU components are often described as “transitioned” or “transitional,” because 2009 is the third
year of transition to a new methodology for calculating practice expense. The new methodology will be
implemented fully in 2010.142
A sample set of RVU data can be found in appendix B at the end of this chapter to illustrate how to
calculate the various components involved in determining compensation using this approach.
Malpractice Expense Component
Section 1848(c) of the Social Security Act, “Payment for Physician Services,” requires CMS to develop resource-based malpractice RVU components as part of the method for physician reimbursement.143 These RVUs correspond to the relative malpractice practice expense for medical procedures.144
These values are updated at least every five years and typically comprise the smallest component of the
RVU.145 Due to the variation in malpractice costs among states and specialties, the malpractice component must be weighted geographically and across specialties.146
Geographic Practice Cost Index
The Geographic Practice Cost Index (GPCI) accounts for the geographic differences in the cost of maintaining a practice. Every Medicare payment locality has a GPCI for the work, practice, and malpractice
component.147 A locality’s GPCI is determined by taking into consideration median hourly earnings of
workers in the area and the average cost of office rental, medical equipment and supplies, and other miscellaneous expenses.148 There were eighty-nine GPCI payment localities as of 2009.149
Conversion Factor
The CF is a monetary amount that is multiplied by the RVU from a locality to determine the payment
amount for a given service.150 This conversion factor is updated yearly by a formula that takes into account (1) the previous year’s conversion factor, (2) the estimated percentage increase in the Medicare
Economic Index for the year (which accounts for inflationary changes in office expenses and physician
earnings), and (3) an update adjustment factor.151 All physician services, except anesthesia services, use
a single conversion factor.152
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The CF is part of an annual update made to the Table 2-2: Medicare Updates: Changes in Physician
Payment*
MPFS by CMS based on an updated formula mandated in the Balanced Budget Act of 1997, which
Year
Physician Update (%)
includes application of the sustainable growth rate
1998
2.3%
(SGR) when determining MPFS rates.153 Based on
1999
2.3%
inflation, Medicare enrollment, growth of GDP,
2000
5.5%
and regulatory developments, the SGR represents
2001
5.0%
a spending target set for total annual expenditures
2002
-4.8%
under Medicare on Part B services, and annual ad2003
1.7%
justments are made to the MPFS based on whether
2004
1.5%
actual spending came in above or below the tar2005
1.5%
get.154 If actual spending is above the target, pay2006
0.2%
ment update rates are adjusted down; likewise, if
2007
0.0%
actual spending is below the target, payment update
2008
0.5%
rates are adjusted up. 155
2009

1.1%

The SGR formula has indicated downward
Average: 1998-2009
1.07%
adjustments to the MPFS every year since 2002;
* “Estimated Sustainable Growth Rate and Conversion Factor, for Medicare
Payments to Physicians in 2010,” Centers for Medicaid and Medicare Services,
however, CMS averted the adjustment in 2003,
November 2007, p. 8, http://www.cms.hhs.gov/SustainableGRatesConFact/
and the United States Congress has intervened and
Downloads/sgr2010p.pdf (accessed October 10, 2009).
overridden the MPFS decreases to the CF for the
past several years, typically replacing scheduled
cuts with increases in payment.156 The annual changes in physician reimbursement from 1998 through
2009, after Congressional intervention, are shown in table 2-2.

Professional Component Versus Ancillary Services and Technical Component
The MPFS differentiates between two distinct revenue streams: the professional services component and
the ancillary services and technical component (ASTC).157 To use the performance of diagnostic services
as an example, a provider performs the technical component when he or she executes functions such as
taking an x-ray or administering an electrocardiogram.158 Providers then perform the professional component when they interpret the results of those tests or write reports.159 Providers must use the appropriate procedure code modifiers on submitted claims to distinguish between the services they performed
and those performed by others, such as the hospital, technicians, or other staff, because a provider may
only bill for services he or she provides.160
CMS Anti-Markup Rule
If a provider orders a diagnostic test from another supplier, he or she may bill Medicare for the technical component of that diagnostic test, even though he or she didn’t perform the technical component.161
However, that provider may not “mark-up” the bill he or she submits for Medicare reimbursement above
the amount he or she paid for the test to reflect additional professional component costs associated with
reading and interpreting the test.162 Additionally, the 2008 MPFS expanded this anti-markup provision
to both professional and technical component revenue generated by tests performed outside the office
of the billing physician.163 For example, with a group practice, both the professional component and the
technical component must be performed in the same building, rather than the technical component being
performed at a separate diagnostic testing facility.164 However, the 2009 MPFS lessened the rigidity of
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the 2008 MPFS rule by incorporating the following two exceptions for times when the billing physician
is exempted from the “anti-markup rule:”
1. The technical component is supervised by a physician who performs “substantially all” (that
is, 75 percent or more) of his or her professional services for the billing physician, physician
organization, or supplier.
2. The technical component is conducted and supervised in the “same building” as the medical
office of the ordering physician or authorized nonphysician provider is located.165
Incidentally, an increasingly volatile regulatory environment surrounding physician ownership is
being driven by competition over who should benefit from ASTC revenues. Federal legislators consistently have advocated against physicians earning profits, which compounds the problem of declining
reimbursement under the MPFS for the professional component of diagnostic imaging services, which
has not kept up with inflation indices and has resulted in consistent decreases in physician professional
component fee reimbursement yield.166 To attempt to counteract this trend, physicians have attempted to
invest in ASTC revenue stream enterprises, for example, ASCs; independent diagnostic testing facilities,
surgical hospitals, physical therapy, etc.167 However, there have been incessant legislative and regulatory efforts undertaken at the federal and state levels, in large part due to massive lobbying initiatives by
oligopoly hospitals and their trade associations, to prevent this trend by restricting physician investment
in ASTC revenue stream enterprises.168 These measures have served to relegate independent physicians
in private practice to receiving only professional fee component revenues or to acquiesce by accepting
employee status under the substantial control of hospital systems or large corporate players.169 In cases
in which physicians receive only the professional fee component, many physician owners are finding it
very difficult to recover both the operating and capital expenses associated with running a practice.
Participating Providers (PARs)—Medicare Allowable Charge
In 2008, approximately 95 percent of all physicians billing Medicare were participating providers
(PARs).170 To encourage physicians to enter into PAR agreements, Congress has developed special
incentives including:
• direct payment of all claims;
• a 5 percent higher fee schedule than for non-participating providers (non-PARs);
• bonuses provided to Medicare administrative contractors for recruitment and enrollment of PARs;
• publication of an annual, regional PAR directory made available to all Medicare patients;
• a special message printed on all unassigned Medicare Summary Notice forms mailed to patients,
reminding them of the reduction in out-of-pocket expenses if they use PARs and stating how much
they would have saved by choosing PARs;
• hospital referrals for outpatient care that provide the patient with the name and full address of at
least one PAR provider each time the hospital provides a referral for care; and
• faster processing of assigned claims.171
In 2008, 94.9 percent of all physicians billing Medicare
were participating providers.
“Providers and Suppliers: Table VI.6—Medicare Participating Physician Program” in “Centers for Medicare and
Medicaid Services Data Compendium” CMS/OFM, December 2008, http://www.cms.hhs.gov/Data
Compendium/16_2008_Data_Compendium.asp#TopOfPage, (accessed August 18, 2009).
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When a PAR bills Medicare for reimbursement 10 percent of cost (the difference between the cost of
the service and the allowable fee) is written off by the PAR.172
Nonparticipating Providers (non-PARs)
Nonparticipating providers (non-PARs) are providers that have not agreed to accept the Medicare
reimbursement amount for every claim. Yet, non-PARs are allowed to accept Medicare assignment on a
claim-by-claim basis (see Nonparticipating Providers Accepting Medicare Assignment on a Claim-byClaim Basis), if they agree to:
• file all Medicare claims,
• restrict their fees for non-assigned claims in accordance with the aforementioned “limiting charge,”
• forgo balance billing patients,
• collect only the patient deductible and co-insurance amounts at the time of service when accepting
assignment on a claim,
• require patients to sign a “surgical disclosure notice” when charges for nonassigned surgical fees
exceed $500, and
• accept assignment on clinical laboratory charges.173
However, it should be noted that even though they have not accepted Medicare’s fee as payment in
full, non-PARs are subject to a “limiting charge,” which dictates what they may charge Medicare beneficiaries for covered services.174
Nonparticipating Providers Accepting Medicare Assignment on a Claim-by-Claim
Basis—95 Percent of Medicare Allowable Charge (80 Percent Medicare,
20 percent Patient)
Non-PARs that accept assignment on a claim-by-claim basis are subject to an allowable fee that is 5
percent less than the allowable fee that PARs are paid for similar services.175 For example, if the Medicare allowable fee schedule for a PAR pays $100 for a service, Medicare would pay the PAR 80 percent
of the allowable fee, or $80. The patient would be responsible for paying the PAR the remaining 20
percent, or $20. However, a non-PAR accepting assignment on the same claim will have an allowable
fee of 5 percent less, or $95 for the same service. Then, Medicare would pay the non-PAR 80 percent of
the non-PAR fee schedule of $95, or a payment of $76. The patient would be responsible for paying the
non-PAR the remaining 20 percent, or $19.
Although Medicare reimbursement differences can lead to a non-PAR being reimbursed more for a
service than a PAR, a non-PAR’s prices are decreased by limiting charges and increasing costs for patients, which may decrease a non-PAR’s competitive advantage (see chapter 4, Boutique and Concierge
Medicine).176
Nonparticipating Providers Rejecting Medicare Assignment—115 Percent of 95 Percent
of Medicare Allowable Charge (100 pPercent from Patient)
A non-PAR may also treat Medicare patients without accepting the claim for assignment. When a nonPAR decides not to accept assignment on a particular claim, he or she may only charge a maximum of
15 percent above the non-PAR fee.177 For example, if the Medicare allowable fee schedule for a PAR
pays $100 for a particular service, Medicare would pay a non-PAR accepting assignment on a claim for
75

V1-B-Chapter 02.indd 75

9/28/10 3:17 PM

Th e A dvi ser ’ s Gu i de to Hea lthca re

the same type of service an allowable fee of 5 percent less, or $95. However, a non-PAR that chooses
to submit a Medicare claim for the same type of service but chooses not to accept assignment may bill
an amount equal to 115 percent of the allowable fee for non-PARs.178 Thus, the provider could charge a
fee equal to 115 percent of $95, or $109.25. In this instance, the provider must file the unassigned claim
with Medicare, which will then write the beneficiary a check for $76, or 80 percent of the allowable fee
of $95. The provider must then collect the $76 from the patient, plus the patient’s 20 percent co-insurance rate, or $19, and the additional $15 that the non-PAR was allowed to bill because he or she chose
not to accept assignment on the claim. The ability to charge more than the Medicare allowable fee is
offset by the increased risk that the provider faces from fact that he or she must collect the entire billable
amount from the patient (see chapter 4, Boutique and Concierge Medicine).

Medicaid and State Children’s Health Insurance Program
Overview
Medicaid is a state-administered health insurance program for low-income individuals and certain
federally recognized eligibility groups.179 Medicaid is funded by participating state governments that
receive federal matching funds as long as they operate their Medicaid programs within parameters set by
the federal government.180
These parameters determine mandatory eligibility groups and mandatory services, that is, the groups
and services the state must cover to receive federal Medicaid money.181 In addition to individuals below a certain income threshold, the federal government mandates that states offer Medicaid coverage to
children six and older whose families earn below 100 percent of the federal poverty level, children under
age six below whose families earn 133 percent of the federal poverty level, parents who earn below
their state’s welfare eligibility cutoff for 1996 (roughly 50 percent of the federal poverty level), pregnant
women earning at or below 133 percent of the federal poverty level, elderly and disabled individuals
earning at or below 74 percent of the federal poverty level who are receiving Supplemental Security
Income, certain working disabled individuals, and Medicare buy-in groups.182
In addition to mandatory groups and services, states may also receive federal funds for covering
other “optional” groups and services.183 States have significant discretion regarding to whom they extend
Medicaid benefits beyond the mandatory groups, and many states opt to extend benefits to individuals
who are above the income cutoffs found in the mandatory groups.184 Additionally, many states extend
Medicaid benefits to individuals with significant recurring healthcare expenses and long-term healthcare
needs.185
Although the federal government determines the medical services that will be covered and paid
for by the federal portion of the program, Medicaid programs vary widely from state to state, as state
governments are free to add additional services or expand eligibility to additional groups.186 Mandatory services include physician services; inpatient and outpatient hospital care; skilled nursing facility
care; laboratory and x-ray services; early and periodic screening, diagnostic, and treatment services for
individuals under the age of twenty-one; family planning and supplies; federally qualified health center
services; rural health clinic services; nurse midwife services; certified pediatric and family nurse practitioner services; nursing facility services for individuals age twenty-one and older; and home health
services for individuals entitled to skilled nursing facility care.187 Optional services, by contrast, may
include prescription drugs, dental services, and medical care provided by allied health professionals and
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other nonphysician providers.188 It is important to look at a particular state’s Medicaid coverage manual
to determine which optional groups and services that state covers.

Children’s Health Insurance Program (CHIP)
In addition to Medicaid, each state, territory, and the District of Columbia have implemented the Children’s Health Insurance Program (CHIP), a state–federal partnership that provides assistance to
children and pregnant women in families whose income is above the threshold for Medicaid.189 Enacted
under the Balanced Budget Act of 1997, and formerly known as SCHIP, CHIP covered approximately
4.8 million children in 2008, which is in addition to the number of children already covered under Medicaid (22.6 million in 2008).190
CHIP covered approximately 4.8 million children in 2008 which
is in addition to the number of children already covered
under Medicaid (22.6 million in 2008).
“Monthly CHIP Enrollment,” by Kaiser State Health Facts, http://www.statehealthfacts.org/comparemaptable.
jsp?ind=236&cat=4&st=3 (accessed October 6, 2009); “Monthly Medicaid Enrollment for Children,” Kaiser State
Health Facts, www.statehealthfacts.org/comparemaptable.jsp?ind=612&cat=4 (accessed October 6, 2009).

CHIP programs vary among states which determine, within federal parameters, who may be eligible
for CHIP funds, as well as other details such as benefits, payment levels, and administration.191 As part
of their autonomy over CHIP programs, states are free to set premiums and co-payment rates on a sliding scale based on income; funds are then matched by the federal government up to a certain capped
amount.192
After a temporary reauthorization of the program in 2007, the Children’s Health Insurance Program
Reauthorization Act of 2009 (CHIPRA) most recently reauthorized SCHIP through September 2013.193
It is estimated that CHIPRA could extend CHIP and Medicaid coverage to 6.5 million children by
2013.194 CHIPRA extends previous SCHIP coverage by now including dental services under the CHIP
program, and it requires states offering coverage for mental health and substance abuse to have mental
health parity.195

Billing and Reimbursement
Reimbursement for services provided to Medicaid patients are paid by states on either a FFS basis or
under a pre-paid managed care arrangement.196 The Medicaid program requires the use of the CMS1500 claim form when seeking FFS reimbursement.197 Providers should consult their state’s Medicaid
managed care organization (MCO) billing manual in order to determine how to bill for noncapitated
managed care services, as these procedures may vary by state.198 Deadlines for filing a Medicaid claim
range from two months to one year from the date of treatment.199 Thus, it is important for providers to be
familiar with their particular state’s rules and deadlines for claim submission. Federal regulation requires states to promptly pay practitioners for clean claims submitted for services rendered to Medicaid
recipients.200 Under the regulation, states must pay 90 percent of clean claims in thirty days, 99 percent
of clean claims within ninety days, and all other claims within twelve months of receipt unless limited
exception apply.201
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Each state is free to develop its own reimbursement process and payment rates, with three
exceptions:
(1) For institutional services, payment may not exceed amounts that would be paid under Medicare
payment rates;
(2) For disproportionate share hospitals (DSH), hospitals that treat a disproportionate number of
Medicaid patients, different limits apply; and
(3) For hospice care services, rates cannot be lower than Medicare rates.202
Thus, states may impose deductibles, co-insurance, or co-payments on certain recipients for particular services.203 PARs in the Medicaid program must accept direct payments from Medicaid for services
rendered as payment in full, and they may not bill patients the difference between their usual fee and the
Medicaid reimbursement rate for covered benefits.204 Medicaid reimburses on a lump-sum basis, meaning providers will receive one payment for several submitted claims.205
Medicaid is considered the “payor of last resort.”206 Thus, for Medicaid patients who also are
covered by an insurance plan or another government program, including Medicare, TRICARE,
CHAMPVA, or IHS, these plans or programs must be billed first.207 Claims should only be submitted to
Medicaid if one of the other payors denies responsibility for payment or reimburses at a rate that is less
than Medicaid’s fee schedule, or if Medicaid reimburses for procedures that are not covered by the other
plans or programs.208

Disproportionate Share Hospital (DSH) Payments
Disproportionate share hospital (DSH) payments are a form of additional reimbursement under Medicaid for hospitals that care for a large number of Medicaid and uninsured patients.209 DSH payments
are allotments from the federal government which augment basic Medicaid reimbursement, and under
federal law, states are required to supplement DSHs in order to receive this additional Medicaid funding.210 DSH payments are intended to supplement hospitals when costs are not adequately covered by
traditional Medicaid and Medicare payments, by SCHIP payments, or by other health insurance.211
DSH payments are calculated differently for each state according to a statutory formula, but no state
receives more than 12 percent of its annual total Medicaid benefits in DSH allotments.212 The states with
the highest DSH allotments are California, New York, Texas, Louisiana, and New Jersey.213 In order to
receive its DSH allotment, a state must submit an annual report and a certified audit documenting payments made to DSHs, though the state has discretion over the hospitals to which it distributes DSH payments.214 The only limit on this discretion is that a state may not distribute DSH payments to any hospital with a Medicaid utilization rate less than 1 percent, and the state must distribute DSH payments to all
hospitals that have either a Medicaid inpatient utilization rate exceeding one standard deviation or more
above the mean for all hospitals in the state, or a low-income utilization rate of more than 25 percent.215
If a state wants to distribute DSH payments to additional hospitals, it is free to do so; however, the state
must distribute payments at a rate in line with the Medicaid DSH payment methodology or based on the
hospital’s low-income utilization rate.216
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TRICARE (CHAMPUS)
Overview
TRICARE, formerly known as the Civilian Health and Medical Program of the Uniformed Services
(CHAMPUS), is the Department of Defense’s healthcare program for active duty military personnel;
members of the National Guard and Reserves; retirees, their dependents, and survivors; and certain former spouses.217 The program uses military healthcare as the main provider of services, and supplements
it with civilian healthcare providers, facilities, pharmacies, and suppliers.218 TRICARE covers approximately 9.4 million beneficiaries worldwide through a variety of plans, including FFS and managed care
plans.219

Billing and Reimbursement
TRICARE reimburses providers for services rendered to beneficiaries using both FFS and managed care
arrangements.220 The allowable fee is determined using Medicare’s RBRVS system, except TRICARE
uses a slightly higher conversion factor and has made minimal modifications to the geographic regions.221 TRICARE only renders payment for services provided by authorized providers, those providers
that meet licensing and certification requirements, and those who have been certified to treat beneficiaries.222 Providers seeking reimbursement must submit claims using the CMS-1500 claim form within one
year from the date the services were rendered.223
TRICARE offers a variety of programs with different beneficiary cost-sharing requirements, including co-insurance, annual enrollment fees, co-pays, catastrophic caps, and deductibles.224 PARs must
accept the allowable fee as payment in full, which prohibits them from billing the patient for more than
the allowable charge for covered services.225 Nonparticipating, authorized providers may accept the allowable fee on a case-by-case basis, or they can refuse to accept the fee, and bill the patient an amount
not exceeding 15 percent above the TRICARE fee schedule.226 Excluded from the 15 percent limiting
charge are claims from independent laboratory and diagnostic laboratory companies, claims for durable
medical equipment, and claims from medical supply companies.227 A potential downside to not accepting TRICARE’s allowable fee schedule is that the beneficiary files the claim using DD Form 2642 and
is reimbursed by TRICARE.228 Thus, the provider must attempt to collect the entire bill from the beneficiary, which is not always an easy task. TRICARE takes pride in the timeliness of its claims processing,
paying more than 99 percent of claims in thirty days and all claims within sixty days.229
TRICARE is a primary payor if a beneficiary qualifies for Medicaid coverage, but it assumes secondary payor status if a patient is covered by another primary health plan.230 In addition, TRICARE will
not pay for occupational injuries or diseases covered by workers’ compensation laws unless these benefits have been exhausted.231 Thus, to ensure prompt payment, providers must understand the relationship
among TRICARE and other insurance or health plans.

Civilian Health and Medical Program of the Department of
Veteran Affairs (CHAMPVA)
Overview
The Civilian Health and Medical Program of the Department of Veteran Affairs (CHAMPVA)
is the Department of Veterans Affairs’ (VA) healthcare program for the spouses and children of veterans who meet certain eligibility requirements. The CHAMPVA program and the beneficiaries are both
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responsible for a portion of the beneficiaries’ healthcare costs.232 To be eligible for the program, a beneficiary must be the spouse or child of a veteran who was declared to have a permanent service connected
disability; the surviving spouse or child of a veteran who died as a result of his or her service related
disability; the surviving spouse or child of a veteran who, at the time of his or her death, was determined
to be permanently or totally disabled due to a service connected disability; or in certain instances, the
surviving spouse or child of a service member who died in the line of duty.233

Billing and Reimbursement
The CHAMPVA program reimburses providers for services rendered on a FFS basis up to the
CHAMPVA allowable amount, which is equal to Medicare and TRICARE’s allowable amount for similar services.234 All claims for reimbursement must be submitted to the CHAMPVA Health Administration
Center within one year from the date of service.235 Claims submitted by providers should use the CMS
1500 or the UB-04 (institutional providers) forms, and an itemized list of charges for each service must
accompany every claim.236
CHAMPVA typically does not sign contracts with providers.237 Instead, providers elect to participate in the program by either submitting a claim or agreeing to treat a beneficiary.238 Providers choosing to treat CHAMPVA beneficiaries must accept the allowable rate as payment in full; they cannot bill
the patient for the difference between their usual fee for the service and the VA allowable amount.239
A provider is free to refuse to accept the CHAMPVA allowable rate if he or she makes this fact clear
to the patient before treatment is rendered.240 In these instances, the patient is responsible for paying
the entire bill and submitting a claim to CHAMPVA for reimbursement up to the allowable amount.241
CHAMPVA reimburses more than 95 percent of their claims within thirty days.242
It is important for providers to understand the relationship among payors, because CHAMPVA
assumes the role of both primary and secondary payor. If a beneficiary is eligible for Medicaid, has a
Medicaid or CHAMPVA supplemental insurance policy, or is eligible for a state’s Victims of Crime
Compensation Program, CHAMPVA assumes the role of primary payor and all claims should be filed
with CHAMPVA first.243 However, some CHAMPVA members may be enrolled in Medicare, covered
by a workers’ compensation policy, or have other health insurance. In these instances, Medicare, the
relevant workers’ compensation program, or the other health insurance plan should be billed first and
CHAMPVA will assume the role of secondary payor.244

Other Public Payors
Workers’ Compensation
Federal and state laws mandate that employers provide workers’ compensation coverage for their employees.245 Workers’ compensation laws provide healthcare coverage and monetary payments to employees injured at work or suffering from an occupational disease. They also provide monetary benefits
for the dependents of employees killed on the job.246 In addition, the laws limit the financial liability of
employers, and they nearly eliminate the financial liability of co-workers for most accidents.247
The Department of Labor’s Office of Workers’ Compensation Programs (OWCP) oversees four
workers’ compensation programs covering federal employees: The Energy Employees Occupational
Illness Compensation Program, the Federal Employees’ Compensation Program, the Longshore and Harbor Workers’ Compensation Program, and the Black Lung Benefits Program.248
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In addition, each state establishes a workers’ compensation board or commission, tasked with administering workers’ compensation programs that cover employees of private companies and state and
local governments.249 Depending on the state, employers can comply with workers’ compensation laws
by obtaining coverage through:250
• State insurance (or compensation) funds—Agencies that provide workers’ compensation insurance
coverage to both public and private employers.
• Self-insurance plans—Plans under which employers set aside a percentage of capital funds to
cover expenses that may arise.
• Commercial workers’ compensation insurance—Policies purchased from commercial insurance
companies.
• Combination programs—Programs under which employers cover their workers through a combination of any of the aforementioned methods.

Billing and Reimbursement
Providers treating ill or injured employees covered under one of the four federal workers’ compensation acts are reimbursed according to the Department of Labor’s OWCP fee schedule for the Federal
Employees’ Compensation Program Act, the Longshore and Harbor Workers’ Compensation Program
Act, and the Energy Employees Occupational Illness Compensation Program Act.251 A modified version of the fee schedule is used to reimburse providers treating patients covered under the Federal Black
Lung Benefits Act.252 The OWCP’s schedule is based in part on the fee schedule developed by CMS with
some program specific adjustments.253 Claims for reimbursement should be submitted to the Department of Labor using the UB-04 form for inpatient hospital charges and the CMS-1500 form for physician services.254 In addition, various forms, progress reports, and supplemental reports may be required
as well.255 Bills must be submitted to OWCP by December 31 of the year following the year in which
services were provided or by December 31 of the year following the year when the condition was first
accepted as covered by the workers’ compensation program, whichever is later.256
Medicare claims for physician services must be submitted using the CMS1500 claim form, whereas ambulance companies, ambulatory surgery
centers, home health agencies, hospice organizations, hospitals, psychiatric
drug or alcohol treatment facilities, skilled nursing facilities, sub-acute
facilities, stand alone clinical or laboratory facilities, and walk-in clinics
must submit the UB-04 claim form. Medicare claims must be filed before
December 31 of the year in which the services were provided, except
in instances in which the service was provided between October 1 and
December 31. These claims receive an extension, and must be filed before
December 31 of the following year.
“Understanding Health Insurance: A Guide to Billing and Reimbursement, Ninth Edition” by Michelle A. Green and
JoAnn C. Rowell, Delmar Cengage Learning, 2008, p. 305, 449.

Most state workers’ compensation programs reimburse providers using a fee schedule based on
RUVs established by the state compensation board or commission, but some states have developed managed care plans, as well.257 The claims forms, progress reports, and supplemental reports used, as well as
the filing deadlines for them, vary from state to state.258
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Providers treating patients eligible for coverage under workers’ compensation programs must accept
assignment, meaning they must accept the compensation as payment in full.259 Patients covered by workers’ compensation programs are charged no fees at the time of treatment; they pay no deductible and no
co-payment.260 In addition, the patient’s employer pays all premiums.261

Indian Health Services (IHS)
The Indian Health Services (IHS) Agency is located within HHS.262 The agency provides healthcare
services to approximately 1.9 million American Indians and Alaska Natives directly through tribal
healthcare programs and indirectly through purchases from private providers.263 Most of the agency’s resources fund the care of American Indians or Native Alaskans living on or near reservations or Alaskan
villages.264 However, Congress has provided some funding for programs for eligible individuals in urban
areas as well.265

Billing and Reimbursement
On occasion, IHS needs to purchase healthcare services from private providers.266 In these instances,
IHS contracts with non-IHS facilities and providers to deliver healthcare services when
1. no IHS facility exists;
2. the direct care element is incapable of providing the required emergency or specialty care;
3. the direct care element has an overflow of medical care workload; or
4. supplementary alternate resources are needed.267
Typically, IHS pays providers for these services in accordance with the terms of the negotiated
contract.268 When these services are purchased from hospitals participating in the Medicare program, the
MMA provides IHS with the authority to limit the reimbursement amount to rates similar to those paid
by the Medicare program.269 Providers should submit their claims to the IHS fiscal intermediary, Blue
Cross Blue Shield (BCBS) of New Mexico, using the appropriate claim form.270
IHS is considered a payor of last resort, so if a patient has other insurance, providers should submit
claims to the patient’s insurance provider first “notwithstanding any state or local law or regulation to
the contrary.”271 The contract standards between IHS and BCBS of New Mexico call for 95 percent of
clean claims submitted to the IHS fiscal intermediary to be completed within twenty-one days.272

Private Payors
Private health insurance consists of commercial insurers, BCBS plans, MCOs, and self-funded plans. In
2007, private health insurance financed 35 percent of the amount spent on personal healthcare.273

Commercial Insurers
Overview
Commercial health insurers entered the health insurance market in the 1940s.274 Commercial health
insurance refers to plans that are offered by life insurance companies, casualty insurance companies,
and companies that were formed for the sole purpose of offering health insurance.275 Commercial insurers are taxable entities organized as either mutual or stock insurers.276 Mutual insurance companies are
owned by their policyholders, whereas stock insurance companies are owned by their stockholders.277
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Commercial insurers typically offer a variety of health insurance plans, which offer varying trade-offs
between cost, the variety of the services covered, and the flexibility to select providers.

Billing and Reimbursement
To compete in today’s health insurance market, many commercial insurers offer a variety of plan options. Thus, it can be hard to generalize patient and insurance billing requirements for commercial insurers, because co-pay and deductible amounts, reimbursement methods, claim form requirements, claims
submission deadlines, remittance schedules, policies, and the claim submittal process will vary by plan.
Further complicating matters, it is uncommon for commercial insurers to publish their billing manuals or
inform providers of changes to their claims process.278 Thus, to avoid claim denials and to ensure maximum reimbursement, it may be important for providers to routinely contact commercial insurers with
whom they frequently work in order to stay informed of any changes to the claims process.

Blue Cross Blue Shield
Overview
Blue Cross began providing private health insurance in 1929 by offering coverage for hospital expenses.279 Blue Shield began providing insurance to cover expenses associated with physicians’ services
in 1939.280 In 1986, the independent boards of directors of the national Blue Cross and Blue Shield
(BCBS) accrediting associations merged to form a single nonprofit BCBS Association (BCBSA).281
Today, the BCBSA consists of thirty-nine independent BCBS companies.282 The BCBSA works to coordinate the nationwide plans by establishing standards for new plans and programs; assisting local plans
with enrollment activities, national advertising, public education, professional relations, and statistical
and research activities; and serving as the primary contractor for processing Medicare hospital, hospice,
and home health claims.283
During the 1990s, many nonprofit BCBS plans were in need of additional capital in order to compete
with for-profit insurers and requested permission from their respective state governments to convert to
for-profit corporations.284 In the instances in which the plans were allowed to convert to for-profit status,
the transitions were closely watched to ensure that the plans’ charitable assets were preserved.285
BCBS plans offer a variety of health insurance options, including FFS coverage, indemnity plans,
managed care plans, a federal employee program, Medicare supplemental plans, and Healthcare Anywhere—an option that allows enrollees of independently owned and operated plans to receive the benefits of their plan from other BCBS plans worldwide.286

Billing and Reimbursement
BCBS reimburses providers using a variety of FFS payments and managed care arrangements.287 The
allowable fee varies based on the plan—some plans use the physician fee schedule and others use a
“usual, customary, and reasonable” system to determine the amount commonly charged by providers in
the region.288 BCBS requires PARs to accept the allowable fee as payment in full.289 Non-PARs may collect their full fee from the patient, who will in turn receive payment directly from BCBS.290
Depending on the enrollee’s coverage and the services sought, patients usually are subject to deductible and co-pay requirements, with co-pay amounts commonly ranging from 20 percent to 25 percent.291
The CMS-1500 claim form is accepted by most BCBS plans, and it typically must be filed within one
year from the date of service unless the provider’s contract states otherwise.292 Although reimbursement
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for claims processed by BCBS varies by plan, some plans pay electronically submitted claims within
fifteen days.293

Managed Care
Overview
Managed care plans integrate the financing (that is, insurance) and provision of health services under
the administration of one MCO in an effort to contain costs.294 Because managed care plans assume risk,
they focus on managing care as well as managing costs. Under managed care, costs are contained by
holding providers accountable to offer quality services at predetermined levels of reimbursement. Managed care plans hold providers accountable for providing care to a population through
1. clinical practice standardization,
2. selective contracting,
3. low-cost settings,
4. reduced discretionary hospital admissions, and
5. effective staff use.295
These mechanisms ensure that financial risk is shared by the managed care plan and the providers,
forcing them both to be accountable for the delivery, cost, and quality of services.
Typically, managed care plans are created by an insurer that owns its own provider network or by an
insurer that creates a network by way of contracts with independent providers.296 Managed care plans are
structured in a variety of ways, each with their own unique characteristics. However, three of the more
popular forms of managed care plans are health maintenance organizations (HMO), preferred provider
organizations (PPO), and point-of-service plans (POS).
Health Maintenance Organizations (HMOs)
Health maintenance organizations (HMOs) are responsible for providing, or arranging for the provision of, healthcare services (including preventative care) for plan enrollees by way of contractual
arrangements with providers.297 The HMO structure benefits health plans, enrollees, and providers.298
Health plans benefit because they are able to limit their financial risk by contracting with providers to
care for the enrolled population for a fixed amount per member per month. Enrollees receive the benefit
of little or no deductibles and nominal or no co-payments for the care they receive; providers benefit
from a steady stream of income regardless of how often enrollees seek care.299
The HMO came into existence in Los Angeles in 1923 with the founding of
the Ross-Loos Clinic. The clinic, founded by two physicians, Donald E. Ross
and H. Clifford Loos, provided medical and hospital care to Los Angeles
Department of Water and Power employees and their families in exchange
for monthly payments.
“Private Health Insurance and Managed Care” in “Introduction to Health Services, Seventh Edition” by Alma
Koch., Thomson Delmar Learning, 2008, p. 115; www.economicexpert.com/a/Ross:Loos:Medical:Group.htm.
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HMO enrollees must receive all of their care from the plan’s PARs except for care provided in emergency situations or in instances in which the plan offers a POS option.300 Under some HMO models,
enrollees must select a primary care physician to oversee and coordinate their healthcare. This physician also helps to control costs by limiting which providers the enrollee has access to; by acting as a
“gatekeeper,” the physician’s authorization is required before the plan will pay for specialized or referral services.301 In addition, because enrollees are typically limited to seeking care from the plan’s PARs,
HMOs do assume responsibility for quality assurance and are able to transfer some of the financial risk
to their preferred providers.302
The following are common forms of HMOs:303
1. Staff model HMOs directly employ all the physicians who provide healthcare services to plan
enrollees.
2. Group model HMOs contract with one physician practice to provide care to plan enrollees.
3. Network model HMOs contract with many independent physician practices that may also treat
other patients who are not enrolled in the plan.
4. Independent Practice Association HMOs contract with an association of independent physicians who maintain their own private practices but have joined together to enter into an agreement to treat the plan’s enrollees.
Preferred Provider Organizations (PPOs)
A preferred provider organization (PPO), a hybrid of an HMO and traditional health insurance plan,
is a managed care plan that allows members to choose from an array of healthcare providers that have
contracted with the plan to provide services on a discounted basis.304 The health plan, the members, and
the providers all benefit when the member chooses to receive services from a provider on the preferred
provider list.305 Health plans benefit through increased purchasing power, which allows them to negotiate
lower prices; members benefit because they are charged lower co-insurance and deductibles when they
see in network providers; and providers benefit because being a preferred provider status may make plan
members more likely to choose them when seeking medical treatment.306
The PPO evolved in California in 1982 in response to the legislature’s
desire to have a system that “would allow selective contracting for
Medicaid through private insurers.”
“Understanding Health Insurance and the PPO” Sheila Guilloton, Examiner, June 15, 2009, www.examiner.com/
x-11804-Health-Care-Examiner~y2009m6d15-Understanding-health-insurance-and-the-PPO, (accessed July 10,
2009).

PPO members are not required to have a gatekeeper physician authorize the care they receive, nor
are PPO members required to use the preferred providers on their plan’s list, although going outside the
network will result in higher co-insurance rates and deductibles.307 However, because members are not
limited to seeking care from the list of preferred providers, PPOs do not usually cover preventative care
because they do not undertake the same responsibility for quality assurance as HMOs.308 Also different
from HMOs, PPOs do not transfer financial risk to their preferred providers.309
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Point-of-Service (POS) Plans
Point-of-service (POS) plans combine many of the elements of HMOs and PPOs.310 POS plans are usually an addition to an HMO product that allows members the benefit of seeking care from non-PARs.311
As with an HMO, when members seek care from in-network providers they typically pay no deductible
or coinsurance.312 However, similar to a PPO, members are free to seek services outside the network
subject to higher cost sharing in the form of deductibles and coinsurance.313 Although the cost is higher,
this freedom of choice is why many consider POS plans to be the least restrictive form of managed
care.314
Like members of an HMO, POS enrollees must choose a primary care physician from the list of innetwork providers to oversee the provision of healthcare services.315 This primary care physician is also
responsible for referrals to specialists and hospitals.316 Should a POS member choose not to seek a referral from his or her primary care physician before undergoing treatment, his or her expenses associated
with this treatment typically will be higher.317

Reimbursement
Types of Managed Care Reimbursement
MCOs use a variety of methodologies to negotiate and calculate reimbursement for their contracted
healthcare providers. The most commonly utilized reimbursement methods for both primary and specialty care physicians are risk-based reimbursement methods like capitation or FFS.318
Capitation
In order to reduce healthcare service utilization, MCOs have passed some of their risk to providers in the
form of capitation.319 Capitation is a pre-paid reimbursement method that pays a provider a set price for
providing medical services to a defined population for a defined set of services, regardless of service utilization. Providers must manage the financial risk of providing adequate care by calculating the expected
volume of referrals, the average cost, and their ability to control utilization.320 These decisions need to
be based on actuarial or historical data to determine an appropriate capitation amount and acceptable
amount of risk to the organization.321
Capitated contracts allow providers to budget for expected medical costs while accepting both the
financial risk and potential rewards, and they provide providers with financial incentives that encourage
them to become more active participants in controlling (and accepting responsibility for) utilization.322
Full Risk Capitation
Full risk capitation occurs when a healthcare plan, facility, or provider accepts the entire financial risk
for a plan’s members.323 However, due to the significant risk involved, any medical group undertaking
full risk capitation must have strong financial management skills and management information systems.324 In absence of such safeguards, many MCOs will refuse such arrangements in order to avoid the
risk of failure.325 Usually, large groups or an organized system of providers are best suited to support full
risk capitation.326
Blended Capitation
Blended capitation is a payment method that combines per-member-per-month rates and FFS remuneration to pay for physician services as a way to counterbalance the faults identified with a purely capitated or a purely FFS payment system. In the healthcare context, the FFS payment method encourages
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providers to see many patients and perform difficult and unpleasant procedures.327 However, a purely
FFS system does not provide the physician with an incentive to reduce costs associated with his or her
practice style, nor does it encourage cooperation among physicians.328 Similarly, capitation rewards
provider activities that strive for high clinical quality and customer service.329 However, without adjustments, a purely capitated form of remuneration may lead a physician to withhold preventative services,
narrow his or her scope of practice, and refuse to treat patients that are in need of a greater amount of
care due to the fear of financial burden.330 As a result, organizations have moved toward reimbursing
their providers using a per-member-per-month capitation system in combination with FFS payments for
specified procedures in an attempt to better balance the multiple objectives of encouraging individual
productivity and clinical cooperation.331
Fee for Service (FFS)
Fee-for-service (FFS) health coverage occurs when healthcare providers receive separate compensation
for each service they provide (for example, an office visit, procedure, etc.).332 Critics condemn FFS systems, stating that physicians tend to over-treat patients upcode andunbundle services in order to receive
higher reimbursement.333 Nonetheless, FFS systems are often used as an incentive for healthcare providers to join an MCO in markets where managed care penetration is low.334
MCOs can sometimes negotiate discounts with providers, based either directly on charges or based
on volume:
1. Straight discount on charges. Discounting a specific amount off the reimbursement rate for every
procedure code.
2. Discount based on volume or a sliding scale. The degree of discount is based upon a pre-agreed
set of procedural volume ranges. For example, if the provider performs five or less of a specific
procedure per month, he or she earns a 10 percent discount. However, should the provider perform six to ten procedures per month, he or she earns a 15 percent discount. Many plans combine
a discount arrangement with a fee maximum. The fee maximum is a fee schedule; the plan pays
the lesser of the discounted charges or the fee maximum.335
Specialty Care Reimbursement
The most commonly utilized reimbursement methods for specialty care physicians (SCPs) are risk-based
models: FFS and capitation.336 However, SCPs are reimbursed by way of additional methods including:
(1) relative value scales or fee allowance schedules, (2) performance-based FFS, (3) retainers, (4) hourly
and salary wages, (5) single fees, (6) bundled case rates or package pricing plans, (7) DRGs, and (8)
periodic interim payments and cash advances.337

Billing Managed Care Organizations
To ensure timely payment and maximum reimbursement, it is important that a provider’s staff be aware
of the managed care contracts in effect in their practice, the rules of the various plans, and how these
contracts affect the claims process.338 Providers should be aware of the co-pay and deductible amounts,
plan requirements, policies, and if applicable, the length of time it takes a plan to remit payment for the
practice’s various contracts, as they will usually vary by plan.
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HMO Billing
Patients in HMOs typically pay a fixed premium to enroll in the plan and co-payments at the time of
treatment ranging from $1 to $35, unless the co-pay is waived because a co-insurance payment, a fixed
percentage of the bill the patient is required to pay after meeting their deductible, is required instead.339
It should be noted that all providers are typically required to file claims with procedure codes for all
services rendered, even those directly employed by the HMO and those compensated on a capitated
basis.340 In turn, HMOs use these claims to adjust rates and track the quality of care.341
PPO Billing
PPOs contract with providers to render services to the plan’s enrollees on a reduced fee basis.342 Patients
in most PPOs have the freedom to receive care from providers outside the plan, with the trade-off being
higher out-of-pocket expenses.343 Members of a PPO usually pay higher premiums, deductibles, and
co-payments than those paid by members of HMOs, but these payments are generally lower than FFS
plans.344
POS Plan Billing
Providers in POS plans generally are reimbursed according to the terms of the contract, except that
specialty services typically are paid on a FFS basis.345 Patients in a POS plan pay only small co-pays
or charges, no co-insurance, and no deductibles for care received from network providers and out-ofnetwork providers to whom they have a referral to see.346 However, when a patient sees a non-network
specialist without first obtaining a referral from his or her primary care physician, the patient usually
will be subject to higher out-of-pocket expenses in the form of a larger deductible and 20–25 percent
coinsurance charges.347

Consumer Driven Health Plans—The Shift From Defined Benefits to
Defined Contributions
To combat the problem of ever increasing premiums for employee health insurance, many employers have begun to implement “defined contribution” health insurance plans instead of the traditional
“defined benefit” plans.348 The goal is to model health insurance programs after “defined contribution”
pension programs, such as 401(k)s.349 Unlike a defined benefit system, in which an employer has the
obligation to contribute the necessary premium for a certain health insurance benefit package, a defined
contribution system allows an employer to contribute a designated amount of money and give the employee the freedom to do with it what he or she chooses.350
The shift toward defined contribution health insurance plans has directed the focus from the employer to the employee when it comes to making healthcare decisions.351 Many forms of defined contribution leave substantial decisions to employee (that is, the consumer of the healthcare services), putting
the employee in the driver’s seat when it comes to deciding which services are worth purchasing from
whom to purchase them.352 To accomplish this, employers occasionally will present employees with
what amounts to a voucher to purchase insurance on their own, but more often, employers will create
an account for each employee into which the employer, the employee or both will contribute funds, and
from which the employee will be able to draw to purchase health services.353
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Health Savings Accounts (HSAs)
One of the most common models of defined contribution health insurance is the establishment of a
health savings account (HSA), coupled with enrollment in a high-deductible health plan (HDHP),
whereby employers and employees both contribute to a special account from which the employee can
draw funds to pay for health services.354 HSAs were first introduced in the MMA. An individual, an employee, or his or her employer may make contributions to an HSA. If the employer contributes, the value
of those contributions is not taxable to the employee. Similarly, if the employee makes contributions,
they count as “above-the-line” deductions.355
Individuals excluded from HSA eligibility are those covered by insurance other than a HDHP, those
who can be claimed as a dependent on someone else’s tax return, veterans who have received medical
care or prescription drugs from a VA facility within the last three months, active duty military personnel,
and Medicare recipients who did not have an HSA prior to enrolling in Medicare.356 However, an individual is not precluded from enrolling in an HSA if he or she has automobile, dental, vision, disability,
or long-term care insurance or is covered by an employer wellness plan, as long as the wellness plan
does not pay for a significant portion of one’s medical care.357 In addition, enrollees are allowed to have
insurance coverage for a specific disease or illness, as long as the coverage, when invoked, pays only a
set monetary amount.358 No requirement exists that an individual have earned income, nor are there any
upper-end limits on income, that would restrict an individual’s ability to contribute to an HSA.359

Legislative Support
In 2006, President George W. Bush signed into law the Health Opportunity Patient Empowerment Act
of 2006, which provided new opportunities for HSA participants to build their funds. Included among
the provisions of the act was an allowance for employers to transfer funds from flexible spending arrangements (FSAs) or health reimbursement arrangements (HRAs) to an HSA plan for those employees
wishing to switch. The new act also increased the maximum HSA contribution amount to a statutorily
defined amount (indexed for inflation), eliminated the system of prorating HSA contributions based on
the number of months that an individual was eligible and replaced it with a system allowing individuals
who enrolled in a month other than January to make a contribution equal to a full year’s enrollment. Additionally, the act allowed for a one-time transfer from an individual retirement arrangement (IRA) to an
HSA, which avoided early withdrawal and income taxes, eliminated FSA coverage previously deemed
as disregarded coverage which reduced HSA contribution for a given year, set an earlier date for cost-ofliving index adjustments, and allowed greater employer contributions for lower-paid employees.360
However, legislative support for HSAs has waned a bit under President Barack Obama’s administration, as lawmakers struggle to develop a comprehensive plan for national healthcare reform. A common
theme in the new administration is the setting of tighter limits on contributions to HSAs and the increasing oversight of how the money is spent.361

Prevalence and Growth of HSAs
According to a 2009 census conducted by America’s Health Insurance Plans (AHIP), the number of individuals covered by HSAs and HDHPs has increased steadily every year since their inception, with just
more than eight million individuals covered as of January 2009.362
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According to a 2009 census conducted by America’s Health Insurance Plans
(AHIP), the number of individuals covered by HSAs or HDHPs has increased
steadily every year since the plans were established, with just more than
eight million individuals covered as of January 2009.
“January 2009 Census Shows 8 Million People Covered By HSA/High-Deductible Health Plans” by Anna Yoo,
America’s Health Insurance Plans, ahipresearch.org, May 2009, www.ahipresearch.org/pdfs/2009hsacensus.pdf,
(accessed August 27, 2009).

Reimbursement with HSAs and HDHPs
Providers may receive reimbursement from an individual with an HSA in a variety of forms, including
debit card, checks, and “automatic claims forwarding.”363 The fact that an individual has an HSA does
not mean that a provider will be paid the day the services are provided, because some HSAs encourage
their patients not to pay for the provider’s services until the plan informs the patient of the amount.364 To
combat this issue, providers should insist on payment at the time of service, always check their patient’s
insurance eligibility to determine how much of the deductible has been met, and if the entire deductible
has been met, whether the service is covered by their HDHP and whether the patient has co-insurance
requirements.365 Performing these tasks at the time of service can ensure the provider receives the appropriate payment in a timely manner, without having to go through the costly and time consuming process
of seeking payment from the patient at a later date or reimbursing the patient due to an overpayment.366

Self Insurance
Self-insurance plans, often referred to as “self-funded” plans, have been one of the leading trends in the
health insurance industry since the late 1970s.367 Self-insuring employers make a conscious choice to
undertake the risks associated with the cost of healthcare and set aside money to pay these costs as they
arise.368 Often, a self-insurer will hire a commercial insurer or third-party administrator to run its medical
benefits program and adjudicate claims.369
Self-insurance plans vary by the amount of risk an employer is willing to assume.370 In a fully selffunded plan, the employer undertakes the responsibility for 100 percent of the healthcare expenses submitted for reimbursement.371 Typically, this type of funding is limited to employers or groups of 5,000
or more, as medical expenses for large groups can be reasonably predicted.372 However, employers with
fewer than 5,000 employees often are unwilling to assume the risk of funding their entire health insurance program.373 Thus, these employers may opt for a partially self-funded plan.374 The most common
type of partially self-funded plans is the “minimum premium plan.”375 Under a minimum premium plan,
the employer covers claims up to a predetermined amount, and an insurance policy assumes liability for
claims thereafter.376 Another popular form of partially self-funded plans involves combining self-funding
with stop-loss insurance.377 Under these plans, the employer covers employee claims up to a predetermined amount per employee, at which time stop-loss insurance covers any employee who exceeds his or
her out-of-pocket maximum.378
Employers choose to self-insure as an alternative to purchasing health insurance policies for several reasons. First, self-insurers avoid the charges, fees, and profits that insurance companies build into
the price of insurance premiums.379 In addition, because self-insurance technically is not insurance,
state taxes assessed on premium revenue can be avoided.380 Perhaps the most important benefit of selfinsurance is the fact that the Employee Retirement Income Security Act of 1974 exempts self-insured
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plans from state regulation.381 This exemption provides the self-insured considerable flexibility to design
benefit programs as they see fit, and it provides them with the opportunity to save considerable money
by avoiding state mandates requiring the coverage of particular services.382
Self-insured employers contract directly with providers and reimburse them according to the terms
of the contract. Employers have designed self-insurance programs to provide coverage for their employees using a variety of plans, including indemnity, HMOs, PPOs, and POS.383 However, some states may
prohibit a self-insured employer from signing capitated contracts with physicians.384 The forms used and
the claims process likely will vary by employer, as will the coverage, co-insurance amount, and length
of time for remittance, as the employer will design its plan in accordance with its particular needs.

Self-Pay
Individuals may pay out-of-pocket for their own healthcare costs for a number of reasons, including
a lack of health insurance, a desire to keep a medical condition from their health insurer, or due to the
conscious decision not to purchase health insurance.
Having decided to treat a self-pay patient, a provider must determine what form of payment to accept
for these medical services, what to charge for these services, and how to collect the payment due.
Most public insurers, like Medicare, set their reimbursement rates independently of a provider’s
actual charges.385 In addition, most private insurers have the bargaining power to negotiate discounts.386
However, most self-pay patients will lack the ability to set their payment amount or negotiate lower
charges, and as a result, at times, they have been presented with bills up to two and a half times higher
than what public or private insurers would pay for the same procedure.387 This billing practice has led to
multiple class action lawsuits against providers, and it has resulted in settlements by which the providers offer both prospective and retrospective discounts to their self-pay patients.388 Thus, to avoid costly
litigation at a later date, a provider may choose to offer all self-pay patients discounts similar to those
negotiated by other payors.
Once a provider has determined what form of payment to accept and what to charge self-pay patients, he or she must face the question of how to collect payment. Staff training and a requirement that
the bill be paid in full before the patient leaves can help reduce the chance that the provider will have to
write off the visit as bad debt.389 In addition, some providers require self-pay patients to give both their
driver’s license and Social Security numbers to ensure they are more readily pursuable should collection
become an issue.390

Payor Mix and the Effect on the Revenue Cycle
It is important to realize that a healthcare provider’s payor mix can have a profound impact on their
practice’s financial performance. Today, many providers are reimbursed for treating patients by an array
of payment sources using a variety of payment methods, FFS, capitation, and self-pay, all of which can
affect financial performance.391
When determining the appropriate payor mix to ensure financial viability, providers must be aware
that it is not uncommon for Medicare, Medicaid, and major health plans to reimburse at levels that are
less than the full or average cost of providing the services.392 In addition, providers must take into account the discounts they offer on billed charges to health plans and the uninsured, and they should
consider the likelihood that they may not collect a large portion of the charges billed to the uninsured
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patients they treat.393 Thus, to remain viable, a provider may need to offset the losses incurred on these
patients by increasing the prices charged to other patients, specifically marketing their services to attract
payors that traditionally reimburse at a more favorable level, or limiting the number of patients they will
accept from lower reimbursing payors.
In addition to having an appropriate payor mix, financial viability also may depend on a provider’s
mix of payment methods; having too many or too few of one type of method may negatively affect a
practice’s revenue. When providers are reimbursed on a FFS basis, practice revenues increase as patient visits and the intensity of the services provided increase.394 However, under a capitation payment
method, a provider’s profits are higher if its patients require minimal medical services and have few, if
any, chronic conditions.395 The provider’s mix of self-pay and uninsured patients and their effect on a
provider’s practice is dependent on the patients’ abilities to pay their bills and the effort expended by
the practice to collect the payments. If a majority of the self-pay and uninsured patients are affluent and
have no trouble paying their bills at the time of service, a provider’s revenue may increase, as they can
avoid the billing and collection process altogether. However, if these patients are not affluent or have
trouble paying their bills, it is likely that the practice’s revenue will decrease because it may now have
to make multiple attempts to receive payment through the billing and collection process or write off
the debt altogether. A provider’s awareness of his or her practice’s reimbursement mix and its effect on
financial performance may help ensure financial viability by providing useful insight when considering
new contracts, renegotiating existing contracts, or dropping less lucrative contracts.396

Emerging Reimbursement Trends
Move Toward Capitation
Originally viewed as a cost saving alternative to FFS arrangements, many capitation contracts actually have been replaced by FFS arrangements because the risk can be difficult for physicians to manage
without the requisite economic and actuarial skills.397 A recent study released by the Center for Studying
Health System Change, shows that the shift from FFS remuneration toward capitation as a method of
physician reimbursement has waned from the mid-1990s.398 According to the data, the number of physicians accepting capitated payments fell 9.5 percent, from 54.2 percent in 1996-97, to 44.7 percent in
2004-05.399
However, beginning in 2008, it appears that capitation as a replacement for FFS may be making
a comeback. The resurgence was led, at least in part, by BCBS of Massachusetts and its “Alternative
Quality Contract” (AQC).400 Unlike previous generation capitation plans designed by insurance companies to place the risk on providers while offering little or no rewards for improved quality of care, the
AQC offers providers the opportunity to earn substantial rewards for quality.401 The new contract reimburses providers on a per-member-per-month basis, with increases yearly for inflation, combined with
incentive payments for meeting national standards in quality, effectiveness, and patient experience.402
In addition, in 2008 the Massachusetts state legislature established the Special Commission on the
Health Care Payment System to recommend improvements to the state’s current payment system that
would “motivate and reward effective, efficient, and patient centered care.”403 The commission concluded that the state should transition to a global payment model used by all payors, including the state
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and federal government, within five years.404 The commission recommended that the payment model
include, in addition to other features, accountable care organizations (ACO), consisting of hospitals,
physicians or other clinicians, and nonclinicians, to manage and coordinate care to meet patient needs,
patient-centered care, pay-for-performance (P4P) incentives, and financial risk sharing among ACOs and
carriers.405

Healthcare Reform Efforts
Although healthcare reform has been a recurring policy theme throughout the past few decades, reform
efforts took center stage with the 2008 presidential election and the subsequent leadership under the
Obama administration. Twenty-first century reform efforts share many common themes, all aimed at
combating the problems of uninsured individuals and the rising cost of services.406
A significant amount of reform rhetoric has been defined by proposals of a public insurance option
and a healthcare exchange that would provide consumers with a choice between private insurance and
the government-run plan.407 However, there has been resistance to that idea, and at least one proposal includes the possibility of creating a nonprofit consumer owned and operated health insurance plan instead
of a public option.408 Further, many reform proposals include provisions to penalize individuals who fail
to obtain health insurance coverage, though at least one proposal includes subsidies for the purchase of
health insurance with tax credits.409
Many common elements to the reform proposals exist. Among these elements are
1. the creation of standardized health insurance benefits packages;
2. reforms of state insurance markets for small and nongroup health insurance;
3. limits on an insurer’s ability to charge higher premiums based on health status, gender, and
other factors;
4. the elimination of insurance coverage denials due to pre-existing conditions;
5. prohibitions on cost sharing for preventative treatments;
6. credits to make premiums affordable;
7. limits on out-of-pocket expenses;
8. coverage of preventative services;
9. the promotion of quality healthcare by the use of provider incentives;
10. the elimination of lifetime and annual limits on dollar value for individual and group policies;
and
11. requirements that employers either provide health insurance for their employees or contribute to
a fund on their behalf.410
To control costs, one proposal would implement the use of ACOs and medical homes, as well as
bundle provider payments for acute and post-acute care and simplify paperwork.411 In addition, the plan
would require the restructuring of physician payments under Medicare by eliminating the SGR and
through rewarding primary care services, care coordination, and efficiency.412
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Increased Emphasis on Quality: Pay-for-Performance (P4P)
and Gainsharing
Pay-For-Performance
In the wake of an ongoing national controversy with several recent studies finding that medical errors
are a leading cause of death in the United States, demands have been waged by both private and public payors regarding the accountability of providers. After a 1999 study from the Institute of Medicine
reported that as many as 44,000–98,000 deaths may be linked directly to medical errors, increased focus
has been placed on paying physicians based on the quality of their services, as a way of improving quality and lowering costs.413
A 1999 study from the Institute of Medicine (IOM) reported that as many as
44,000–98,000 deaths may be linked directly to medical errors.
“Errors in Health Care: A Leading Cause of Death and Injury” in “To Err is Human: Building a Safer Health System”
edited by Linda T. Kohn, Janet M. Corrigan and Molla S. Donaldson, Committee on Quality Health Care in America,
Institute of Medicine, 2000, p. 26.

Pay-for-performance (P4P) is a remuneration system in which part of the payment is dependent on
performance as measured against a defined set of criteria.414 Although a P4P system can be structured in
several ways, the common elements to all systems are (1) a set of targets or objectives that define what
will be evaluated; (2) measures and performance standards for establishing the target criteria; and (3)
rewards—typically financial incentives—that are at risk, including the amount and the method for allocating the payments among those who meet or exceed the reward threshold.415 Proponents of P4P remuneration systems argue that they have the potential to improve the quality of care and slow the growth in
healthcare costs through improvements in quality and provider efficiency.416

P4P’s Impact on Practice Revenue
The impact of P4P on quality outcomes has been demonstrated by two distinct studies. A 2003 study
conducted by CMS and Premier, Inc., measured cost and quality improvements among P4P providers for
five different patient populations.417 The study concluded that “if all hospitals nationally were to achieve
the three-year cost and mortality improvements found among the [study] project participants for [the five
different patient populations], they could save an estimated 70,000 lives per year and reduce hospital
costs by more than $4.5 billion annually.”418
A second study, conducted by researchers from University of California, Los Angeles, and supported
by the Hawaii Medical Service Association in Honolulu, showed improved quality of care among P4P
providers in PPO settings, as well as an increased number of patients going to P4P physicians.419 The
study analyzed eleven quality indicators for patients enrolled in PPOs over six years and found that the
patients who visited only physicians who were participating in the study had significantly higher odds of
receiving recommended care as measured by the indicators.420
However, some providers are worried that the transition from a FFS payment system to a P4P model
could have a profound impact on practice revenue. Providers may have to undertake the time consuming process of hand collecting and reviewing the data needed to satisfy reporting requirements or make
a significant capital investment in an electronic health records system.421 Regardless of the collection
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method used, the bonuses for achieving the requisite reporting standards may not be sufficient to offset the costs associated with the data collection process.422 In addition, providers who practice in lowincome, minority communities may see their revenue fall, as it is likely that these providers will miss
out on incentive pay because of lower quality scores due to their treating patients who may be less likely
to obtain preventative care, follow treatment recommendations, and return for further investigation into
abnormal test results than their wealthier counterparts.423

Healthcare Professional Practice Gainsharing Arrangements
The term “gainsharing” refers to a shared savings program “under which a hospital gives physicians a
share of the reduction in the hospital’s costs (that is, the hospital’s cost savings) attributable in part to
the physician’s efforts.”424

History and Background
In 2008, CMS proposed a new exception to the Stark law for certain incentive payment (that is, P4P)
and shared savings programs, including gainsharing arrangements.425 An exception to the Stark law is
necessary, despite the fact that successful gainsharing programs can foster high quality, cost-effective
care, because the arrangements involve making payments to physicians whose efforts contribute to
these successes. The concern is that “improperly designed or implemented programs pose [a high risk of
program or patient abuse],” and that “additional risk is posed by [gainsharing arrangements] that reward
physicians based on overall cost savings without accountability for specific cost reduction measures.”426
Recognizing the potential for abuse, but also the potential to improve quality and cost effectiveness, the
proposed exception to the Stark law for properly structured gainsharing arrangements focuses on three
crucial aspects: transparency, quality controls, and safeguards against payments for referrals.427

Office of the Inspector General’s (OIG’s) Denial and Subsequent Approval
Historically, gainsharing arrangements were found to violate the civil monetary penalty statute and the
antikickback statute, despite the potential cost-saving benefits of well-structured arrangements.428 In
2005, however, the Office of Inspector General (OIG) began to approve gainsharing arrangements in
light of their cost-saving and quality improving potential, despite the fact that the basic arrangements
themselves were still technical violations of the statutes, reasoning that the potential for fraud was reduced when certain safeguards were present.
In those arrangements that it approved, the OIG looked for three types of safeguards: (1) measures
that promote accountability and transparency, (2) adequate quality controls, and (3) controls on payments related to referrals.429 To this end, in 2008, OIG approved an existing arrangement between a
hospital and four cardiology groups and one other radiology group that sought to pay the physicians a
portion of cost savings resulting from physician efficiency.430 The cost savings paid to physicians were
derived from the use of supplies and equipment during certain procedures.431 Savings were created
through the standardization of procedures and reduction in the inappropriate use of supplies and medical
devices.432 Although the agreement could have led to illegal payments to physicians, the transparency
of the calculated payments, a cap on the amount of payments, and the fact that there was found to be no
encouragement for physicians to reduce services, resulted in the OIG declining to issue sanctions against
the group thereby permitted their gainsharing arrangement.433
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Legislative Parameters and Safeguards

To be protected under the exception to the Stark law proposed by CMS, a gainsharing arrangement must
abide by the following requirements. These also represent common elements considered by the OIG
when reviewing a gainsharing arrangement.
1. The arrangement must include patient care quality or cost savings measures (or both) which
are in CMS’s Specifications Manual for National Hospital Quality Measures and supported by
objective, independent medical evidence indicating that the measures would not adversely affect
patient care.
2. The arrangement must employ cost savings measures that use an objective methodology, are verifiable, supported by credible medical evidence indicating that the measures would not adversely
affect patient care, can be traced individually, and reasonably relate to the services provided.
3. The arrangement must be able to be reviewed prior to implementation and at least annually thereafter to ascertain the program’s impact on patient quality of care. Such reviews must be independent medical reviews conducted by a person or organization with relevant clinical expertise.
4. The arrangement must provide for immediate and corrective action (up to and including termination of the program) in the event a review reveals an adverse impact on quality.
5. The arrangement must limit participation in the program to those physicians who are members of
the hospital’s medical staff at the commencement of the program. Participating physicians participate in “pools” of five or more (formed at the commencement of the program) among whom
the aggregate cost savings that result from the efforts of the physicians in the “pool” be shared on
a per capita basis.
6. The arrangement must support the distribution of shared savings program payments with written
documentation.
7. The arrangement may not determine eligibility for physician participation in the program based
on the volume or value of referrals or other business generated between the physician the
hospital.
8. The arrangement may not limit the discretion of physicians to make medically appropriate decisions for their patients, nor may it limit the availability of, or access of physicians to, any specific
item, supply, or device that is linked through objective evidence to improved outcomes, is clinically appropriate, and was available at the commencement of the program.434
Payments made under shared savings programs
1. must be distributed on a per capita basis,
2. may not include any amount that takes into account the provision a greater volume of federal
healthcare patient procedures or services than the volume provided by the participating physician
or qualified physician organization during the period of the same length immediately preceding
the commencement of the program as that covered by the payment, and
3. must be limited in duration (no shorter than one year and no longer than three years) and
amount.435
Two potential ways to limit amount of payments exist, one or both of which may be adopted:
1. limits based on set percentages of cost savings available to hospital through program, and
2. limits to address the risk that physicians will continue to receive financial rewards for already
implemented changes.436
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Also, arrangements in which physicians receive payments for actions taken that result in a reduction
below a predetermined target based on objective historical and clinical measures will not be protected.
Additionally, CMS is considering whether to extend the exception for qualified physician organizations to multispecialty physician practices composed of both PARs and non-PARsparticipating and
nonparticipating physicians. To promote transparency, hospitals and participating physicians will be
required to disclose the nature of the program to patients affected by it.
Requirements related to transparency include:
1. tracking of the ages and payors of the patient population treated by participating physicians (to
prevent cherry picking, etc);
2. limiting physician payment to only that which is related to the physician’s own efforts, combined
with the efforts of the other physicians in their pool, on a per capita basis;
3. applying all measures uniformly to all patients, including Medicare beneficiaries (and not applying them disproportionately to federal healthcare program beneficiaries), with the possibility of
having the program audited; and
4. prohibiting the counseling or promotion of a business arrangement or other activity that violates
any federal or state law.437

Increased Reimbursement to Encourage Implementation of
Electronic Health Records (EHR)
With the passage of the American Recovery and Reinvestment Act of 2009 (ARRA), the government
adopted, as part of the overarching economic stimulus package, a stimulus plan to promote the universal
implementation of electronic health records (EHR).438 Through the Health Information Technology for
Economic and Clinical Health (HITECH) Act, incorporated into the ARRA, providers are incentivized
with increased reimbursement rates to implement EHR systems.439 As part of this process, the HITECH
Act officially established the Office of the National Coordinator for Health Information Technology
(ONCHIT) and HIT Policy and Standards Committees to recommend, develop, and promote a national
HIT infrastructure.440
In particular, the HITECH Act permits the secretary of HHS to appropriate funds each year, beginning 2009 through 2013, to promote the implementation of EHR.441 Under the act, nonhospital-based
physicians will receive financial incentives or penalties through Medicare for use or nonuse of EHRs.
Beginning in 2011, eligible professionals can receive incentive payments of 75 percent of allowed Medicare charges to a total maximum of $44,000 over a five-year period if meaningful use of an EHR system
begins by 2012.442 Adoption by 2013 reduces the total maximum charges to $39,000, and adoption by
2014 reduces the total maximum charges to $24,000.443 Beginning in 2015, practitioners not adopting
meaningful EHR use will receive a 1 percent reduction in their MPFS payment.444 This will increase to a
2 percent penalty in 2016 and 3 percent penalty in 2017. The secretary of HHS will have the discretion,
if less than 75 percent of practitioners have not adopted meaningful use of EHRs before 2018, to raise
the penalty to as high as 5 percent. Medicaid providers will also receive incentives.445
Similarly, hospitals will receive millions of dollars in increased reimbursement under Medicare and
Medicaid for successfully implementing HIT and certified EHR systems.446 Additionally, rural health
clinics, federally qualified health centers, and other providers other than physicians and hospitals will be
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eligible for incentive funding under Medicaid or through grants offered for the implementation of EHR
systems.447
Although the term “meaningful use” has yet to be defined, it would include electronic prescribing,
information exchange between systems, qualitative reporting methods, additional coding of the use of
and EHR system, and the ability to complete survey responses in the system.448 ONCHIT would set standards for EHS systems for the hospital setting and the Certification Commission for Health Information
Technology would certify software meeting this definition. In 2011, funding will become available for
Medicare ($23.1 billion) and Medicaid ($21.6 billion) incentives.449
A total of $1.5 billion will go toward federal grants for the implementation of EHR systems and
capital improvements of EHR systems.450 In 2011, for every $10 the federal government provides toward
state planning and implementation grants to promote HIT, the state must provide $1. In 2012, this ratio
drops to seven to one. Starting in 2013, for every $3 of federal grant money the state must provide $1.451

Reimbursement of Aesthetic and Reconstructive Procedures
As technological advances in recent years have increased the accessibility of plastic surgery, the number
of many procedures has increased despite downswings in the economy. In 2008, there were 17 million
plastic surgery procedures performed in the United States, a number up 3 percent from the previous
year.452 Of these, 12.1 million were cosmetic procedures, divided between surgical (1.7 million) and
minimally-invasive (10.4 million), while 4.9 million were reconstructive procedures.453
Despite this increased prevalence, however, reimbursement for elective cosmetic procedures has
remained minimal. In the field of plastic surgery, the two types of procedures are treated differently by
payors. Aesthetic, or cosmetic, procedures typically are performed at the election of the patient to reshape a normal part of the body to the patient’s satisfaction.454 Because aesthetic procedures are elective
surgeries, they generally are not covered by health insurance plans.455
By contrast, reconstructive procedures are necessary for the correction of physical disfigurement or
function or to restore a normal appearance following trauma or disease.456 Examples include skin grafts
and the rebuilding of bones for burn and accident victims.457 These procedures generally are covered by
most health insurance policies, though specific coverage may vary by procedure, as well as the degree to
which the procedures are covered.458
When procedures that typically are classified as cosmetic are medically necessary to correct a problem or relieve symptoms (for example, a patient needs rhinoplasty to correct a breathing problem), insurance carriers may treat that procedure as reconstructive and cover part or all of the cost of the surgery.459
In such cases, the payor will generally require verification of the true reason for the surgery (that is,
whether it was truly reconstructive or merely cosmetic), as well as require that the physician obtain prior
approval and then supply post-procedure documentation from which the payor can determine how much
it will reimburse.460
Like most private payors, Medicare and Medicaid do not cover cosmetic procedures that are not
medically necessary.461
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Concierge Medicine
Recent years have seen the emergence of the practice of concierge, or boutique, medicine. Although this
trend is further explored in chapter 4, Boutique and Concierge Medicine, and in chapters 1 and 2 of Professional Practices, in terms of reimbursement, it is important to understand that boutique medicine is
not a substitution for traditional insurance. Patients will typically keep their traditional health insurance
to pay for any tests or scans ordered by their physician. Medicare beneficiaries cannot be charged more
than 115 percent of the rate for services, and many politicians have said that the annual fees patients pay
is a lot more than the Medicare rate and, thus, is illegal billing.462

Medical Home Model
The term “medical home” was coined in 1967 and originally was used by the American Academy of Pediatrics “to describe a single source of medical information about a patient.”463 The term evolved overtime and is now used to describe a patient centered model of healthcare delivery and payment reform,
which focuses on improving the quality of care and reducing costs through its emphasis on the role of
primary care.464
The medical home is comprised of seven components: (1) “a personal physician” who provides
a patient with ongoing, comprehensive care; (2) “physician-directed medical practices” in which the
physician and his or her team members assume responsibility for the ongoing care of their patients; (3)
“whole person orientation” which tasks the physician with the responsibility to ensure that the patient
receives all necessary care, including care provided by other qualified healthcare professionals; (4) “coordinated or integrated care” calls for the use of information technology, registries, and health information exchanges to coordinate and integrate patient care within the community; (5) “quality and safety”
improvements through the use of a variety of quality improvement activities, feedback, and evidence
based decision support systems; (6) “improved access” is sought through the timely access to care and
improved communication with patients; and (7) “payment” methods that reimburse physicians for direct
patient interaction, coordinating patient care, adopting information technology for quality improvement,
and achieving quality improvement goals, which allows physicians to share in the savings attributed to
reduced hospitalizations.465
In addition to being endorsed by various medical associations, the medical home model has gained
the attention of the federal government. The Tax Relief and Health Care Act of 2006 mandated a Medicare medical home demonstration project to measure the effectiveness of the model.466 The two-year
project will examine the efficacy of “targeted, accessible, continuous, and coordinated care to Medicare beneficiaries with chronic or prolonged illnesses requiring regular medical monitoring, advising,
or treatment” and is slated to run from 2010 through 2012.467 This reform initiative is also discussed
in chapters 2 and 3 of Professional Practices—as well as various sections in chapter 2 of Professional
Practices.

Payment Bundling
Bundling is a method of reimbursement that combines institutional and professional charges into a
single payment (see chapter 4, Physician or Provider Suppliers, and chapter 2 in Professional Practices).468 Recently, several proposals have been advanced by legislators to reduce Medicare costs by
various methods of bundling payments to hospitals and physicians for services provided over the course
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of a patient’s treatment plan. This trend is demonstrated by the United States Senate Finance Committee’s “Proposals to Improve Patient Care and Reduce Health Care Costs,” whereby it released a plan to
use the bundling of payments for inpatient and post-discharge care.469 Further, CMS has also created a
pilot program to examine the benefits of bundling Part A and Part B Medicare payments.470
The intent of the Senate Finance Committee’s proposal is to bundle payments for acute inpatient
care and post-acute care occurring or initiating up to thirty days following a patient’s discharge, including home health, skilled nursing, rehabilitation, and long-term hospital services. This bundled payment
would include the inpatient Medicare Severity Diagnosis-Related Group (MS-DRG) amount plus postacute care costs for the treatment of patients in that MS-DRG, including any expected or planned readmissions within the thirty-day window. Although the hospital would receive the bundled payment even
if no post-discharge care was given, the bundled amount will have already been adjusted to “capture savings from the expected efficiencies gained from improving patient care and provider coordination within
the bundled payment system.”471
In addition to the Senate Finance Committee’s proposals, the Acute Care Episode Demonstration
(ACE) project is a pilot program developed by CMS to provide for greater efficiencies and continuity of
care amongst Part A and Part B providers (also discussed in chapter 2 of Professional Practices). The
three-year program effectively eliminates the MPFS and provides one, global payment under the IPPS.
The new, bundled payment will cover both hospital and physician fees for one “episode of care” for
cardiovascular or orthopedic procedures. Participating sites (referred to as “Value-Based Care Centers”)
have met certain volume thresholds, have quality care initiatives in place, and have competitively bid for
their bundled DRG payments. The program also provides for gainsharing arrangements with physicians
who meet or exceed quality standards.472 Further, patients who choose to receive care from participating
demonstration providers based on quality and cost are eligible to receive up to 50 percent of the savings
to Medicare, as long as such payments do not exceed the patient’s Part B premium of $1,157 per year.473
Proponents of bundled payments assert that the move toward bundled payments could provide
higher coordination between providers and more efficient levels of care.474 However, critics articulate
concern regarding the level of savings and patient care improvement that a blanket bundling of payments
will actually generate. For example, the AMA expressed concern that such bundling proposals could
result in the withholding or limiting of appropriate post-discharge or inpatient services.475 The AMA
also called for the appropriate distribution of the payments to individual providers, risk-adjustment for
patients whose care exceeds the amount accounted for in the bundled payment, and safeguards to ensure
that patient care decisions remain in the hands of the individual providers.476 Similarly, in a letter to the
Senate Finance Committee, the American Hospital Association stated that the administration’s approach
to bundling payments was “problematic” and would require a “paradigm shift in health service delivery” resulting in the revision or withdrawal of numerous regulations promulgated to manage the current
healthcare delivery and payment system.477 Finally, the American Association of Medical Colleges,
which supports the concept of care coordination provided through bundling, criticized Medicare’s ACE
program for not ensuring that payments are made directly to all parties (that is, physicians) who provide
the services.478
Although no actual bundling policy has been implemented, recent actions by both the Senate and
CMS have demonstrated that such initiatives on the healthcare horizon and may soon become a part of
the healthcare reimbursement environment.

100

V1-B-Chapter 02.indd 100

9/28/10 3:17 PM

C hap ter 2 : R ei mbu r semen t E n vi ron men t

Accountable Care Organizations (ACOs)
Also being proposed for inclusion in the healthcare reimbursement environment is a concept called
the “accountable care organization” (ACO) or accountable care system.479 These entities would bring a
patient’s healthcare providers voluntarily together in order to better coordinate patient care.480 This could
be a combination of primary care physicians, nurse practitioners, specialists, and allied health practitioners, as well as hospitals, nursing homes, ASCs, or any other entity in the patient’s continuum of care.481
Because of this, ACOs could more effectively implement initiatives to improve the quality and control
the cost of care and be held accountable for the resulting outcomes and spending.482 This method can be
distinguished from the medical home model discussed previously because a separate entity focuses on
coordinating all of a patient’s healthcare providers instead of placing the responsibility on physicians
and their staff.483 A combination of additional physician payment updates, capitation, P4P, and gainsharing bonuses could be used to incentivize healthcare providers to join ACOs and reduced co-insurance or
lower deductibles could be used to incentivize private-pay patients.484 For more information see chapter
2 in Professional Practices.

Conclusion
Major shifts are taking place in the healthcare reimbursement environment. As healthcare reform efforts
that focus on reducing costs begin to gain traction, providers may feel even more squeezed between the
cost of services and the value of reimbursement. As more emphasis is placed on quality improvement
efforts like P4P and gainsharing, however, providers are likely to see increased efficiency, which should
reduce the cost of service and give providers some degree of reprieve. These trends will most likely be
dictated by federal and state government payors, which, as the benchmarks for all healthcare reimbursement, will lead any future developments of the reimbursement environment.

Key Sources

Key Source

Description

Citation

Hyperlink

United States Department of
Health and Human Services (HHS)

“The Department of Health and Human Services
(HHS) is the United States government’s principal agency for protecting the health of all Americans and providing essential human services.”
HHS has eleven agencies, among which are the
Centers for Medicare and Medicaid Services
(CMS), Indian Health Services (IHS), the Office
of the Inspector General (OIG), and the National
Institutes of Health (NIH).

“About HHS,” Department of
Health and Human Services,
www.hhs.gov/about/ (accessed
October 6, 2009).

www.hhs.gov

Centers for Medicare and
Medicaid Services (CMS)

CMS administers the Medicare, Medicaid, and
CHIP programs. CMS is responsible for setting
reimbursement rates under Medicare and
Medicaid. The CMS website contains important
information for beneficiaries of these programs,
as well as for guidelines for providers.

“Mission, Vision & Goals:
Overview” Centers for Medicare
and Medicaid Services, U.S. Department of Health and Human
Services, www.cms.hhs.gov/
MissionVisionGoals/ (accessed
September 22, 2009).

www.cms.hhs.gov
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Key Source

Description

Citation

Hyperlink

United States Department of
Health And Human Services (HHS)
Office of Inspector General (OIG)

The OIG of HHS oversees all of the department’s
programs in order to protect the integrity of
the programs and the health and welfare of
beneficiaries.

“Office of the Inspector General,”
U.S. Department of Health and
Human Services, http://oig.hhs.
gov/ (accessed September 22,
2009).

http://oig.hhs.gov

TRICARE

The TRICARE website provides useful information to program beneficiaries.

“TRICARE,” www.tricare.mil
(accessed October 6, 2009).

www.tricare.mil/

Civilian Health and Medical
Program of the Department of
Veteran Affairs (CHAMPVA)

The CHAMPVA page of the U.S. Department of
Veterans Affairs website provides useful enrollment and benefit information for CHAMPVA
enrollees.

“Department of Veterans
Affairs Health Administration
Center: CHAMPVA,” United States
Department of Veterans Affairs,
www.va.gov/hac/for
beneficiaries/champva/champva.
asp (accessed October 6, 2009).

www.va.gov/hac/
forbeneficiaries/champva/
champva.asp

Indian Health Services (IHS)

IHS is a division of HHS, and the website
provides comprehensive information on the
activities of IHS, as well as useful information
on health programs for Native Americans and
Alaska Natives.

“Indian Health Service,” www.
ihs.gov (accessed October 6,
2009).

www.ihs.gov

BlueCross BlueShield (BCBS)

The website of the BlueCross BlueShield Association contains information on regional BCBS
carriers, as well as up-to-date news affecting the U.S. healthcare and health insurance
industries.

“BlueCross BlueShield Association,” www.bcbs.com (accessed
October 6, 2009).

www.bcbs.com

Department of Labor (DOL)

The DOL website includes information regarding
employer sponsored health insurance plans and
the laws that govern them, such as the Employment Retirement Income Security Act.

“Health Plans and Benefits,”
United States Department of
Labor, http://www.dol.gov/dol/
topic/health-plans/index.htm
(accessed October 6, 2009).

www.dol.gov
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Appendix A

Changes in Medicare Payments in Select Industry Sectors
From 2005–Present
2006–07

General Practice

2%

0.20%

3%

0%

0%

6%

Internal Medicine

2%

-0.10%

5%

0%

0%

5%

Surgical
Specialties

General Surgery

2%

0.20%

0%

-1%

0%

4%

Orthopedic Surgery

1%

-0.40%

-1%

-1%

0%

2%

Medical
Specialties

Anesthesiology

2%

-0.70%

-7%

14%

-1%

3%

Radiology

2%

0.40%

-5%

0%

0%

-16%

Chiropractor

1%

-1.30%

-8%

-2%

-1%

4%

Podiatrist

2%

1.30%

-1%

2%

2%

6%

Nurse Anesthetist

2%

-0.40%

-8%

22%

0%

4%

Physical or
Occupational
Therapist

-1%

1.50%

-5%

1%

1%

8%

Diagnostic Testing
Facility

3%

-2.40%

-2%

0%

-1%

-34%

(1)

(2)

(3)

(5)

(6)

Primary
Care

2005–06

Allied Health
Practitioners

Specialties

Suppliers

Mid-Level
Providers

Practitioners
Source

2007–08

(4)

2008–09

2009–10
(Jan.-Feb.)

2004–05

Sources:
1 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2005; Final Rule”, Federal Register, Vol. 69, No. 219 (November 15, 2004),
p. 66401 (change in total allowed charges).
2 “Medicare Program; Revisions to payment policies under the Physician Fee Schedule for Calendar Year 2006; Proposed Rule” Federal Register, Vol. 70, No. 151 (August 8, 2005),
p. 45860.
3 “Medicare Program; Revisions to Payment Policies, Five-Year Review of Work Relative Value Units, Changes to the Practice Expense Methodology Under the Physician Fee Schedule, and Other Changes to Payment Under Part B; Revisions to the Payment Policies of Ambulance Services Under the Fee Schedule for Ambulance Services; and Ambulance
Inflation Factor Update for CY 2007,” U.S. Department of Health and Human Services: Centers for Medicare and Medicaid Services, Federal Register, Vol. 71, No. 231,
December 1, 2006, p. 69766.
4 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, and Other Part B Payment Policies for CY 2008”, Federal Register, Vol. 72, No. 227
(November 27, 2007), p. 66390.
5 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, and Other Part B Payment Policies for CY 2009”, Federal Register, Vol. 73, No. 130
(July 7, 2008), p. 38595.
6 “Medicare Program, Payment Policies Under the Physician Fee Schedule, and Other Part B Payment Policies for CY 2010, Proposed Rule”, Federal Register, Vol. 74, No. 132
(July 13, 2009), p. 33661.
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Appendix B

Sample Analysis of Compensation—General Surgery
Table 1: Range of Annual Total Compensation (Excluding Trauma Call Coverage) per Level of Work RVU Productivity
A

B

C

D

E

F

Work
RVUs
(1)

WRVU
per
Physician
(2)

Base
Cash
Compensation
(3)

Incentive
Comp
wRVU>8,500
(4)

Productivity
Incentive
Payment
(5)

Total
Productivity
Cash
Compensation
(6)

7,000

$45.00

$ 315,000

$ 0.00

$      0

$ 335,000

7,500

$45.00

$ 340,000

$ 0.00

$      0

$ 360,000

8,500

$45.00

$ 380,000

$10.00

$      0

$ 400,000

1,100

$45.00

$ 480,000

$10.00

$ 22,000

$ 500,000

30,500

$45.00

$1,400,000

$10.00

$220,000

$1,420,000

Notes

N=

MGMA WRVU—ALL

(13)

671

AMGA WRVU—ALL

(15)

756

Sullivan Cotter WRVU—ALL

(16)

181

Weighted Average Industry Annual WRVU Production

(17)

Table 2: Industry Annual Work RVU Production (wRVU)

Table 3: Industry Annual Compensation per Work RVU

Notes

N=

MGMA Comp/WRVU—ALL

(13)

671

AMGA Comp/WRVU—ALL

(15)

756

Sullivan Cotter Comp/WRVU—ALL

(16)

181

Weighted Average Industry Compensation per Work RVU

(19)

Notes:
1. Hypothetical total annual work RVUs to be performed by employed physicians.
2. According to hypothetical agreements, employed physicians will be compensated $45.00 for each work RVU generated.
3. Calculated base cash compensation given per work RVU production in Column A ($45/work RVU).
4. Per hypothetical agreements, employed physicians will be compensated an incentive amount of $10.00 for each work RVU generated above 8,500.
5. Calculated compensation given per work RVU production in Column A ($55/work RVU for over 8,500 work RVU).
6. Calculated cash compensation given per work RVU production in Column A, that is, $45/work RVU under 8,501 and $55/work RVU over 8,500 (Column C + Column E).
7. Per hypothetical agreements, employed physicians will be compensated for meeting established quality of care and patient satisfaction performance measures of up to $20,000
per each year of the Employment Term.
8. Calculated cash compensation given per work RVU production in Column A, that is, $45/work RVU under 8,501 and $55/work RVU over 8,500 + Quality Incentive Payment
(Column C + Column E + Column G).
9. Total nose coverage cost to subject enterprise per employed physician.
10. One-fifth of nose coverage cost (Column J5) (assuming amortization of nose coverage cost over five-year employment agreement).
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G

H

I

J

K

L

Quality
Incentive
Payment
(7)

Total
Cash
Compensation
(8)

Total
Nose
Coverage
Cost
(9)

Annual
Nose
Coverage
Cost
(10)

Total
Annual
Compensation
(11)

Total
Compensation
per WRVU—
Excluding
Trauma Call
(12)

$20,000

$ 335,000

$82,000.00

$16,400

$ 351,400

$ 50.20

$20,000

$ 360,000

$82,000.00

$16,400

$ 376,400

$ 50.19

$20,000

$ 400,000

$82,000.00

$16,400

$ 416,400

$ 48.99

$20,000

$ 522,000

$82,000.00

$16,400

$ 538,400

$489.45

$20,000

$1,640,000

$82,000.00

$16,400

$1,656,400

$ 54.31

Survey Weight of
Consideration
(18)

25th
Percentile

Median

Mean

75th
Percentile

90th
Percentile

33%

5,565

6,893

7,308

8,703

10,681

33%

5,410

7,163

7,585

9,537

11,002

33%

5,250

6,335

6,858

8,004

10,114

100%

5,577

6,936

7,383

8,803

10,703

SurveyWeight of
Consideration
(18)

25th
Percentile

Median

Mean

75th
Percentile

90th
Percentile

33%

$41.13

$49.25

$54.09

$59.94

$77.51

33%

$37.68

$48.07

$50.95

$62.00

$74.25

33%

$36.69

$45.26

$47.45

$54.59

n/a

100%

$42.26

$50.11

$53.41

$61.46

$76.83

11. Calculated cash compensation given per work RVU production in Column A, that is, $45/work RVU under 8,501 and $55/work RVU over 8,500 + Quality Incentive Payment +
amortization of nose coverage (Column H + Column J).
12. Calculated proposed total annual compensation (Column L5) divided by Work RVUs generated (Column B5).
13. Industry Annual Work RVU Productivity for all general surgeons. Source: Medical Group Management Association (MGMA) “Physician Compensation and Production Survey 2009
Interactive Report Based on 2008 Data.”
14. Industry Annual Work RVU Productivity for midwest general surgeons. Source: Medical Group Management Association (MGMA) “”Physician Compensation and Production
Survey 2009 Interactive Report Based on 2008 Data.”
15. Industry Annual Work RVU Productivity for all general surgeons. Source: American Medical Group Association (AMGA) “2009 Medical Group Compensation and Financial Survey:
2009 Report Based on 2008 Data.”
16. Industry Annual Work RVU Productivity for all general surgeons. Source: Sullivan Cotter and Associates, Inc. “2008 16th Annual Physician Compensation and Productivity Survey
Report.”
17. Weighted average industry annual work RVU production based upon survey weight of consideration (Column D).
18. Survey weight of consideration based upon geographical location and number of survey responses.
19. Weighted average industry compensation per work RVU based upon survey weight of consideration (Column D).
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Corporate Practice
of Medicine

The corporate practice of medicine doctrine was created by the American Medical
Association (AMA) to protect the public as well as the profession of medical doctors.
The doctrine essentially bans unlicensed individuals and entities from engaging in
the practice of medicine by restricting them from employing licensed physicians.
The intent of the doctrine was to ensure that only licensed professionals delivered
medical care and that lay persons and entities not influence treatment decisions.
The premise underlying the doctrine was that it would protect patients from
potential abuses because commercialized medicine would ultimately divide a
physician’s loyalty between profits and the delivery of quality patient care.

“Corporate Medicine in 21st Century Health Care,”
John W. Jones, Esq., Physician’s News Digest, June
2007, www.physiciansnews.com/law/607jones.
html, (accessed July 9, 2009); People v. United
Medical Services, 362 Ill. 442, 200 N.E. 157, 163
(1936).

Health Insurance
Portability and
Accountability Act of
1996 (HIPPA)

The HIPAA Privacy Rule provides standards for the use and disclosure of “protected
health information” (PHI) to safeguard patient privacy. PHI is anything that relates
to a patient’s past, present, or future physical or mental health condition and the
provision of healthcare services to the patient and the past, present, or future
payment for the provision of healthcare to the individual. The Privacy Rule governs
health plans, healthcare clearinghouses, and any healthcare provider that transmit
health information in electronic form in connection with a transaction for which the
secretary of Department of Health and Human Services (HHS) has adopted HIPPA
standards (“covered entities”). The act was updated by the Health Information
Technology for Economic Clinical Health (HITECH) Act, located within the Recovery
and Reinvestment Act of 2009, and allows patients to request an audit trail that
shows all disclosures of their PHI, prohibiting the sale of a patient’s PHI without
his or her authorization, and requiring individuals to be notified if there is an
unauthorized disclosure or use of their PHI.

45 C.F.R. 160.103; 45 C.F.R. 164; “Summary of
the HIPAA Privacy Rule,” OCR Privacy Brief, United
States Department of Health and Human Services,
May 2003, p. 4, www.hhs.gov/ocr/privacy/hipaa/
understanding/summary/privacysummary.pdf
(accessed June 17, 2009).

False Claims Act
(FCA)

Creates civil liability for knowingly presenting false or fraudulent claims for
reimbursement to the federal government. Amended in 1986, it has become one
of the primary weapons used to combat healthcare fraud. Under the statute’s qui
tam (whistleblower) provisions, any private citizen can enforce the FCA by filing
a complaint alleging fraud against the federal government. The incentive is the
potential to share in the recovery of any ill-gotten funds. In 1998, the Office of
Inspector General (OIG) and the Department of Justice issued guidelines limiting
enforcement actions.

“False Claim Act” 31 U.S.C. 3729; “Health Care
Fraud Report: Fiscal Year 1998,” Department
of Justice, justice.gov, 1998, www.justice.gov/
dag/pubdoc/health98.htm#national (accessed
December 9, 2009); “False Claims Act” 31 U.S.C.A.
§3730(d)(1).

Covered Entities
Under HIPAA

“Health plans, healthcare clearinghouses, and any health care provider who
transmits health information in electronic form in connection with a transaction
for which the Secretary of HHS [Department of Health and Human Services] has
adopted [HIPAA] standards.”

“Summary of the HIPAA Privacy Rule,” OCR
Privacy Brief, United States Department of Health
and Human Services, May 2003, p. 2, www.hhs.
gov/ocr/privacy/hipaa/understanding/summary/
privacysummary.pdf (accessed June 17, 2009).

Office of the
Inspector General
(OIG)

“The mission of the Office of Inspector General (OIG), as mandated by Public Law
95-452 (as amended), is to protect the integrity of Department of Health and Human
Services (HHS) programs, as well as the health and welfare of the beneficiaries
of those programs. OIG has a responsibility to report both to the Secretary and
to the Congress program and management problems and recommendations to
correct them. OIG’s duties are carried out through a nationwide network of audits,
investigations, evaluations and other mission-related functions performed by OIG
components.”

“Mission.” U.S Department of Health Services,
Office of the Inspector General, http://oig.hhs.gov/
(accessed July 14, 2009).

The Department of
Health and Human
Services (HHS)

“The Department of Health and Human Services (HHS) is the United States
government’s principal agency for protecting the health of all Americans and
providing essential human services, especially for those who are least able to help
themselves.”

“About HHS,” U.S Department of Health and Human
Services, www.hhs.gov/about/ (accessed July 14,
2009).

Fraud Enforcement
and Recovery Act of
2009 (FERA)

Expands government resources to combat fraud in the housing and mortgage
arena, and expands the scope of the FCA by clarifying the term knowingly to
mean; a person who acts, “1) has actual knowledge of the information; 2) acts
in deliberate ignorance of the truth or falsity of the information; or, 3) acts in
reckless disregard of the truth or falsity of the information.” FERA also reduces the
government’s burden of proof, no longer requiring it to provide “proof of specific
intent to defraud,” and expanded the definition of claim.

Sec. 4 Clarifications to the False Claims Act to
Reflect the Original Intent of the law,” United States
Senate, Fraud Enforcement and Recovery Act
S.386, April 2009, http://thomas.loc.gov/cgi-bin/
query/F?c111:3:./temp/~c111f3yFGF:e10867:
(accessed May 1, 2009); “Fraud Enforcement and
Recovery Act of 2009 (FERA),” Anne Sharamitaro,
Esq. and Kelly Gordon, Health Capital Topics, Vol. 2,
No. 5, May 2009.
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Health Care Quality
Improvement Act
of 1986

Among other things, established the National Practitioner Data Bank to improve the
availability of information obtained during the peer review process.

“Title IV of Public Law 99-660: The Health Care
Quality Improvement Act of 1986.”

Medicare and
Medicaid Patient &
Program Protection
Act of 1987
(MMPPPA)

Amended the 1987 antikickback statute by including an alternative civil remedy to
violation: exclusion from the Medicare Program.

“Medicare and State Health Care Programs: Fraud
and Abuse,” OIG Anti-Kickback, Department of
Health and Human Services, July 29, 1991, 42
CFR Part 1001.; “Medicare and Medicaid Patient &
Program Protection Act of 1987,” Pub. L. 100-93
(Aug. 18, 1987).

National Health
Planning and
Resources
Development Act
of 1974

Legislation that pushed Certificate of Need regulations to the forefront of
government healthcare cost containment efforts. The act required that federal
agencies pass health policy planning guidelines and establish “a statement of
‘national health planning goals’ ”.

“The National Health Planning and Resources
Development Act of 1974,” Pub. L. No. 93-641,
Jan. 4, 1975, § 1501; Frank A. Sloan, et. al., Cost,
Quality, and Access In Health Care: New Roles for
Health Planning In A Competitive Environment, p.
31 (Josey-Bass Publishers 1988).

Balanced Budget
Act of 1997

Added a civil monetary penalty of treble damages, or three times the illegal
remuneration, plus $50,000 per violation of the antikickback statute.

“The Balanced Budget Act of 1997,” Pub. L. 10533, Section 4304 (Aug. 5, 1997).

Patient Safety and
Quality Act (PSQIA)

Legislation that established a voluntary reporting system for medical errors to
increase the availability of such and more efficiently address issues related to
patient care and quality.

“Patient Safety and Quality Improvement; Final
Rule” 42 CFR Part 3, Center for Medicare and
Medicaid Services, November 21, 2008, p. 70732.

Health Information
Technology for
Economic Clinical
Health (HITECH) Act

Legislation used to promote widespread adoption of health information technology,
particularly electronic health records (EHRs). Also used to protect the privacy
and security of PHI by allowing patients to request an audit trail that shows all
disclosures of their PHI, prohibiting the sale of a patient’s PHI without his or her
authorization, and requiring individuals to be notified if there is an unauthorized
disclosure or use of their PHI.

“Health Information Technology for Economic and
Clinical Health,” found in “American Recovery and
Reinvestment Act of 2009,” Pub. L. No. 111-5
(Feb. 17, 2009), Title XIII.

Stark Law

The federal physician self-referral law, or “Stark law,” prohibits physicians from
referring Medicare or Medicaid patients to an entity for designated health services
(defined by HHS) if the physician, or an immediate family member, has a financial
relationship with that entity. It began in 1989 and has been revised many times.

42 U.S.C. 1395nn(a)(1)(A); 60 Fed. Reg. 41914
(Aug. 14, 1995); 69 Fed. Reg. 16054 (Mar. 26,
2004); “Phase III Regulations Result in Dramatic
Changes to Stark Law,” J. Kelly Barnes, et al., BNA
Health Law Reporter, Vol. 16, No. 40, October 11,
2007, p. 1220; 72 Fed. Reg. 51028 (Sept. 5, 2007).

Stark I (1989)—The Ethics in Patient Referrals Act—physicians can’t refer to family
members.
Stark II Phase I (2002) and Phase II (2004)—physicians can’t refer if they have an
ownership interest.
Stark II Phase III (2007)—any financial arrangement is a direct compensation
arrangement.
Stark IV (2009)—physician with any ownership is considered part of the whole
physician organization.
There are many specified exceptions to Stark law.
Antikickback
Statute

Enacted in 1972, the federal antikickback statute makes it a felony for any person
to “knowingly and willfully” solicit or receive or to offer or pay, any “remuneration”
directly or indirectly in exchange for the referral of a patient for a healthcare service
paid for by a federal healthcare program. Penalties were amended by Medicare and
Medicaid Patient and Program Protection Act of 1987 and The Balanced Budget Act
of 1997. Congress enacted “safe harbors,” which detail specific regulatory criteria
that must be met to shield an arrangement from liability and are meant to protect
practices unlikely to result in fraud or abuse.

“Criminal Penalties for Acts Involving Federal
Health Care Programs” 42 U.S.C.A. § 1320a-7b(b).

Centers for
Medicare and
Medicaid Services
(CMS)

Regulate Medicare and Medicaid reimbursements and services in an attempt to
“ensure effective, up-to-date health care coverage and to promote quality care for
beneficiaries.”

“Mission, Visions & Goals,” Department of Health
and Human Services, Centers for Medicare
and Medicaid Services, www.cms.hhs.gov/
MissionVisionGoals/ (accessed July 14, 2009).
(continued)
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Osteopath

“Osteopathic medicine is dedicated to treating and healing the patient as a whole,
rather than focusing on one system or body part. An osteopathic physician will often
use a treatment method called osteopathic manipulative treatment (also called
OMT or manipulation)—a hands-on approach to make sure that the body is moving
freely. This free motion ensures that all of your body’s natural healing systems are
able to work unhindered. A doctor of osteopathic medicine (D.O.) is a physician
licensed to practice medicine, perform surgery, and prescribe medication.”

“Doctor of Osteopathy” Medical Encyclopedia,
National Library of Medicine, www.nlm.nih.gov/
medlineplus/ency/article/002020.htm (accessed
July 14, 2009).

Medicare
Prescription Drug,
Modernization, and
Improvement Act of
2003 (MMA)

Implemented an eighteen-month moratorium on the development of new specialty
hospitals, which represented a compromise between the idea that the “whole
hospital” exception should be removed for all hospitals and the position of removing
it only for specialty hospitals. The moratorium officially ended on June 8, 2005.

“Medicare Prescription Drug, Modernization, and
Improvement Act of 2003” §507(a)(1)(B); “Valuation
of Healthcare Ancillary Service Providers,” Robert
James Cimasi ASA, CBA, AVA, FCBI, CM&A, CMP,
President, Health Capital Consultants, National
Association of Certified Valuation Analysts:
Consultants’ Training Institute 2007, September 13,
2007, p. 10.

Emergency Medical
Treatment and
Active Labor Act
(EMTALA)

Enacted by Congress in 1986 “to ensure public access to emergency services
regardless of ability to pay. Section 1867 of the Social Security Act imposes specific
obligations on Medicare-participating hospitals that offer emergency services
to provide a medical screening examination (MSE) when a request is made for
examination or treatment for an emergency medical condition (EMC), including
active labor, regardless of an individual’s ability to pay. Hospitals are then required
to provide stabilizing treatment for patients with EMCs. If a hospital is unable to
stabilize a patient within its capability, or if the patient requests, an appropriate
transfer should be implemented.”

“EMTALA Overview” Department of Health and
Human Services, Centers for Medicare and
Medicaid, www.cms.hhs.gov/emtala/ (accessed
July 14, 2009).

Certificate of Need
(CON)

Requires that healthcare providers obtain state approval before either developing
new services, or expanding existing services.

“Certificate-of-Need Law in Illinois Slammed
by Feds, AMA” by Amy Lynn Sorrel, American
Medical News, Oct. 6, 2008, www.ama-assn.org/
amednews/2008/10/06/gvsb1006.htm, (accessed
June 22, 2009).

Sherman Antitrust
Act

Prohibits any “contract, combination . . . or conspiracy, in restraint of trade or
commerce to combat unfair competition and abuse of monopolistic power.” Used by
federal government to combat kickbacks and self-referral joint ventures.

15 U.S.C. § 1; “Health Care Fraud: Enforcement
and Compliance,” By Robert Fabrikant, et al., Law
Journal Press, 2007, p. 2-59-2-60.

Racketeer
Influenced
and Corrupt
Organizations Act

Federal law which carries both criminal and civil penalties with the aim of
protecting the public from, “parties who conduct organizations affecting interstate
commerce through a pattern of criminal activity.” Makes it illegal for any person
to use or invest any income derived from a “pattern of racketeering activity” in
an enterprise, to acquire or maintain control of any enterprise through a pattern
of racketeering activity, and for any person employed by or associated with any
enterprise to conduct the affairs of the enterprise through a pattern of racketeering
activity.

“Health Care Fraud: Enforcement and Compliance,”
by Robert Fabrikant, et al., Law Journal Press,
2007, p. 3-84, quoting 115 Cong. Rec. 9566, 9568
(April 18, 1969), statement of Sen. McClellan; 18
U.S.C. 1962.

The Occupational
Safety and Health
Act of 1970

Established standards for occupational health and safety, and requires states
to enact legislation implementing standards and procedures developed by the
Department of Labor.

“Individual Providers and Caregivers,” “Problems
in Health Care Law, Ninth Edition,” Robert D. Miller,
Jones and Bartlett Publishers, 2006, p. 184–85.

Clinical Laboratory
Improvement Act
(CLIA)

Requires laboratories to regulate all laboratory testing performed on humans,
except the testing performed for research purposes, in order to improve the
accuracy, reliability, and timeliness, of test results. Requires that healthcare
providers that perform laboratory testing on specimens derived from humans to
obtain a certificate and abide by established standards in order to operate these
services. Overseen by CMS.

“Overview: Clinical Laboratory Improvement
Amendments” Centers for Medicare and Medicaid
Services, May 07, 2009, www.cms.hhs.gov/clia/,
(accessed June 30, 2009); “Clinical Laboratory
Improvement Amendments” United States Food
and Drug Administration, June 16, 2009.

The United States
Nuclear Regulatory
Commission (NRC)

An independent agency created by Congress in 1974 to ensure the safe use of
radioactive material (including those used in medical facilities) for civilian purposes
through a combination of regulatory requirements, licensing, safety oversight,
operational evaluation, and support activities. Under section 274 of the Atomic
Energy Act of 1954, the NRC is authorized to delegate its authority to oversee
certain licensees to state regulatory commissions, or agreement states.

“Medical, Industrial, and Academic Uses of Nuclear
Material” United States Nuclear Regulatory
Commission, June 02, 2008, www.nrc.gov/
materials/medical.html, (accessed June 30, 2009);
The Atomic Energy Act of 1954, Public Law 83-703,
68 Stat. 919 Sec. 274 August 30, 1954.
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Section 1122
of the 1972
Social Security
Amendments

Allowed the secretary of Health, Education, and Welfare to enter into agreements
with states that had a “designated planning agency,” an agency responsible
for determining whether healthcare facilities could make capital expenditures.
States failing to institute health policy planning programs could lose Medicare and
Medicaid cost reimbursement.

“Compilation of the Social Security Laws:
Limitation on Federal Participation for Capital
Expenditures,” United States Government, Sec.
1122, 2009, www.socialsecurity.gov/OP_Home/
ssact/title11/1122.htm (accessed
January 4, 2010).

Medical Injury
Compensation
Reform Act

California legislation that caps pain and suffering and malpractice damages.

Cal. Civ. Code § 3333.2.

Help Efficient,
Accessible,
Low-Cost, Timely
Healthcare Act of
2009

Introduced before the U.S. House of Representatives in February 2009 as a new
attempt to pass a federal cap on noneconomic damages in medical malpractice
suits, which has been a continuing congressional goal since the same bill was first
introduced in the House in 2002.

“H.R. 4600: Help Efficient, Accessible, Low-Cost,
Timely Healthcare (HEALTH) Act of 2002: Related
Legislation,” govtrack.us, www.govtrack.us/
congress/bill.xpd?bill=h107-4600&tab=related
(accessed September 8, 2009).

Federal Trade
Commission (FTC)
Act

Prohibits “unfair methods of competition in or affecting commerce . . .,” One of the
federal government’s primary means of combating unfair competition and abuse of
monopolistic power.

15 U.S.C. § 1.

Deficit Reduction
Act (DRA)

Enacted February 8, 2006, and continued the suspension of CMS’s enrollment of
new specialty hospitals (from MMA) for about six months, until the release of the
CMS’s final report on specialty hospitals as required by the DRA.

“Moratorium on Specialty Hospitals Expires” by
Jennifer Gordon, Dallas Business Journal, http://
assets.bizjournals.com/dallas/stories/2005/06/20/
story8.html (accessed June 25, 2009).

Overview
The U.S. healthcare industry is replete with overlapping state and federal regulations which shape the
practice of medicine and delivery of healthcare services in the twenty-first century. A significant number
of regulations apply to both physician and nonphysician practitioners. While regulation has traditionally
been directed at physicians and allied health professionals, regulation of mid-level providers has increased resulting from the expanding scope of services provided under their own Medicare or Medicaid
provider numbers. This chapter discusses the general provisions of federal and state regulations, noting
whether they apply solely to medical professionals or to allied health professionals and mid-level providers as well. The regulatory environment surrounding these specific professions will be examined in
further detail in the chapters dedicated to each profession.

Healthcare Liability
Generally speaking, liability is a measure of responsibility and accountability under the law.1 Liability
within healthcare is uniquely allocated, as practitioners and practices cannot completely shelter each
other from all the various laws governing medicine. Historically, healthcare professionals were liable
solely for their professional actions, that is, the provision of medical care to patients. As healthcare grew
in complexity, from the practice of medicine to the business of medicine, practitioners began to face
liability as industry entrepreneurs as well. As such, liability in healthcare can be classified, as it affects
both practice and practitioner, into three distinct categories: professional liability, financial liability, and
tax liability (see chapter 1 in Professional Practices).2 Hospitals and practices, as business enterprises,
are held liable for the way in which they file their taxes; depending on the affiliation, ownership, and arrangement structure, a practitioner can be held liable for tax purposes as well (see IRS Tax Status).3 Practitioners with ownership interest may be financially liable for any violations related to business practices
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and, as a result, may suffer personal losses (see Fraud and Abuse Laws).4 Lastly, each practitioner shoulders a certain amount of professional liability for services rendered based on their scope of practice and
supervision or supervisory status (see Tort Reform).5 As healthcare grows in complexity, both medically
and entrepreneurially, the liability that practitioners and practices face likely will increase in complexity
as well.

The Shift from Cottage Industry to Corporate
Practice of Medicine
Historically, the practice of medicine has been a “cottage industry” with little crossover seen between
specialties and practices (see chapter 1, Shift to Managed Care). The gradual corporatization of medicine necessitates the regulation of emerging entrepreneurial concerns, that is, business arrangements,
fraud and abuse, tax compliance, and practitioner compensation. The Corporate Practice of Medicine
doctrine is the most fundamental legislative manifestation of the healthcare transition from a “cottage
industry” to, effectively, the corporate practice of medicine.

Corporate Practice of Medicine (CPOM)
The American Medical Association promulgated the Corporate Practice of Medicine (CPOM) to prohibit
unlicensed individuals from engaging in the practice of medicine by employing licensed physicians.6
CPOM was intended to ensure that licensed physicians could provide medical care without pressure
from lay persons whose goals may not be in the best interest of the patient, as medicine should not “be
subject to commercialization or exploitation.”7
The CPOM is regulated by the states.8 Although restrictions vary by jurisdiction, forty-eight states
and the District of Columbia have some form of regulation that follows a CPOM standard.9 Of these
forty-eight states, eight have statutory provisions restricting the CPOM.10 In thirty states, the CPOM
has been restricted or outlawed by case law, opinions of the state attorney general, or state licensing
boards.11 Although, in eight of the states where the CPOM is regulated, the trend is less restrictive, and
corporations are allowed to employ physicians as long as they do not interfere with the physician’s independent medical judgment.12 Currently, five states affirmatively permit the CPOM.13 Because the regulations vary significantly, it is important to understand restrictions regarding the CPOM on a state-by-state
basis.
Certain healthcare organizations are generally exempt from the application of the CPOM doctrine. In
all states, physicians are allowed to incorporate as professional corporations. In some states, the organization of health maintenance organizations (HMOs) and contracts between HMOs and professionals
for the provision of services are exempted specifically from the doctrine.14 Further, some states exempt
nonprofit healthcare entities under the rationale that the lack of profit incentive eliminates the dangers
associated with the CPOM.15
As a result of CPOM, new practice areas have surfaced that may be prone to running afoul of current
statutes. A new practice area that may violate existing CPOM restrictions is the growth in “quick clinics,” or physician offices generally found in large “doc-in-a-box” stores or pharmacies.16 Although retailers in states with CPOM restrictions typically cannot open in-store clinics and staff physicians, CPOM
laws generally allow corporations to rent or lease space to providers.17
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Another growing trend in CPOM violation is the practice of nonphysician-owned spas offering
Botox injections and other medical procedures with physicians staffed as medical directors.18 Under this
arrangement, unlicensed spa owners may be involved in the unlicensed practice of medicine, and the
physician may be aiding and abetting.19 At least one state, California, has issued regulations prohibiting
this practice.20
CPOM also has been influenced by the creation of new enforcement strategies and regulations that
aid in the prevention of fraud. In 2005, the New York Court of Appeals held that no-fault insurance
carriers could refuse payment for medical services provided by fraudulently incorporated medical businesses.21 The court based its holding on two premises: (1) a business corporation law that prohibits individuals from owning a share in a professional service corporation if they are not licensed to practice in
the same profession as the corporation and (2) an insurance regulation that excludes payments made to
unlicensed or fraudulently licensed providers.22 The defendant corporation argued that it should be reimbursed because all its patients received care from licensed providers.23 However, because the corporation
was owned by nonphysicians, the court found the organization to be in clear violation of state law.24
Despite these regulations, CPOM has found its way into the marketplace
through new entities that utilize technology to address patient concerns
while bypassing traditional methods of patient consultation. Examples of
this trend include companies that provide medical consultation services by
phone or e-mail and “quick clinics” that generally are found in larger “big
box” stores and can take advantage of the store’s clientele while allowing
patient consumers to do efficient one-stop shopping (that is, they can shop
while they wait for a physician to see them). These particular types of
entities should be cognizant of the most recent CPOM in their states to avoid
running afoul of restrictions.
“Demand Growing for Corporate Practice of Medicine,” By Devon Herrick, Consumer Driven Health Care, National
Center for Policy Analysis, Jan. 1, 2006, http://healthcare.ncpa.org/commentaries/demand-growing-for-corporatepractice-of-medicine (accessed June 24, 2009).

Healthcare Regulation at Federal and State Levels
Healthcare can be regulated at both the state and federal level. State legislation and enforcement measures actually may stem from federally elicited incentives or compliance standards (that is, Medicaid
reimbursement (see chapter 2, Medicaid and State Children’s Health Insurance Program). Conversely,
some issues are federally regulated, which constitutionally binds states in compliance. Under these circumstances, federal guidelines are preserved but tailored through supplemental state law to meet statespecific needs.
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Licensure
State laws typically control the licensure of healthcare providers under the state’s police powers.
Through these laws, states can regulate entry into the field, restrict professional scope of practice, and
hold professionals accountable accordingly. State licensing laws specify the minimum level of qualification needed to practice in a field. It is argued that licensure is intended to ensure the public’s safety
by providing a standard for the evaluation of provider expertise and accurate assessment of the risks of
substandard care.25 However, the domination of professional licensure boards by the professionals themselves also has been criticized as serving the interests of the profession more than the interests of the
public.26 Licensure of the various provider types is discussed in the corresponding sections of chapters 3,
4, 5, 6, and 7 in Professional Practices.

Individual Professional Licensure
Every state and the District of Columbia require licensure of all allopathic (M.D.) and osteopathic (D.O.)
physicians.27 Although the exact requirements for licensure vary by state, each state requires candidates
to submit proof of “good moral character, adequate educational preparation [at an accredited medical
school], appropriate practical experience, and successful completion of a licensure exam.”28
A physician applying for licensure typically is found to be of good moral character absent his or her
involvement in illegal activities.29 Most physicians satisfy the exam requirement by submitting to the
licensure board proof of their successful completion of the United States Medical Licensing Examination or the Comprehensive Osteopathic Medical Licensing Examination.30 However, because some
practicing physicians may have been licensed under a previously administered exam, some state licensing boards may consider a combination of other examinations as sufficient for licensure, as long as those
exams were completed prior to 2000.31 Once licensed, most states’ scope of practice definitions allow
physicians to perform almost all healthcare related activities, as the practice of medicine is the broadest
definition in healthcare licensure.
As part of the Health Care Quality Improvement Act of 1986, the United States Congress established
the National Practitioner Data Bank to improve the availability of information obtained during the peer
review process.32 The Department of Health and Human Services (HHS) is responsible for overseeing the system. The act requires state medical and dental licensing boards to report disciplinary action
taken against a licensed professional, in regard to his or her professional competence and professional
conduct.33 Hospitals also are required to periodically check the status of the database for each member
of their medical staff, and individual practitioners may request their own records, however, the general
public does not have access the data bank.34
In addition to physicians, all states require the licensure of dentists, registered nurses, practical
nurses, dental hygienists, pharmacists, optometrists, physical therapists, podiatrists, chiropractors, and
administrators of nursing homes.35 Frequently, physician assistants, midwives, psychologists, social
workers, opticians, physical therapy assistants, audiologists, and speech pathologists also are subject to
state licensure laws.36 As with physician licensing, state rules vary on licensure requirements for these
professions.
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Physician Versus Nonphysician Scopes of Practice
Because the licenses issued to nonphysician practitioners are limited in scope so as not to run afoul of
the prohibition against the unlicensed practice of medicine, these professionals must be careful to only
practice within the limits set forth by relevant statutes. This has led nurses and allied health professionals to lobby legislatures and seek judicial rulings to expand the practice limits placed on their licenses.
Recent changes in technology, better education for nurses and allied health professionals, physician
shortages, and the government’s and third party payor’s insistence on controlling healthcare costs, have
led to expanded roles for nonphysician professionals.37
Practitioners are liable for violation of state laws that regulate the range of services they are permitted to provide. Additionally, Medicare fee schedules indirectly influence professionals by navigating the
degree and magnitude of reimbursement rates, as well as which services are covered.38 Overseen by the
Centers for Medicare and Medicaid Services (CMS), Medicare reimbursement rates vary based on the
level of specialization of each type of practitioner. For nonphysician practitioners, reimbursement rates
are dictated by incident-to policies, which state the percentage of a service cost that a nonpractitioner
may be reimbursed through Medicare.39 These rates vary based on the level of supervision required (if at
all) and the type of services provided (see chapter 4 in Professional Practices).40 Further, the final rule
of the 2010 Medicare physician fee schedule (MPFS) modified supervision requirements for in-hospital
outpatient services to allow certain nonphysician practitioners (for example, clinical psychologists,
physician assistants, nurse practitioners, clinical nurse specialists, certified nurse-midwives, and licensed
clinical social workers) to be direct supervisors for all outpatient therapeutic services allowable under
state laws.41
In some cases, Medicare rules and state laws overlap, which may be cause for controversy. For example, Certified Registered Nurse Anesthetists are authorized to administer anesthesia, without supervision, to Medicare patients if a state’s governor petitions CMS on the basis of state need (see chapter 4
in Professional Practices).42 Contention between physicians and mid-level providers has led to several
lawsuits regarding this topic by physician groups interested in protecting physician provision of certain
services.43
As the overlap between the scope of practice for physicians and nonphysicians increases, malpractice liability, which jeopardizes the licenses of both the supervising physician and the nonphysician
professional, may increase as well.44 For more information on mid-level provider competition with physicians see chapter 4 in Professional Practices.

Specialty Licensure and Certification
Technological advances during the past forty years have led to an increase in the specialization of
healthcare personnel.45 Accompanying this rise in specialization is the development of new categories
of providers within the traditional healthcare professions, including pediatric nephrologists and hospitalists, physicians whose primary focus is the delivery of care in hospitals.46 The creation of these specialties has been mirrored by a rise in various professional medical associations, which have created their
own systems for credentialing specialists.47 Although certification requirements vary by specialty, they
typically include additional educational attainment, examinations, and work experience.48 Unlike a state
licensure board, a professional association cannot bar a licensed physician from practicing in a particular specialty for failing to obtain board certification, although board certification is viewed favorably by
hospitals and healthcare service providers as an indicator of competence.49
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Advances in technology also have led to the development of new categories of healthcare providers,
including radiological technologists and speech pathologists, as well as the state licensing programs and
private certifying agencies governing these providers.50

Healthcare Facility and Practice Licensure
Although the licensing of healthcare entities typically is handled by state governments, significant interplay exists between state and federal government regulations. Most states require entities to meet practice standards set forth by Medicare as a condition of licensure, and Medicare requires state licensure as
a condition of reimbursement.51 As with other types of professional licensure, the licensure of healthcare
facilities is intended to ensure that patients receive quality healthcare.
State regulation designates which healthcare facilities must be licensed. All states require hospitals
to be licensed, and most states also require nursing homes to be licensed.52 In addition, many states require further licensure of specialized areas within an already licensed facility, including hospital pharmacies, clinical laboratories, and hospital-based ambulatory surgery centers (ASCs).53
In order to maintain licensure, facilities may need to meet certain building requirements and limit
the number of beds allowed.54 In addition, regulations, such as locally adopted zoning laws, occupancy
permits, building codes, and building permits, may place increased demands on healthcare entities.
Physicians typically are not required to license their solo or group practices, because the state exercises control over these facilities through control of each physician’s license.55 However, as the provision
of medical care continues to shift to the outpatient setting, more states have expanded the scope of their
licensing regulations to require the licensure of facilities performing outpatient procedures similar to
those performed in inpatient facilities for which a license is ordinarily required.

Accreditation
Accreditation is the process by which private organizations assess participating institutions and programs and issue accreditation certificates to institutions that meet their requirements. Ensuring the
quality and safety of services is the focus of most accreditation standards; however, many also include
documentation and other requirements.56 If a participating institution or program fails to maintain the
requisite standards, they may not incur penalties other than the loss of their accreditation. In most states,
there is no link between accreditation and institutional licensure, although, some states will forego further inspection and accept accreditation by organizations, such as the Joint Commission, as the basis for
the state licensure of certain providers.57
Accreditation can be beneficial to organizations for purposes of federal compliance. Medicare grants
deemed status to hospitals accredited by the Joint Commission58 or the American Osteopathic Association (AOA).59 Deemed status allows providers to participate in the Medicare program unless a later
Medicare validation survey finds noncompliance with the conditions of participation requirements set
forth in federal regulations.60 Accreditation is also important because some payors will only contract
with accredited providers.61
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Major accrediting bodies in the United States include the Joint Commission on Accreditation of
Healthcare Organizations (JCAHO), the AOA, and the National Committee for Quality Assurance
(NCQA).

The Joint Commission
JCAHO is a nongovernmental organization that strives to ensure the safety and quality of healthcare
services provided to the public.62 The Joint Commission pursues this goal by conducting on-site reviews
and setting standards for institutional governance, support services, and patient care.63 Facilities seek
Joint Commission accreditation because it helps ensure the provision of quality services, attract quality
staff, qualifies them to receive Medicare reimbursement, and in some states, is a licensure requirement.64
The Joint Commission provides accreditation for ambulatory care centers, behavioral health centers,
critical access hospitals, home health services, general hospitals, laboratory services, long-term care
facilities, office-based surgery centers, and international healthcare providers.65

American Osteopathic Association
The AOA is the main board certifying entity for osteopathic physicians (D.O.), and it is the accrediting
body for every osteopathic healthcare facility and medical college.66 The AOA strives to promote the
practice of osteopathic medicine by ensuring quality in education, research, and the delivery of healthcare services. In terms of accreditation, the AOA functions much like the Joint Commission.67

National Committee on Quality Assurance
The National Committee for Quality Assurance (NCQA) is a nonprofit organization that works with
employers, doctors, policymakers, patients and health plans to improve the quality of healthcare through
the accreditation of managed care plans.68 NCQA performs this duty, much like other accrediting bodies,
through the setting of standards and collection of outcome and performance data.69

Certificate of Need (CON)
A Certificate of Need (CON) program is one in which government determines where, when, and how
capital expenditures will be made for public healthcare facilities and major equipment.70 CON is based
on the theory that, in an unregulated market, healthcare providers will provide the latest costly technology and equipment, regardless of duplication or need.71 Despite CON’s aim to reduce healthcare costs
by preventing duplication of services, healthcare costs have continued to rise.72
Despite CON’s aim to reduce healthcare costs by preventing duplication of
services, healthcare costs have continued to rise.
“Improving Health Care: A Dose of Competition: Chapter 8: Miscellaneous Subjects,” A Report by the Federal
Trade Commission and Department of Justice, July 2004, p. 2.
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Overview: The Federal Certificate of Need Program
CON statutes and regulations specify those healthcare facilities, medical equipment, and services which
require applications and approval to operate. The enactment of federally mandated CON laws was the
product of government-mandated health policy planning efforts that dated back to the post–World War
II era. While federal regulations provided legislation and enforcement provisions, however, program
development and implementation generally took place at the state or local level.73
The enactment of federally mandated CON laws was the product of
government mandated health policy planning efforts that dated back to the
post–World War II era.
“Beyond Health Care Reform: Reconsidering Certificate of Need Laws in a “Managed Competition” System,”
Patrick John McGinley, 23 Fla. St. U. L. Rev. 141, 145-148 (1995).

The National Health Planning and Resources Development Act of 1974 pushed CON regulations to
the forefront of government healthcare cost containment efforts.74 The act required that federal agencies
pass health policy planning guidelines and establish “a statement of national health planning goals.”75 It
prompted states to enact CON programs by guaranteeing federal funding for state CON review programs
and conditioning the receipt of certain healthcare funding on enacting CON programs.76 It also specified
that state CON programs must meet federal guidelines in order to receive federal funding.77 In response
to the act, all fifty states developed some form of CON review program.78
Congress repealed the 1974 legislation in 1987, which caused fourteen states to discontinue their
CON programs.79 Despite the discontinuation of a formal CON program, all fourteen states retain certain
regulatory mechanisms intended to prevent duplication of services.80
CON laws were modeled after federal legislation, but current CON regulation is based on various
state statutes, rules, and regulations that designate an agency or board to administer the approval process.81 State CON programs are administered according to statutes and regulations controlling market
entry for regulated facilities, services, and equipment. Hospitals, nursing homes, certain freestanding
clinics, home health agencies, and ASCs are often among the healthcare facility providers covered by
CON.82 CON also often applies to healthcare services, including the change of one service to another,
the purchase of medical equipment, and new technology. State CON programs generally have two functions: (1) to develop a health plan promoting equitable access to healthcare services and (2) to review
CON applications submitted by healthcare providers.83
CON regulatory policy has been highly contentious in the state legislative arenas for many years,
and it has been the subject of significant administrative agency study and review. Beyond these activities, the grant or denial of a CON application frequently has resulted in complex and costly litigation.
In the four decades that CON has existed, approximately 800 reported legal cases have involved CON
issues.84 During this period, CON also has been the subject of numerous academic and governmental
scientific research studies, as well as the subject of thousands of news and journal articles.
One argument against CON regulatory policy is that its intervention disrupts natural market forces
and limits competition.85 Seeking to preserve competition in healthcare markets, the Federal Trade Commission (FTC) consistently has criticized CON as a failed public health regulatory policy that creates
barriers to new market competitors.86
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The Federal Trade Commission and CON
The FTC has evaluated the impact of CON on competition for many years. A 1988 FTC study estimated
that total hospital costs might decline by 1.4 percent, or $1.3 billion per year, if all states with CON laws
doubled the dollar thresholds at which they require CON review of hospital expenditures.87
A 1988 FTC study estimated that total hospital costs might decline by 1.4
percent, or $1.3 billion per year, if all states with CON laws doubled the
dollar thresholds at which they require CON review of hospital expenditures.
“The Effect of State Certificate-of-Need Laws on Hospital Costs: An Economic Policy Analysis,” By Daniel
Sherman, Federal Trade Commission, Jan. 1988, p. vi, www.ftc.gov/be/econrpt/232120.pdf (accessed
October 10, 2009).

In November, 2002, FTC Chairman Timothy J. Muris announced that the FTC would hold joint
hearings with the Department of Justice (DOJ) on competition in healthcare in the following year.88 On
July 23, 2004, following the conclusion of the hearings, the FTC and DOJ issued a joint report in which
the agencies recommended that states decrease barriers to entry into provider markets.89 Following the
testimony, the agencies suggested that instead of reducing costs, there is evidence that CON programs
actually drive up costs by “fostering anticompetitive barriers to entry.”90 In addition to raising prices,
the FTC has condemned CON regulation as causing lower quality and reduced innovation in healthcare
markets.91
The FTC and DOJ stated their belief that ASCs are beneficial for consumers and that state CON laws
pose an anticompetitive barrier to entry. In response to ASC provider allegations that general hospitals
have attempted to use CON laws to prevent ASCs from entering the market, the agencies committed to
aggressively pursue activities of anticompetitive conduct.92 However, they acknowledged that antitrust
laws do not prevent individual hospitals from unilaterally approaching state governments in connection
with CON proceedings.93
Currently, thirty-six states and the District of Columbia retain some sort of CON program.94 See box
3-1 for a complete list of states with CON legislation.
As of mid-2008, thirty-six states and the District of Columbia retained
some sort of CON program.
“Certificate of Need: State Health Laws and Programs,” By National Conference of State Legislatures, April 30,
2009, www.ncsl.org/IssuesResearch/Health/CONCertificateofNeedStateLaws/tabid/14373/Default.aspx (accessed
June 24, 2009).

The Application Process
Every state has its own unique CON application process. However, general procedures tend to guide the
application process in all states. The typical application process involves submission of an application
for review, agency review for consistency with planning criteria, and a public hearing and decision by
the granting authority.95 If an application is approved, the project must typically begin within a specified amount of time.96 If a CON holder fails to fulfill the requirements of the CON, the state may retain
the right to revoke it.97 In some states, a CON may be transferable, but laws governing such rights differ
from state to state.
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Box 3-1: S tates With Certificate of Need Legislation
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.

Alabama
Alaska
Arkansas
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Illinois
Iowa
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Mississippi
Missouri

20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.

Montana
Nebraska
Nevada
New Hampshire
New Jersey
New York
North Carolina
Ohio
Oklahoma
Oregon
Rhode Island
South Carolina
Tennessee
Vermont
Virginia
Washington
West Virginia
Wisconsin

The Appeal Process
Because CON is an administrative process, an appeal of a negative application decision would first
go through the proper administrative channels,
which could then be appealed to the appropriate
state court.98

Privacy Laws

Because practitioners, providers, and organizations have regular access to patient medical
records, the handling of confidential healthcare
information must be regulated to protect patients
and ensure that their privacy is secure. Specifically, the Health Insurance Portability and Accountability Act of 1996 (HIPAA) regulates
Source: “National Directory State Certificate of Need Programs: Health Planning
access to medical information, and the Red Flags
Agencies,” By American Health Planning Association, 2008, p. 5.
Rules regulate access to financial information.
With healthcare organizations typically managing
both patient medical information and billing for services, practices with varying degrees of complexity
and size are expected to comply with both laws.

Health Insurance Portability and Accountability Act of 1996
Although HIPAA serves many purposes, it is most widely used for safeguarding the privacy of protected health information (PHI), or individually identifiable health information.99 This protection
extends to information relating to the “past, present or future physical or mental health condition of an
individual; the provision of healthcare services to an individual; or the past, present or future payment
for the provision of healthcare to an individual.”100 The HIPAA Privacy Rule provides standards for the
use and disclosure of PHI by covered entities, as well as rights for individuals to control how their PHI
is used.101 The Privacy Rule governs such covered entities as, “health plans, healthcare clearinghouses,
and any health care provider who transmits health information in electronic form in connection with a
transaction for which the Secretary of HHS [Department of Health and Human Services] has adopted
[HIPAA] standards.”102 Transactions by healthcare providers falling under the HIPAA Privacy Rule include claims, benefit eligibility inquiries, referral authorization requests, and other transactions for which
HHS has established particular standards.103 These transactions are covered regardless of whether they
are performed by the healthcare provider themselves, a billing service, or any other third party under
contract with the provider.104 When a covered entity contracts with a third-party entity to perform billing
or other business associate activities, including, among other activities, claims processing, data analysis, and utilization review, the covered entity must impose specific safeguards of PHI.105 The business
associate agreement and the covered entity cannot authorize the business associate to use PHI in a way
that would violate the Privacy Rule.106 Even the proper destruction of PHI is protected under HIPAA.
Approved technologies and methods of destroying records are listed in 74 Fed. Reg. 42742.
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Health Information Technology for Economic and
Clinical Health (HITECH) Act
Recently, the American Recovery and Reinvestment Act of 2009 (ARRA) made changes to HIPAA’s
health information privacy and security provisions.107 The ARRA used the Health Information Technology for Economic Clinical Health (HITECH) Act in order to promote widespread adoption of health
information technology, particularly electronic health records (EHR).108 Provisions in the HITECH
Act also protect the privacy and security of PHI by allowing patients to request an audit trail that shows
all disclosures of their PHI, prohibiting the sale of a patient’s PHI without his or her authorization, and
requiring individuals to be notified if there is an unauthorized disclosure or use of their PHI.109 This latter provision also requires practices to publicly post information about security breaches affecting ten or
more patients who cannot be directly contacted, and it requires public notification to the HHS website,
prominent media outlets, and the secretary of HHS of breaches affecting 500 patients or more.110 Though
these new notification requirements were effective as of September 23, 2009, enforcement was delayed
until February 17, 2010.111 The exceptions to the HITECH Act for PHI include
1. unintentional access to, acquisition of, or use of PHI by a worker of the covered entity, acting in
good faith, within the scope and course of duties, as long as act does not lead to disclosure under
HIPAA;
2. inadvertent disclosure from one worker of the covered entity to another, when both workers were
authorized to access information and no future disclosure occurs; and
3. unauthorized disclosure to an unauthorized person, when there is reasonable belief that the
recipient would not retain information.112

Medicare National Provider Identifiers (NPI)
Originally, all providers seeking reimbursement under Medicare were given a unique physician identification number (UPIN). UPINs were discontinued as of June 2007 and replaced by National Provider
Identifiers (NPI) to meet the “Administrative Simplification Standard” required under HIPAA.113 The
NPI is a ten-digit unique identification number required for all covered healthcare providers expecting reimbursement under Medicare, Medicaid, or any federal health program.114 NPIs contain an entity
type code, one being used for individual practitioners (for example, physicians, dentists, nurses, chiropractors, pharmacists, and physical therapists) and two being for healthcare provider organizations
(for example, hospitals, group practices, ambulance companies, medical suppliers, etc.).115 Mid-level
providers who “furnish healthcare but do not necessarily conduct covered transactions” also are eligible
for NPIs.116 The use of NPIs is intended to improve, “the effectiveness and efficiency of the health care
industry in general, by simplifying . . . administration . . . and enabling the efficient electronic transmission of certain health information.”117

Red Flags Rules
On November 9, 2007, the FTC and other agencies published a list of “red flags,” which indicate the
possibility of identity theft, and mandated the implementation of an identity theft prevention program.118
The deadline for required, written compliance programs has since been deferred until June 1, 2010.119
This rule is intended to include all businesses defined as creditors (a “business or organization that . . .
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provide[s] good or services and bill[s] customers later”) that deal with covered accounts. Under the Red
Flags Rules, a covered account includes:
1. “Consumer account you offer customers that’s primarily for personal, family or household purposes that involves or is designed to permit multiple payments or transactions; or,
2. Any other account that a financial institution or creditor offers or maintains for which there is a
reasonably foreseeable risk to customers or to the safety and soundness of the financial institution or creditor from identity theft, including financial, operational, compliance, reputation, or
litigation risks.”120
Healthcare institutions will have to (1) review their billing practices and payment procedures and
(2) create a program to ensure compliance.121 Written compliance programs must include strategies and
procedures for identifying existing “red flags,” avoiding future “red flags” violations, preventing and
mitigating identity theft, and developing and implementing a procedure for re-evaluating and updating
program protocols.122 Although varying degrees of detail are required depending on organizational complexity, all enterprises, healthcare and otherwise, are subject to regulation under the Red Flags Rules.123

The Patient Safety and Quality Act of 2005
The Patient Safety and Quality Act (PSQIA) of 2005 effective January 19, 2009, established a voluntary
reporting system for medical errors to increase the availability of such quality reporting and to more
efficiently address issues related to patient care and quality.124 Under PSQIA, confidentiality provisions
to protect “patient safety work product” were established such that reporting organizations may maintain compliance with HIPAA and other regulations, guidelines, and rules.125 Patient safety work product
includes any information that is collected while reporting and analyzing patient safety events.126 Under
PSQIA, Patient Safety Organizations are charged with collecting and analyzing data under the supervision of the Agency for Healthcare Research and Quality.127

Fraud and Abuse Laws
The corporatization of healthcare triggered a surge of fraud and abuse regulation of practice and practitioner arrangements.

False Claims Act (FCA)
The False Claims Act (FCA) is a federal law that creates civil liability for any person who “knowingly
presents, or causes to be presented, to an officer or employee of the United States government or a member of the Armed Forces of the United States a false or fraudulent claim for payment or approval.”128
Since Congress amended the FCA in 1986, it has become one of the primary weapons used to combat
healthcare fraud, particularly when used in conjunction with the federal physician self-referral (Stark)
law and the federal antikickback statute.129 The 1986 amendments strengthened the statute’s qui tam, or
whistleblower provision.130 Under the statute’s qui tam provisions, any private citizen can enforce the
FCA by filing a complaint alleging fraud against the federal government.131 Qui tam actions are often
brought by former employees, but they can also be brought by competitors.132 The DOJ assumes primary
responsibility for prosecuting the claim if it believes the claim has merit.133 The whistleblower is entitled
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to share in a portion of any recovery the government makes.134 Because the FCA provides for treble
damages plus an additional penalty for each false claim, potential liability can be tremendous.135
Although potential violations of the FCA include upcoding and billing for unnecessary services, recent DOJ enforcement actions have shifted from targeting intentional criminal activity to targeting legitimate providers. For example, an action was brought in 2002 against a Kentucky orthopedic surgeon for
failing to properly supervise residents.136 However, in 1998, the Office of the Inspector General (OIG)
and the DOJ issued guidelines limiting enforcement actions.137 Still, qui tam actions pose a significant
threat to providers, as the potential to share in the recovery of any ill-gotten funds creates a strong incentive for private individuals to bring these actions.
In addition to direct violations, the FCA is also used to prosecute violations of Stark laws (see Stark
Law) and the federal antikickback statute (see Antikickback Statute). In particular, physician acceptance
of kickbacks (that is, monetary bribes, free travel, and various other prerequisites) from pharmaceutical and medical device manufacturers recently have come under increased scrutiny as violations of the
FCA.138
Recently, the Physician Payments Sunshine Act of 2009 has been introduced
to address illegal kickback activities. If passed, the act will require makers of
pharmaceuticals, medical devices, and biologics to issue public statements
concerning the money they give to doctors that exceeds $100 every year.
Penalties for knowingly failing to disclose information under the act could
be as high as $1 million per violation. Senators Chuck Grassley (R-IA) and
Herb Kohl (D-WI) have been working on getting the Physician Payments
Sunshine Act passed for a couple of years, and they seem confident that it
will be passed by the 111th Congress.
“Grassley, Kohl Continue Campaign to Disclose Financial Ties Between Doctors and Drug Companies,”
Press Release, United States Senate Special Committee on Aging, Jan. 22, 2009, http://aging.senate.gov/record.
cfm?id=307097 (accessed June 25, 2009).

Fraud Enforcement and Recovery Act of 2009 (FERA)
In 2009, the federal government enacted the Fraud Enforcement and Recovery Act of 2009 (FERA),
which focuses on expanding government resources to combat fraud in the housing and mortgage arena
and expands the scope of the FCA.139 FERA changes what the United States Supreme Court has interpreted to be the FCA’s definition of “knowingly” to ensure the designation is more in line with the intent
of the law.140 Under the new definition, a person who acts knowingly, “1) has actual knowledge of the
information; 2) acts in deliberate ignorance of the truth or falsity of the information; or, 3) acts in reckless disregard of the truth or falsity of the information.”141 In addition, FERA reduces the government’s
burden of proof, no longer requiring it to show specific intent to defraud. It now requires only a showing by a preponderance of the evidence of “deliberate ignorance” or “reckless disregard of the truth or
falsity” of information.142
FERA also expanded the definition of “claim” to include any request for money or property offered
to a government employee or official, as well as requests to contractors working on behalf of the government.143 The expanded definition also includes any attempt to defraud the government regardless of
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Box 3-2: S tates With False Claims Act Legislation
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.

California
Delaware
Florida
Georgia
Hawaii
Illinois
Indiana
Louisiana
Massachusetts
Michigan
Minnesota
Montana
Nevada

14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.

New Hampshire
New Jersey
New Mexico
New York
North Carolina
Oklahoma
Rhode Island
Tennessee
Texas
Virginia
Washington, D.C.
Wisconsin

Source: “State False Claims Acts,” The False Claims Act Legal Center, Taxpayers Against
Fraud Education Fund, http://www.taf.org/statefca.htm (Accessed February 10, 2010).

whether the government is currently in possession of the money or whether the accused party
intended to defraud the government.144 Further,
organizations are only liable if they “knowingly”
retain improper payments.145

State False Claims Acts
Twenty-three states, the District of Columbia, and
the individual cities of New York and Chicago
have enacted false claims acts.146 For the complete
list, see box 3-2.
Additionally, some other states may have false
claims acts that apply specifically to healthcare
fraud, but which may or may not have qui tam
provisions. See box 3-3.

Violations of state false claims acts can result in fines as high as $15,000 per false claim.147 Although
the state statutes commonly mirror the federal FCA, some differences can include expanded liability
provisions in state false claims acts, jurisdictional bars not found in the federal FCA, and damage and
penalty provisions that may differ from the federal law.148
It is projected that the number of states with false claims acts will grow in the coming years, as
Congress passed legislation in 2005 creating financial incentives for states to create their own acts.149
In the Deficit Reduction Act (DRA),150 the federal government incentivized state governments to enact
state false claims acts similar in scope to the federal FCA by promising to return 10 percent of the funds
recovered from Medicaid enforcement actions to the state.151 Prior to DRA, that money would have gone
to the federal government.152 Since its implementation in January 2007, the incentive has compelled
many states to amplify their existing false claims laws, and it has encouraged more states to develop new
false claims acts.153
The OIG for HHS is charged with reviewing state false claims laws to ensure they meet the requirements for the DRA incentive program. Programs must154
1) establish liability to the state for false or fraudulent claims described in the FCA with respect to
any expenditures related to the state Medicaid plans described in section 1903(a) of the Social
Security Act,
2) contain provisions that are at least as effective in rewarding and facilitating qui tam actions for
false or fraudulent claims as those described in the FCA,
3) contain a requirement for filing an action
under seal for sixty days with review by
the state attorney general, and

Box 3-3: States With False Claims Act Legislation and no
Qui Tam Provision

4) contain a civil penalty that is not less than
the amount of the civil penalty authorized
under the FCA.155

1. Arkansas
2. Michigan
3. North Carolina

4. Oklahoma
5. Utah
6. Washington

Source: “Health Care Fraud: Enforcement and Compliance,” By Robert Fabrikant, et al.,
Law Journal Press, 2007, p. 4-72.4, n.1.
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To date, the OIG has reviewed the false claims acts of twenty states, finding fourteen to be in compliance with the requirements of the DRA.156 The OIG found that the false claims laws of the other six
states were not as effective at facilitating and rewarding qui tam actions as the federal FCA.157
In addition, the DRA also requires that entities receiving more than $5 million annually from Medicaid establish an employee education plan covering state and federal false claims laws and whistleblower
protections.158 The education plan must provide information on the federal FCA, administrative remedies
for false claims and statements, any civil or criminal penalties under state false claims laws, and whistleblower protections under federal and state law.159 The DRA made this education requirement a prerequisite of Medicaid participation for entities making or receiving payments totaling more than $5 million
a year from participation in Medicaid; failure to comply with the January 2007 deadline meant possible
exclusion from the program.160

Antikickback Statute
Enacted in 1972, the federal antikickback statute makes it a felony for any person (physician, allied
health professional, or paraprofessional with a Medicare provider number) to “knowingly and willfully”
solicit or receive or to offer or pay any “remuneration” directly or indirectly in exchange for the referral
of a patient for a healthcare service paid for by a federal healthcare program.161 Violations of the antikickback statute are punishable by up to five years in prison, criminal fines up to $25,000, or both.162
The original statute was amended in 1987 with the passage of the Medicare and Medicaid Patient
and Program Protection Act of 1987 (MMPPPA) to include an alternative civil remedy: exclusion from
the Medicare program.163 The Balanced Budget Act of 1997 added a civil monetary penalty of treble
damages, or three times the illegal remuneration, plus $50,000 per violation.164 Civil penalties are
believed to be a more effective way of enforcing the statute because the government need not prove the
violation by the criminal standard of beyond a reasonable doubt.165 Instead, to impose a civil penalty,
the government need only prove the violation by the lesser standard of a preponderance of the evidence,
meaning at least 51 percent of the evidence points to a certain conclusion.166

Regulatory and Court Interpretations of Statute
The OIG periodically issues “Special Fraud Alerts” providing insight into how the OIG believes the
statute should be applied to particular business arrangements and which arrangements will violate the
statute. The OIG has issued “Special Fraud Alerts” on a number of topics including, joint venture arrangements and rental agreements for space in physician offices.167
Both the OIG and case law have adopted expansive interpretations of the statute.168 Therefore, many
financial relationships, such as the exchange of anything of value between providers, could result in a
potential violation.169

Thornton Letter—Office of the Inspector General
In 1992, the OIG Associate General Counsel D. McCarty Thornton launched a direct attack against
physician owners of specialty care practices.170 He sent a letter to the Internal Revenue Service (IRS)
regarding kickback concerns related to an acquisition involving a charitable 501(c)(3) buyer.171 Thornton claimed that any amount paid to physicians in excess of the fair market value of the practice’s hard
assets was suspect and could be considered inducement for referrals.172 Effectively, this prohibited
payments for goodwill, value of an ongoing business unit, covenants not-to-compete, exclusive dealing
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arrangements, patient lists, and patient records.173 In many cases, the Thornton letter resulted in a diminution of practice asset value considered by some to be an unconstitutional taking of property, as the
effect of the letter made it difficult for specialists to sell their practices for a reasonable amount.174
The Thornton letter resulted in a diminution of practice asset value considered by some to be an unconstitutional “taking of property,” which made it
impossible for specialists to sell their practices for a reasonable amount.
“Aspects of Fraud in Healthcare Valuation,” by Robert James Cimasi, Speech to National Association of Certified
Valuation Analysts, June 2, 2006, p. 12.

“One Purpose” Test
The “one purpose” test, established in United States v. Greber, is one of the most far reaching interpretations of the statute. Under the one purpose test, the antikickback statute is violated if even one purpose
of the arrangement is to offer illegal remuneration.175 Subsequently adopted by the OIG, under the one
purpose test, providers reasonably can expect referrals to result from a business arrangement, but the expectation must not be a reason for entering into the arrangement.176 Critics of the one purpose test claim
that it treats a legitimate relationship with a referral component in the same manner as an arrangement
primarily intended to violate the statute.177 Opponents also argue that it is impossible for providers to
expect referrals and not consider referrals when entering into a business arrangement.178

Safe Harbors
Due to the broadness of the antikickback statute, legitimate business arrangements also may be prohibited. For example, if the statute was interpreted literally, a physician would not be allowed to receive
dividend payments from a publicly traded pharmaceutical company if the physician prescribed products produced by the company.179 Therefore, Congress created a number of statutory exceptions and
gave HHS authority to protect other business arrangements through safe harbors.180 Safe harbors detail
specific regulatory criteria that must be met to shield an arrangement from liability, and they are meant
to protect practices unlikely to result in fraud or abuse.181 The failure to comply with every requirement
does not mean that the arrangement is illegal,182 if there is a low risk of fraud and abuse.183
The MMPPPA directed HHS to promulgate regulations specifying payment practices that did not
violate the statute. Congress created the following statutory exemptions from the antikickback statute,
protecting legitimate business arrangements, including
1) properly disclosed discounts;
2) payments to bona fide employees for employment;
3) certain payments to group purchasing organizations;
4) co-insurance waivers to Medicare services for patients qualifying for certain public health service programs;
5) payment practices specified by the HHS secretary in regulations promulgated under the MMPPPA or nonmonetary remuneration necessary and used solely to receive and transmit electronic
prescription information in accordance with the standards promulgated under 42 U.S.C.
1395w-104;
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6) certain risk-sharing and arrangements with managed care organizations;
7) waiver or reduction by pharmacies of any cost-sharing imposed under Medicare Part D which
has met certain conditions under 42 U.S.C. 1320a-7a(i)(6)(A);
8) any remuneration between a federally qualified health center and a Medicare Advantage organization pursuant to a written agreement; and
9) any remuneration between a healthcare center entity and any entity providing goods, items, services, donations, loans, or a combination thereof to that entity pursuant to a contract, lease, grant,
loan or other agreement if such agreement contributes to the ability of the healthcare center to
serve an underserved population.184
These safe harbors were intended to “permit physicians to freely engage in business practices and
arrangements that encourage competition, innovation and economy.”185 HHS has created a number of
safe harbors since 1989, and it clarified existing safe harbors in 1999. The 1991 safe harbors included
promulgations protecting investments in large publicly held healthcare companies and investments in
small healthcare joint ventures.186 In 1999, HHS added safe harbors protecting investments in healthcare
entities located in underserved areas, investments in ambulatory surgical centers (ASCs), and investments in group practices.187
The most important safe harbors for the purposes of physician integration protect certain physician
investment interests. Certain investment interests were protected because, “Congress did not intend to
absolutely bar any investment by physicians in other health care entities.”188 Certain business investments “represent the extension of a physician’s office space and not a means to profit from referrals.”189
Business arrangements which are “functionally an extension of a physician’s office” pose less “risk of
improper payments for referrals.”190 The OIG intended to protect these physician investment interests,
because the OIG believed that the risk of improper referrals was relatively low when the physician
personally performed services at, for example, the ASC on his or her own patients.191 The OIG also was
influenced by CMS’s policy of promoting greater utilization of ASCs. Physicians were a natural source
of capital for ASCs because hospitals were reluctant to invest in ASCs that might compete with their
surgery departments.192 These investment safe harbors were intended to protect arrangements that “can
significantly reduce costs for Federal health care programs, while simultaneously benefiting patients.”193
In particular, HHS wanted to avoid “chill[ing] group practice integration that is crucial in an increasingly managed care environment.”194
There are a total of twenty-five safe harbors under the antikickback statute. As used in section 1128B
of the act, box 3-4 includes all of the twenty-five safe harbors and are not considered remuneration as
long as the safe harbor’s requirements are satisfied.
Box 3-4: Safe Harbor Regulations
The following twenty-five safe harbor regulations can be found in the antikickback statute:
1)	Returns on investment interests. Payments that are in the form of a return on an investment.
2)	Space rental. Payments for the use of premises made by a lessee to a lessor.
3)	Equipment rental. Payments for the use of equipment made by equipment lessees to equipment lessors.
4)	Personal services and management contracts. A principal’s payments to an agent for the agent’s services.
5)	Sale of practice. A payment made by one practitioner for the purchase of the practice of another practitioner.
6)	Referral services. Payments for the exchange of anything of value between a “participant” and a referral service.
7)	Warranties. Payments or the exchange of anything of value under a manufacturer’s or supplier’s warranty.
8)	Discounts. A discount given on an item or service for which a payment may be made in full or in part by Medicare, Medicaid, or other
federal healthcare programs.
(continued)
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Box 3-4: Safe Harbor Regulations (continued)
9)	Employees. A payment made by an employer to an employee who has a bona fide employment relationship with the employer to
deliver any item or service for which a payment may be made in full or in part by Medicare, Medicaid, or other federal healthcare
programs.
10)	Group purchasing organizations (GPO). Payments made by a vendor of goods or services to a GPO, pursuant to an agreement to
furnish the goods or services.
11)	Waiver of beneficiary coinsurance and deductible amount. A reduction or waiver of a Medicare or state healthcare program beneficiary’s coinsurance or deductible.
12)	Increased coverage, reduced cost-sharing amounts, or reduced premium amounts offered by health plans. The additional coverage
of items or services offered by health plans to enrollees, reductions in the enrollee’s obligation to pay the health plan or healthcare
provider, or reductions in premiums for items and services covered by the health plan, Medicare, or a state healthcare program.
13)	Price reductions offered to health plans. Price reductions found in a contract between a provider and a health plan for the provision
of items or services to enrollees covered by the health plan, Medicare, or a state healthcare program.
14)	Practitioner recruitment. Payments or the exchange of anything of value given by an entity to influence the relocation of a practitioner who has been practicing in his or her current specialty for less than one year, or to influence any other practitioner, to relocate
their practice into a health professional shortage area (HPSA) for their specialty that is served by the entity.
15)	Obstetrical malpractice insurance subsidies. Payments made by hospitals or entities that are providing malpractice insurance when
the payments are used to subsidize or pay all of the costs of malpractice insurance premiums for practitioners who routinely engage
in obstetrical practice as a part of their medical practice in a primary care HPSA.
16)	Investments in group practices. Payments, in the form of a return on an investment, made to a practitioner investing in his or her own
practice or a group practice.
17)	Cooperative hospital service organizations (CHSO). Payments between a CHSO and its patron hospital, tax-exempt entities described
in section 501(e) of the Internal Revenue Code of 1986, when the CHSO is owned by two or more patron hospitals.
18)	Ambulatory surgery centers (ASC). Payment that is a return on an investment, as long as the entity is certified in accordance with
part 416 of this title, its operating and recovery room space is exclusively dedicated to the ASC, all patients referred to the entity by
an investor are fully informed of the investor’s ownership interest, and all the following applicable standards are met within one of
the following categories:
a.	
Surgeon-owned ASCs: To fall within the safe harbor for surgeon-owned ASCs
		 i.	the investment terms offered to an investor may not be tied to the previous or expected number of referrals, services furnished,
or the amount of business for the entity otherwise generated by the investor;
		 ii.	at least one-third of the surgeon investor’s practice income for the prior fiscal year or the prior twelve-month period must come
from the surgeon’s performance of procedures;
		 iii.	neither the entity nor any investor can loan funds or guarantee a loan for an investor, if the investor uses any portion of the loan
to acquire the investment interest;
		 iv.	an investor’s payment in return for his or her investment must be directly proportional to the amount of capital he or she invested; and
		 v.	ancillary services performed for beneficiaries of federal healthcare programs must be related to the primary procedures performed at the entity and may not be billed separately to Medicare or other federal healthcare programs.
b.	
Single-Specialty ASCs: To fall within the safe harbor for single-specialty ASCs
		 i.	the investment terms offered to an investor may not be tied to the previous or expected number of referrals, services furnished,
or the amount of business for the entity otherwise generated by the investor;
		 ii.	at least one-third of the surgeon investor’s practice income for the prior fiscal year or the prior twelve-month period must come
from the surgeon’s performance of procedures;
		 iii.	neither the entity nor any investor can loan funds or guarantee a loan for an investor, if the investor uses any portion of the loan
to acquire the investment interest;
		 iv.	an investor’s payment in return for his or her investment must be directly proportional to the amount of capital she or she
invested;
		 v.	ancillary services performed for beneficiaries of federal healthcare programs must be related to the primary procedures performed at the entity and may not be billed separately to Medicare or other federal healthcare programs; and
		 vi.	patients receiving medical benefits or assistance under any federal healthcare program must not be discriminated against by
the entity or any physician investor.
c.	
Multi-Specialty ASCs: To fall within the safe harbor for multi-specialty ASCs
		 i.	the investment terms offered to an investor may not be tied to the previous or expected number of referrals, services furnished,
or the amount of business for the entity otherwise generated by the investor;
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Box 3-4: Safe Harbor Regulations (continued)
		

ii.	at least one-third of the surgeon investor’s practice income for the prior fiscal year or the prior twelve-month period must come
from the physician’s performance of procedures;
		 iii.	physician investors must perform at least one-third of their procedures for the prior fiscal year or the prior twelve-month period
at the investment entity;
		 iv.	neither the entity nor any investor can loan funds or guarantee a loan for an investor, if the investor uses any portion of the loan
to acquire the investment interest;
		 v.	an investor’s payment in return for his or her investment must be directly proportional to the amount of capital he or she
invested;
		 vi.	ancillary services performed for beneficiaries of federal healthcare programs must be related to the primary procedures performed at the entity and may not be billed separately to Medicare or other federal healthcare programs; and
		 vii.	patients receiving medical benefits or assistance under any federal healthcare program must not be discriminated against by
the entity or any physician investor.
d.	
Hospital or Physician ASCs: To fall within the safe harbor for hospital or physician ASCs
		 i.	the investment terms offered to an investor may not be tied to the previous or expected number of referrals, services furnished,
or the amount of business for the entity otherwise generated by the investor;
		 ii.	neither the entity nor any investor can loan funds or guarantee a loan for an investor, if the investor uses any portion of the loan
to acquire the investment interest;
		 iii.	an investor’s payment in return for his or her investment must be directly proportional to the amount of capital he or she
invested;
		 iv.	patients receiving medical benefits or assistance under any federal healthcare program must not be discriminated against by
the entity, an investor in the entity, or any physician investor;
		 v.	ancillary services performed for beneficiaries of federal healthcare programs must be related to the primary procedures performed at the entity and may not be billed separately to Medicare or other federal healthcare programs;
		 vi.	the hospital’s report, or any other claim for payment from a federal healthcare program, may not include any costs associated
with the ASC unless the federal healthcare program requires their inclusion; and
		 vii.	the hospital cannot directly or indirectly make or influence referrals to any investor or entity.
19)	Referral arrangements for specialty services. Exchanges of value between individuals and entities, where one party has agreed to refer
a patient for specialty care payable in full or in part by Medicare, Medicaid, or any other federal healthcare program in return for an
agreement to refer the patient back at an agreed upon time or circumstance.
20)	Price reductions offered to eligible Managed Care Organizations (MCOs). Payments in the form of price reductions offered between
eligible MCOs and any first-tier contractor for providing for or arranging for items or services, or between a first-tier contractor and a
downstream contractor or between two downstream contractors for the provision or arrangement of items or services.
21)	Price reductions offered by contractors with substantial financial risk to MCOs. Payments in the form of price reductions offered between a qualified managed care plan and a first-tier contractor for the provision of or arrangement for items and services, or between a
first-tier contractor and a downstream contractor or between two downstream contractors for the provision of or arrangement for items
or services.
22)	Ambulance replenishing. Gifts or transfers of drugs or medical supplies from a hospital or other receiving facility to an ambulance provider in order to restock the drugs and medical supplies used in connection with the transport of the patient. To qualify for this exception, the ambulance must be used to provide emergency ambulance services an average of three times per week.
23)	Health centers. The transfer of any goods, items, services donations, loans, or a combination thereof from an individual or an entity to a
health center.
24)	Electronic prescribing items and services. Nonmonetary remuneration that is necessary for, and used solely to, send and receive electronic prescription information.
25)	Electronic Health Record Items and Services. Nonmonetary remuneration that is necessary for, and used predominantly to, create,
maintain, transmit, or receive electronic health records.
Source: “Exceptions” 42 C.F.R. 1001.952(a)-(x) (2004).

Although these exemptions allow federally funded healthcare programs to lessen their liability under
the antikickback statute, many business interactions may still be suspect under Stark law.
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Stark Law
The federal physician self-referral, or Stark law, prohibits physicians from referring Medicare or Medicaid patients to an entity for designated health services (DHS), defined by HHS, if the physician, or an
immediate family member, has a financial relationship with that entity.195 HHS defines physician under
Stark law, as a “doctor of medicine or osteopathy, a doctor of dental surgery or dental medicine, a doctor
of podiatric medicine, a doctor of optometry, or a chiropractor, as defined in section 1861(r) of the [Social Security] Act.”196 Since its promulgation in 1989, the Stark law has gone through multiple revisions
that have both increased the scope of its provisions and added exceptions to what kind of transactions
the prohibitions apply.
Prohibitions of physician self-referral are similar to the antikickback legislation, in that both laws
prohibit conduct which induces physicians and allied health professionals to profit from referring patients to particular facilities. The difference between the two statutes is that the self-referral prohibition
addresses the financial incentives of the physician who makes the referral, and the antikickback statute is
concerned with the financial relationship between providers.197 The other important difference between
the regulations is that the self-referral prohibitions apply only to Medicare and Medicaid, but the antikickback legislation applies to all federally funded state healthcare programs.198
The physician self-referral prohibitions are named after the legislation’s chief supporter, Congressman Fortney “Pete” Stark (D-CA). Congressman Stark supported the legislation based on studies indicating that despite the broad scope of the antikickback statute, self-referrals were prevalent in the healthcare industry.199 One such study, published by the OIG in 1989, reported on physician investments in
healthcare facilities and found that patients at physician-owned laboratories received more services than
other Medicare patients.200

Stark I
The Ethics in Patient Referrals Act (Stark I) was promulgated in 1989 and was implemented in various
stages during the early 1990s.201 Stark I prohibited physicians from making referrals to clinical laboratories if the physician, or an immediate family member of the physician, had an ownership or investment
interest in the lab.202 Further, the lab was prohibited from billing for those services.203

Stark II
In 1993, Stark I was amended to expand the prohibition against referrals to clinical laboratories in which
physicians had an ownership or investment interests, to ten additional categories of DHS (see definition
of DHS).204 Stark II was to be implemented in two phases, the first of which became effective on January 4, 2002.205 In 2004, the second phase of Stark II was published, which implemented Stark II as an
interim final rule to replace the 1995 Stark I final rule.206

Stark II, Phase III
On September 5, 2007, CMS issued the final rule establishing the Stark II Phase III regulations, which
contained many changes that were predicted to have a significant impact on healthcare provider relationships.207 One requirement, as set out in the Phase I regulations, stipulated that there exist at least two
financial relationships between the physician and the DHS entity in order for an indirect compensation
arrangement to exist.208 The Phase III regulations changed the definition of an indirect compensation
arrangement so that physician members, employees, and contractors of the physician organization were
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now deemed to stand in the shoes of the physician organization, that is, they would have the same compensation direct compensation arrangement as the physician organization itself.209 As a result, a hospital
that has a contract for professional services with a physician group, considered indirect under the Phase
I regulations due to a financial relationship between individual physicians and their group practice as
well as a relationship between the group practice and the hospital, is now considered to have a direct
compensation arrangement.210 Under this revision of the rule, a physician organization is no longer
considered an intervening entity for purposes of establishing an indirect compensation arrangement, and
arrangements between providers, and DHS entities may need to be structured differently to avoid Stark
liability.211
This change applies to physician-owners, physician-employees, and physician-contractors of a physician organization.212 However, other arrangements, such as an arrangement between a DHS entity, a
leasing company, and a physician, are analyzed as an indirect compensation arrangement.213

Stark IV
Stark IV refers to the changes made to the Stark law in the 2009 Inpatient Prospective Payment System
(see chapter 2, Facility-Based Reimbursement Rates).214 Most notably, Stark IV modified the stand in
the shoes provision, changed the definition of “entity,” and prohibited per-click leasing under four of the
exceptions to the Stark law.

Stand in the Shoes
In Stark IV, CMS modified the stand in the shoes provision first introduced in Stark II Phase III. Under
the final Stark IV version of the provision, physicians who have an ownership or investment interest in a
physician organization are considered to stand in the shoes of the physician organization for the purpose
of Stark laws.215 Accordingly, the physician collapses into the physician organization, resulting in the
physician organization no longer being considered an intervening entity for the purpose of establishing
an indirect compensation arrangement with a DHS.216 This mandatory provision applies only when the
ownership or investment interest includes the ability or right to receive financial benefits.217 However, in
situations in which a physician organization employs both physician owners and nonowner physicians,
DHS entities are allowed to treat the nonowner physicians as standing in the shoes of the physician
organization so that two different compensation analyses are not required.218 Exempted from the provisions are arrangements which meet the requirements of the academic medical centers exception.219 Additionally, the rule refrained from finalizing stand in the shoes provisions originally proposed for DHS
entities.220

Expansion of “Entity” to Include Under Arrangement Service Providers
CMS also changed the framework of under arrangements in Stark IV, such that both the physicianowned entity (which provides the service), as well as the hospital (which bills for the service), are
considered DHS entities for purposes of Stark law.221 The result of this provision is that it will preclude
physician-owned entities from performing services on hospital patients under arrangements with the
hospitals, unless the physician-owner(s) can satisfy the ownership exception under Stark. CMS concluded that any entity that performs a service under arrangement for a hospital which is then billed by
the hospital is now considered a DHS entity, even if that service would not have been considered a DHS
entity if the service was done outside the hospital setting. The only exception to this final conclusion is
for lithotripsy services, procedures using shock waves to break up stones in urinary organs.222
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Prohibition of “Per-Click” Arrangements and Percentage-Based Rent
Stark IV, effective October 1, 2009, also modified the exceptions for space and equipment leases, fair
market value compensation, and indirect compensation arrangements to prohibit basing the charge for
rented space and equipment on a per-click, or per-unit basis, as they are seen as gainsharing agreements.223 A gainsharing agreement is a pay-for-performance system that rewards employees for boosts
in productivity and reductions in costs associated with poor quality.224 This means that physicians and
DHS entity lessors may not charge physician lessees rent based on the number of services provided by
the lessees which are referred to them by the lessors. CMS concluded that on-demand time-based rental
arrangements also are considered per-click arrangements and, therefore, fall under the limitation, as
well.225
Similarly, CMS finalized a rule prohibiting rental charges based on a percentage of revenues earned
in the rented space or with the rented equipment, regardless of whether the services were referred from
the lessor.226 Excluded from this prohibition are arrangements in which physicians pay on a percentage basis for management and billing services.227 CMS also declared that the rule would not prohibit
gainsharing arrangements, as long as they are properly structured incentive payment and shared saving
programs.228

Exceptions to Stark Law
The very broad prohibition of physician self-referrals is limited by a number of statutory exceptions. The
exceptions are intended to promote practice integration and to protect arrangements in which there is
little risk of abuse.229 Similar to concerns on the restrictive nature of the antikickback statute, Congress
intended to protect group practices to avoid loss of integration.230 There are thirty-five total exceptions to
the Stark law, and the statute gives the secretary of HHS the authority to promulgate additional exceptions.231 A significant difference between the antikickback legislation and Stark is that, under Stark, any
financial relationship between a healthcare entity and a physician must fall within one of the statutory
or regulatory exceptions.232
The thirty-five exceptions to the Stark law are divided between exceptions that apply to both ownership or investment interests and compensation arrangements,233 exceptions that apply to only ownership
or investment interests, and exceptions that apply to only compensation arrangements.234 Exceptions
which apply to both ownership and investment interests and compensation agreements include exceptions for
1. physician services;
2. in-office ancillary services;
3. services furnished by organization to enrollee of health plan;
4. academic medical centers;
5. qimplants furnished by an ASC;
6. EPO and other dialysis-related drugs;
7. preventative screening tests, immunizations, and vaccines;
8. eyeglasses and contact lenses following cataract surgery; and
9. intrafamily rural referrals.235
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Exceptions that apply to only ownership or investment interests include exceptions for
1. publicly traded securities,
2. mutual funds, and
3. specific providers (for example, rural providers, hospitals located in Puerto Rico, and whole
hospital ownership).236
There are a total of thirty-five exceptions to the Stark law, and the secretary
of HHS has the authority to promulgate additional exceptions.
42 C.F.R. 411.355-411.357; 42 U.S.C. 1395nn(a)(1)(A).

The final subpart to this last exception, commonly known as the whole hospital exception, allows a
physician to have an ownership interest in a hospital if the physician performs services at the hospital.237
Finally, exceptions that apply to only compensation arrangements can be found in box 3-5.

Federal and State Efforts to Eliminate Stark Whole Hospital Exception
The whole hospital exception allows physician self-referrals to
hospitals in which they have an ownership stake as long as the
physician is authorized to perform services at the hospital and
the ownership or investment interest is in the entire hospital.238
When proposed, there was little worry that this arrangement
would create a risk of abuse, as it was believed that “ownership
interests in an entire hospital would be so diluted that it would
have no effect on referral decisions.”239
Proponents of the whole hospital exception contend that it
allows for the development of specialty and niche providers,
which leads to healthcare services being provided in a more cost
effective manner, while also maintaining and improving quality
and beneficial outcomes.240 However, the exception’s opponents
argue that because specialty hospitals are smaller in size, they
are comparable to the individual departments within general
hospitals.241 Therefore, opponents argue, physician ownership
of specialty hospitals raises the same concerns as does the ban
on physician ownership in specialty departments within general
hospitals: the risk that a physician’s referral decisions and clinical judgment will be affected by the ability to influence his or
her own income.242
Although healthcare has traditionally been regulated by the
states, the federal government, as the largest payer of health
care services, can mandate how these services are provided in
the United States. Accordingly, opponents of the whole hospital exception repeatedly have lobbied the federal government
to eliminate or mitigate the effects of the safe harbor. In 2001,

Box 3-5: C
 ompensation Arrangement
Exceptions
A list of Stark Law compensation arrangement
exceptions include:
1. Rental of office space
2. Rental of equipment
3. Bona fide employment relationships
4. Personal service arrangements
5. Physician recruitment
6. Isolated financial transactions
7. Certain arrangements with hospitals
8. Group practice arrangements with hospitals
9. Payments by attending physicians
10. Charitable donations by attending physicians
11. Nonmonetary compensation
12. Fair market value compensation
13. Medical staff incidental benefits
14. Risk sharing arrangements
15. Compliance training
16. Indirect compensation arrangements
17. Referral services
18. Obstetrical malpractice insurance subsidies
19. Professional courtesy
20. Retention payments
21. Community-wide health information
technology systems
22. Electronic prescription items and services
23. Electronic health records items and services
Source: “Exceptions to the Referral Prohibition Related to
Ownership or Investment Interests” 42 C.F.R. 411.356
(October 1, 2008).
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congressmen Pete Stark (D-CA) and Jerry Kleczka (D-WI) unsuccessfully introduced the Hospital
Investment Act with the intention of limiting the whole hospital exception.243 The act would have required newly formed specialty hospitals to undertake an initial public offering, instead of merely offering investment opportunities to the physicians practicing at the hospital, a requirement that would have
rendered the startup of specialty hospitals too expensive to undertake.244
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) implemented an eighteen-month moratorium on the development of new specialty hospitals.245 The moratorium represented a compromise between congressmen Kleczka and Stark, who believed that the whole
hospital exception should be removed for all hospitals, and Senator Breaux, who advocated removing
the exception only for specialty hospitals.246 The moratorium officially ended on June 8, 2005.247 However, the DRA, enacted on February 8, 2006, continued the suspension of CMS’s enrollment of new specialty hospitals until six months after enactment of the DRA or the release of the final report on specialty
hospitals by CMS required by the DRA, whichever came earlier.248
The eighteen-month moratorium on the development of new specialty
hospitals, implemented by the MMA, lasted until June 8, 2005, only to be
reinstated by the DRA on February 8, 2006.
“Medicare Prescription Drug, Modernization, and Improvement Act of 2003” §507(a)(1)(B); “Moratorium on
Specialty Hospitals Expires” By Jennifer Gordon, Dallas Business Journal, http://assets.bizjournals.com/dallas/
stories/2005/06/20/story8.html (accessed June 25, 2009); “Payment Provisions in Original Medicare Program
Immediately Affected by The Deficit Reduction Act,” Press Release, Centers for Medicare and Medicaid Services,
February 10, 2006, www.cms.hhs.gov/apps/media/press/release.asp?counter=1779 (accessed March 2, 2005).

On August 8, 2006, CMS released its report on specialty hospitals, Final Report to the Congress and
Strategic Implementing Plan (Report).249 The report’s recommendations included many aspects designed
to make investing in specialty hospitals less attractive, such as a downward adjustment of specialty hospital reimbursement.250 Additionally, the report recommended aligning physician and hospital interests
to promote “better hospital physician collaboration,” ensuring that all hospitals be in compliance with
the Emergency Medical Treatment and Active Labor Act (EMTALA) (see Emergency Medical Treatment and Active Labor Act) when they provide services and requiring investment disclosure by physicians informing patients of their ownership interest before treatment.251 Finally, the report recommended
subjecting specialty hospitals to greater Stark and antikickback statute scrutiny.252
In recent years, efforts to eliminate or mitigate the effects of the whole hospital exception have
continued at the federal level. For example, both Congressman Stark’s proposed amendment to the
Children’s Health and Medicare Protection Act of 2007 and the U.S. House of Representatives’ legislation, the Paul Wellstone Mental Health and Addiction Equity Act of 2008 (see chapter 6 in Professional
Practices), unsuccessfully attempted to restrict physician ownership of hospitals.253
State law efforts to eliminate or mitigate the effects of the Stark law’s whole hospital exception can
take various forms including licensure, quality inspections, facility requirements, facility taxes, state
CON laws, and state self-referral regulations.254
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Licensure
Licensing provides a framework for the delivery of quality healthcare services, but it does not guarantee that quality care will be provided.255 Historically, states have required that hospitals be licensed (see
Healthcare Facility and Practice Licensure). Under the licensure schemes in most states, a specialty
hospital is considered to be a general hospital for the purposes of licensure.256
Licensing legislation also has been proposed as an attempt to prevent competition by physicianowned specialty hospitals. In 2007, a community hospital CEO in California unsuccessfully pushed for a
bill that would have prohibited the building of hospitals in the district if they did not have an emergency
department.257

Quality Inspections and Facility Requirements
Quality inspections and facility requirements subject medical facilities to periodic inspections and the
attainment of minimum standards.258 For example, a New York law, the New York Patient Protection
Bill, which took effect in July 2009, created a new rule requiring that physicians performing office-based
surgery have their offices accredited.259 The new bill forced many doctors, especially those in urban
areas with offices not conducive to a remodel, to seek office space elsewhere.260 Although New York’s
standards were enacted to ensure patient safety, it is reasonable to assume that opponents of the whole
hospital exception may attempt to utilize rigid quality inspection and facility requirement standards in an
effort to thwart competition from specialty hospitals.

Facility Taxes
Some states have attempted to level the playing field between general and specialty hospitals through
certain tax initiatives. In June 2004, the New Jersey legislature imposed a tax on certain ambulatory
care facilities, specifically excluding those owned by a hospital.261 The measure places a 3.5 percent tax
on gross revenues of ambulatory care centers and a 6 percent tax on gross receipts from cosmetic procedures, with the revenues raised to be used to compensate hospitals for charity care.262 Facilities taxed
include, ASCs, facilities providing diagnostic imaging services, and outpatient cancer centers.263 The
facility itself is taxed under the corporate business tax, and the physician-owners are taxed under the
personal income tax code.264

Certificate of Need
CON regulation requires that health care providers obtain state approval before either developing new
services, or expanding existing services (see Certificate of Need (CON)).265 Because stringent CON regulation effectively can prevent or limit specialty and niche providers from entering a state, thereby protecting general hospitals from competition, the use of CON laws has become one of the primary attacks
on physician-owned hospitals at the state level.266 As of 2008, thirty-six states and the District of Columbia had CON laws.267

Antikickback and Self-Referral Laws
Forty-two states and the District of Columbia have laws prohibiting kickbacks and limiting selfreferrals. For the complete list see box 3-6.
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Box 3-6: S tates With Self-Referral and Antikickback
Legislation
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.

Alabama (antikickback)
Arizona
Arkansas
California
Colorado
Connecticut
Delaware (antikickback)
Florida
Georgia (self-referral)
Hawaii (self-referral)
Illinois
Indiana (antikickback)
Kansas
Kentucky
Louisiana
Maine (self-referral)
Maryland (self-referral)
Massachusetts
Michigan
Minnesota (self-referral)
Mississippi (antikickback)

22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.

Missouri
Montana
Nevada
New Hampshire
New Jersey
New Mexico (antikickback)
New York
North Carolina
Ohio
Oklahoma
Pennsylvania
Rhode Island (antikickback)
South Carolina
South Dakota
Tennessee (self-referral)
Texas (antikickback)
Utah
Virginia
Washington
West Virginia
Wisconsin

Updates to State Self-Referral Laws
New Jersey Update to “Codey Act”
After the 2007 decision in Health Net of New
Jersey, Inc. v. Wayne Surgical Center, LLC,
physicians in New Jersey who referred patients
to an ASC in which they had an ownership interest were suddenly at risk of being in violation of
New Jersey’s anti–self-referral law, the Codey
law.268 Most unexpectedly, the Health Net decision rejected a widely relied upon 1997 New
Jersey Board of Medical Examiners (BME)
advisory opinion, which held that an ASC constitutes an “extension of the physician’s medical
office,” such that the arrangement did not violate
Codey.269

After the ruling in Health Net, the BME adopted emergency rules declaring that doctors who
referred patients to physician-owned ASCs were
not in danger of violating the law.270 In response,
Source: “Health Care Fraud: Enforcement and Compliance” By Robert Fabrikant, et al.,
legislators in New Jersey, led by Senate President
Law Journal Press, New York, NY: 2007, p.2-64.
Richard Codey (the namesake of the original law),
proposed an amendment to the Codey law which would allow self-referral to physician-owned ASCs.271
In 2009, New Jersey amended the Codey law to permit physician referrals to facilities in which
they have a financial stake, if the physicians perform the procedure personally, their compensation as
an owner is equal to their ownership interest, all patient related decisions at facilities with nonphysician
owners are made by physicians, and the physicians inform the patients of their ownership share at the
time of referral.272 In addition, the statute also prohibits the issuance of new registrations for surgical
practices and ambulatory care facilities unless one of the limited exceptions applies.273

Physician Compensation Restrictions
Generally
Increased regulatory scrutiny related to avoiding violations of federal fraud and abuse laws in transactions between healthcare providers affects the compensation paid to physicians for professional clinical, on-call, medical directorship, as well as administrative and executive related services. For example,
physician compensation arrangements are scrutinized under the traditional concepts of fair market value
(FMV), as well as under the related threshold of commercial reasonableness,274 that is, compensation
arrangement may be simultaneously at FMV and also be determined to be commercially unreasonable.
A failure to meet these two standards may result in a violation of the FCA if the healthcare provider
knowingly submits a claim for reimbursement to a government entity for services under compensation
arrangements which are deemed to be Stark and antikickback violations.275 Accordingly, compensation
arrangements for physician clinical and executive services (for example, medical directorships) must
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be both at FMV and commercially reasonable to avoid liability under the Stark law, the antikickback
statute, and the FCA.276 The impact of fraud and abuse regulation on structuring physician compensation
plans is discussed further in chapter 3 of Consulting with Professional Practices.
Compensation arrangements for physician and executive services must be
both at FMV and commercially reasonable to avoid liability under the Stark
law, the antikickback statute, and the FCA.
“All Eyes on Physician-Hospital Arrangements,” By Lewis Lefko, HealthLeaders Media, Jan. 24, 2008, www.
healthleadersmedia.com (Accessed September 18, 2008).

The test for commercial reasonableness is a threshold that is distinct from that of the standard of
FMV. FMV looks to the reasonableness of the “range of dollars” paid for a product or service; the
standard of commercial reasonableness looks to the “reasonableness of the business arrangement
generally.”277

Definitions of Fair Market Value
Federal fraud laws define fair market value somewhat differently than it is defined by traditional business valuation principles. Under Stark II Phase I, the Health Care Financing Administration (HCFA;
now CMS) defined FMV as “the value in arm’s-length transactions, consistent with general market
value.”278
General market value is defined as:
[T]he price that an asset would bring as a result of bona fide bargaining between well-informed
buyers and sellers who are not otherwise in a position to generate business for the other party, or
the compensation that would be included in a service agreement as a result of bona fide bargaining between well-informed parties to the agreement who are not otherwise in a position to generate business for the other party, on the date of acquisition or the asset or at the time of the service
agreement.279 [emphasis added]

Elaborating on that definition in 2001, HCFA provided the following guidance for determining when
a payment for services provided is at FMV:
We believe the relevant comparison is aggregate compensation paid to physicians practicing in
similar academic settings located in similar environments. Relevant factors include geographic
location, size of the academic institutions, scope of clinical and academic programs offered, and
the nature of the local health care marketplace. . . . we intend to accept any method [for establishing FMV] that is commercially reasonable and provides us with evidence that the compensation
is comparable to what is ordinarily paid for an item or service in the location at issue, by parties
in arm’s-length transactions who are not in a position to refer to one another. . . . The amount of
documentation that will be sufficient to confirm FMV . . . will vary depending on the circumstances in any given case; that is, there is no rule of thumb that will suffice for all situations.280

In 2004, CMS noted that valuation methods under Stark law, “must exclude valuation where the
parties to the transaction are at arm’s-length but in a position to refer each other.”281 Because FMV under
Stark law does not “necessarily comport with the usage of the term in standard valuation techniques and
methodologies,” a purely market-driven determination of FMV may not always be considered commercially reasonable for the purposes of federal fraud laws.282 For example, even if an arrangement meets
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traditional FMV standards, if it does not meet commercial reasonableness standards, it may not withstand scrutiny under Stark.
In the Stark II Phase II legislation, dated March 2004, CMS stated that it “will consider a range of
methods of determining [FMV] and that the appropriate method will depend on the nature of the transaction, its location, and other factors.”283 Additionally in the Stark II Phase II legislation, CMS created a
voluntary safe harbor provision within the regulatory definition of FMV for hourly payments to physicians for their personal services, which could have been used with regard to any hourly compensation
paid by any DHS entity.284 Under the FMV safe harbor, there were two methodologies that would result
in an hourly arrangement being considered to be at FMV: (1) when the physician’s hourly rate is less
than or equal to the hourly rate for emergency room physician services in the relevant geographic market
(provided there are at least three hospitals with emergency rooms) or (2) when the physician’s hourly
rate is calculated by averaging the 50th percentile of the national compensation level for physicians with
the same specialty (or general practice if specialty is not identified) in at least four of six listed salary
surveys, then dividing that figure by 2,000 hours.285 Subsequently, the United States Appellate Court for
the D.C. Circuit discerned in Renal Physicians Association v. HHS that these two safe harbor tests would
also result in the consideration of an agreement being presumptively reasonable.286
However, concerns about the impracticality and infeasibility of the CMS FMV voluntary safe harbor
forced CMS to eliminate that provision in the September 2007 Stark II Phase III rule. At that time, however, CMS emphasized that it will continue to scrutinize the FMV of arrangements and indicated that
“[p]arties to a transaction may calculate FMV ‘using any commercially reasonable methodology that is
appropriate under the circumstances and otherwise fits [within] the definition’ of FMV for purposes of
Stark.”287
Further, in the Stark II Phase III provisions, CMS stated, in response to a request for confirmation as
to whether a FMV hourly rate could be used to compensate physicians for both physician clinical and
administrative services and whether that hourly rate could be used to determine an annual salary, that
A fair market value hourly rate may be used to compensate physicians for both administrative
and clinical work, provided that the rate paid for clinical work is fair market value for the clinical
work performed and the rate paid for administrative work is fair market value for the administrative work performed. We note that the fair market value of administrative services may differ
from the . . . value of clinical services. A fair market value hourly rate may be used to determine
an annual salary, provided that the multiplier used to calculate the annual salary accurately reflects the number of hours actually worked by the physician.288

FMV is also a critical requirement under several antikickback safe harbors.289 Although FMV is not
specifically defined within the antikickback statute,290 the OIG has provided guidance on this issue and
stated in Thornton’s widely circulated 1992 letter that
When considering the question of FMV [Fair Market Value], we would note that the traditional
methods of economic valuation do not comport with the proscriptions of the Anti-Kickback
statute. Items ordinarily considered in determining the FMV may be expressly barred by the AntiKickback statute’s prohibition against payments for referrals. Merely because another buyer may
be willing to pay a particular price is not sufficient to render the price to be paid FMV. The fact
that a buyer in the position to benefit from referrals is willing to pay a particular price may only
be a reflection of the value of the referral stream that is likely to result from the purchase.291
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Definitions of Commercial Reasonableness
HHS has interpreted commercially reasonable to mean that an arrangement appears to be “a sensible,
prudent business agreement, from the perspective of the particular parties involved, even in the absence
of any potential referrals.”292 The Stark II Phase II commentary also suggests that, “an arrangement will
be considered ‘commercially reasonable’ in the absence of referrals if the arrangement would make
commercial sense if entered into by a reasonable entity of similar type and size and a reasonable physician of similar scope and specialty, even if there were no potential DHS referrals.”293
When determining the commercial reasonableness of a compensation arrangement, one should consider (1) if it is necessary to have a physician perform a certain service and (2) if it is necessary to have
a physician of that specialty perform a certain service. For example, the FMV compensation for more
specialized physicians and surgeons generally is higher than that of general practitioners and nonphysician practitioners. As a result, if a specialized physician is receiving compensation within the higher
range of FMV to perform duties that a less skilled practitioner could perform for less compensation,
the arrangement may not be deemed to be commercially reasonable despite the fact that it is within the
range of FMV for that specialist. In such situations, there tends to be a presumption of fraud, unless the
healthcare provider can demonstrate that using the physician specialist was reasonably necessary for
specified reasons (for example, experience) or that the position’s requirements could not have been done
sufficiently by a less-skilled practitioner.
The IRS has listed several specific factors to weigh in determining the commercial reasonableness of
a physician compensation arrangement:
(1) Specialized training and experience of the physician
(2) The nature of duties performed and the amount of responsibility
(3) Time spent performing duties
(4) Size of the organization
(5) The physician’s contribution to profits
(6) National and local economic conditions
(7) Time of year when compensation is determined
(8) Whether the compensation is in part or in whole payment for a business or assets
(9) Salary ranges for equally qualified physicians in comparable organizations294
The IRS also will examine the independence of the board or committee that establishes a physician’s
compensation arrangement.295

Steps to Establishing Commercial Reasonableness
With regard to FMV under Stark law and the antikickback statute, a 2002 federal district court stated,
“Payments exceeding FMV are in effect deemed ‘payment for referrals.’ ”296 Later courts have developed
more analytical approaches to determining if a compensation arrangement will survive fraud and abuse
scrutiny, particularly, by looking to whether physicians are actually performing the services outlined in
the arrangement. As an example of the potential liability of hospitals and physicians for not abiding by
commercial reasonableness standards, a 2009 case against an Iowa hospital system settled for $4.5 million after the DOJ alleged that Iowa’s Covenant Medical Center compensated five referring physicians at
rates far above FMV.297
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The DOJ alleged that the Covenant physicians—specifically, two orthopedic surgeons, two neurosurgeons, and a gastroenterologist—were reportedly among the highest-paid physicians in the entire United
States, making as much as $2.1 million, despite Covenant’s nonprofit status.298 In the Covenant case, the
hospital asserted that the specialist physicians had been working in understaffed areas of the hospital.299
However, the DOJ cited significant discrepancies between the compensation of the five Covenant physicians and other physicians in the region and around the country. These findings led the DOJ to conclude
that the hospital was paying the physicians for referrals, in violation of the Stark law.300 The Covenant
settlement clearly reflects the government’s increased vigilance against remuneration related to physician compensation arrangements that do not meet FMV and commercial reasonableness thresholds.
In those circumstances in which the physicians are not actually performing those services that are
required within the scope of the compensation agreement, courts have found that the compensation arrangement does not meet standards of commercial reasonableness.301 For this reason, a typical medical
director agreement, for example, requires that contemporaneous logs are kept that document the number
of actual hours worked, as well as the fulfillment of the tasks, duties, responsibilities, and accountabilities that are mandated in the compensation agreement for the medical director position.302 It is important
to note that several types of medical directorships may exist, including those related to quality management, patient care, clinical research, patient relations, business development and community outreach,
clinical operations, and medical information services.
As part of the development of the commercial reasonableness threshold, a more specific test to
determine whether an arrangement is commercially reasonable was proposed by a government expert.303
In the 2004 case, U.S. v. SCCI Hospital Houston, a whistleblower suit which eventually was settled, the
United States challenged the commercial reasonableness of the compensation paid by the hospital to
three physician medical directors.304 In this case, the government’s financial expert stated that commercial reasonableness depends on the agreement being “essential to the functioning of the hospital.”305 The
expert noted that in order to be commercially reasonable, there had to be “sound business reasons for
paying medical director fees to referring physicians.”306
The expert in the SCCI Hospital Houston case looked to several factors in assessing commercial reasonableness, including (1) the size of the hospital, number of patients, patient acuity levels, and patient
needs; (2) the quality, activities, and involvement of medical staff and the need for medical direction; (3)
the number of regular committees and meetings that require physician involvement; and (4) the quality
of hospital management and interdisciplinary coordination of patient services.307 The expert also stated
that “commercial reasonableness . . . depends on the hospital performing a regular assessment of the actual duties performed by the medical director [, as well as assessing] how effectively the medical director is performing his duties and whether there is a bona fide need for continuing the services.”308
Although medical director compensation may be based on an hourly payment (with the maximum
number of hours specified in the contract) or an annual payment (determined by a projected number of
hours multiplied by a FMV hourly rate), it may be critical to surviving regulatory scrutiny for the employer to track and document the actual number of hours the medical director spends performing the services, as well as to make sure that the documentation is consistent with the hours outlined in the medical
director contract.309 Accordingly,
[j]ustifying the need for . . . medical director services goes hand-in-hand with showing that the
services are actually furnished. Any situation with more than one medical director for a single
department is likely to be viewed with suspicion. If such arrangements exist, hospitals should be
especially thorough in demonstrating the necessity for the arrangements.310
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In 2000, the OIG issued a notice that suggested that a compliance program in which regular internal monitoring and auditing is conducted may be an effective way to both ensure that services provided
are considered to be reasonable and necessary and to determine whether any incentives for unnecessary
services exist.311 Reflecting the importance of reasonable necessity, the OIG determined in a 2007 advisory opinion, that an on-call physician compensation arrangement that did not meet an antikickback safe
harbor was nevertheless reasonable, because the structure of the arrangement was tailored to the specific
unmet needs of the hospital.312
In summary, compensation arrangements will likely be deemed commercially reasonable if (1) the
arrangements are at FMV, (2) the arrangements list the actual duties being performed by the physician,
(3) services performed are reasonably necessary to the provider based on the details of the situation, and
(4) the services could not be adequately provided for less compensation.

Internal Revenue Service and the Internal Revenue Code
IRS Tax Status
Healthcare providers may qualify for a federal tax exemption if they meet the IRS requirements for
charitable organizations under section 501(c)(3) of the Internal Revenue Code (IRC).313 In 2002, nonprofit hospitals nationwide saved an estimated $12.6 billion from tax exemptions.314 Such benefits of
federal tax exemption come with concordant burdens. To maintain tax-exempt status, an organization
has to prove that it benefits the public in return for the public’s foregoing of tax collections. To be taxexempt under the IRC, an organization must be organized and operated exclusively for exempt purposes,
and none of its earnings may be allocated to private shareholders or individuals.315 Exempt purposes include those which are charitable, religious, educational, and scientific. The federal tax regulations define
charitable activities as relief of the poor, the distressed, or the underprivileged; lessening the burdens
of government; lessening neighborhood tensions; and combating community deterioration and juvenile
delinquency.316 Most healthcare organizations that are tax-exempt under federal law have that status
because they are classified as charitable organizations.317
In 1969, the IRS expanded the definition of the term “charitable” and declared that to qualify as a
healthcare provider that promotes health as its charitable purpose, an organization must meet the community benefit standard described in revised ruling 69-545, as well as the other requirements of IRC
501(c)(3).318 The community benefit standard list several things that are important to section 501(c)(3)
qualification for general acute care hospitals, such as a community-based board without financial interests in the institution, a full-time emergency room open to all without regard to ability to pay, treatment
of Medicare and Medicaid patients without discrimination, and appropriate mission-related use of net
earnings.319
With at least $12.6 billion at stake, clear communication between tax-exempt organizations and the
IRS is crucial. The IRS sought to ease the reporting process for nonprofit healthcare providers in 2007
by issuing an updated version of Form 990, the return that charities and other tax-exempt organizations
are required to file annually. The redesign of Form 990 is based on three guiding principles: (1) enhancing transparency, (2) promoting tax compliance, and (3) minimizing the burden on the filing organization.320 The most significant changes to Form 990 include (1) adding a summary page that provides “a
snapshot of the organization’s key financial, compensation, governance, and operational information;”
(2) “requiring governance information, including the composition of the board and financial practices;”
and (3) revising and adding “schedules that will focus reporting on certain areas of interest to the public
and the IRS.”321
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2010 IRS Audits and Compliance with Section 409A
Beginning in February 2010, the Tax Exempt and Government Entities Division of the IRS called for
random audits of tax-exempt organizations to ensure their compliance with section 409A. The IRS is
seeking a thorough examination of all executive compensation and benefit arrangements, including executive retirement contracts and deferred compensation arrangements.322 The increased enforcement comes
amid a growing public outcry against excessive executive compensation arrangements in both for-profit
and nonprofit companies. Similar to the new Form 990, the goal of the audits is to increase transparency
and hold tax-exempt organizations accountable for the benefits they receive.
If an exempt organization is found to not be in compliance with section 409A, then the IRS has the
ability to impose (1) additional payroll taxes and interest, (2) significant tax penalties on individuals for
failure of nonqualified deferred compensation plans to meet the requirements of section 409A, and (3)
substantial monetary sanctions if the IRS determines that the executive compensation arrangement constitutes an excess benefit transaction.323 An excess benefit transaction is a transaction in which an economic benefit is provided by an applicable tax-exempt organization, directly or indirectly, to or for the
use of a disqualified person, and the value of the economic benefit provided by the organization exceeds
the value of the consideration received by the organization.324
The IRS is expected to examine up to 1,500 exempt organizations across all industries over a threeyear period.325 If fringe benefits for executives in these exempt organizations were incorrectly treated as
tax-free, they could result in additional taxes owed by both the recipient and the employer.326

Specific Application of Fraud Laws to Physician Compensation
On September 20, 2007, the OIG issued Advisory Opinion No. 07-10, regarding the compensation paid
for physician services related to on-call coverage.327 The opinion stated that the key inquiry for determining whether the compensation arrangement for providing emergency on-call coverage violates the antikickback statute, “is whether compensation is: (i) [at] fair market value in an arm’s length transaction for
actual and necessary items or services; and, (ii) not determined in any manner that takes into account the
volume or value of referrals or other business generated between the parties.”328
The subject arrangement involved a nonprofit hospital experiencing a shortage of physicians to
provide emergency department coverage and follow-up care due to the high volume of indigent patients
unable to pay for services.329 Some hospitals have responded to certain specialists’ refusal to provide services without compensation by paying per diem rates to physicians who entered into a two year contract
to provide care in the emergency department.330
Although the OIG found that the subject arrangement did not “fit squarely into the terms of the safe
harbor” for personal services and management contracts, because the amount of compensation was not
set in advance and varied monthly, the compensation arrangement was nevertheless deemed low risk
because (1) the per diem rates were at FMV without regard to referrals, the physicians were required to
treat any patient who entered the emergency department until discharge with no additional compensation, and the physicians provided certain volunteer (uncompensated) services; (2) the emergency department was understaffed prior to on-call compensation being paid, therefore, the likelihood that the arrangement was instituted to provide remuneration to physicians for referrals was minimized; and (3) all
physicians were given a chance to participate in the on-call program on equal ground, and the program
was not being used to reward physicians for referrals.331
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Federal Antitrust Laws
Antitrust is a body of law which aims to combat anticompetitive behavior. The Sherman Antitrust Act
(Sherman Act), which prohibits any “contract, combination . . . or conspiracy, in restraint of trade or
commerce,”332 and Section 5 of the FTC Act, which prohibits “unfair methods of competition in or affecting commerce. . .,”333 are the federal government’s two primary means of combating unfair competition and abuse of monopolistic power. Further, Section 2 of the Sherman Act prohibits the abuse of monopoly power.334 The Sherman Act has been used to combat kickbacks and self-referral joint ventures,
which have been recognized and an impediment to competition by providers outside the self-referral or
kickback network.335
The Sherman Act also has been used to address concerns related to physician integration under
physician–hospital organization models, independent practice associations (IPAs), and the ability of
such organizations to negotiate on behalf of physician members.336 The FTC typically examines such arrangements under a rule of reason analysis, balancing procompetitive and anticompetitive effects of the
integration arrangement on the market.337
Recently, a FTC finding of illegal price fixing by a Texas IPA was upheld by a federal appellate
court.338 The court held that negotiation (on behalf of physician members) that doesn’t involve risk
sharing with payors or any form of improved efficiency from clinical integration runs afoul of antitrust
laws.339
Traditionally, IPAs have only been able to negotiate on behalf of their members if the joint-contracting agreement has an element of risk-sharing built into it or if the IPA has embarked on a clinical integration scheme to improve efficiency among its members.340 However, even under this latter exception,
only two clinically integrated IPAs have successfully survived antitrust challenges.341
Additionally, many community hospitals have come under scrutiny by antitrust authorities for
engaging in exclusionary practices in an effort to respond to the negative financial impact of physicianowned facilities (POFs).342 Many hospitals have attempted to shut POFs, particularly specialty hospitals, out of the market, which has resulted in some POFs initiating antitrust suits, claiming that such
exclusionary behavior violates the Sherman Act.343 Many of these cases have failed because antitrust
authorities generally are protective of general hospitals that have taken measures to combat, what they
claim to be, cream skimming by specialty hospitals.344 However, some courts have found in favor of
POFs in cases when a general hospital abused its market power to pressure other hospitals and payors
into agreeing to exclude the POF from the market.345
While antitrust challenges by POFs will not always fail, still important and unresolved issues exist
that the courts have yet to determine. One of the most important elements of any antitrust challenge is
the requirement of an agreement between competitors in the restraint of trade.346 In a majority of these
cases, the allegations of agreement are launched at hospital boards that are in supposed agreements with
their medical staffs.347 The circuits are split, however, on whether or not a hospital and members of its
medical staff can be considered separate entities for the purposes of forming an agreement to restrain
trade.348 Some circuits argue that a medical staff is simply a subpart of a larger hospital entity and, therefore, cannot be judged as separate decision-making entities.349 In the absence of an agreement by separate entities, unilateral activity, as long as it is not predatory, is legal.350 However, courts also are split
on the question of whether certain actions taken by hospitals in response to POFs can be considered to
have legitimate business justifications.351 If a general hospital can show that its actions are in pursuit of
a legitimate business goal, such as protecting its ability to cross-subsidize unprofitable services so that it
may continue to provide those services to the community or to protect from cream skimming, then some
courts may find the actions justified even if detrimental to the POF.352
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Racketeer Influenced and Corrupt Organizations Act (RICO)
The Racketeer Influenced and Corrupt Organizations Act (RICO)353 is a federal law that carries both
criminal and civil penalties with the aim of protecting the public from, “parties who conduct organizations affecting interstate commerce through a pattern of criminal activity.”354 The general prohibition of
RICO is against using a business to commit a crime. When applied to healthcare, RICO makes it illegal for any person to (1) use or invest any income derived from a pattern of racketeering activity in an
enterprise and (2) acquire or maintain control of any enterprise through a pattern of racketeering activity.
Additionally, it is illegal (3) for any person employed by, or associated with any enterprise to conduct
the affairs of the enterprise through a pattern of racketeering activity.355 It is also a violation of RICO to
conspire to engage in any of these three activities.356 A pattern of racketeering activity involves committing at least two acts of racketeering activity.
RICO has been used to prosecute physicians, attorneys, and patients who conspire to defraud payors
by filing false claims related to fictitious automobile accidents, billing for services not actually rendered,
and unnecessarily prescribing controlled substances.357

Other Federal Regulations
Occupational Safety and Health Act (OSHA)
The Occupational Safety and Health Act of 1970 (OSHA) established standards for occupational health
and safety, and it requires states to enact legislation implementing standards and procedures developed
by the Department of Labor.358 OSHA promulgated regulations include those designed to protect health
care employees from blood borne diseases, latex allergies, needle sticks, tuberculosis, patient violence,
ionizing radiation, and anesthetic gasses that leak into the surrounding room during medical procedures,
among others.359

Clinical Laboratory Improvement Act (CLIA)
Congress passed the Clinical Laboratory Improvement Act (CLIA) and its subsequent amendments in
order to improve the accuracy, reliability, and timeliness of test results.360 The act requires laboratories to regulate all laboratory testing performed on humans, except the testing performed for research
purposes.361 CMS assumes the responsibility for overseeing the CLIA program.362 CLIA requires that
healthcare providers who perform laboratory testing on specimens derived from humans in order to gain
information for the diagnosis, prevention, or treatment of disease or the assessment of health to abide by
federally established quality standards in order to operate these services.363

United States Nuclear Regulatory Commission (NRC)
The United States Nuclear Regulatory Commission (NRC) is an independent agency created by Congress in 1974.364 The goal of the agency is to ensure the safe use of radioactive material for civilian
purposes through a combination of regulatory requirements, licensing, safety oversight, operational
evaluation, and support activities.365 Under section 274 of the Atomic Energy Act of 1954, the NRC
is authorized to delegate its authority to oversee certain licensees to state regulatory commissions, or
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agreement states.366 An agreement state then has the authority to regulate the use of nuclear material by
certain licensees. To date, the NRC has entered into agreements with thirty-seven states.367
The NRC or the agreement state regulates the medical use of radioactive material through the licensing of medical facilities and physicians, inspection of facilities, and enforcement of regulations and
procedures. The types of medical use regulated by the NRC and the agreement state include the production of radiation from imaging devices used by hospitals, physicians, dental offices, and podiatry offices;
the use of nuclear material to deliver pain reliving or therapeutic doses to parts of the body; and medical
research involving the use of nuclear material in human subjects.368

Emergency Medical Treatment and Active Labor Act
(EMTALA)
The Emergency Medical Treatment and Labor Act (EMTALA) was enacted in 1986 by the Consolidated
Omnibus Budget Reconciliation Act of 1985 and applies only to hospitals that participate in the Medicare program and have an emergency room.369 EMTALA requires covered hospitals to provide “medical
screening” to any patient coming to the hospital’s emergency department.370 Anyone suffering harm as a
“direct result” of a hospital’s violation of EMTALA can bring a claim against the hospital.371 Additionally, EMTALA provides for civil penalties against the hospital.372
Of note is that EMTALA does not require hospitals to have an emergency department. Some specialty hospitals, however, are required by state licensure laws to have an emergency department.373

Tort Reform
Malpractice, defined as “professional misconduct or unreasonable lack of skill,” has always been a risk
inherent in the practice of medicine.374 Medical malpractice litigation became popular in the 1970s, and
since then, medical malpractice litigation has been a recurring problem in healthcare, as physicians have
been forced to practice defensive medicine, leading to the overprovision of care and increased healthcare
costs.375 As malpractice litigation has increased due to improved technology and increased volume of
patients, physicians have been forced to pay higher premiums for malpractice insurance, causing some
physicians to move out of states with high premiums, close their medical practices, take early retirement,
or choose to go naked, that is, practice without malpractice coverage.376 While many physicians have not
had to take such drastic action, high malpractice premiums have led to increases in the cost of services,
and, therefore, to increased costs of consumer health insurance premiums.377
Tort reform proponents have alleged that the United States has the most
expensive tort system in the world, with costs per citizen of about $845 per
person in 2003.
“Tort excess: the necessity for reform from a policy, legal and risk management perspective.” by David Dial, et al.,
p.1, http://server.iii.org/yy_obj_data/binary/727182_1_0/tortreform.pdf (accessed September 8, 2009).

Malpractice litigation stems from the U.S. tort system, which allows patients who are injured in
some way, to sue the wrongdoer, or tortfeasor.378 If found liable, the tortfeasor is held accountable for
his or her actions, and the injured party is able to recover for damages incurred as a result of the tort.379
Damages in a malpractice suit generally are classified as economic (loss of wages, etc), noneconomic
(pain and suffering, etc), or punitive damages (intended to punish and deter future behavior).380 Tort
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reform proponents have alleged that the United States has the most expensive tort system in the world,
with costs per citizen of approximately $845 per year in 2003.381 Despite the fact that the vast majority
of cases are settled out of court, an estimate of the 2001 direct costs of the U.S. tort system was $205.4
billion.382

State Tort Reform
In response to this problem, there have been multiple tort reform initiatives, at both the state and federal
level, aimed at capping malpractice damages.383 Many states have caps already in place.384 Such caps,
often modeled after California’s Medical Injury Compensation Reform Act (MICRA), place limits on
pain and suffering awards to plaintiffs.385 Similarly, in 2003, the Texas legislature passed a $750,000
cap on damages ($250,000 per defendant).386 As of 2009, thirty-seven states had passed laws that place
limits on noneconomic or punitive damages in medical malpractice suits.387 Of the thirteen states that do
not place caps on damages, five have determined such caps to be unconstitutional, and four have constitutional provisions which outlaw caps on damages.388
In addition to damages caps, another method used to provide limits on financial risk to insurers has
been the establishment of statutes of limitations on claims made by plaintiffs.389 Other methods of tort
reform called for by proponents would enable or enhance the ability of defendants to countersue claimants who file frivolous lawsuits.390 Another way to lower malpractice premiums would be to create
compensation programs outside of the court system to handle malpractice cases.391 Additionally, a more
proactive and preventative approach to prevent lawsuits by lowering medical malpractice awards (and
therefore premiums) would include building rapport with patients, reducing medical errors, and establishing honesty policies for full disclosure of errors.392

Federal Tort Reform
Though medical malpractice law has traditionally been regulated at the state level, the federal government has taken an interest in tort reform. A 2002 HHS report alleged that the legal system was to blame
for rising medical malpractice premiums, citing California’s noneconomic damages cap as a model for
national tort reform.393 While there have been efforts at federal tort reform, a federal cap on damages has
yet to be signed into law. The most recent effort to cap damages at the federal level, the Help Efficient,
Accessible, Low-Cost, Timely Healthcare Act of 2009, was introduced before the House of Representatives in February 2009.394 This bill is a new attempt to pass a federal cap on noneconomic damages in
medical malpractice suits, which has been a continuing congressional goal since the same bill was first
introduced in the House in 2002.395 Similar bills have repeatedly passed in the House, however, no version of the bill has yet to be passed in the United States Senate.396
Proponents of tort reform historically have pushed for caps on punitive damage awards.397 However,
more viable reform proposals include shifting tribunals (for example, from judicial to administrative
panels) or creating federal safe harbors for physicians who practice in accordance with credible comparative-effectiveness research.398 Additionally, insurance companies are experimenting with disclosure-and
offer programs, in which providers offer compensation to patients immediately upon disclosure of a
negative outcome, reducing the number of malpractice lawsuits.399
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Conclusion
The healthcare regulatory environment is constantly changing. As physicians and other providers find
it more and more difficult to survive under crippling regulations and reimbursement rates, they are
being forced to find ways around regulations directed at limiting the ways in which they may receive
remuneration for services provided. The numerous modifications of the Stark law are a good example
of how CMS has had to continuously modify existing regulations in an effort to keep up with providers
who are finding new ways to join together and use new technologies to survive in a regulation-ridden
environment.
As healthcare reform pushes forward, it is unlikely that providers will be faced with fewer regulations. It is more likely that reform efforts will focus on increased regulation and increased prosecution
of regulatory violations. Notable recent events have demonstrated that agencies such as the HHS, the
DOJ, and the FTC are cracking down on any activity that could have the potential to drive up the cost of
healthcare services. All of these agencies have demonstrated their commitment to combating healthcare
fraud and are likely to continue to promulgate new regulations to accomplish this task in the future.
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4

Impact of
Competitive Forces
There are perhaps few things upon which all men are so agreed
as that the problems which beset them today surpass in difficulty
those which confronted any previous generation. It is maintained
that never has knowledge been so complex nor the pace of life
so insistent; that never has it been so difficult to take thought
on those larger considerations which allow men to appreciate
the trend of events and the measures by which they might be
controlled.
Harold Himsworth, 1953

KEY TERMS
- Cherry-pick or
Cream-skim
- Economic Demand
- Economic Supply

- Monopsony
- Niche Providers
- Purple Pill
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Key Concept

Definition

Citation

Normal Markets versus
Healthcare Markets

Competition in healthcare is unique from competition in other
sectors because traditional theories of economic forces do not
always govern the choices made.

n/a

“Corporatization” of Medicine

The transformation of vertically organized bureaucracies into
government-owned corporations that are exposed to market-like
pressures. In healthcare, this means the establishment of publically
owned hospitals as private corporations. Corporatization is usually
seen along with autonomization.

“Understanding Organizational Reforms: The Corporatization
of Public Hospitals” by April Harding and Alexander S. Preker,
Health, Nutrition, and Population, The World Bank, September
2000, p. vii, 15.

“Three-Legged Stool” Model of
Healthcare

Cost, quality, and access are each considered distinct elements of
healthcare administration.

“Why Competition Law Matters to Health Care Quality,” by
William M. Sage, David A. Hyman, and Warren Greenberg,
Health Affairs, Vol. 22, No. 2, (March/April 2003), p. 35–36.

Emergency Medical Treatment
and Labor Act

Hospital emergency departments are required to provide care under
certain circumstances, even to patients who are uninsured and
unable to pay for that care.

“Could U.S. Hospitals Go The Way Of U.S. Airlines?” by Stuart
H. Altman, David Shactman, and Efrat Eilat, Health Affairs, Vol.
25, No. 1, (Jan/Feb 2006), p. 11.

“Most Favored Nation” Status

A provider contractually agrees to not charge an insurance
company any more than it charges any other customer.

“Improving Health Care: A Dose of Competition: Chapter 6,
Competition Law: Insurers,” A Report by the Federal Trade
Commission and Department of Justice, July 2004, p. 20.

Trend Toward Physician
Ownership

Physicians have become owners and investors in surgical facilities,
such as ambulatory surgery centers, and specialty hospitals, that
compete with the same general hospitals to which the physicians
traditionally have referred patients.

“Hospital-Physician Relations: Cooperation, Competition, or
Separation?” by Robert A. Berenson, Paul B. Ginsburg, and
Jessica H. May, Health Affairs, Web Exclusive,
(Dec. 5, 2006), p. w34.

Effect of Declining Patient
Volumes

Hospitals began offering additional services and entering into the
practice of providing insurance and primary care services, taking
on a powerful role as both provider and insurer through integrated
delivery systems. In addition, hospitals to begin merging with each
other so that they could leverage their consolidated bargaining
power against private insurers.

“Competition in Health Care: It’s Evolution Over the Past
Decade,” by Paul B. Ginsburg, Health Affairs, Vol. 24, No. 6,
Nov/Dec 2005, p. 1513–14.

Federal Specialty Hospital
Moratorium of the Medicare
Prescription Drug, Improvement,
and Modernization Act of 2003

Placed an eighteen-month moratorium on physician investment
in, and referrals to, specialty hospitals in which the referring
physician had an ownership or investment interest in order to study
the impact of specialty hospitals on Medicare payment rates and
referral practices. Expired in 2005.

“CMS Outlines Next Steps and Moratorium on New Specialty
Hospitals Expires,” Press Release, Centers for Medicare
and Medicaid Services, June 9, 2005, www.cms.hhs.gov/
apps/media/press/release.asp?Counter=1478 (accessed
November 9, 2009).

Conflict of Interest Credentialing

The limiting or terminating physician-investors’ privileges and
medical staff membership.

“Banning Physician Self-Referral is an Important Step
Toward Health Reform,” by Rich Umbdenstock and Chip
Kahn. HA News Now, www.ahanews.com/ahanews_app/jsp/
display.jsp?dcrpath=AHANEWS/AHANewsArticle/data/AHA_
News_090720_ Physician&domain=AHANEWS (accessed
November 9, 2009).

Michael Porter’s Five
Competitive Forces

(1) The threat of new market entrants. (2) The bargaining power of
suppliers. (3) Threats from substitute products or services. (4) The
bargaining power of buyers. (5) Rivalry among existing firms.

“Competitive Strategy: Techniques for Analyzing Industries
and Competitors:,” by Michael E. Porter, The Free Press,
1980, p. 4.

Strategies to Out-perform
Porter’s three generic strategies are (1) overall cost leadership, (2)
Competitors or Maintain a Market differentiation, and (3) market niche or segmentation.
Position Against Competition

“Making Competition in Health Care Work.” by Michael E.
Porter, et al., Harvard Business Review, July/August, 1994.

Medical Tourism

The practice of patients traveling to countries to receive medical
“Could U.S. Hospitals Go The Way Of U.S. Airlines?” by Stuart
procedures at a fraction of what they would cost in the United States. H. Altman, David Shactman, and Efrat Eilat, Health Affairs, Vol.
25, No. 1, (Jan/Feb 2006), p. 18.

Medicare Improvements for
Patients and Providers Act of
2008

Includes a provision requiring accreditation of physicians who
provide the technical component for advanced diagnostic imaging
services (for example, magnetic resonance imaging , computed
tomography, and nuclear medicine or single photon emission
computed tomography) for which payment is made under the
Medicare physician fee schedule. All suppliers of the technical
component of advanced diagnostic imaging services will need to be
accredited by January 2012.

“Medicare Improvements for Patients and Providers Act of
2008,” Pub. L. 110-275, 122 Stat. 2494, July 15, 2008, Sec.
135(a).

McCarran-Ferguson Act

Limits federal scrutiny of insurers and places states in primary
control of antitrust enforcement.

“McCarran-Ferguson Act” 15 U.S.C 1011 et seq.
March 9, 1945.
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Overview
Competition in healthcare is unique from competition in other sectors because traditional theories of
economic forces do not always govern the choices made by professional practice enterprises within the
healthcare industry. Unlike other markets, in which competition is viewed positively as a necessary element of capitalism, competition in the healthcare sector frequently is considered to be resistant to the
universal availability and accessibility of quality care.
Although traditional notions of economic supply and demand, and the inherent concept of competition, have gained influence over healthcare professional practice enterprises in recent years, these factors historically were subjugated to a normative argument in favor of the mission-centered provision of
services regardless of cost. This has led to the perception that healthcare demand is supply-driven and
operates within an inelastic pricing mechanism, the circumstances of which will be discussed in detail
later in this chapter.
As the relationship between price and quality of care generally is defined by providers rather than
patients, consumers (that is, patients) are less equipped to make informed purchase decisions than they
are in other markets. Further, the intensive regulation of medical professionals, new technologies and
treatments, and evolving drug therapies may delay or disable the development of substitutes, and, therefore, stymie innovation, which is one of the fundamental drivers of quality improvement and the underlying dynamic of an organization’s ability to compete.
In addition to the impact of regulation on the delivery of healthcare services (discussed in chapter 3,
Regulatory Environment), the government’s role as the single largest payor for healthcare services exerts
enormous pressure on providers to reduce costs. The impact of these changes has not been limited to
Medicare and Medicaid fees; it is also reflected in reimbursement policies of other third-party payors.
This pre-eminent influence on, and pervasive dominance of, government over the healthcare industry
presents a significant and essentially unique differential between healthcare and other industries.
Finally, the past two decades have seen the accelerated transformation of U.S. healthcare professions
into a service industry enterprise, whereby many believe that professional health services have been
unitized, protocolized, and homogenized in order to facilitate their “sale,” just like if they were any other
market commodity (for example, frozen orange juice, soy beans, or pork bellies). These changes have
accelerated the “corporatization” of medicine as demonstrated by the increase in for-profit healthcare in
hospitals, outpatient technical component providers [for example, independent diagnostic testing facilities (IDTFs) and ambulatory surgery centers (ASCs)], and large for-profit health insurance payors.

Economics of Healthcare
Healthcare costs are not just rising, they are growing at a proportionally greater rate compared to the rise
in cost of other goods and services in the U.S. economy.1 The percentage of the gross domestic product
(GDP) devoted to healthcare services has grown from 6 percent in 1965 to almost 18 percent at the time
of publication, and it is projected to surpass 20 percent by 2018.2 Although many causes exist for this
gap between growth in healthcare spending and growth in GDP, note that the impact of the economic
recession, which started in 2008, was more severe on GDP than it was on healthcare spending, though
the growth rate of the latter did decline slightly.3
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The percentage of the gross domestic product (GDP) devoted to healthcare
services has grown from 6 percent in 1965 to almost 18 percent at the time
of publication, and is projected to surpass 20 percent by 2018.
“Three Decades of Government-Financed Health Care in the United States,” by Patrick Fleenor, Tax Foundation,
August 1994, www.taxfoundation.org/files/bd006ece1a4b8166023dbc913175b7b7.pdf (accessed November 11,
2009); “Health Spending Projections Through 2018: Recession Effects Add Uncertainty to the Outlook,” by Andrea
Sisko, et al., Health Affairs, Web Exclusive, Feb. 24, 2009, p. w347.

Some economists have cited the aging population as the reason for the increase in healthcare’s share
of the GDP. Other voices have asserted that greed among health maintenance organizations (HMO),
pharmaceutical companies, hospitals, and medical providers, such as doctors and nurses, is responsible.4
In reality, the rise in healthcare expenditures is, at least in large part, the result of much deeper economic
forces. As economist William J. Baumol explains, “the relative increase in healthcare costs compared
with the rest of the economy is inevitable and ineradicable part of a developed economy. The attempt [to
control relative costs] may be as foolhardy as it is impossible.”5
Documented and significant differences exist in productivity growth between the healthcare sector
of the economy and the economy as a whole. Healthcare services have experienced significantly lower
productivity growth rates than other industry sectors for three main reasons. First, healthcare services
are inherently resistant to automation, so innovation (in the form of technological advancement) has
not made the same impact on healthcare productivity as it has on productivity in other industries. The
manufacturing assembly line robot increases assembly line productivity by accelerating the process and
reducing labor input. In contrast, most medical technology is still applied in a labor-intensive process,
that is, patients are cared for one at a time, and diseased or ill patients cannot be disposed of as routine
work product error like automated factories can cost-effectively reject a percentage of defective items.
Healthcare providers cannot (and, most would agree, should not) try to operate as factories, because
each patient is unique and disease is widely variable. This makes providers unable to adapt to the productivity gains and efficiency derived from mass production techniques.6
Second, unlike other labor-intensive industries, healthcare is local in nature and cannot be imported.
Despite the technology advances described previously, healthcare services mainly are provided by
skilled workers within a local market in which the providers compete locally and are compensated at
higher levels.7
Third, healthcare consumers believe that quality of service is correlated with the amount of labor
expended in its provision, in contrast to mass production, in which the number of man-hours per unit is
not an important predictor of product quality.8

Supply and Demand in Healthcare
Historically, healthcare was considered a “special” economic market, in which quality of care traditionally trumped general economic notions of the consumer-driven model of supply and demand. Competition law, which considers quality as only one element of a good or service, inherently conflicts with
the traditional perspectives of providers who see quality as “an irreducible minimum standard, to be
determined by physicians without reference to cost.”9 Prior to the mid–twentieth century, healthcare was
dominated by these providers who justified anticompetitive behavior under the guise of quality control
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(see chapter 6 of Professional Practices for a discussion of the highly publicized Wilk v. American
Medical Association, in which the American Medical Association (AMA) attempted to boycott chiropractic practices, stating that doctors of chiropractic were unscientific practitioners, as well as chapter 4
of Professional Practices regarding the highly contested 2008 Missouri Supreme Court decision to allow the independent practice of nurse midwives under constitutional law).10 In the mid- to late-twentieth
century, however, the stringency of competition policy was heightened in order to address such behavior
among providers, and, as such, competition laws have begun to regulate the healthcare sector, as an economic market, more directly.11
Prior to the mid–twentieth century, healthcare was dominated by
these providers that justified anticompetitive behavior under the
guise of quality control.
“Why Competition Law Matters to Health Care Quality,” by William M. Sage, David A. Hyman, and Warren
Greenberg, Health Affairs, Vol. 22, No. 2, (March/April 2003), p. 39.

Additionally, competition law now addresses the traditional notion of the “three-legged stool” model
of healthcare, under which cost, quality, and access are considered distinct elements of healthcare administration. As the impact of competition law on healthcare policy has grown, these three “legs” have
demonstrated their interconnectedness, with price being viewed as having a direct impact on quality of
care. Competition laws have been used to combat the practice of increasing prices above competitive
levels, as well as to prevent providers from excising certain competitors from the market in the pursuit
of “higher quality of care” (see chapter 3, Federal Antitrust Laws).12
Also unique to the healthcare sector is the widespread notion of providing services irrespective of
the client’s (that is, the patient’s) ability to pay. Under laws such as the Emergency Medical Treatment
and Labor Act (EMTALA), general hospital emergency departments are required to provide care under
certain circumstances, even to patients who are uninsured and unable to pay for services rendered.13 Additionally, the power of Medicare and Medicaid forces providers to operate at a loss for many services,
because those programs typically reimburse providers only for a fraction of the amount the services cost.
As these payors provide nearly 60 percent of a hospital’s revenue, the general relationship between cost
and price found in other markets is not commonly followed in the healthcare sector.14
Medicare and Medicaid provide nearly 60 percent of a hospital’s revenue.
“Could U.S. Hospitals Go The Way Of U.S. Airlines?” by Stuart H. Altman, David Shactman, and Efrat Eilat, Health
Affairs, Vol. 25, No. 1, (Jan/Feb 2006), p. 14.

Further, competition in healthcare does not divide neatly between supply and demand, further contributing to the complexity that distinguishes competition within healthcare market from other industry
sectors. Ultimately, the major players on the supply side of the healthcare industry are powerful private
insurance companies and large hospital systems. Despite the fact that providers actually supply services
to treat patients, insurance companies are able to limit access to services through the use of provider networks, and hospitals are incentivized to keep costs low by treating only what is necessary, knowing that
readmission will mean additional reimbursement.15
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Additionally, many community hospitals are finding it increasingly difficult to cross-subsidize
expensive treatments due to competition from specialty providers and increased demands for price
transparency by consumers.16 Difficulties in accessing capital to support the provision of money-losing
services have pushed many smaller hospital systems to consolidate with larger, for-profit systems.17
At the same time, insurers operate as consumers of healthcare services by paying for the services
provided and deferring that cost from the actual consumer, the patient.18 On this side of the equation,
large insurance companies have been able to enjoy monopsony (that is, single purchaser; opposite of
monopoly) power in the United States which has allowed them to demand “most favored nation” status
in their contracts with providers; that is, the provider contractually agrees to not charge the insurance
company any more than he or she charges any other customer.19 This has allowed insurance companies
to prevent competitors from entering the market, which, combined with numerous mergers, has led to
a highly concentrated insurance market and paved the way for insurers to set malpractice premiums at
rates so high, and reimbursement payments at rates so low, that they are driving physicians and small
hospitals out of business or forcing them to join large hospital system conglomerations.20
At the same time, consumers enduring the repercussions of high insurance premiums are choosing
to switch to more consumer-driven healthcare insurance by contributing to a health saving account
(HSA) from which to pay their medical expenses, then supplementing the HSA with high-deductible
health plans (HDHP) to cover catastrophic conditions.21 (For more information about HSAs, see
chapter 2, Health Savings Accounts (HSA)). This shift to consumer-driven healthcare has changed the
demand environment of the healthcare industry such that providers are now dealing directly with patients, who are starting to scrutinize more closely the procedures and services they purchase.22 By making these purchasing decisions directly, rather than relying on an insurance provider to pay most of the
cost of treatment, the ability of healthcare consumers to affect demand in the healthcare market has increased, and the demand side of this sector is finally beginning, in some capacity, to mimic that of other
industries.23

Impact of Government Regulation
Healthcare institutions are subject to extensive regulatory control at both the state and federal levels of
government. Some of the most significant regulations address the financial relationships between providers (see chapter 3, Stark Law). State and federal fraud and abuse laws have profoundly affected the
provision of healthcare services in the United States because they, in part, prohibit particular financial
relationships between healthcare providers. Proponents of these laws contend that practitioner medical
judgment is influenced by financial relationships with referral sources.24 However, substantial regulation
has the capacity to limit free market competition in the healthcare industry.25 Additionally, the influence of the government as both regulator and purchaser of healthcare services has the potential to distort
consumer responses to prices, as well as harm consumers directly by creating disincentives for the provision of quality care by reducing rewards for innovation, despite the aim of regulations to prevent market
forces from running amok and hurting quality (for more information related to government regulation of
the healthcare industry, see chapter 3, Regulatory Environment).26
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Supply: Cooperation and Competition Between Hospitals
and Physicians
Historically, physicians and hospitals each provided distinct services to patients, with physicians providing physician services, and hospitals providing surgical and other related services to patients referred
to the hospital in which the physicians enjoyed staff privileges.27 Under this symbiotic dynamic, there
was relatively little to no competition between physicians and hospitals.28 However, this trend has begun
to shift as physicians have become owners and investors in surgical facilities, such as ASCs and specialty hospitals, that compete with the same general hospitals to which the physicians traditionally have
referred patients. Additionally, the willingness of physicians to volunteer for responsibilities within a
hospital has declined significantly in recent years, marking another shift toward a more competitive and
adversarial relationship between physicians and hospitals (for more detail related to the organizational
structure of healthcare services in the current market, see chapter 1 of Professional Practices).29

Hospitals
During the 1990s, the focus of managed care on the role of primary care physicians as “gatekeepers”
resulted in declined patient volumes for hospitals.30 With reduced patient volumes, hospitals began offering additional services and entering into the practice of providing insurance and primary care services,
taking on a powerful role as both provider and insurer through integrated delivery systems.31 Declining
patient volumes also prompted hospitals to begin merging with each other so that they could leverage
their consolidated bargaining power against private insurers.32 As time progressed, concerns regarding access to capital have led to continued hospital consolidation, such that smaller, typically nonprofit,
hospitals are faced with the grim choice of going bankrupt or joining larger, for-profit hospital systems
to survive.33
A particular impact of competition on hospitals is that they are asked to provide money-losing
services in an environment in which price-competitiveness is promoted. Traditionally, hospitals could
cross-subsidize cost-ineffective services (for example, those falling under Medicare or Medicaid,
services provided to indigent patients, etc.) by charging more to insured patients who were not pricesensitive and did not have the capacity to know the difference.34 However, the rise of competition with
specialty hospitals and niche providers (see Threat of New Market Entrants) has led to increased price
transparency, which allows those insured patients who have been footing the bill for money-losing
services to demand that prices reflect the services actually provided to them, and nothing more.35 The
potential decrease in demand for services that are priced too high could force hospitals to eliminate costineffective services in the struggle to compete with other hospitals and specialty providers.36

Competition Between General and Specialty Hospitals
Although specialty and niche providers are not new providers, the increase in their number has led
to concerns that more and more providers will be able to “cherry-pick” and “cream-skim” the most
profitable patients and procedures away from community hospitals. Specialty hospitals focus on providing only cost-effective or profitable services, and they refuse to provide services that result in a net loss
or treat patients who cannot pay.37 Further, the development of new technology has made it possible for
physicians to perform, in their office or ASC, services traditionally provided by hospitals.38 Specialty
hospitals and ASCs have been able to compete better than community hospitals for more profitable patients by (1) concentrating only on specific diagnosis-related groups (DRG), (2) treating far fewer costly
Medicaid patients, and (3) opting out of emergency room facilities and services, the latter to forego
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the related regulatory requirements under laws, such as EMTALA, that pertain to the provision of care
regardless of a patient’s ability to pay.39
Specialty hospitals and ASCs treat some of the most profitable diseases in a predominantly outpatient setting. These facilities have grown due to the increased incidence of these diseases, as well
as changes in consumer demands and new technologies. “Specialty hospitals are also able to achieve
economies of scale and scope by providing high volumes of a limited scope of services and lowering
fixed costs by reengineering the care delivery process.”40 This narrow focus helps achieve profitability
and makes such facilities more competitive than more generalized providers, because “greater diversification into a wider array of activities has the potential to lead to diminished financial performance.”41
The ability to provide services at a reduced cost is a double-edged sword for ASCs. Under the Medicare system, reimbursement rates for hospital outpatient departments (HOPD) are substantially higher
than reimbursement rates for the same procedures performed in an ASC or a physician’s office.42 For
most services performed in an ASC, payment is made under a system that aligns ASC reimbursement
rates at a percentage of the Outpatient Prospective Payment System (OPPS) rates.43 Because of the need
to ensure budget neutrality between the old ASC payment system and the revised system, the reimbursement rate for ASC procedures was set at 65 percent of the OPPS rate in 2008.44 Centers for Medicare
and Medicaid Services (CMS) cut this rate again in 2009,45 with a zero percent adjustment for inflation,46
and only increased the conversion factor for payments to ASCs by 1.2 percent for 2010, despite an
increase of 2.1 percent for HOPDs for the same year.47 Because CMS accounts for an average of 34 percent of ASC revenue, changes to CMS reimbursement rates greatly affect the ability of ASCs to provide
quality patient care services (see chapter 1 of Professional Practices).48
Medicare and Medicaid account for an average of 34 percent of an
ambulatory surgery center’s (ASC’s) revenue.
“10 interesting facts and statistics for ASCs,” by S. Becker, Becker’s ASC Review, January 2008, www.beckersasc.
com/ambulatory-surgery-center/surgery-center-education/10-interesting-facts-and-statistics-for-ascs.html
(accessed May 17, 2010).

Further, physicians who provide outpatient services in their offices only receive the physician fee
component reimbursement rate under the Medicare physician fee schedule.49 When procedures are
performed in a HOPD, hospitals (in the absence of bundled payments) receive both the physician fee,
with which they reimburse their doctors, and the facility fee reimbursed under the OPPS rate.50 Further,
although the payment differential between HOPDs and ASCs is standardized for the most part, the payment differential between services provided in HOPDs or ASCs and services provided in physicians’
offices varies substantially by payor and service (for more detail on Medicare reimbursement see
chapter 2, Medicare).51
Campaign Against Physician Ownership
Competition between hospitals and physicians has been intensified by a growing tension between the
American Hospital Association (AHA) on one side and the American Medical Association (AMA)
and Physician Hospitals of America on the other side, a tension which has risen out of the debate over
physician ownership of specialty hospitals.52 At its heart, the controversy regarding specialty and niche
providers is a turf war between physicians and hospitals related to the technical component revenues
from procedures and diagnostic testing. Physicians, who have seen decreased reimbursement rates for
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the professional fee component of their services under the Medicare physician fee schedule, have begun
to invest in ancillary services and technical component (ASTC) revenue stream enterprises (for example,
ASCs, IDTFs, and specialty hospitals) so that they may also be reimbursed for the procedure under the
OPPS.53
As many also assert that the practice of physician investment in healthcare from which they seek to
earn a profit is a practice that is normatively controversial and should be avoided, physician owners of
ASTC revenue stream enterprises have come under attack at the hands of regulators that have been lobbied incessantly by powerful community hospital systems.54 In particular, opponents of specialty hospitals consistently have lobbied for the elimination of the “whole hospital exception” to the Stark law (see
chapter 3, Stark Law), which allows physicians to refer patients to facilities in which they have ownership or investment interest as long as the ownership or investment interest is in the whole hospital and
not just a subdivision of it.55
Legislative proposals to remove the whole hospital exception in 2003 prompted the General Accounting Office (GAO) to investigate the development and effects of specialty hospitals.56 In April 2003,
GAO issued its first report on the market share and physician ownership of specialty hospitals.57 The
GAO found that specialty hospitals represented a growing share of the hospital market and that there has
been rapid growth in the number of specialty hospitals.58 The GAO also found that physicians owned 70
percent of all specialty hospitals.59 The GAO issued a more detailed report in October 2003 analyzing
the impact of specialty hospitals on general hospitals. The October report found that specialty hospitals
were less likely to have emergency rooms than general hospitals, treated fewer Medicaid patients than
general hospitals, and derived less income from inpatient services than general hospitals.60
In response to this report, the United States Congress, as part of the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003 (MMA), placed an eighteen-month moratorium on physician investment in, and referrals to, specialty hospitals in which referring physicians had an ownership
or investment interest in order to study the impact of specialty hospitals on Medicare payment rates
and referral practices.61 Typically, the whole hospital exception to the Stark law would have protected
such physicians who have an ownership or investment interest in the whole hospital from violating the
Stark law by referring patients to that facility. However, the MMA’s eighteen-month moratorium on the
development of new specialty hospitals62 was the culmination of a multiyear battle against this perceived
loop-hole in the Stark law allowing physicians to have ownerships interests in hospitals. The temporary
moratorium appears to represent a compromise between the faction wanting to eliminate the whole hospital exception for all hospitals and the faction concerned only with the perceived threat from specialty
and niche providers.
The AHA, a long-time supporter of restrictions limiting physician self-referrals and investment,
supports extending the specialty hospital moratorium contained in the MMA.63 Recognizing that it may
be difficult for physicians to unite against the hospital industry, the AMA has demonstrated its support
of specialty hospitals and a “level playing field” between general and specialty hospitals.64 The AMA
has stressed that it supports competition between healthcare providers because it “promotes delivery of
high-quality, cost effective healthcare.”65 However, the AMA does not speak for all physicians on this
issue. The American Academy of Family Physicians (AAFP) has announced its support for extending
the specialty hospital moratorium. The AAFP has sided with the AHA, believing that specialty hospitals
could cream-skim patients with profitable diagnoses.66
Although the specialty hospital moratorium expired without being perpetuated in 2005, the debate
regarding physician ownership of specialty hospitals continues, with organizations such as the AHA
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accusing specialty hospitals of leaving community hospitals with the brunt of uninsured and underinsured patients.67 At the same time, physicians counter that physician-owned facilities (POFs) are able to
offer improved competition leading to lower costs, higher quality, better outcomes, increased efficiency
derived from more focus on specific services, more convenient services than offered by general hospitals, and better amenities. POFs also offer physicians greater control over delivery of services and the
ability to supplement their otherwise decreasing revenues.68
Exclusionary Boycotts
In response to the threat from specialty hospitals, many community hospitals also have started to fight
back in ways that may be perceived as being in violation of antitrust laws. In situations when specialty
hospitals are owned in whole or in part by physicians with privileges on the medical staff of a general
acute care hospital and when the specialty hospital competes with the general hospital either on an inpatient or outpatient basis, many general hospitals have engaged in activities that attempt to shut the POF
out of the market. Some of these practices include refusing to assist or cooperate with specialty hospitals, pressuring other members of the medical staff or community physicians to not do business with
the specialty hospital, pressuring payors to exclude specialty hospitals from the payors’ networks, and
limiting or terminating physician-investors’ privileges and medical staff membership (conflict of interest credentialing).69 In response to these practices, some POFs have initiated antitrust suits, claiming that
general hospitals are engaging in illegal exclusionary boycotts.70
Although courts typically have favored general hospitals that have been trying to combat cream
skimming by specialty hospitals, one notable case brought by Heartland Surgical Specialty Hospital, a
Kansas City–area hospital, in 2005, demonstrates that courts will not always overlook anticompetitive
behavior by hospitals. The specialty hospital filed an antitrust lawsuit alleging horizontal conspiracies
between multiple health plans and multiple hospitals, as well as vertical conspiracies between the hospitals and payors directly, resulting in pressure on payors, as well as direct agreements with them, to
exclude the specialty service hospital from their networks.71 The eventual settlement in this case demonstrates that antitrust laws still protect against entities with market power from using that market power to
pressure others (in this case, other hospitals and payors) into agreeing to exclude a competitor from the
market.72

Physicians
Competition in the healthcare industry operates predominantly at the level of hospitals, health plans,
and provider networks, rather than at the level of healthcare delivery with an independent practitioner.73
This has incentivized physicians to join together in one of many types of emerging healthcare models
(see chapter 2 of Professional Practices) so that they may improve their positioning vis-à-vis third-party
payors. However, because physician manpower shortages are projected through the first quarter of this
century, the independent practice of medicine may become less common.

Consolidation with Other Physicians
There has also been a noticeable shift in competition among physicians in recent years. Originally, many
physicians operated as independent competitors, perhaps allied only with the hospital(s) to which they
referred patients.74 The more recent trend has been for physicians to join networks with other physicians and to clinically integrate their services in an effort to lower costs and improve quality.75 Managed
care has placed pressure on these organizations to reduce costs, maintain quality, and protect market
share.76 A key driver of physician integration has been the potential negotiating power it merits, namely
178

V1-D-Chapter 04.indd 178

9/28/10 3:20 PM

C hap ter 4 : Impact of C ompeti ti ve Forces

for contracting with hospitals and Managed Care Organizations (MCOs).77 The independent practice
association (IPA) has been one of the more successful physician integration models.78 Other forms of
physician integration include group practices without walls, physician practice management companies
(PPMCs), and consolidated medical groups.79 These organizations have not achieved the success levels
of IPAs.80 However, management services organizations (MSOs) have been successful in the integration
of both providers and healthcare institutions.81 They generally offer an array of medical support services, including billing and administrative support.82 They also help negotiate contracts with third-party
payors.83 For detail on each of these types of physician integration models see chapter 2 of Professional
Practices.

Manpower Shortage
In 1980, the Graduate Medical Education National Advisory Committee projected a surplus of 70,000
physicians in the year 2000, which led to the implementation of a cap on medical school enrollment
to control supply of physicians to the market. Due to tightly controlled managed care in the 1990s, the
projections of a physician surplus in the next decade were reaffirmed, and the number of graduates per
year remained unchanged for nearly twenty-five years.84 As economic recession hit in 2008, the physician workforce, like many other professions, experienced a shortage that is expected to continue through
the next decades, reaching a possible a shortage of 159,000 physicians by the year 2025.85 The shortage
can be attributed to both the increased demand resulting from the growing baby boomer population and
the misaligned cap on medical school enrollment.
The physician workforce shortage is expected to continue through the
next two decades, reaching a possible a shortage of 159,000 physicians
by the year 2025.
“The Complex Dynamics of the Physician Workforce: Projected Supply and Demand through 2025” by Michael J.
Dill and Edward S. Salsberg, Center for Workforce Studies, Association of American Medical Colleges, November
2008, p. 6.

Primary care is one of the practice areas suffering most from the physician shortage, which likely
can be attributed to the gap in pay between primary care physicians and specialists.86 Further exacerbating this particular shortage is the focus of medical schools on advanced specialization arising out of low
reimbursement rates for academic medical centers (AMCs). As a result, AMCs are forced to rely on
higher reimbursement rates for training by subspecialists, leading to a focus on subspecialties.87 Additionally, many surgeons have specialized so much that they do not feel qualified to provide emergency
services, with some surgeons only providing outpatient care.88

Demand: Third-Party Payors and Consumer-Driven
Healthcare
Although chapter 2, Reimbursement Environment, provides an extensive discussion of third-party payor
reimbursement, it is important to remember that the power of third-party payors as purchasers of healthcare services is significant. Insurers essentially hold all the cards when dealing with both providers and
patient-consumers. Although there will always be a significant amount of patient demand, how that demand affects the market is affected by the existence of an intermediary between supplier and consumer
that takes most of the purchasing burden off the consumer, as a result eliminating traditional demand
forces that work in other markets to keep prices at reasonable levels.
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Insurance and Managed Care
With regard to demand, the presence of third-party payors in the healthcare industry may be capable of
distorting the traditional supply and demand model by shifting the risks associated with ill health from
patient (consumer) to a third party that pays for the management of those risks.89 By shifting that risk,
consumers are insulated from the cost of the services needed to manage their health and, therefore, do
not make entirely informed choices when balancing costs with benefits, resulting in an imperfect demand curve.90 Conversely, insurance companies bear the costs associated with healthcare but generally
do not capture the full benefits, which may further discredit the application of a traditional supply and
demand model to the healthcare competitive market.91
Health insurance further affects the healthcare marketplace by offering misaligned incentives to physicians who are reimbursed by third-party payors at levels that do not reflect quality of care, but rather,
focus mainly on the procedural volumes.92 As a result, physicians may be neither rewarded nor punished
based on the quality of their work.93 This has the effect of insulating physicians from traditional competitive forces which force low-performing participants out of other markets.94
MCOs, such as HMOs and preferred provider organizations (PPOs), also can distort the traditional
competitive marketplace model by integrating the financing and delivery of healthcare services under
the administration of one organization.95 MCOs may be attractive to consumers because they offer lower
premiums, deductibles, and co-payments than traditional third-party payors.96 However, MCOs also
take many choices out of a patient’s hands by creating restricted networks of providers from which the
insured must choose in order to obtain those lower prices.97 One way of reducing the cost of care employed by MCOs is to contract with select physicians who agree to lower costs in order to be admitted
to the MCO’s provider network. In this way, MCOs force price competition between providers, which
allows them to negotiate volume discounts with providers, something that would not be possible for
individual consumers to do on their own.98
However, when the popularity of more restrictive forms of managed care began to wane at the end
of the twentieth century, flexibility began to re-emerge in managed care, which has re-introduced traditional supply and demand back into the health industry. As the popularity of point-of-service (POS),
PPOs, and pay-for-performance (P4P) plans has grown, patients have been able to once again take a
more active role as consumers in the healthcare marketplace.99 POS plans allow patients to use out-ofplan specialty physicians for some services as long as they start with an in-plan primary care gatekeeper;
PPOs allow patients to choose out-of-plan providers listed as preferred providers without the need for a
gatekeeper.100
MCOs are beginning to push their way into smaller markets, offering broader provider networks in
the process. There is nothing new about mergers in the managed-care arena—consolidation has grown
steadily for years. However, industry analysts and investment bankers predict that 2005 saw several new
trends emerge to help accelerate the kinds of mergers and acquisitions that have become commonplace
in the managed-care marketplace.101 According to a recent AMA report, a single insurer dominates in
most of the nation’s markets.102 In the combined HMO and PPO markets, 96 percent of metropolitan
areas have few competing health insurers, with the dominant insurer having a market share of 30 percent or greater.103 In 64 percent of the markets, the dominant insurer had a market share of 50 percent or
greater.104
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Public Payors
Prior to 1983, Medicare and most private insurers reimbursed providers on a fee-for-service (FFS) basis,
which paid hospitals and physicians based on the cost and the number of services they provided.105
Beginning in 1983, however, CMS adopted the hospital Inpatient Prospective Payment System (IPPS)
as a means of combating rising costs associated with FFS.106 The IPPS reimbursed hospitals based on
the DRG of the patient’s diagnosis at the time he or she was discharged, which reflected the average
cost treating patients in that DRG.107 By reimbursing hospitals at this fixed amount, the IPPS introduced
a more competitive, market-like environment for hospital reimbursement and encouraged hospitals to
reduce costs so that procedures remained profitable.108 Similarly, the hospital Outpatient Prospective
Payment System (OPPS) was implemented in 2000 to accomplish the same competitive environment for
outpatient procedures by reimbursing hospitals based on one of a number of Ambulatory Payment
Classifications (APCs).109

Consumer-Driven Healthcare
The prevalence of third-party payors that deflect a substantial portion of the true cost of services away
from the consumer (that is, the patient) is unique to the United States.110 However, the rise of consumerdriven healthcare (CDHC) shows that healthcare markets may be shifting away from the traditional
model and that the market distortion which arises out of the third-party payor system may be beginning
to dissolve (see chapter 2, Consumer Driven Health Plans—The Shift From Demand Benefits to Defined
Contributions). A significant competitive trend in health insurance is the rise of individual, high-premium insurance plans coupled with HSAs.111
However, the rise of Consumer-Driven Healthcare (CDHC) shows that
healthcare markets may be shifting away from the traditional model and
that the market distortion which arises out of the third-party payor system
may be beginning to dissolve.
“Could U.S. Hospitals Go The Way Of U.S. Airlines?” by Stuart H. Altman, David Shactman, and Efrat Eilat, Health
Affairs, Vol. 25, No. 1, (Jan/Feb 2006), p. 16.

CDHC is a growing trend based on neoclassical economic theory and studies that have shown that
insured individuals with higher deductibles tend to purchase less healthcare services than do insured
individuals with low deductibles.112 CDHC advocates the idea that consumers who pay for services
directly are more likely to compare price to quality and demand higher-quality care, a theory which supports the use of HSAs coupled with HDHPs.113 Generally, HSAs are personalized accounts into which
an individual contributes. An individual’s employer may contribute as well. The individual then may
withdraw funds to cover healthcare expenses.114 HSAs put the purchasing power directly into the hands
of the patient, who may use the tax-free funds to cover basic qualified medical expenses, including preventive care and over-the-counter drugs.115 HDHPs are then used in the traditional insurance context to
pay the costs associated with catastrophic events like trauma and chronic disease.116
Although proponents of CDHC argue that the use of HSAs and HDHPs will promote better analysis
of cost and quality at the point of service,117 skeptics argue that there is not enough evidence to demonstrate that CDHC leads to better informed choices based on quality.118 Nonetheless, CDHC plans
have the capacity to alter the traditional healthcare marketplace, which has become accustomed to the
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third-party payor system. The mere existence of CDHPs may alter the healthcare industry landscape
to look more like markets in other industries in which consumers make purchasing decisions and more
carefully scrutinize what they receive for their money. Additionally, by making consumers more aware
of the actual cost of procedures, this trend may affect the ability of hospitals to cross-subsidize for costly
care.119

Barriers to Free Market Competition in
Healthcare Delivery
Perfectly competitive markets exist only in economic theory. In reality, industries and markets have
varying constraints on competition. The healthcare industry often has been characterized as unique in
its many significant barriers to free market competition. Much of the inhibition from market controls on
price and quality result from factors that can be expressed in three general categories:
• The nature of health creates an unpredictable, urgent, and infinite level of demand.
• The ubiquitous involvement of insurance, private and governmental, as an intermediary in the purchase of healthcare interferes with consumer motivations and consequently their choice of providers and services.
• The difficulties in measuring healthcare quality and beneficial outcomes (both of quantifying and
qualifying) and the lack of information on the relative costs of healthcare providers and services
also inhibits consumer selection, further removing incentives to providers to increase quality and
lower costs.
Included among the many barriers to competition in healthcare delivery are the following:
1. Patients don’t purchase services directly from providers.
2. Patients don’t compare prices between providers.
3. The government is the largest purchaser of healthcare.
4. Private purchasers often lack market power.
5. Patients, purchasers, and providers lack information.
6. Many providers have monopoly or near monopoly power (yet antitrust laws prevent some potentially beneficial integration).
7. Providers are rewarded for increasing costs.
8. Capital investments are overly subsidized.
9. Certificates of Need, regulation, and licensing laws are entry barriers to competing and substitute providers and services.
10. Exit barriers protect low quality providers.
The government is the largest purchaser of healthcare services.
“The Next Antitrust Agenda: The American Antitrust Institute’s Transition Report on Competition Policy to the
44th President of the United States,” by The American Antitrust Institute, Albert A. Foer, Ed., Vandeplas Publishing
(2008), p. 344.
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The Application of Porter’s Five Forces to Hospitals and
Physician Groups
Harvard Business School Professor Michael Porter is considered by many to be one of the world’s leading authorities on competitive strategy and international competitiveness. Porter argues that all businesses must respond to five competitive forces: (1) the threat of new market entrants, (2) the bargaining
power of suppliers, (3) threats from substitute products or services, (4) the bargaining power of buyers,
and (5) rivalry among existing firms.120 When attempting to understand competitors and select competitive strategies, a review of these five forces may be useful to understand the underlying fundamentals of
competition.121
Healthcare often is described as being different from other industries for a number of reasons
including the
1. large role of governmental regulation and reimbursement,
2. seemingly limitless demand for healthcare,
3. necessity of having local providers,
4. removal of consumers from the direct purchasing decisions because of employer driven insurance purchasing, and
5. difficulties in quantifying health and the quality and costs of care.
Yet these differences may be found individually in other industries, and, increasingly, the barriers
to competition in healthcare are under pressure to be removed, diminished, or altered because of rising costs. Therefore, Porter’s five forces model may well be applicable to healthcare just like any other
industry.122 Porter has further explored the value of his model as a process or framework for use when
examining competition in healthcare.123
Porter’s model applies to a company operating within a given industry, therefore, it is necessary to
define “healthcare industry,” which contains numerous subsets interacting with each other including,
among others, hospitals, nursing homes, medical practices, home health agencies, sub-acute providers,
ASCs, and urgent care centers. The totality of these facilities and providers along with the administrators, equipment suppliers, pharmaceutical companies, and other support and managerial providers may
be considered for this exercise in definition, because they share the common goal of maximizing human
health. This is not an easily quantifiable outcome, but it can be viewed as the common denominator
among all the factions in the healthcare industry, and advances are being made in the sciences of quality
and outcomes research.
A hospital that does not acknowledge the local independent family medical practice or cardiology
group as working in the same industry as a competitor (as well as a customer) may have missed the
point. There is a complex relationship between the various subsets of the healthcare industry, and any
competitive evaluation should assess this relationship from several different perspectives.
Porter recommends three generic strategies to out-perform competitors or maintain a market position
against competition: (1) overall cost leadership, (2) differentiation, and (3) market niche or segmentation. Each of these is a strategy that has a different set of ethical consideration related to its application
by healthcare providers in a care and treatment environment.124
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Threat of New Market Entrants
Historically, many hospitals and physicians have believed that there is a low risk (or even no risk) of
new market competitors due to the entry barriers in their segments of the industry. Healthcare has been
viewed as a localized industry because providers must personally administer services to their patients. In
the current healthcare environment, however, new entrants do not necessarily compete within their local
market. Advances in technology and communication, as well as the ability to recruit providers nationally, are changing some aspects of the direct physician–patient relationship such that this emphasis on
localized competitive markets is no longer universal or absolute. Traditionally, healthcare has differed
from many industries because financial return does not always drive the decision process. However, the
overall threat from evolving market entrants on a given healthcare industry sector may be related to the
size of the financial return in that particular segment of the industry.

Rise of Niche Providers
The predominance in the market of limited-service providers, that is niche or specialty providers, has
grown in recent years.125 The AHA broadly defines niche providers to include “heart hospitals, orthopedic hospitals, surgical hospitals, ASCs, cancer hospitals and centers, dialysis clinics, pain centers, imaging centers, mammography centers, and a host of other narrowly focused providers.”126 The AHA does
not include other types of specialty and niche services, such as trauma and intensive care, which require
extensive specialization and are provided solely within the traditional inpatient community hospital
setting. However, the definition of niche provider changes depending on who is attempting to classify
this subjective and potentially broad range of limited-service providers. The definition may be expanded
to include surgical hospitals, ASCs, specialty hospitals, and virtually all providers who provide a specialized service outside of a hospital setting. Alternately, the definition may be limited to only those
providers treating patients with either a cardiac or orthopedic condition or those performing surgical
procedures.127
Healthcare providers falling into the broad niche provider category focus on a section or group of
buyers, a segment of a product line, or a specific area of a geographic market. The assumption is that
by focusing on a narrow target, healthcare providers can provide value to customers more effectively
than rivals who compete more broadly. The past decade has seen explosive growth in both inpatient and
outpatient limited service providers, increasingly owned, at least in part, by the physicians who refer
patients to them.

Boutique and Concierge Medicine
Concierge, or boutique, medical practices began in 1996 in Seattle and are now in several major metropolitan areas. Concierge medical practices are concentrated principally on the East and West coasts, with
most practices focused on providing primary care services.128 Concierge medicine is basically a return
to old fashioned medicine, in which physicians limit their client base and devote more time to each
patient (for more information, see chapter 2, Concierge Medicine, and chapters 1 and 2 of Professional
Practices). Patients usually can see their physician within a day of requesting an appointment, and most
have twenty-four-hour access to their physician by beeper or cell phone. Concierge medical practices
typically charge patients an annual retainer fee, which provides for guaranteed, around-the-clock access
to standard healthcare services, as well as increased access to personalized physician care.129 Physicians,
tired of long hours, not having enough time with their patients, and dealing with overbooked caseloads,
are turning to concierge medicine as a way of balancing their work and their life and providing quality
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care for their patients.130 Patients who have physicians in this type of practice appreciate the perks received in exchange for a yearly fee—similar to annual membership dues. These fees can range anywhere
from $1,000 per year to $10,000 per year depending on the patient’s age, benefits received, area of the
country, and type of practice.131 Amenities vary by practice, but some include more time with the physician (for example, a thirty-minute office visit), increased access to physicians, newsletters or conditionspecific information sent by e-mail, accompaniment on medical visits to outside specialists, and house
calls.132
Although concierge medicine may provide many benefits for patients, including more and in some
cases, nearly unlimited access to their physicians, it has been met with some scrutiny. Some say that this
type of medicine is elitist—that it is available only to wealthy patients who can pay the annual fees.133
However, many physicians report that the bulk of their clients are middle-income people who are willing to pay more for this kind of care.134 Boutique medicine is not a substitution for traditional insurance.
Patients typically will keep their traditional health insurance to pay for any tests or scans ordered by the
concierge physician.135 Medicare beneficiaries cannot be charged more than 115 percent of the rate for
services, and many politicians have said that the annual fee requirement is significantly greater than the
Medicare rate and, consequently, is illegal billing.136

Certificate of Need
A Certificate of Need (CON) program is one in which government determines where, when, and how
capital expenditures will be made for public healthcare facilities and major equipment.137 By their very
nature, CON programs are anticompetitive, a principle that serves as, de minimis, part of the rationale
for the inception of CON programs, in response to concern that market forces were not adequate to
prevent providers from overinvesting in equipment and facilities and, as a result, driving-up the cost of
healthcare.138 CON is based on the theory that, in an unregulated market, healthcare providers will utilize
the most up-to-date, costly technology and equipment, regardless of duplication or need.139 However,
various shifts in the healthcare industry in the years since CON legislation (see Certificate of Need
(CON)) was introduced have fueled disputes against the implementation of CON programs in order to
avoid excess capacity.140
A central argument against CON regulatory policy is that intervention disrupts the natural market
forces and is significantly anticompetitive. As a result, CON often serves as a barrier to new market
entrants and has been viewed by many healthcare economists as a strong disincentive to the introduction
of potentially advantageous innovations and technologies. In any industry, the underlying dynamic is the
same, and competition compels companies to deliver increasing value to customers.141 The fundamental driver of this effort in continuous quality improvement and cost reduction is innovation.142 Without
incentives to sustain innovation in healthcare, short-term cost savings soon will be overwhelmed by the
desire to widen access to care, the growing health needs of an aging population, and a perceived resistance to receiving care that may be anything less than the best treatments available.143 Inevitably, the
failure to promote innovation will lead to lower quality or more rationing of care—two results viewed as
equally undesirable.144
This bears semblance to the continuing consensus among health economic analysts that competition between providers drives patient quality of care and beneficial outcome, as well as a force for cost
efficiency. Hospitals in more competitive markets have exhibited lower levels of spending on average
than hospitals found in less competitive markets.145 Healthy competition appears to offer patients and
payors a means of economic leverage by creating choices for consumers and raising quality standards as
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providers compete for patient loyalty. When patient choice is diminished, decisions about access, quality, and beneficial outcomes become the sole purview of oligopoly market players that, as decision makers acting in the absence of healthy competition, are free to ignore patient demands and needs.
In markets that are competitive, attempts to promote the implementation of CON legislation are perceived as a notable shift from its original purpose of supporting competition by preventing overinvestment in healthcare facilities.146 Most notably, proponents of CON programs argue that CON legislation
may prevent healthcare markets from becoming oversaturated with ASCs and other specialty hospitals;
this is a position that has helped community hospitals use the regulatory environment in their campaign
against POFs.147
For now, the federal specialty hospital moratorium (see Campaign Against Physician Ownership)
has ended, and many states are moving forward with their own initiatives to prevent market entry of
POFs through state CON regulations.148 In light of continued evidence refuting the efficacy of CON
legislation in reducing healthcare costs, arguments are now being made to support the use of CON in
preventing physician self-referral and continuing the viability of community hospitals’ charity care
policies.149

Rise of Urgent Care Walk-In Clinics
Urgent care centers are becoming increasingly popular in the United States. Acute care patients, tired
of the progressively longer waits for appointments with primary care physicians or for emergency room
services, are attracted to the convenience of urgent care centers (for example, the extended hours, the
availability of walk-in appointments, etc.).150 With the supply of primary care physicians projected to
dwindle during the next two decades, combined with many family physicians declining to accept new
Medicare FFS patients and fewer emergency departments nationally, urgent care utilization may continue to rise.151 However, research remains unclear regarding the impact of urgent care centers on cost,
quality, and access to care.152

Medical Tourism
Another competitive force in the healthcare industry is the growing incidence of medical tourism. Medical tourism is the practice of patients traveling to countries, such as India, Thailand, or any number of
other countries, to receive medical procedures at a fraction of what they may cost in the United States.153
By avoiding structural, regulatory, and legal barriers that are present in the United States, foreign hospitals may be freer to innovate in ways that potentially can decrease the cost of many procedures.154 Generally, these procedures are performed by skilled physicians, who sometimes trained in the United States,
who may employ the latest technology with a risk of infection and mortality no higher than in the United
States.155 This trend demonstrates how globalization has reached the healthcare industry, and, as with
globalization in other sectors, it could mean that new competition for domestic suppliers is worldwide.

The Bargaining Power of Suppliers
Healthcare suppliers are primarily professional services providers but can also include anyone or anything involved in the provision of improved quality patient care. Physicians are, in this sense, suppliers
(as long as they are not employees of the organization in which they practice).156 Other suppliers may include such entities, including medical supply companies, pharmaceutical companies, and outsourcers.157
Suppliers may have the potential to affect healthcare professional practices if they are able to influence
practice spending.158 Healthcare supplier prices often are controlled or influenced by government fee
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schedules for reimbursing certain products or services.159 The bargaining power of suppliers is subject to
increasing regulatory and reimbursement pressures. Healthcare is different from other industries in that
the suppliers are often also the customers, as in hospital–physician relationships.160

Hospital Suppliers
The thrust of the campaign by community hospitals against specialty and niche providers is the desire
to maintain monopoly or oligopoly power in the marketplace, as hospital consolidation continues to
bolster the bargaining position of hospitals vis-à-vis insurers.161 This position is supported by the argument that monopolistic hospitals may use that power to (1) maintain access for those who need it, (2)
cross-subsidize uninsured patients and expensive procedures, and (3) maintain high quality standards
through the intake of steady patient volumes.162 Although community hospitals may need a substantial
volume of patients to be able to make up the cost of money-losing procedures and patients, the separation between payor and consumer in the healthcare market also allows hospitals to use their monopoly
power to set prices above what a monopoly might be able to charge in other markets.163 In a marketplace
in which elasticity of demand already is inhibited by necessity in many cases, the presence of insurance
companies acts as a buffer between supplier and consumer and allows the supplier (that is, the hospital)
to charge the insurer high prices that have no direct impact on the consumer.164

Physician or Provider Suppliers
In contrast to hospitals, the impact of physician providers on the healthcare competitive market continues to diminish due to regulatory (see chapter 3, Regulatory Environment) and reimbursement (see chapter 2, Reimbursement Environment) restraints, which include payment bundling, physician restrictions
regarding group ventures under antitrust laws, and the decline of the primary care physician with the rise
in MCOs and specialties.
The first reason for the declining effect of physician providers, is that “bundling” is a fairly new
method of payment promoted by CMS (see chapter 2, Payment Bundling). Bundled payments change
the way doctors and hospitals are reimbursed by Medicare; the FFS system would allocate two separate payments: one to the hospital for treating a patient and one to the physicians for their relative value
units.165 Using the bundled payment system, Medicare would allocate one payment to be split between
the hospital and the physicians for services rendered.166
Although, in theory, bundled payments should improve the quality of care and streamline the reimbursement process by eliminating charges for unnecessary services, there is some backlash among
physicians, mainly because hospitals would be determining how they get paid. For example, specialists could be compensated more favorably than primary care doctors.167 In a 2009 letter to the Senate
Finance Committee, the AHA voiced concerns, stating that the “bundling of hospital and post-acute
payments is problematic” and “(p)roposals to bundle Medicare payments for general acute hospital and
post-acute care (PAC) services call for a paradigm shift in health service delivery.”168 The AMA commented in a 2008 letter to the Committee on Ways and Means, stating that “bundling payments provides
more incentives for efficient care but also carries the risk that appropriate services are withheld or limited.”169 The concerned parties agree bundling needs to be tested in many different venues and contexts
before a reliable system can be managed.
Another reason for the waning physician provider impact is the many antitrust laws restricting physicians from joining together in groups such as IPAs. By definition, an IPA is a “legal entity organized
and directed by physicians in private practice to negotiate contracts with insurance companies on their
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behalf.”170 Although advantageous because they perform a variety of services for the medical practice,
including negotiating contracts, organizing the delivery of care, and disbursing payments to physicians,
IPAs have been attacked by antitrust legislation.171 For example, a violation of Section One of the Sherman Antitrust Act could involve one of three things: (1) “an agreement between two or more independent physician practices regarding prices for medical services;” (2) “an agreement among two or more
independent physician practices regarding patients they will treat and services they will offer;” or (3)
“two or more independent physician practices agreeing not to deal with a particular competitor, healthcare entity, or managed care plan.”172 Because of these restrictions, some IPAs have violated antitrust
laws.173 As physician influence within independent or group practices exceeds that of physicians within
organizations, the decline of the IPAs due to antitrust law has damaged their impact in the healthcare
market.
The final reason for the drop in physician provider influence on the healthcare competitive marketplace is the decline of the primary care doctor due to the rise of MCOs and the emphasis on specialties.
In a seminal 1994 report by the AMA, the organization indicated that enrollment in managed care plans
had jumped from 12.5 million people in 1983 to 45 million ten years later.174 In conjunction with this
finding, the AMA found that between 1986 and 1993, “the proportion of US medical school graduates
matched to residencies in one of three potential generalist streams (internal medicine, pediatrics, and
family medicine) declined from 52 percent to 38 percent, and the majority of those in internal medicine
and pediatrics became subspecialists.”175 Statistics from 2008 by the Association of American Medical
Colleges suggest that this trend continues, “with the supply of primary care physicians that many already
believe to be insufficient are likely to intensify as demand outpaces supply faster for primary care than
any of the specialty groups.”176 The decline in general surgeons is no different. The promise of better
working hours, less on-call time, and less involvement in the business end of the practice have attracted
more students to specialties.177 Notably, 70 percent of graduating surgical residents chose specialized
instead of general surgery in 2007.178
As such, instead of building relationships with patients and focusing on preventative care, many doctors are now opting for the specialty track. Growing disparities in compensation likely affect this trend.
A 2006 study showed primary care physicians at the bottom of the physician pay scale, making almost
$300,000 less per year than radiologists—the highest paid specialty—in 2004.179 However, a 2005 study
by Barbara Starfield et al. indicated that a “greater supply of family physicians is associated with an
earlier detection of breast cancer, colon cancer, cervical cancer, and melanoma.”180 The study also found
that primary care physicians were better at managing health problems before the problems became serious enough to require hospitalization.181

Hospital System and Physician Practice Realignment
Due to economic incentives and changing legislation regarding competition, hospitals and physicians
have increased their collaboration both through employment and joint ventures.
Hospital Acquisition of Physician Practices
Recently, hospitals have returned to the 1990s trend of directly employing physicians and increasingly
competing for physicians’ time and loyalty. As more physician-owned specialty hospitals open, this
allows a growing number of physicians to refuse on-call emergency room duties and other traditional
medical staff responsibilities.182 Although hospitals mainly employed primary care physicians during the
1990s, the recent employment trend has seen a rise in the number of specialists employed by hospitals.183
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Joint Ventures Between Community Hospitals and Niche Providers
In an attempt to strengthen relationships and align economic incentives to enhance market position
and financial success between physicians and hospitals, many specialty providers, such as orthopedic
surgeons, are entering into joint ventures with one another.184 As competition for technical component
revenue streams between physicians and hospitals remains intense, new forms of joint ventures and
revenue-sharing options are developing in an attempt to repair their recently contemptuous relationship
and to offer patients increased quality services and access.185 “Ambulatory surgery centers and imaging
centers are the most popular hospital–physician enterprises founding our communities. Threatened with
potential loss of volume, hospitals have found innovative ways to share income streams with specialists
that comply with Stark laws or other regulations.”186 Several key factors play a role in the growth of joint
ventures between hospitals and physicians. As mentioned previously, in the past twenty years, physician
incomes have decreased due to managed care and government reimbursement constraints. Consequently,
many physicians have found hospital investments to be an enticing opportunity to supplement decreasing income.187 The economic benefits of a physician and hospital joint venture, including the development of ASC joint ventures, are significant. Collaboration between physicians and hospitals creates an
economy of scale not achieved if each continued to operate independently, thereby increasing hospital
and health system interest.188 Some hospital executives believe joint ventures with physicians increase
their facility’s quality of service, leading to increased profit for their hospital.189
According to Jay Klarsfeld, M.D., many advantages exist to a hospital–physician joint venture.190
Hospitals make most of their money from inpatient services, and opening a separate outpatient surgery
center often is not economically feasible; because ASCs perform outpatient procedures economically
and safely, it behooves hospitals to form business relationships with physician-owners. When these hospitals send patients to their new surgery center affiliates, they share in the profit.191 Additionally, when
physicians have pull in the design process and ownership of an outpatient facility, things run smoother
and more efficiently.192 Studies have shown that when, “physicians have an economic stake [they] show
up on time, don’t waste minutes in the OR, and make smarter purchasing decisions.”193 Physicians have
advantages as well. Most hospitals have a reputation in the community as being safe and reliable, and
the physician-owner shares this good reputation in a joint venture, making his or her ASC more credible.194 These physicians also gain exposure to hospital vendors, and association with hospitals can be
helpful in purchasing.195

Threats from Substitute Products or Services
Nontraditional healthcare providers increasingly are competing with their traditional counterparts.
Nontraditional providers, such as chiropractors, have taken a larger market share, and some healthcare
systems and MCOs have embraced the changes in patient preferences and developed networks of these
providers. Technology has fueled the entry of new competitors in many other industries, and healthcare is no exception. Patients searching for medical advice on the Internet is a trend that the industry
must consider. With advances in medical imaging communication, technology groups of radiologists in
remote locations can outsource x-ray film readings for hospitals at lower prices (see chapter 5, Telemedicine and Telehealth). The role of the pharmacy and pharmacist is changing and may become a threat to
some portion of the service, advice, or monitoring business of medical offices. Competition can come in
many forms and affect many subsets of healthcare services. Planning and analyzing potential substitute
products and services requires creative thinking as well as in-depth, substantive research.
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One of the primary differences between the healthcare industry and other industries in regard to
substitute products and services may well be the regulation of medical professionals, treatments, and
drugs that may delay or prohibit substitutes. The regulation, therefore, stymies innovation—previously
discussed as the fundamental driver of quality improvement and the underlying dynamic of a company’s
ability to compete.

“Purple Pill”
Increasingly, drugs serve as alternative treatment options, and often at a lower cost, reducing hospital
stays or need for costly surgeries or procedures. For example, the introduction of the Purple Pill revolutionized the treatment of bleeding ulcer patients. Administering a proton-pump inhibitor like Prilosec
(omeprazole) prior to endoscopy stopped patients’ bleeding faster than patients who took a placebo,
thereby reducing both the need for surgery and the length of hospital stays.196

Battle Lines Among Providers
Competition exists not only among hospitals and physician-owned facilities but also among different
types of providers (for example, ophthalmologists versus optometrists; anesthesiologists versus Certified
Registered Nurse Anesthetists, obstetricians and gynecologists versus certified nurse midwives). As discussed in chapter 6 of Professional Practices, physician suppliers compete with allied health professionals for the provision of many primary care services. Similarly, as discussed in chapter 4 of Professional
Practices, physicians also are experiencing competition from mid-level providers whose ability to practice without the supervision of a physician is growing due to less stringent regulations in certain states.
For example, nurse practitioners (NPs) are capable of obtaining their own Medicare provider numbers,
which allows them to bill Medicare directly for services provided without the need for a supervising
physician.197 This ability has resulted in a growing number of nurse practitioners who provide primary
care services to patients who never actually see a physician until they need services which are beyond an
NP’s capability.198
One of the most prevalent areas of competition is related to providers of imaging services. The issue of in-office ancillary imaging pits radiologists against other physicians. Radiologists continue to
face increased competition from referring physicians.199 A study funded by the Radiological Society of
North America in 2004 claimed that self-referral lead to increased utilization of diagnostic imaging.200
The study recommended that the radiologist professional community lobby the federal government to
enact regulations making self-referrals more difficult. According to the chief researcher, Dr. David C.
Levin, “[o]rthopedic surgeons really don’t belong in the business of owning MR [magnetic imaging]
scanners.”201
The result of such efforts was reflected in the passage of the Medicare Improvements for Patients
and Providers Act of 2008 (MIPPA).202 After the American College of Radiology announced plans to
lobby for legislation requiring Medicare to define standards for physicians performing diagnostic imaging, and the Medicare Payment Advisory Commission (MedPAC) staff members stated “it’s important
for CMS to set national standards for each imaging modality . . . ,” Congress included in the MIPPA
a provision requiring accreditation of physicians who provide the technical component for advanced
diagnostic imaging services (for example, magnetic resonance imaging, computed tomography, and
nuclear medicine or single photon emission computed tomography) for which payment is made under
the Medicare physician fee schedule.203 After the secretary of the Department of Health and Human Services (HHS) designates accreditation organizations in 2010, all suppliers of the technical component of
advanced diagnostic imaging services will need to be accredited by January 2012.204
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The Bargaining Power of Buyers
Most healthcare services are paid for by insurance, whether private or governmental. Most private health
insurance is purchased through employers that, to a great degree, make most of the buying decisions.
Employer coalitions have emerged, but most command leverage on price rather than quality or value.
This often leaves healthcare providers as the only advocates for consumers, because buyers are not. Corporate buyers have asserted substantial, if disproportionate, influence over healthcare companies but not
necessarily always in the best interests of the consumers or the community at large.
Recently, however, payors have begun to shift toward P4P plans that assess certain performance outcomes and offer financial incentives to providers that attain them (see chapter 2, Pay-For-Performance
(P4P)). P4P programs have been shown to improve quality of care,205 and by offering financial incentives to providers, P4P also will allow consumers to recognize quality of care when making choices for
provision of services.206

Power of the Insurance Lobby
The rise of antitrust law in the healthcare marketplace indirectly has led to support of insurance companies’ preferences by the courts. As agents for the consumers protected under the laws (that is, patients),
insurance companies have emerged as the dominant force in articulating competitive preferences for
price and quality. Courts have deemed insurance providers to be the best voice for the needs of consumer patients, and, therefore, have overlooked the traditional competitive transgressions of insurance
companies (that is, selective contracts with health professionals or onerous contractual requirements on
network providers).207
Further adding to the power of the industry, insurance companies as an industry sector have enjoyed
an exemption from federal antitrust laws since 1945. The McCarran-Ferguson Act limits federal scrutiny
of insurers and places states in primary control of antitrust enforcement.208 State legislation is preserved
in the bill, but whether states are powerful enough to prevent insurance companies from engaging in
price fixing, bid rigging, and market allocations, deterring competition, and impairing consumers has
been questioned.209

Power of Medicare and Other Public Payors
The government is the country’s largest third-party payor. Through programs like Medicare, Medicaid,
and TRICARE, it exerts one of the most influential competitive forces in the health insurance industry.
As the largest national purchaser of health services, the government exerts influence over not only the
public delivery of health services but also over the private sector.210 Many private insurers negotiate their
own arrangements with providers, but some private third-party payors base their arrangements on the
Medicare payment systems or use those systems as a starting point for negotiations.211
Medicare’s influence on competition in certain sectors is limited, however. Under the MMA, the
secretary of HHS is prohibited from negotiating drug prices with pharmaceutical manufacturers under
Medicare Part D, a prohibition which also inhibits free market competition in healthcare.212 Instead,
negotiations are undertaken by private insurers and Pharmacy Benefit Managers (PBMs) that then offer
prices they obtain through those negotiations to Medicare beneficiaries.213 Under this system, the Medicare program is unable to use its power as, what would be, the largest purchaser of prescription drugs, to
bring the cost of such drugs down.214 Proponents of the noninterference provision argue, however, that
it prevents the federal government, which is motivated by taxpayers, voters, and Medicare beneficiaries
alike, monopsony power to affect the price of prescription drugs, consequently stifling the ability of
pharmaceutical companies to earn the profits that allow them to develop new drugs.215
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Rivalry Amongst Existing Firms
Integrated physician organizations and other types of emerging healthcare organizations (EHOs) may be
viewed as new market entrants or simply as a reorganization of existing providers in order to better compete. Provider organization and EHO volumes have grown significantly through integration, consolidation, and mergers, but, in many ways, their effectiveness as competitors is still uncertain. The collapse of
PPMCs, poor performance of hospital managed physician practices [including physician-hospital organizations (PHOs)], the failure of capitated groups and IPAs in California, and the current trend toward
divestiture of acquired practices would seem to indicate that EHOs have not been effective competitors.
Nonetheless, a strong argument could be made that the competitive forces that led to the formation of
these integrated organizations still exist and that these initial failures have more to do with mismanagement and poor planning than the concept of physician integration itself (see chapter 2 of Professional
Practices).
Integration, affiliation, and collaboration among providers may, in some cases, be viewed as a means
of circumventing competition, unless the clinical benefits to patients can be demonstrated. Because
the overarching mission of the healthcare delivery system is inherently human value-based, it is often
deemed to be in conflict with the economic and financial goals of healthcare organizations, especially
in the for-profit arena, as well as incompatible with the competitive forces that have been successful
in other industries. These differences in basic values and their expression between businesses in other
industries, as well as the various existing organizations in healthcare, are deeply rooted and important to
understand in assessing the impact of rivalry on the potential for competition to succeed in stimulating
quality and efficiency.

Antitrust Issues
Antitrust law traditionally has been used to combat anticompetitive behavior arising from professionaland payer-imposed barriers to competition, as well as against consolidations (either by collaboration or
merger) by provider groups and health systems.216 However, at the beginning of this decade, strict antitrust enforcement in the healthcare sector tended to shift away from providers and toward pharmaceuticals in a larger shift away from strict application of antitrust law to the healthcare sector generally.217
During that timeframe, antitrust jurisprudence began to shift to a significantly increased level of judicial
deference to professionalism in health market transactions, which chilled the ability of federal antitrust
authorities to bring effective enforcement actions against violators.218 Additionally, federal enforcement
agencies generally won cases against hospital mergers between the mid-1980s and the mid-1990s; those
agencies lost all the hospital merger cases brought in federal court between 1995 and 2001.219 During
this timeframe, courts tended to take a purely economic look at elements of antitrust decisions, such as
a provider’s market share and price, ignoring other elements germane to healthcare, such as patients’
personal and logistical considerations when choosing a provider.220
Promulgated by recent healthcare reform efforts, the Federal Trade Commission (FTC) and Department of Justice (DOJ) have expressed renewed concern regarding the adequacy of existing standards for
horizontal mergers, maintaining that fortified measures of antitrust enforcement are crucial to cutting
costs and improving quality of healthcare.221 Most recently, the DOJ and FTC have focused their efforts
on evaluating the affect of horizontal consolidation of certain healthcare organizations (for example,
pharmaceutical giants, payors, outpatient clinics, and hospitals) to determine whether their respective
market sectors experience a decrease in competition as a result.222
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As legislators continue to focus on reducing the cost of healthcare while improving quality and access, antitrust enforcement is likely to take on a larger role in the healthcare sector. With the promotion
of a public option as part of healthcare reform legislation, more focus has been placed on the benefits of
competition in the healthcare insurance marketplace, and the proposed repeal of the McCarran-Ferguson
Act (see Power of the Insurance Lobby) demonstrates how legislators will continue work to improve
competition throughout the healthcare industry in an effort to reduce costs and improve quality.223
The FTC and DOJ have taken special interest in the impact of hospital consolidation on market competition. Most research conducted to date suggests a potential correlation between hospital consolidation
and higher prices for hospital services; the magnitude of price increase estimated by these studies ranges
from 5 percent to greater than 50 percent.224 While some dispute exists on the impact of consolidation on
quality of care, studies utilizing methods perceived to be robust tend to show a reduced level of quality.225 Surmising a sudden surge of hospital consolidation as a result of impending reform initiatives
and continued technological growth, the FTC and DOJ may heighten the stringency of regulations and
guidelines in order to ensure competitive veracity within the hospital sector.226

Clinical Integration
One area of antitrust enforcement that did not suffer as significant a decline toward the beginning of the
new millennium involves collective actions by healthcare professionals that thwart competition and violate Section 1 of the Sherman Antitrust Act, which prohibits agreements between competitors in restraint
of trade.227 Commonly taking the form of IPAs and PHOs that wish to clinically integrate, these cartels
generally are found to violate antitrust laws. In the wake of two FTC advisory opinions favorable toward
clinical integration, however, it is likely that IPAs and PHOs will see a resurgence the near future.
Clinical integration among provider networks traditionally has been scrutinized by the FTC as
generally being anticompetitive and in violation of antitrust laws. Part of the reason for this is that
provider networks typically involve competing providers that agree to fix prices between them. Such
practices are per se unlawful under antitrust law.228 However, since the 2002 FTC Advisory Opinion for
MedSouth229 and the 2007 Advisory Opinion for the Greater Rochester Independent Practice Association
Inc. (GRIPA), it has now become clear that clinical integration is not necessarily considered to be a per
se violation of antitrust regulations.230 If the subject transaction is not deemed to be a per se violation,
the FTC reviews joint contracting arrangements under a rule of reason analysis, determining whether the
arrangement would actually lead to procompetitive outcomes. The benefits of clinical integration are that
it allows a network of competing providers to participate in both joint-pricing and risk sharing, therefore
leading to improved efficiency that will benefit consumers.231
It is important to note, however, that the MedSouth and GRIPA opinions do not mean that all clinical integration programs will be approved by antitrust enforcement agencies. In fact, more recently than
GRIPA, an FTC decision striking down a clinical integration program in Texas from 2005 was affirmed
by the Fifth Circuit Court of Appeals in 2008.232 When analyzing any clinical integration scheme, the
FTC will first ask whether the proposed collaboration offers the potential for proconsumer cost savings
or qualitative improvements in the provision of healthcare services, and then ask whether any price or
other agreements exist among participants, in particular the terms on which they will deal with healthcare insurers, and if the terms are reasonably necessary to achieve those benefits.233 If both questions are
answered affirmatively, only then will the FTC consider the procompetitive and anticompetitive effects
of the collaboration.234 At that point, “as long as such collaborations cannot exercise market power, they
are unlikely to raise significant antitrust concerns, precisely because they have the potential to benefit,
not harm, consumers.”235
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Above all, it is important to note that the antitrust enforcement agencies support precompetitive
clinical integration of provider networks as a means of increasing efficiency and reducing costs, especially in an environment where these two objectives are part of the overall goals of healthcare reform.
Collaborations among providers often implement efficiency-producing tools, such as electronic health
records, and collaboration among clinicians to create guidelines, measure performance, and develop
remedial measures and consequences for failure to meet those guidelines.236
Antitrust enforcement agencies also will continue to carefully scrutinize hospital mergers to ensure
that no one hospital gains enough market share such that patients are deprived of choices, and that the
hospital is able to increase prices to both patients and insurers.237

Healthcare Reform and Its Effect on Competition
The fundamental debate that historically has impeded healthcare reform efforts has centered on the costs
associated with providing universal, comprehensive care. In light of twenty-first-century healthcare
reform, this debate has led to competition for the overall healthcare dollar, that is, there is only so much
money to go around, and everyone in the industry is vying for it. As demonstrated in this chapter, the
power of the insurance companies, pharmaceutical companies, and hospitals has subjugated the power
of the independent physician or provider such that providers are no longer operating on a level playing
field.
It is not an exercise in paranoia to view the overall effect of the attacks on physician ownership as
being aimed not only at rolling back the calendar to an earlier time but also an attempt to severely diminish the overall role and status of physicians in the delivery of care continuum. This profoundly concerning onslaught against the professional stature and economic interests of physicians arises not only from
hospital and insurance industry advocacy campaigns but even from widely cited purported supporters of
physician independence, such as Harvard Professor (and former New England Journal of Medicine editor), Arnold S. Relman, MD (see chapter 1, Historical Development).238
From the perspective of many, the inevitable outcome of these efforts at placing additional restrictions on physician independence will be to these professionals and their practice of medicine, to the
status of, at best, the healthcare equivalent of sharecropping, and, at worst (per Relman), the status of
hired help. This begs the question whether physicians and their patients, who have benefited from independent physician ownership of ASTC enterprises, will now acquiesce to being “kept down on the farm”
or whether they either can or will resist the forces arrayed against them.

Reform of the Insurance and Pharmaceutical Industries
Insurance Industry
In the past ten years, there have been more than 400 health insurer mergers, which have resulted in a
highly consolidated market and negative consequences for consumers.239 Part of the reason for this consolidation is that there have only been two cases in the past seven years in which the DOJ has required
the restructuring of a merger agreement between two insurers.240 The prevalence of these mergers without a strong enforcement of antitrust law has permitted a variety of anticompetitive behavior by major
insurers, resulting in higher costs (whether from higher premiums, deductibles or co-pays), compromised patient care, and a record high level of uninsured Americans.241
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In order to reverse the trend of insurer consolidation, healthcare reform proposals are likely to include provisions for identifying exclusionary conduct by insurers. As some critics blame the ability of
insurers to consolidate (and the resulting monopoly/monopsony power enjoyed by large firms) on the
federal antitrust exemption for insurance companies contained in the McCarran-Ferguson Act, reform
initiatives have suggested a repeal of the exemption.242 Although the act exempts all types of insurance
providers, the application of the act to the healthcare industry has drawn particular criticism from the
DOJ and lawmakers, both of which claim that the exemption has led to anticompetitive behavior that has
resulted in higher healthcare costs to both providers and patients.243
Reform efforts aimed at repealing this exemption are part of the current healthcare reform agenda,244
but proponents of the exemption argue that states have done a good job to prevent anticompetitive
behavior by insurers, and that there is no conclusive evidence that such repeal will have any positive
impact on the insurance industry.245 Legislators in support of the repeal were motivated by soaring insurance costs and an increasing number of uninsured Americans, however, they noted that the repeal signified the first step in a continuing evaluation of the antitrust system.246 Beyond the repeal of the insurance
company exemption, such legislation demonstrates the beginning of potential widespread impact of
health reform on antitrust enforcement, particularly when a single-payor system is the end goal of many.

Pharmaceutical Industry
Related to the insurance industry is the constantly maturing PBM industry. This area of the healthcare
industry has grown as consumer use of pharmaceutical drugs has grown and insurers have worked pharmacy benefits into their plans.247 Forty to fifty PBMs exist around the country, and some insurers manage
pharmacy benefits internally, however, only three major national PBMs are in operation, so careful attention to ensuring fair competition in this industry is important as more and more healthcare spending is
devoted to pharmaceuticals.248 Specific competition concerns include the impact of factors such as PBM
pricing, generic substitution, therapeutic interchange, and repackaging practices, in addition to industry
practices such as PBM ownership of mail-order pharmacies.249
It should be noted, however, that recent reform efforts have addressed the possibility of removing
the noninterference provision, discussed previously from the MMA, which would result in granting the
secretary of HHS the ability to negotiate directly with pharmaceutical companies.250 In such an event, the
market power of PBMs may cease to be a threat to healthcare competition.

Commoditization of Healthcare
Payment for healthcare services has evolved over time, starting with the implementation of Medicare
in 1965 under a FFS paradigm, followed by the creation of the prospective payment system (PPS) for
hospital and physician services through the 1980s and 1990s, to the current framework based on bundled
payments that combines institutional and professional charges, or inpatient and post-discharge fees,
into a single payment.251 Beginning with the implementation of the PPS, whereby patients are classified
into DRGs based on the average cost of services for a particular diagnosis, healthcare services are now
bought and sold based on homogenous units of payment.252 Even MedPAC’s Payment Basics publications discuss Medicare reimbursement under the heading of “the products that Medicare buys.”253
With the recent focus on bundling, hospitals are incentivized to provide the appropriate amount of
care to make the procedure cost-effective, rather than the appropriate amount of care to treat the patient’s condition.254 Similar to how healthcare evolved under capitation systems, hospitals will receive
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payments based on a charge per episode of care methodology, which the hospitals will then distribute to
physicians and other providers within the hospital who provided care for that patient.255 The charge-per
system places the focus on the amount of money a hospital will receive for a given diagnosis and will
place the focus on reducing services to save money as well as incentivize hospitals to hire physicians
who are not as expensive (that is, not as well qualified) in order that the hospital facility may retain as
much of the payment as possible.256
Further evidence of the commoditization of the American healthcare system is reflected in the presence of a marketplace for durable medical equipment (DME), whereby DME manufacturers submit
competing bids to Medicare based on the charge per unit, the lowest of which is then chosen to be the
only Medicare provider of DME in ten different metropolitan areas.257 The competitive bidding program
was implemented in 2008, but an eighteen-month moratorium was then placed on it under MIPPA in
response to pressure from DME suppliers that claimed that the program would lower quality of care
and reduce access.258 Set to relaunch in 2010, the DME competitive bidding program demonstrates how
competition has influenced the healthcare industry by turning healthcare into a commodity that can be
freely bought and sold.

Conclusion
The healthcare professional practice, while still a business, has been buffered from the full onslaught
of commercialism, including the ever-present attraction of competition. Whether to control quality or
cost, outside forces have regulated competitive forces within the healthcare industry. Supported by the
provider shortage increased population demands (that is, the baby boomers) regulations of the scope of
mid-level providers have been lessening. This, along with a staining economy, causing physicians to
expand the services they offer, is creating an overlap of services, which will likely continue to increase
fueling the emergence of new competitors in the healthcare market. In addition, the rise in consumer
driven healthcare will continue to change the way in which healthcare professional practice, as a business, is run, further removing the buffer between healthcare and pure commercialism. As the impact of
competitive forces rises, in response to a changing system, government regulations will also adapt to the
new healthcare environment.
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Medicare Physician Fee Schedule
(PFS)

The Medicare PFS is how
reimbursement is determined for
physicians and nonphysicians by CMS
for their services.

“Overview” Centers for Medicare
and Medicaid Services, www.
cms.hhs.gov/PhysicianFeeSched/
(accessed January 29, 2010).

www.cms.hhs.gov/
PhysicianFeeSched

Physician Hospitals of America
(PHA)

“Offers support, advocacy and
educational services to the physician
owned hospital industry, reflecting
at all times the best interests of
the patients, physicians, and other
providers who play an inextricable
and essential role in the provision of
healthcare services.”

“About PHA” Physician Hospitals of
America, www.physicanhospitals.
org/organization_mission.php
(accessed September 24, 2009).

www.physicianhospitals.org
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General Accounting Office (GAO)

Referred to as the congressional
watchdog, the GAO is an “independent,
nonpartisan agency that works for
Congress” to “investigate how the
federal government spends taxpayer
dollars.”

“About GAO” U.S. Government
Accountability Office, www.gao.gov/
about/index.html (accessed
January 29, 2010).

www.gao.gov

American Academy of Family
Physicians (AAFP)

The AAFP attempts to affect “health
care policy through interactions with
government, the public, business
and the health care industry,” with
a particular focus on equitable
healthcare for all people.

“Mission and Strategic Plan”
American Academy of Family
Physicians, 2010, www.aafp.org/
online/en/home/aboutus/theaafp/
strategicplan.html (accessed
January 29, 2010).

www.aafp.org

Graduate Medical Education
National Advisory Committee
(GMENAC)

Part E of Title VII of the Public Health
Service Act, establishes the GMENAC,
and “charges it with assessing
physician workforce needs on a long
term basis, recommending appropriate
Federal and private sector efforts
necessary to address these needs,
and providing a forum to enable
appropriate consideration of these
needs.”

“Charter” Graduate Medical
Education National Advisory
Committee, August 17, 2005, www.
cogme.gov/charter.htm (accessed
January 29, 2010).

www.cogme.gov

Centers for Medicare and
Medicaid Services (CMS)

CMS, a portion of the U.S. Department
of Health and Human Services,
controls “Medicare health plans,
Medicare financial management,
Medicare fee for service operations,
Medicaid and children’s health,
survey & certification and quality
improvement.”

“CMS Consortia” Centers for
Medicare and Medicaid Services,
U.S Department of Health and
Human Services, www.cms.hhs.
gov/Consortia/ (accessed
January 29, 2010).

www.cms.hhs.gov

Medicare Payment Advisory
Commission (MedPAC)

“An independent Congressional
agency established by the Balanced
Budget Act of 1997 (P.L. 105-33) to
advise the U.S. Congress on issues
affecting the Medicare program.”

“About MedPAC” Medicare Payment
Advisory Commission, www.
medpac.gov/about.cfm (accessed
January 29, 2010).

www.medpac.gov

Federal Trade Commission (FTC)

The FTS, “is the only federal agency
with both consumer protection and
competition jurisdiction in broad
sectors of the economy.”

“About the FTC” Federal Trade
Commission” www.ftc.gov/ftc/about.
shtm (accessed January 29, 2010).

www.ftc.gov
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Contact
Information

National

American Hospital
Association

“The national organization that
represents and serves all types of
hospitals, health care networks, and
their patients and communities.”

“About the
American Hospital
Association,”
American Hospital
Association, 2009,
www.aha.org/aha/
about/index.
html (accessed
January 28, 2010).

www.aha.org

American Hospital
Association
One North Franklin
Chicago, IL 60606
Phone: 312-422-3000
Fax: n/a
E-mail: n/a

National

American Medical
Association

An association that “helps doctors
help patients by uniting physicians
nationwide to work on the most
important professional and public
health issues.”

“Our Mission,”
American Medical
Association, 2009,
www.ama-assn.
org//ama/pub/
about-ama/ourmission.shtml
(accessed
January 28, 2010).

www.ama-assn.org/

American Medical
Association
515 N. State Street
Chicago, IL 60654
Phone: 800-621-8335
Fax: n/a
E-mail: n/a

National

Ambulatory Surgery
Center Association

Merger between the American
Association of Ambulatory Surgery
Centers and the Federated
Ambulatory Surgery Association in
2008 resulted in this association.

“ASC Association”
Ambulatory Surgery
Center Association,
2009, http://
ascassociation.org/
about/association/
(accessed January
29, 201010).

http://ascassociation.
org

Ambulatory Surgery Center
Association
1012 Cameron St
Alexandria, VA 22314
Phone: 703-836-8808
Fax: 703-549-0976
E-mail: ASC@
ascassociation.org

National

American Health
Insurance Plans

“The national association
representing nearly 1,300 member
companies providing health
insurance coverage to more than
200 million Americans.”

“About AHIP,”
American Health
Insurance Plans,
2009, www.ahip.
org/content/default.
aspx?bc=31
(accessed
January 28, 2010).

www.ahip.org

American Health Insurance
Plans
601 Pennsylvania Avenue,
NW
South Building
Suite 500
Washington, DC 20004
Phone: 202-778-3200
Fax: n/a
E-mail: ahip@ahip.org

National

Radiological Society
of North American
(RSNA)

Founded in 1915, RSNA is a
membership of medical imaging
professionals committed to patient
care through education and
research. RSNA host the world’s
largest annual radiological meeting.

“About RSNA”
Radiological Society
of North America,
2010, www.rsna.
org/About/whoswho/
staff-departments.
cfm (accessed
January 20, 2010).

www.rsna.org

Radiological Society of
North America, Inc.
820 Jorie Blvd.
Oak Brook, IL 60523
Phone: 630-571-2670 /
800-381-6660
Fax: 630-571-7837
E-mail: n/a

National

American College of
Radiology (ACR)

ACR’s mission is to maximize
the “value of radiology, radiation
oncology, interventional radiology,
nuclear medicine and medical
physics by advancing the science of
radiology, improving the quality of
patient care, positively influencing
the socio-economics of the practice
of radiology, providing continuing
education for radiology and allied
health professions and conducting
research for the future of radiology.”

“About Us”
www.acr.org
American
College of Radiology,
www.acr.org/
MainMenu
Categories/about_
us.aspx (accessed
January 29, 2010).

American College of
Radiology
1891 Preston White Dr
Reston, VA 20191
Phone: 703-648-8900
Fax: n/a
E-mail: info@acr.org
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5

Technology
Development
In these days when science is clearly in the saddle and when our
knowledge of disease is consequently advancing at a breathless
pace, we are apt to forget that not all can ride and that he also
serves who waits and who applies what the horseman discovers.
Harvey Williams Cushing, 1926

KEY TERMS
- Adverse Drug Effect
(ADE)
- Alert Fatigue
- Biologics
- Biopharmaceuticals
- Biosimilar Production
- Brachytherapy
- Clinical Decision Support (CDS)
- Computerized Physician
Order Entry (CPOE)
- Degrees of Freedom
- Electronic Health Record
(EHR)
- Enteral
- Epidural
- External Beam Radiation
Therapy (EBT)
- Follow-on biologics
- Gamma Knife
- Gene Therapy
- Genomics
- Intensity Modulated
Radiation Therapy
(IMRT)
- Intravenous
- Laparoscopy
- Linear Accelerator
(LINAC)
- Medical Imaging

- NightHawk Radiology
Services
- Nonparenteral Drug
Delivery
- Nurse Licensure
Compact
- Personalized Medicine
- Picture Archives and
Communications Systems (PACS)
- Point-of-Care
Technology
- Radiation Therapies
- Reciprocal (Limited)
Licensure
- Reparative Medicine
- Stem Cells
- Stereotactic
Radiosurgery
- Store and Forward
- Subcutaneous
- Telehealth
- Telemedicine
- Teleradiology
- The National Center
for Human Genome
Research Institute
(NCHGRI)
- Two-Way Interactive
Television
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Key Concept

Definition

Source Location

Rural Health Care Pilot Program

Created by the Federal Communications Commission to
increase patient access to telemedicine and support the
transfer of EMRs. Sixty-seven nationwide projects in fortytwo states and 6,000 health facilities are eligible for the
$417 million in grants under the program.

“FCC Update on Rural Healthcare Pilot Program Initiative,”
by Federal Communications Commission, April 16, 2009,
fcc.gov/Daily_Releases/Daily_Business/2009/db0416/
DOC-290141A1.pdf. (Last Accessed July 14, 2009).

The Medicare Telehealth
Enhancement Act (HR 2068)

Provided $30 million in grants to health facilities to pay
for telehealth equipment and expand telehealth support
services. Also expected to address Joint Commission
of Accreditation of Healthcare Organizations (JCAHO)
and Centers for Medicare and Medicaid Services (CMS)
credentialing issues.

“Medicare Telehealth Enhancement Act of 2009”, 111th
Congress, Bill H.R. 2068, introduced April 23, 2009;
“Telemedicine Boosts Access to Needed Care” By Robert
J. Waters, Roll Call, sponsored by Congress.org, June 8,
2009.

Licensed Independent Practitioners
(LIPs)

JCAHO accreditation, according to JCAHO standards,
suffice to license practitioners who diagnose or treat
patients by way of telemedicine link. CMS, however,
requires LIPs to be credentialed at their originating site.

“Existing Requirements for Telemedicine Practitioners
Explained” Joint Commission Perspectives, Feb. 2003.

The Joint Commission Revised
Standards (section MS.13.01.01)

The revised standards released in November 2008
compromise the difference between JCAHO and CMS
standards, but the commission reverted back to their
original opinion in March of 2009.

“The Joint Commission and Telemedicine: The Final
Word?” Accreditation Monthly, May 13, 2009.

GRNOPC1

Geron Corporation’s investigational new drug that became
the first human embryonic stem cell-based therapy
approved for clinical trial. It is used in patients with acute
spinal cord injury.

“Geron receives FDA clearance to begin world’s first
human clinical trial of embryonic stem cell-based therapy,”
by Geron: Visionary Therapeutics, January 23, 2009, www.
geron.com/media/pressview.aspx?id=1148 (accessed
July 1, 2009).

Molecular Diagnostics

A more accurate and effective diagnosis than traditional
methods. The capabilities of molecular diagnostics have
since evolved to include genetic disorder screening, preimplantation screening, and cancer screening procedures.

“Proteomics—Technologies, Markets, and Companies,”
by LeadDiscovery, www.leaddiscovery.co.uk/registration/
(accessed July 1, 2009).

CMD tTechnology

Allows practitioners to diagnose cancer, choose and
develop personalized treatment plans, and identify
predispositions twice as quickly as other assays and for
only a fraction of the drug development costs.

“Cancer Molecular Diagnostics Take the Stage: CMDS Are
at the Forefront of Evolving Healthcare Practices,” Genetic
Engineering and Biotechnology News, Vol. 29, No. 7,
April 1, 2009.

Advanced Imaging Modalities

Magnetic resonance imaging, computerized tomography
(CT), and nuclear medicine; these modalities are also the
expensive services, accounting for 54 percent of total
imaging expenditures.

“Medicare Part B Imaging Services: Rapid Spending
Growth and Shift to Physician Offices Indicate Need for
CMS to Consider Additional Management Practices,”
Government Accountability Office, June 2008,
GAO-08-452.

Multidetector Row CT (MDCT)

MDCT has raised the standard for image quality and
accuracy in identifying differences in patient. In addition
to greater acuity, MDCT (namely 64-slice technology) also
operates at an increased speed compared to previously
existing CT technology.

“CT Flexes Muscle in Coronary Disease Detection,” By
James Brice, Diagnosticimaging.com, November 2005,
available at www.diagnosticimaging.com/showArticle.
jhtml?articleID=174402602 (accessed July 14, 2006).

“Fusion” Imaging

A hybrid technology that combines nuclear medicine
cameras with CT detection methods.

“Nuclear Medicine Usage, Grows, Led by PET,” IMV
Medical Information Inc. Newsline, Vol. 47, No. 10, (2006),
p. 13N.
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Key Concept

Definition

Source Location

“Meaningful use”

Services of meaningful use will benefit from the recovery
provisions (that is, test exchange methods), reporting
of the percentages of patients older than age fifty
screened for colorectal cancer, and the receipt of annual
mammograms.

“Fed Advisors review ‘meaningful use’ recommendations
for health IT,” Greg Freiherr, DiagnosticImaging,
June 16, 2009, www.diagnosticimaging.com/display/
article/113619/1423016?CID=rss (accessed June 29,
2009).

Image Guided Radiotherapy (IGRT)

Technology implemented by one-third of all radiation
oncology sites at the time of publication and implements
ultrasound, x-ray, and CT most frequently.

“IMV Reports Increased Use of Image-Guided Radiotherapy
in Radiation Oncology,” by the Gale Group, BusinessWire,
(2007), (accessed June 29, 2009).

Stereotactic Rradiosurgery

A nonsurgical innovation that serves as an increasingly
preferred alternative to invasive surgery for soft tissue
tumors.

“DOTmed Industry Sector Report: Linear Accelerators
and Simulators,” by Barbara Kram, DOTmed News,
November 19, 2008, www.dotmed.com/news/story/7013/
(accessed June 29, 2009).

Minimally Invasive Procedures

Procedures that avoid many of the risks traditionally
associated with surgical procedures through use of several
small incisions to guide fiber-optic cameras to areas that
necessitate treatment.

Minimally Invasive Surgery,” Mayo Clinic, 2009, www.
mayoclinic.org/minimally-invasive-surgery/ (accessed
April 6, 2009).

Cell Culture Market

Influential in the manufacture of biopharmaceuticals, most
specifically vaccines, monoclonal antibodies, recombinant
proteins, and stem cells.

“Biopharmaceutical benchmarks 2006: The rate of
biopharmaceutical approvals has leveled off, but some
milestones bode well for the future,” by Gary Walsh, Nature
Biotechnology, Vol. 24, No. 7, July 2006, p. 769–76.

Molecular Engineering

Molecular revision has defined development and
advancement in biopharmaceuticals.

“Biopharmaceutical benchmarks 2006: The rate of
biopharmaceutical approvals has leveled off, but some
milestones bode well for the future,” by Gary Walsh, Nature
Biotechnology, Vol. 24, No. 7, July 2006, p. 769–76.

Genedicine

The first gene therapy commercially approved (2004) for
treatment of head and neck squamous cell carcinomas.

“Biopharmaceutical benchmarks 2006: The rate of
biopharmaceutical approvals has leveled off, but some
milestones bode well for the future,” by Gary Walsh, Nature
Biotechnology, Vol. 24, No. 7, July 2006, p. 769–76.

Public Health Service Act

“Rx Watchdog Report, Trends in Manufacturer Prices
of Specialty Prescription Drugs Used by Medicare
Beneficiaries, 2004-2007,” by Stephen W. Schlondelmeyer,
Leigh Purvis, and David J. Gross, American Association of
Retired Persons, September 2008.

Legislation that has kept generic biopharmaceuticals from
being marketed.

Da Vinci System

A robotic system that was introduced in 1996 that
revolutionized minimally invasive surgery by overcoming
the limitations of both traditional surgical procedures and
conventionally implemented noninvasive technology.

“Minimally Invasive and Robotic Surgery”, by M.J. Mack,
Surgical Endoscopy, Vol. 20 (2006), p. S488-S492; “RobotAssisted Surgery,” Mayo Clinic, 2009, www.mayoclinic.org/
robotic-surgery/ (accessed April 6, 2009).

Automated Endoscopic System for
Optimal Positioning (AESOP)

The first laparoscopic camera holder.

“Robotic assisted laparoscopic radical prostatectomy: a
review of the current state of affairs,” by V.R. Patel, M.
F. Chammas Jr., and S. Shah, Int. J. Clin. Pract, February
2007, Vol. 61, No. 2, p. 309–14.

EndoWrist Technology

Allows the surgeon to fully rotate his or her hand, therefore
giving the surgeon the capacity to reach around, beyond
or behind The EndoWrist technology provides the surgeon
with seven degrees of freedom.

“Robotic Technology in Surgery: Past, Present, and Future,”
By David B. Camarillo, Thomas M. Krummel, & J. Kenneth
Salisbury, The American Journal of Surgery, Supplement to
October 2004, 2S–15S.

207

V1-E-Chapter 05.indd 207

9/28/10 3:20 PM

Th e A dvi ser ’ s Gu i de to Hea lthca re

Overview
Demographic shifts, the economic downturn, and changes in market-based technology collectively have
contributed to the restructuring of the healthcare industry over the years. Currently, financially struggling healthcare and pharmaceutical industries face two problems: (1) the increasing incidence and
prevalence of chronic disease in an aging population and (2) the introduction of new infectious diseases
that are more aggressive than those of preceding generations.1 Restructuring of the current healthcare
industry, therefore, has become vital in order to contend with these pressures, and a successful transition
is predominantly conditional upon insightful use of current technological instruments and innovative
development of new advanced methodologies.
Improvements in diagnostic and therapeutic medicine, paired with the efficient use of available
resources in both management and clinical arenas, have the capacity to improve quality of care while
minimizing the number of medical errors. Through the effective use of electronic health records and
prescription management systems, providers are able to save money for themselves, as well as for their
patients. Also, progressive and dynamic research findings in molecular and imaging technology continue
to affect the diagnostic industry’s influence as a driver of the therapeutic market.2

Management Technology
Inpatient Versus Outpatient Care: A Bilateral Market
The development of minimally invasive technology, pharmaceutical advances, increased demand for
services, and higher costs associated with inpatient care has fueled a growth in outpatient care whereby
outpatient visits nearly doubled from 67 million in 1995 to 102 million in 2006. Simultaneously, the
technology utilized in inpatient care has augmented the quality and efficiency of care for inpatient beneficiaries over the age of sixty-five, which has nearly doubled from 1970 to 2006.3 This demographic shift
indicates that efforts to maximize technological implementation in the delivery of home care and patient
compliance monitoring systems should be employed to increase both access to and quality of care.
Outpatient visits nearly doubled from 67 million in
1995 to 102 million in 2006.
“Health, United States, 2008 (with chartbook),” by the National Center for Disease Statistics, Centers for Disease
Control and Prevention, U.S. Department of Health and Human Services, 2009.

Electronic Health Records (EHR)
Electronic health records (EHR) work through a system of longitudinal data collection and maintenance to “automate and streamline the clinician’s workflow.” The EHR has the ability to generate a
complete record of a clinical patient encounter, as well as supporting other care-related activities directly
or indirectly by way of an interface that includes evidence-based decision support, quality management,
and outcomes reporting.4 Facilities that use EHR systems increase the ease with which practitioners can
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file, manage, organize, and find their patients’ demographic data, progress notes, problems, medications,
vital signs, past medical histories, immunizations, laboratory data, and radiology reports.5

Trends in EHR
Though paper health records have been used effectively in the past, drawbacks exist to administrative
systems that continue to utilize nonelectronic documentation of patient information.6 In addition to hindering the delivery of quality medical care, studies have indicated that paper records are costly, cumbersome, and easily misplaced, and they are difficult to use for meaningful decision analysis.7 Furthermore,
paper records cannot be effectively searched or used to track, analyze, or chart voluminous clinical
medical information, and they cannot be easily copied or saved off-site.8
The first EHRs were adopted in the 1960s, but many healthcare professional practices at the time did
not view updates to their “anachronistic” medical record systems as a priority, despite the advent of technologies such as power files, audiotapes, microfilm, electronic data processes, and cathode ray tube realtime read-outs.9 Many of today’s EHRs are based on the work conducted in academic medical centers
for use by major government clinical care organizations. The most notable of these include
• COSTAR (the Computer Stored Ambulatory Record), developed at Harvard Medical School and
placed in the public domain in 1975;
• HELP (Health Evaluation through Logical Processing), developed at Latter-Day Saints Hospital
at the University of Utah (brought to market by the 3M Corporation), which pioneered decision
support features;
• TMR (The Medical Record), developed at Duke University Medical Center;
• THERESA, developed at Grady Memorial Hospital at Emory University, which encouraged direct
physician data entry;
• CHCS (Composite Health Care System), used by the Department of Defense;
• DHCP (De-Centralized Hospital Computer Program), developed and used by the Department of
Veterans’ Affairs (VA); and
• Technical Data System(TDS), developed by Lockheed in the 1960s and 1970s.10
Early attempts to design and implement EHR technology encountered several difficulties, and
although many improvements have been made,
Table 5-1: Status of Electronic Health Record
certain lingering problems in today’s systems
Implementation (2009)*
may explain why EHRs have not yet been widely
implemented (See table 5-1 for status of EHR
Stage of Implementation
Percentage
implementation as of 2009).
Not Yet Begun
5%
Although EHR implementation, is progressing
at a relatively slow rate, it has continued to increase
steadily since 2003. Notably, an estimated 43.9
percent of office-based physicians reported using an
EHR system of some form in the first few months
of 2009, although only 6.3 percent of systems were
considered “fully functional.”11

Developed a Plan
Signed a Contract

15%
2%

Begun to Install in One Facility

37%

Fully Operational in One Facility

24%

Fully Operational Across Whole Organization

17%

Unknown
*

1%

“20th Annual 2009 HIMSS Leadership Survey” By HIMSS, Healthcare CIO Final
Report, April 6, 2009, p. 24.
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Cost-Benefit Analysis
Using computer-based programs to track patients’ medical records, approve physician orders, and prescribe medication can drastically improve patient outcomes and reduce costs. According to the American Medical Association, practices that implement EHR technology will benefit from a system of documenting patient vitals and test results, better supporting documentation in malpractice claims, improved
reporting regarding patient practices, and improved communication between physicians.12 Furthermore,
results from a recent study published in Health Affairs suggests that implementation of EHRs could save
more than $81 billion per year by preventing disease, reducing medical errors, and promoting efficiency
within the healthcare system.13
Additionally, the implementation of an EHR system allows for computerized physician order entry
(CPOE), which may reduce adverse drug events in inpatient and ambulatory settings.14 These point-ofcare technology systems make patient clinical data readily available, and they provide physicians with
access to scientific information essential to patient care and decision-making.15
Practices that utilize EHR technology reduce their costs associated with utilizing and maintaining
traditional paper medical records.16 In addition to superior physician accessibility, EHRs allow physicians to enter key findings and progress notes at the point of care, minimizing duplicate documentation.17
Additionally, problems with legibility are eliminated, reducing potential interpretation errors and saving
time.18

Barriers to Implementation
Obstacles, such as cost and physician resistance to change, have delayed the widespread adoption of
EHRs.19 Some physicians admit that the cost of new technology is the greatest challenge for the conversion from paper health records to EHR.20 However, research suggests that physicians who use EHRs
with sophisticated Medicare coding support could see a revenue increase of up to 30 percent more than
physicians who continue using paper records.21 Some cardiology practices have already reported substantial EHR benefits, including lower Medicare rejection rates, fewer days in accounts receivable, the
ability to increase their number of patients without an increase in staff, increases in revenue, and reductions in transcription and postage costs.22 One multispecialty practice observed $2.5 million per year in
EHR related savings.23
Physicians who use EHRs with sophisticated Medicare coding support
could see a revenue increase of up to 30 percent more than doctors
who continue using paper records.
“The Benefits of Evidence Based Medicine in EHR Systems,” by Tom Doerr, MD, EHR Scope, (Spring 2008).

The cost associated with utilizing EHR technology can vary based on facility size, patient volume,
and type of software, which extends beyond the software license. Often, the cost of the software is only
50 percent of the cost for a new system.24 Furthermore, it is estimated that the total cost per provider can
be upward of $10,000; if the loss of productivity associated with initial implementation is accounted for,
the cost of transitioning to an EHR system could be greater than $20,000.25
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Regulatory and Reimbursement
Regulatory
As with all medical records, EHRs must align with current Health Insurance Portability and Accountability Act (HIPAA) regulations (see chapter 3, Health Insurance Portability and Accountability Act of
1996 (HIPAA) for further discussion of these regulations). Due to ease of transfer and accessibility, practitioners and healthcare facilities that use EHR technology must be cautious about compliance.
In 2007, the Federal Trade Commission (FTC) issued a set of regulations known as the Red Flags
Rules, requiring that certain entities develop and enforce written identity theft prevention and detection
programs by August 1, 2009. These programs are targeted at all transferable personal files, including
EHRs, and are discussed further in chapter 3, Red Flags Rules.

Reimbursement
In response to the slow transition to EHRs, the government has prioritized proactive legislation promoting universal access to electronic records. Congress recognized the impending healthcare crisis in its
American Recovery and Reinvestment Act (ARRA), signed by President Barack Obama on February 17,
2009.26 The ARRA allotted $19.2 billion to ensure that every patient has a complete, interoperable EHR
by 2014. The net return of this investment will include long-term cost savings, improved outcomes, and
increased ease of communication between physicians. In an effort to incentivize the implementation of
EHR use, beginning in 2011, funding will increase reimbursement for Medicare and Medicaid providers
(up to $65,000 per physician and $11 million per hospital) that use EHRs.27 Conversely, in 2015, physicians who are not using EHRs will be penalized through reduced reimbursement.28
The ARRA allotted $19.2 billion to ensure that each American has a
complete, interoperable EHR by 2014.
“Healthcare and the American Recovery and Reinvestment Act,” by Robert Steinbrook, MD, The New England
Journal of Medicine, March12, 2009, http://content.nejm.org/cgi/content/full/NEJMp0900665 (accessed
February 20, 2009).

Specific provisions of the ARRA, namely, Title IV of Division B and Title XIII of Division A,
collectively are known as the Health Information Technology for Economic and Clinical Health Act
(HITECH Act). These sections of the ARRA incentivize implementation of EHR and establish “meaningful use” criteria for EHR utilization by healthcare entities and providers.29 For healthcare providers to
qualify for HITECH incentives, they must demonstrate fulfillment of three requirements for “meaningful
use” of EHRs:
(1) Use of certified EHR technology in a meaningful manner (for example, electronic prescribing); (2) that the certified EHR technology is connected in a manner that provides for the electronic exchange of health information to improve the quality of care; and, (3) that, in using certified EHR technology, the provider submits . . . information on clinical quality measures and such
other measures selected by the Secretary.30

In addition to the aforementioned criteria for “meaningful use,” upheld by both Medicare and
Medicaid, which currently link many EHR incentive programs, Medicaid also requires that healthcare
providers receiving incentives under HITECH must indicate efforts to “adopt, implement, or upgrade
certified EHR technology” wherever possible.31 States also reserve the right to implement additional
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requirements for “meaningful use” beyond the minimum standard upheld by Medicare, which will
undergo additional changes as definitions for “certified EHR technology” and a “qualified EHR” are
finalized.32

Electronic Prescribing: Computerized Physician Order
Entry (CPOE)
Computerized physician order entry (CPOE) allows physicians and providers to electronically order
laboratory, pharmacy, and radiology services.33 Electronically entering orders minimizes error by eliminating the hassle and ambiguity associated with handwritten orders.34 CPOE is designed to “streamline
medication ordering by standardizing the process, introducing controls, eliminating bad handwriting,
making an order easily traceable to a provider; additionally, with decision support installed, CPOE can
also help assure adherence to evidence-based guidelines.”35
More than 1 million serious medication errors occur every year in the United States.36 One adverse
drug effect (ADE) adds, on average, $2,000 to the cost of hospitalization, which is currently more than
$7.5 billion per year nationwide.37 An ADE is an injury caused by drugs, typically in the form of an allergic reaction or adverse physiological response to a certain combination of medications. Preventable
ADEs are injuries that are caused by human error, such as prescribing or administering the wrong dose
of a drug.38 A 2008 study by the Leapfrog Group, a large consortium of healthcare purchasers, found that
CPOE systems can reduce the frequency of ADEs by as much as 88 percent.39
Only 8 percent of hospitals have fully implemented CPOE systems. In
addition, CPOE hospitals tend to be larger, nonprofit, and teaching hospitals.
“Full Implementation of Computerized Physician Order Entry and Medication-Related Quality Outcomes:
A Study of 3364 Hospitals”, by Feliciano B. Yu et. al, American Journal of Medical Quality, American College of
Medical Quality, June 5, 2009, p. 1.

Trends in CPOE
CPOE systems were first introduced in the late 1960s, but CPOE use was fairly sporadic until a 1999
study by the Institute of Medicine (IOM), “To Err Is Human,” found that 44,000 deaths annually are attributable to medical errors and touted CPOE adoption as the solution to this newly recognized national
crisis.40
Between 2004 and 2005 the agency for healthcare research and quality
awarded more than $166 million in funding for health IT, much of which
focused on implementation and evaluation of CPOE.
“Inpatient Computerized Provider Order Entry (CPOE): Findings from the AHRQ Health IT Portfolio”, by Brian E.
Dixon and Atif Zafar, U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality,
January 2009, http://healthit.ahrq.gov/images/jan09cpoerport/cpoe_issue_paper.htm (accessed June 22, 2009), p. 2.
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CPOEs have received much public attention following the IOM’s call for the use of electronic
prescribing systems in all healthcare organizations by 2010 and the decision by the Leapfrog Group to
encourage CPOE adoption by hospitals as a means to improve care and reduce costs.41 Despite these
initiatives, a 2009 study published in the American Journal of Medical Quality found that only 8 percent
of hospitals have a fully implemented CPOE system. Additionally, these hospitals tended to be larger,
nonprofit, teaching hospitals.42 For a hospital to qualify as having a “fully implemented” system, 75 percent of all orders must go through its CPOE system, the system must alert physicians of possible errors,
and it must require a physician response if an alert is overridden.43
In 2008, 472 U.S. hospitals had a CPOE system in place. Of those organizations using CPOE, 62
percent were described as having aggressive use (50 percent or more of orders are entered into CPOE
system) (see table 5-2). Additionally, the following table 5-3 details the breakdown of CPOE usage
measured by percentage of orders that are filled out through the hospital’s CPOE system.44
Table 5-2: Number of Organizations using Computerized Physician Order Entry, 2008*

Pilot
(1–15%)

Moderate
(16–50%)

Significant
(51–85%)

Deep
(86–100%)

Number

95%

102%

60%

229%

Percentage

20%

22%

13%

49%

*

“Computerized Physician Order Entry Usage in North America: The Doctor is In” By Stacilee Oakes Whiting and Adam Gale, HIT Report from KLAS, Healthcare Quarterly, Vol.
11, No. 3 (2008) p. 94.

Table 5-3: Approximate Uses of Computerized Physician Order Entry (CPOE) in Inpatient and
Ambulatory Settings, 2008*
% of MD’s Using CPOE

Level of Use

% of All Patient Orders MD’s Enter

% of Medication Orders
Electronic vs. Paper

% MD’s Entering Notes
Electronically

Inpatient Ambulatory Inpatient Ambulatory Inpatient Ambulatory Inpatient Ambulatory

Pilot

18

4

21

9

21

15

65

45

Moderate

22

12

19

25

16

8

9

11

Significant

10

12

22

20

19

8

5

4

Deep

46

70

38

48

44

65

19

35

*

“Computerized Physician Order Entry Usage in North America: The Doctor is In” By Stacilee Oakes Whiting and Adam Gale, HIT Report from KLAS, Healthcare Quarterly,
Vol. 11, No. 3 (2008) p. 95.

Other national organizations also have promoted the adoption of CPOE based on its potential to improve quality and reduce medical error. These include the Joint Commission on Accreditation of Healthcare Organizations (Joint Commission) and the President’s Information Technology Advisory Committee.45 Despite this initiative and support, hospital ownership and teaching status have historically been
cited as important factors in whether a hospital is likely to implement a CPOE system (see table 5-4).46
Government hospitals have been the most likely to start implementing CPOE systems (including
nonfederal community, city-, state-, and county-owned government hospitals) at three and seven times
the rates of adoption by nonprofit and for-profit hospitals, respectively.47 Larger government hospitals
have been more prone to incorporating CPOE technologies, and teaching hospitals have been roughly
three times as likely as nonteaching hospitals to adopt the technology.48
Studies indicate that institutions that adopt CPOE systems primarily are focused on the safe and
proper delivery of clinical services.49 Political interests in clinical safety are more prevalent in governmental facilities than in for-profit hospitals. Physicians are also the stakeholders most opposed to the
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Table 5-4: Computerized Physician Order Entry (CPOE)
Investment by Hospital Ownership*
Ownership Type

Government

Non-for
Profit

For-Profit

No CPOE System

24.1%

41.4%

54.1%

Early-Stage Adoption

12.7%

9.6%

6.8%

Middle-Stage
Adoption

15.2%

12.1%

3.8%

Fully Implemented

10.1%

2.2%

0.0%

*

“U.S. Adoption of Computerized Physician Order Entry Systems” By David M.
Cutler, Naomi E. Feldman and Jill R. Horitz, Health Affairs, Vol. 24, No. 6 (Nov./
Dec. 2005), p. 1657.

adoption of CPOE systems and accordingly, “[i]t
may be that physicians are sufficiently powerful to
prevent (CPOE) adoption at private hospitals but
not sufficiently powerful to delay (CPOE) adoption at public institutions.”50 Additionally, the large
percentage of teaching hospitals implementing
CPOE systems could be explained as a correlation
between education and a heightened commitment to
innovation, as “. . . results suggest that information
about CPOE systems has not spread widely enough
among key physicians or hospital decision makers
outside of teaching institutions.”51

Cost-Benefit Analysis
Prudent prescription and medication use has a substantial impact on the total cost of healthcare.52 Overall, the financial impact of reported CPOE use has had a positive effect on the net operating income of
an institution.53
A 2008 survey by the Massachusetts Hospital CPOE Initiative calculated that Massachusetts saved
$2.7 million per hospital annually with the adoption of CPOE technology.54 The initiative found that the
increased savings for Massachusetts hospitals essentially would generate sufficient return in approximately twenty-six months to cover the costs of installing and adapting CPOE software and protocols.
In addition, the average annual benefits to Massachusetts payors amounts to approximately $900,000
per hospital. The initiative concluded that statewide adoption of CPOE systems would save, on average,
$170 million a year, preventing 55,000 ADEs from occurring.55
Although some studies have shown that implementation of CPOE systems has resulted in considerable gains in ordering process efficiency, other potential benefits of CPOE systems appear to have been
disproved.56 For example, although CPOEs are touted for their potential to promote effective leadership
and other quality performance indicators, studies have so far shown that hospitals with complete CPOE
systems do not systematically outperform, with regard to these factors, those without.57 In addition,
studies of CPOE systems are constrained by the technology’s comparative youth, continued evolution,
emphasis on evaluation of potential rather than actual errors, and limited dissemination.58
Despite these cost concerns, research has indicated that many hospitals respond proactively to financial incentives, especially for-profit hospitals, which have been shown to make calculated decisions
based on profitability.59 “Investments in patient safety—although a moral obligation—usually provide
financial benefits to payors and purchasers rather than to the organization, a point not lost on stressed
organization leaders.”60 Additionally, changing the reimbursement environment to favor adoption of
CPOE systems could offer a short-term solution to increasing investment in these systems.61
Between 2004 and 2005, the Agency for Healthcare Research and Quality (AHRQ) awarded more
than $166 million in funding for health information technology (IT), much of which focused on implementation and evaluation of CPOE. This amount only covered part of the capital needed to secure and
implement a CPOE system. Providers were required to utilize alternate funding sources, including
payors, state-based loan programs, and organizational IT budgets. However, with shrinking organizational budgets and competing IT projects, the task of funding CPOE implementation can be daunting for
hospital administrators.62 A 2008 survey of Massachusetts hospitals found that, on average, capital costs
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associated with implementing a CPOE system was slightly more than $2 million and ongoing use and
maintenance was just more than $425,000.63
On average, one adverse drug effect adds $2,000 to the cost
of hospitalization, which is more than $7.5 billion per year
nationwide in hospital costs.
“Leapfrog Hospital Survey Results” The Leapfrog Group, 2008, p. 3.

Clinical Decision Support (CDS)
Clinical decision support (CDS) is a technology that provides clinicians with real-time feedback for a
wide range of diagnostic and treatment related decisions as they are entering electronic patient records.64
CPOE systems with CDS can minimize the incidence of medical errors by informing practitioners of
potential drug interactions, patient allergies to prescribed medication(s), medication contraindications,
and renal- and weight-based dosing. CDS systems provide pop-up warnings when a complication exists
with an order. However, “alert fatigue” can occur when there is a combination of critical medical alerts
and a high volume of marginally medically consequential alerts.65 An overabundance of warnings may
desensitize and even annoy practitioners.66
Quality of Care Improvements
A recently published study in the American Journal of Medical Quality found significant positive associations between specific objective quality indicators and CPOE implementation.67 Hospitals with CPOE
systems noted that errors related to legibility of paper orders were eliminated. Also, alerts regarding allergies, potential drug interactions, and dosing standards, improved patient safety, and “stat” orders were
fulfilled quicker, because pharmacies were receiving the orders instantly.68
In addition to preventing ADEs, CPOE systems alert physicians of available generic options for any
prescription drug, alert clinicians of redundant orders or laboratory test entries, and list the drug delivery
methods suitable for any prescribed drug to prevent delivery errors (for example, intravenous administration of orally administered drugs). CPOE systems could be even more beneficial in long-term care
facilities because residents are prescribed, on average, more than six concurrent drug therapies, which,
exacerbated by problems associated with advanced age, can increase the risk of an ADE.69 Table 5-5
shows expected minimal rates of improvement for preventable adverse occurrences with implementation
of CPOE.

Barriers to Implementation

In addition to the costs associated with implementing a CPOE system (see Cost-Benefit Analysis), several other challenges should be considered: technical issues, costs, and clinician compliance.70
Technical Issues
It should be noted that there is no “one size fits all” CPOE system, so many hospitals may need to customize their systems, including the integration of current systems.71 This process necessitates thorough
project planning and execution, which may hinder production and cause unforeseen delays.
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Table 5-5: Minimal Expected Rates of Improvement for
Given the customization needed to integrate a
Preventable Adverse Events with Computerized
CPOE system into any facility’s infrastructure, a
Physician Order Entry*
fair amount of training is required to ensure that clinicians, technicians, and practitioners will maintain
Preventable Event Year 1
Year 2
Year 3
and use the system consistently and correctly.72
ADEs

15%

50%

70%

Expensive Drugs

20%

60%

80%

Unintended Errors
Renal Dosing
15%
60%
93%
CPOE system technology introduces other poI.V. to Oral
50%
75%
82%
tential unintended errors, which include delivery
Redundant Labs
50%
75%
85%
of orders on incorrect patients, errors of clinician
* “Saving Lives, Saving Money: The Imperative for Computerized Physician Order
omission, lack of communication among clinical
Entry In Massachusetts Hospitals” By Mitchell Adams et al., Massachusetts
Technology Collaborative, New England Healthcare Institute, Feb. 2008, p.18.
staff regarding the status of an order, loss of information during care transitions, and overlapping
medication orders.73 A 2005 study found that one CPOE system facilitated twenty-two types of medication error risks, generated by the fragmentation of data and failure to integrate the hospital’s multiple
computer and information systems and human-machine interface flaws reflecting machine shortcomings
in light of generally accepted workplace practices and dynamics.74 However, as systems become more
advanced, some of these unforeseen problems are decreasing in frequency. In 2003, the average number
of electronic patient entries being re-entered was 48 percent, whereas in 2008, this percent dropped to 21
percent.75
Physician Unwillingness
Another potential barrier to use of CPOE is provider reluctance. User satisfaction has been identified as
an important predictor of the success of CPOE adoption and compliance.76 Generally, younger interns
and residents are more willing to use CPOE, although older, more experienced physicians tend to be less
satisfied with CPOE.77
One of the primary complaints from physicians is that it takes longer to enter an order electronically.
Physicians also have reported a loss of professional autonomy, because CPOE systems can prevent
them from ordering the type of tests or medication(s) they prefer, force them to comply with clinical
guidelines they do not embrace, and limit their flexibility through structured rather than free-text clinical
documentation.78

Regulatory and Reimbursement
Regulatory
Individual states have enacted laws to reduce medical errors. The California Health and Safety Code
Section 1339.63 states, “As a condition of licensure under this division, every general acute care hospital
. . . special hospital . . . and surgical clinic . . . shall adopt a formal plan to eliminate or substantially reduce medication-related errors. . . . This plan shall include technology implementation, such as, but not
limited to, computerized physician order entry.”79 This law required all plans to be submitted by 2002,
with the licensure changes taking affect January 1, 2005. A similar law in Massachusetts requires statewide implementation of CPOE systems by 2012.80
On a federal level, there have been several bills proposed in both the United States House of Representativesand the Senate regarding implementation of CPOE systems.81 Although none of the bills specifically requiring CPOE implementation have been passed, the Patient Safety and Quality Improvement
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Act of 2005 called for a report including suggestions on the reduction of medical errors to be submitted
to the IOM.82 In addition, the Centers for Medicare and Medicaid Services (CMS) 2004 final rule entitled, “Medicare and Medicaid Programs; Hospital Conditions of Participation: Quality Assessment and
Performance Improvement,” created a quality assessment and performance improvement program to
reduce medical errors, including medication errors.83

Reimbursement
In the past, financial incentives to support investments in CPOE technology were lacking. One reason
for this is that public payors paid the same reimbursement for unsafe care as they did for safe care.84 To
combat this, some private insurers are leading the charge to incentivize hospitals to incorporate CPOE.85
The Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) created an incentive
program for professionals to start e-prescribing. Section 132 of MIPPA establishes incentives for 2009
through 2013, in which Medicare professionals who are successful e-prescribers will receive payments
of 2 percent for 2009 and 2010, 1 percent for 2011 and 2012, and 0.5 percent for 2013. The goal of these
incentives is to allow the Government Accountability Office (GAO) to submit a report on the implementation of the incentives for electronic prescribing to Congress by September 1, 2012.86

Outsourcing Billing Services
With physician professional practices under economic pressure to cut costs and adhere to heightened
regulations regarding security and compliance, a greater number of practices use outsourcing as a “tool
for survival and growth.”87
Outsourcing in healthcare has yielded higher efficiency levels and more cost-effective outcomes
and also has provided increased physician and patient satisfaction.88 Many health practices are utilizing
foreign companies for medical billing in response to those companies’ guarantees of dramatic savings
compared to their American counterparts.89
Despite the financial benefits of outsourcing billing, it also raises issues of compliance with HIPAA.
A 2005 study showed that although many outsourcing service providers have implemented HIPAA requirements, others have chosen not to comply, citing “no public relations or brand problems anticipated
with noncompliance” and “no anticipated legal consequences for non-compliance.”90 With lawmakers
increasing penalties for noncompliance with privacy laws, it is likely that outsourcing services providers will begin to increase their compliance efforts. The HITECH Act, enacted as part of ARRA,91 delineates a tiered system for determining the appropriate penalties for HIPAA privacy violations.92 HITECH
provisions significantly increase the penalties for violations of HIPAA, allowing for penalties up to $1.5
million.93

Telemedicine and Telehealth
Telemedicine is the transfer of electronic medical data (high resolution images, sounds, live video, and
patient records) from one location to another in order to enhance the quality and efficiency of patient
comfort and care. This technology utilizes a variety of telecommunication technologies, including,
but not limited to ordinary phone lines, integrated services digital network, fractional to full T-1 lines,
ATMs, the Internet, and satellites.94 Telehealth is closely related to telemedicine and is used to describe
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the broader definition of remote healthcare that does not always involve clinical services, although the
two terms are often used interchangeably.95
Utilizing communication equipment to link healthcare practitioners and patients in different locations increases cost efficiency; reduces transportation expenses, improves patient access to specialists
and mental health providers, improves quality of care, and enhances communication among providers.96
Telemedicine services have been integrated successfully into approximately sixty different medical subspecialties.97 The United States has approximately 200 telemedicine networks, involving close
to 3,500 medical and healthcare institutions.98 Some of the services offered through telemedicine are
specialized and primary care consultations, imaging services, remote patient monitoring, remote medical education and consumer information, networked programs linking hospitals to rural clinics, pointto-point connection using private networks between hospitals and ambulatory care sites, primary or
specialty care to home connections, home to monitoring centers, and Web-based e-health patient service
sites. Today, nearly five hundred hospitals in the United States outsource some of their medical imaging
services, often referred to as teleradiology.99
Telemedicine services have been successfully integrated into approximately
sixty different medical subspecialties.
“What is Telemedicine and Telehealth?” American Telemedicine Association, info@americantelemed.org
(accessed June 30, 09).

Trends in Telemedicine
The range of telemedicine technology is divided into two main application groups. Store and forward
is the transfer of digital images between locations, most commonly seen in teleradiology and telepathology (the use of pathology slides for diagnostic consultation).100 Two-way interactive television is used
in telemedicine for face-to-face consultation. These real-time consultations often occur between patients
or nurses in rural environments and practitioners.101
Some states, supported by Blue Cross Blue Shield (BCBS), have begun to implement virtual clinics
using telehealth technologies. The virtual clinic is a pilot project, so far only fully adopted in Hawaii, in
which for a flat fee, a patient can communicate with a physician using a webcam and an instant messaging program over the Internet for approximately ten minutes. Patrick Geraghty, the president of BCBS of
Minnesota (one state beginning implementation), claims that these virtual clinics will change the current
model of how physicians get paid and will save patients from expensive trips to the emergency room
and clinic. Roy Schoenberg, M.D., the creator of the virtual clinic software, describes how the software
connects patients to generalists, pediatricians, or other specialists who will have instant accesses to their
patients’ EHR provided by BCBS data. Currently, only in-state licensed physicians are allowed to participate in the program.102
Advances in robotics now allow telehealth to have a tangible component. Mercy Hospital in California recently unveiled a robot diagnostic tool (costing approximately $500,000) that can be operated
by a neurospecialist remotely to examine stroke victims.103 Additionally, Night Hospitalist Company
LLC (NHC) provides telephonic medical care from 7 p m to 7 am for hospitals with ongoing staffing shortages. NHC employs both allopathic and osteopathic physicians, who are licensed in multiple
states, to provide medical services from their homes for $500 per night. NHC costs $50 to $70 per hour,
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approximately half the cost of an in-house hospitalist.104 Another pilot telehealth initiative, the RP-7
robot, at Eagle Hospital in Atlanta, Georgia, can maneuver through hospital floors through a telehealth
link. Currently, ten hospitalists are participating in the pilot program.105
Digital telemedicine is allowing X-rays to be read overnight in India, psychotherapy to be conducted remotely, and mammograms to be screened automatically through digital scanning. This
explosion of technology applications holds not only the promise of more efficient and more
effectively distributed care but also the potential for significant disruption for certain medical
specialties.106

Cost-Benefit Analysis
The federal government has predicted that by 2020, there will be a shortage of approximately 24,000
physicians and nearly 1 million nurses.107 For hospitals suffering from physician shortages, telemedicine
facilitates hospitalist recruitment, providing more attractive work hours and the ability for a single practitioner to provide services to multiple hospitals at one time. In general, solving the physician shortage
may help control “burnout” for hospitalists, leading to higher productivity and longevity of practitioners.
In addition, telemedicine has enhanced access for hospitalists and their patients to medical specialists
and better technology. Telemedicine also allows hospitals to expand their market service area by employing telemedicine technology at outlying medical clinics and offices.108
Telemedicine also allows hospitals to expand their market area by
employing telemedicine technology at outlying medical clinics and offices.
“Night-Shift Solutions” By Lisa Ryan, The Hospitalist, April 2009, www.the-hospitalist.org/detains/article/183090/
NightShift_Solutions.html (accessed June 20, 2009).

The VA is the largest provider of remote medical services, delivering an estimated 350,000 patient
services remotely.109 Through telemedicine, the VA has reduced the average length of stay at hospitals
by 25 percent and has reduced hospitalization by 19 percent for patients using home health services.110
Through telemedicine, the VA has reduced the average number of days
hospitalized by 25 percent and reduced hospitalization by 19 percent for
patients using home health.
“New VA Study Shows Home Telehealth Makes Health Care More Effective” Government Health IT News,
Jan. 7, 2009.

Many healthcare practitioners have obtained federal funds for investments in telemedicine technology through grants, contracts, and direct services. In 2003, the American Telemedicine Association (ATA) estimated that approximately $279 million was spent on federal grants and contracts in
telemedicine.
The ARRA set aside $2.5 billion to be put into affiliated grants and loans for telemedicine. The act
also called for complete adoption of EHRs by 2014, without which the implementation of telemedicine
may have been hindered.111 Further, the Medicare Telehealth Enhancement Act of 2009 (HR 2068) will
provide $30 million in grants to health facilities to pay for telehealth equipment and expand telehealth
support services.112
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Finally, the Federal Communications Commission created the Rural Health Care Pilot Program to
increase patient access to telemedicine and support the transfer of EHRs. Sixty-seven nationwide projects in forty-two states and 6,000 health facilities are eligible for the $417 million in grants under the
program.113

Barriers to Implementation
The two main barriers to telemedicine implementation are (1) reimbursement obstacles from Medicare
and certain private health insurers and (2) medical licensing. Depending on the licensing practices of the
state, practitioners who use interstate telemedicine may have to be licensed in each of the states in which
they treat patients, which can be time-consuming and expensive.114
Some physicians refrain from using telemedicine systems due to liability issues and skepticism
regarding the competency of the technology. Generally, patients expect physicians at their bedside, not
a video or voice transmitted through the Internet or satellite. Without traditional bedside care, there may
be a greater likelihood of lawsuit if a problem occurs.115
As with any form of technology, startup and training costs are associated with telemedicine. These
vary depending on the technology being implemented and have the potential to hinder implementation
for some providers, including some of the rural geographic locations most in need.

Regulatory and Reimbursement
Regulatory
State
Physicians practicing medicine in any state must be approved by the licensure board of that state. As of
2006, twenty states have restrictive licensure laws regarding interstate telemedicine.116
These licensure laws require a practitioner to be fully licensed in each state in which he or she provides medical care in order to deliver telemedicine care across state lines, but it can be expensive and
time consuming for a practitioner to maintain licenses in more than one state.117
However, licensure laws typically have several exceptions that allow interstate telemedicine without
a license from both states, such as if
1. interstate telemedicine is infrequent,
2. a contractual relationship with compensation is not formed,
3. consultations are between two parishioners only (no patient involvement),
4. educational purposes,
5. telemedicine is used in a medical emergency or natural disaster,
6. the referring practitioner retains primary medical control, or
7. telemedicine is used in service of the U.S. military.118
Reciprocal or limited licensure provides an interstate license for use with telemedicine that practitioners can apply for through a simple application process and for reduced licensing fees. Reciprocal
licenses work through a mutual exchange of privileges and permit one state to recognize the license a
practitioner holds in another jurisdiction and subject practitioners to the rules from in the jurisdiction
where the practitioner resides.119 This license is solely for practicing telemedicine and may not be used
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by practitioners to provide bedside care in another state. As of 2006, reciprocal licenses were only accepted in Alabama, California, and Oregon.120 See table 5-6 for a summary of state participation in various types of interstate licensing practices. As an exception to this rule, an interstate license for nurses,
first created in 2000, has been widely accepted and used through the National Council of State Boards
of Nursing. A nurse residing in a state that participates in the Nurse Licensure Compact may hold a
license in his or her home state and practice either physically or remotely in another state, while being
subject to the practice laws and regulations of both states.121
Table 5-6: Summary of Telemedicine Interstate Licensure Types, 2006*

Type
Number of States
*

No Action

Restrictive

Reciprocal

Nursing

28

20

3

30

“Telemedicine Licensure Report” Center for Telemedicine Law, Office for the Advancement of Telehealth, June, 2003; Updated numbers from “Interstate Licensure of
Telemedicine Practitioners” By Glenn W. Wachter, Telemedicine Information Exchange, March 10,2000, updated By TIE on Nov. 15, 2006, http://tie.telemed.org/articles/article.
asp?path=article&article=interstateLicensure_gw_tie0 (Accessed 7/1/09).

Federal
Similar to any electronic transfer of patient medical information, telemedicine practitioners must comply
with HIPAA regulations. Telehealth and telemedicine are also subject to Joint Commission standards.122
Current Joint Commission standards focus on services provided by licensed independent practitioners
(LIPs) who diagnose or treat patients by way of a telemedicine link.123 Under the current standards, most
recently revised in 2004, a hospital may rely on the site of the LIP providing the service (referred to as
the distant site) for credentialing as long as that site is accredited by the Joint Commission. Otherwise,
the LIP must be credentialed at the site where the patient is located (the originating site).124
Telehealth and telemedicine are also subject to the JCAHO standards.
“Hospital-wide PACS Need Tighter Data Security” Diagnostic Imaging PACS Supplement, Feb. 2000, www.dimag.
com/db_area/archives/2000/0002pnews.3-7.html (accessed March 31, 2000).

The same Joint Commission standards apply to practitioners who provide interpretive services
(teleradiology and telepathology) and those who provide consultations.125 These services are usually
contracted out for and must therefore also meet the contracted service standard (LD.3.50).126 In contrast,
CMS requires LIPs to be credentialed at the originating site. In November 2008, the Joint Commission
revised its standards to reflect this discrepancy but reverted back to its original opinion in March 2009.127
HR 2068, introduced to Congress on April 23, 2009, was referred to the House Ways and Means committee (without further advancement) and addressed the Joint Commission and CMS credentialing
issues.128

Reimbursement
State
In 2006, at least twenty-nine states had private insurers that were reimbursing for telemedicine services, with at least twenty-five states having passed legislation mandating some level of private payor
reimbursement of telemedicine.129 Some states, including Louisiana, California, Oklahoma, Texas, and
Kentucky, have all-inclusive legislation prohibiting health insurers from denying coverage for services
appropriately provided through telemedicine and subject to individual insurance contracts.130
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A 2003 private payor survey conducted by the ATA found that 53 percent of telemedicine programs
offer billable service and receive private payor reimbursement.131 As of 2006, thirty-four states reimburse through Medicaid for telehealth services, and nineteen states have specific legislation that provides
for Medicaid reimbursement.132
Federal
The Balanced Budget Act of 1997 limited the scope of Medicare telehealth coverage to consultation
services. Section 223 of the Medicare, Medicaid and SCHIP Benefits Improvement and Protection Act of
2000 (BIPA), however, revised Medicare reimbursement to cover telehealth serviced on or after October
1, 2001, to include consultations, office visits, individual psychotherapy, and pharmacologic management. Services were only covered for cases with interactive audio and video telecommunication systems
when the patient was present and participating in the telemedicine visit. Eligible geographic areas included rural health areas with practitioner shortages and counties not classified as part of an established
metropolitan statistical area.133
Section 149 of MIPPA amended BIPA to reimburse services provided on or after January 1, 2009, for
telehealth services performed in the office of a physician or practitioner, hospital, critical access hospital
(CAH), rural health clinic, federally qualified health center, hospital-based or CAH-based renal dialysis
facility, skilled nursing facility, or community medical center. In addition, as of 2009, both the distant
physician or practitioner and patient are required to be present at the telehealth “visit” and interacting in
real-time communication.134

Clinical Technology
The Gateway: Genetics, Genomics, and Genome Technology
The landmark discoveries accompanying the advent of genome sequencing transformed the field of
clinical medicine. In 2001, The Human Genome Project at the National Institute of Health completed
the initial mapping of the human genome, a milestone that fueled interest in the field of genomics.135
The technological advancements that followed served as the foundation for a new genre of pharmaceutical and therapeutic medicine. Biotechnology and biopharmaceuticals are influential drivers in today’s
market, accounting for 93 percent of dollars spent on healthcare merger and acquisition activity in May
2009.136
In 2001, The Human Genome Project at the National Institute of Health
completed the initial mapping of the human genome.
“The era of ‘omics unlimited,” by Raj P. Kandpal, Beatrice Saviola, and Jeffrey Felton, BioTechniques, Vol 46, April
2009 (special issue), p. 351–55.
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Biotechnology and biopharmaceuticals are influential drivers in today’s
market, accounting for 93 percent of dollars spent on healthcare merger
and acquisition activity in May 2009.
“Drug Deals Dominate M&A: Biotech and Pharma Outspend All Other Sectors,” by the Healthcare M&A Monthly,
Vol. 14, Issue 6, June 2009, p. 1.

Genomics is the evaluation of the hereditary information provided by an organism’s DNA and the
application of research findings to the fields of genetic engineering and enhancement, cloning, stem cell
research, and eugenics.137 The National Center for Human Genome Research Institute (NCHGRI)
is comprised of more than fifty researchers who are each dedicated to specific facets of genetic and
genomic research and contribute accordingly to one of seven branches of the NCHGRI: Cancer Genetics, Genetic Disease Research, Genetics and Molecular Biology, Genome Technology, Inherited Disease
Research, Medical Genetics, and Social and Behavioral Research.138

Stem Cell Research
Within any living organism, each cell is specialized to a specific biological system. Stem cells are
unspecialized cells capable of renewing themselves through cell division, sometimes after long periods
of inactivity, and adapting their function to accommodate a certain type of tissue or organ under the
proper conditions. The unique regenerative capacity of stem cells has the potential to change the way
health problems, such as diabetes and heart disease, are treated. As such, efforts to advance reparative
medicine (therapies that heal the body’s natural tissue) by developing efficacious cell therapies are at
the forefront of medical research.139 On January 23, 2009, the first human embryonic stem cell (hESC)based therapy was approved for clinical trial; Geron Corporation announced clearance of their Investigational New Drug application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.
GRNOPC1 manipulates the growth-stimulating properties of nerve cells to provide rehabilitation for
acute spinal cord injuries.140
On January 23, 2009, the first human embryonic stem cell (hESC)-based
therapy was approved for clinical trial.
“Geron receives FDA clearance to begin world’s first human clinical trial of embryonic stem cell-based therapy,”
by Geron: Visionary Therapeutics, January 23, 2009, www.geron.com/media/pressview.aspx?id=1148 (accessed
July 1, 2009).

Stem cell research is also used to investigate the causes of birth defects, enhance drug development
by providing molecular insight, and expedite the drug approval process by facilitating preliminary drug
testing. Additionally, understanding the differences between embryonic and nonembryonic stem cell
proliferation may be the key to understanding—and treating—cancer.141
The completion of the draft human genome sequence in 2001 was followed by research inquiries
targeting transcripts (transcriptomics), RNAi/miRNAs (interferomics and micro-RNomics), proteins
(proteomics), interacting proteins (interactomics), DNA and chromatin modifications (epigenomics),
and metabolites (metabolomics).142 Developments in these areas contributed significantly to the molecular understanding of biology, pathology, and pharmacology; any advances in molecular research
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are dictated by progress in these genomic substrata.143 Furthermore, molecular diagnostics represent the
sector of the genomics market with the most promise.144

Diagnostic Technology
Diagnostic medicine is the utilized in both acute and chronic care for the purposes of prevention, screening, monitoring of health conditions, and disease detection and management. This staple of healthcare
claims that, “A penny of prevention is worth a pound of cure . . . The pharmaceutical industry has long
been focused on treatment of disease but it will be far more cost-effective to prevent disease than cure
it, and this will be a driver of innovation.”145 Recent diagnostic advances support an attitude of prevention that, though inherently accepted, has not been practiced sufficiently in healthcare to date. In order to
truly realign demand and delivery of healthcare services, future developments may need to be directed at
a diagnostic market increasingly driven by prevention and early detection.

Molecular Diagnostics
Molecular diagnostics originally were used to screen for infections (for example, HIV, hepatitis, and
tuberculosis) more accurately and effectively than traditional methods.146 The capabilities of molecular
diagnostics since have evolved to include genetic disorder screening, pre-implantation screening,
and cancer screening procedures, thereby facilitating the transition toward preventative healthcare.147
Similarly, advances in genetic engineering and enhancement, pharmacogenetics, and pharmacogenomics
have lead to a fusion of molecular diagnostics and therapeutic measures for specialized screening
and treatment plans; this fusion is characteristic of personalized medicine. The capabilities afforded
by molecular diagnostics have relied on developments in polymerase chain reaction (PCR)-based
technology, electrochemical detection of DNA, biochip technology, nanotechnology, and proteomic
technologies.148 The developments that materialized as a result of these molecular capabilities continue
to affect the molecular, nonmolecular, and in vitro diagnostic markets.149
The field of cancer diagnostics, utilizing molecular technologies, has been influential in the transition
to personalized care. Cancer molecular diagnostics (CMD) most likely will not replace traditional pathological examinations but rather serve to supplement and enhance these methods by employing them in
conjunction with microarrays, reverse transcriptase polymerase chain reaction (RT-PCR), mass spectrometric proteomic analyses, and protein chips.150 CMD technology will allow practitioners to diagnose
cancer, choose and develop personalized treatment plans, and identify predispositions twice as quickly
as other assays for only a fraction of the drug development costs.151

Trends in Molecular Diagnostics
The global market for molecular diagnostics encompasses more than 500 companies and, as of 2008, the
United States controlled the majority of the market.152 The area of greatest promise lies in developing
companion diagnostics that incorporate therapeutic care.153

Regulatory and Reimbursement
In the past, molecular diagnostic innovations fell outside the stringent compliance requirements set by
the Federal Drug Administration (FDA). In response to increased demand, regulations targeting in vitro
diagnostic multivariate integrated assays (IVDMIA) and analyte-specific reagents (ASRs) were issued to
increase FDA supervision of the field and elevate quality standards.154 These draft guidelines, published
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by the FDA’s Office of In Vitro Diagnostic Device Evaluation and Safety in July 2007 and September
2007, for IVDMIA and ASR regulation, respectively, will serve as a challenge for developers, especially
for companies entering the market for the first time.155
Despite that diagnostic testing influences 70 percent of all healthcare decisions made, diagnostics
only comprises 2 percent of overall Medicare spending. In a healthcare system historically focused on
the quality of acute care provided, reimbursement for services targeting prevention and chronic disease
management have not been thoroughly assessed since the 1980s.156
Despite the fact that diagnostic testing influences
70 percent of all healthcare decisions made, diagnostics
only comprise 2 percent of Medicare spending.
“Medicare Needs to Get With the Times” The Burrill Report, Burrill and Company, 2009.

Imaging Technology
Medical imaging is defined as a “non-invasive process used to obtain pictures of the internal anatomy
or function of the anatomy using one of many different types of imaging equipment and media for creating the image.”157 Imaging is one the fastest growing categories of services covered under Medicare
Part B across all modalities, namely computed tomography (CT), magnetic resonance imaging (MRI),
nuclear medicine, ultrasound, x-ray, and other standard imaging techniques.158 Under the 2005 Deficit
Reduction Act, CMS moved to constrain spending on these services. The act stated that, with certain
exceptions, physician payments under the CMS fee schedule must be capped at the levels established for
independent diagnostic testing facilities under the Outpatient Prospective Payment System (OPPS).159
See chapter 2, Facility-Based Reimbursement Rates for more detail regarding billing under OPPS. In
June 2008, the GAO released a report affirming the findings that procured CMS’s decision. Spending for
imaging services more than doubled from 2000 to 2006, increasing to approximately $14 billion, with
80 percent of this growth explained by the increased quantities of complex imaging services.160

Trends in Imaging Technology
Continuous development and improvement of existing technology has characterized much of imaging
development. For example, ultrasound is undergoing extremely promising improvements, with greater
speed and enhanced quality affording higher frequency, better resolution, and three-dimensional (3D)
imaging. This increased strength will foster an array of possibilities, including added specificity of
results, a reduction in the necessity of biopsies, and more standardized ultrasound use. One substantial
drawback to ultrasound is its reliance on operator competence. Compounded by the healthcare manpower deficit, the shortage of professionals qualified to perform ultrasound procedures can be affected
additionally by lagging reimbursement and liability concerns. Accordingly, professionals believe the
repercussions of relying on operator capabilities will result in increased interest in technologies that
promote ease-of-use.161
Of all the imaging services contributing to the $14 billion in imaging spending, the highest observed
growth rates were attributable to advanced imaging modalities (MRI, CT, and nuclear medicine), with
an average annual growth rate of 17 percent. These modalities are also the most expensive services.
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Advanced imaging accounted for 54 percent of total imaging expenditures, with spending having more
than doubled from $3 billion in 2000 to $7.6 billion in 2006.162
Advances in Magnetic Resonance Imaging
Functional MRI (fMRI), a combined positron emission tomography (PET) and MRI system, enables
physicians to observe brain function while patients perform physical and mental tasks.163 fMRI is one
of the most popular methods of brain imaging in today’s market.164 Open MRI systems, or short bore
magnet systems, are another example of technological improvements to existing imaging technologies.
These systems reduce claustrophobia for patients but generate images of comparable quality to those
produced by traditional imaging technology.165
As a result of these technological advances, an estimated 26.6 million MRI procedures were performed in 2006, representing an average annual growth rate of 3 percent, and a 10 percent total increase
from the 24.2 million procedures conducted in 2003.166 Spending on MRI services accounted for nearly
half of the $4.6 billion increase in Medicare spending from 2000 to 2006.167 The ease of use afforded by
these technological expansions has resulted in increased outpatient procedures; in 2006, 84 percent of all
MRI procedures were performed on an outpatient basis versus 16 percent on an inpatient basis.168
Advances in Computed Tomography
Computed tomography (CT) has transformed both diagnostic and interventional medicine. The quality
of CT images appears to surpass the anatomical detail of competing imaging technologies due to the
cross-sectional scanning capabilities they afford.169 Since its creation in 1970, use of CT technology has
grown rapidly, with a 600 percent increase in utilization between the mid-1980s and the mid-1990s.170
As of 2000, approximately 46 million scans per year were taken in the United States.171 Additionally, CT
appears to expedite and improve initial triage of patients on an outpatient basis in the emergency room,
allowing patients to either return home or be admitted for evaluation.172 The number of visits for which
diagnostic imaging services were ordered grew from 28.3 percent in 1996 (3.2 percent being CT) to 44.2
percent in 2006 (11.6 percent being CT).173
Multidetector Row Computed Tomography (MDCT)
The advent of multidetector row (also known as multi-slice) CT (MDCT) technology has redefined
imaging on the molecular and cellular levels, and thereby enhanced patient management and care.174
Through the evolution from the 4-slice CT scanner, the 16-slice CT scanner, and finally, the 64-slice CT
scanner, MDCT has raised the standard for image quality and accuracy allowing for the production of
3D images.175 Recent market research indicates that CT accounts for 13 percent of all diagnostic procedures in the United States, and that the 64-slice CT is the most popular CT technology in use.176
64-Slice CT is the most popular CT technology in use, as it made
cardiac and cerebral CT imaging possible.
“Nuclear cardiology adopts hybrid and dynamic imaging” by David Berman, M.D., Diagnostic Imaging.com, 10/06,
www.diagnosticimaging.com/display/article/113619/1193342 (accessed February 10, 2009).
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In addition to producing images with greater acuity, the 64-slice CT also operates at an increased
speed compared to previously existing CT technology. The average scanning time for the 64-slice scanner was 313 seconds, which was sixty-four seconds faster than second generation 16-slice scanners.177 A
64-slice CT scanner can complete a scan in as little as eight to twelve seconds, compared to a traditional
CT scanner’s time of twenty to thirty seconds.178
With diagnostic imaging trends indicating that continued growth in the field is largely due to adult
diagnosis and screening procedures by proxy of the available MDCT technology, the four areas of most
interest at present are CT cardiac screening, CT colonography, CT lung screening, and CT whole body
screening.179
Dynamic Volume Computed Tomography
The latest in CT technologies, the 256- and 320- detector row systems, collectively are referred to
as dynamic volume CT. Dynamic volume CT technology is capable of imaging an entire organ with
isotropic resolution in one rotation and as a complete volume. The temporally uniform data are then
reconstructed as a whole unit, thereby reducing the chance of artifacts and misregistrations in the image
caused by creating a composite image.180 In addition to being quicker and more accurate, dynamic
volume CT exposes a patient to a significantly lower dose of radiation than both 64-slice imaging and
invasive diagnostic technologies. Similarly, dynamic volume CT scanning is sensitive enough to allow
physicians to detect subclinical problems, facilitating earlier diagnosis and treatment.181
“Fusion” Imaging—Nuclear Medicine and Combined Technologies
The adoption of CT in nuclear medicine has resulted in a hybrid technology known as “fusion” imaging
that combines nuclear medicine cameras with CT detection methods.182 Positron emission tomographyCT (PET-CT) as well as single, photon emission computed tomography-CT (SPECT-CT) systems have
various qualities that may prove advantageous in addressing the problems posed by each independent
system. By using a dual-system (SPECT-CT or PET-CT), patients can undergo both procedures at once,
resulting in minimized error rates and better images.183
According to IMV Medical Information Inc. (IMV), a leading market research firm, “PET-CT scanners have become the preferred technology for PET imaging, as the integration of functional PET images with anatomical visualization of CT has allowed more accurate and faster diagnosis.”184
PET technology allows for substantially higher sensitivity than single-photon imaging technologies,
such as SPECT.185 However, due to the longer half-life of single-photon emitters, SPECT tracers last
six hours; PET tracers have only a seventy-five second half-life. A longer half-life enables the use of a
wider observational time window.186 SPECT is much more available, widely used, and more affordable
than PET-CT technology (a SPECT camera costs between $400,000 and $600,000, and the PET-CT
can cost $2 million). Finally, the 1.6 million PET-CT procedures performed in 2007 cannot compete in
quantity with the 15.9 million SPECT procedures performed during the same time period.187 However,
SPECT is subject to longer scan times and can produce low-resolution images that are prone to artifacts
and attenuation (especially in larger patients).188
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PET technology allows for substantially higher sensitivity than singlephoton imaging technologies like the SPECT.
“PET versus SPECT: strengths, limitations, and challenges,” by Arman Rahmim and Habib Zaidi, Nuclear Medicine
Communications, Vol. 29, (2008) p. 193–207.

IMV also reported increased use of SPECT-CT, capable of CT-based attenuation correction which,
paired with CT calcium scanning, will significantly increase accuracy and interpreter confidence. Due
to the insufficient sensitivity of current SPECT imaging technology, SPECT-CT may become the standard way in which SPECT studies are performed.189 Recent market research indicates that nearly half of
SPECT sales globally are in fact SPECT-CT sales.190
Despite these international trends, 75 percent of purchases in the United States are still SPECT.
However, SPECT-CT trends are unlikely to mimic the dynamic increases in PET-CT use. Compounded
by the current reimbursement environment, the main barrier to the SPECT-CT market is a shortage in
technetium, the isotope most frequently needed for such nuclear procedures.191 Additionally, the majority of SPECT procedures are performed in the field of cardiology, where SPECT-CT is only beneficial
if it can generate sixty-four or more slices.192 Often, the cost allocated to such technologies is beyond
the budgeting capacity of many cardiology departments.193 By contrast, PET-CT technology has been
incorporated into many oncology practices, where budgets appropriately match the necessity of such
technology.194
PET-CT technology has been most incorporated in oncology practices, in
instances when budgets appropriately match the need.
“Great expectations and the saga of SPECT-CT,” by Greg Freiherr, Diagnostic Imaging, June 25, 2009, www.
diagnosticimaging.com/display/article/113619/1425226?CID=rss (accessed June 29, 2009).

Telemedicine and Imaging: Picture Archives and Communications Systems (PACSs) and
Other Advances in Teleradiology
Teleradiology is the electronic transfer and storage of electronic imaging data. It is the market’s solution
to ensuring a greater number of radiologists in the marketplace (average annual growth in the number
of radiologists in the United States is 1.5 percent to 2 percent) and to increase in the number of images a
radiologist must interpret (between 6 percent and 12 percent). Teleradiology allows for an increased reliance on remote reading of scans, which helps imaging providers by alleviating the off-hour burden that
night reads can cause to radiology groups.195
Other advances in teleradiology technology have allowed for the connection of digital x-rays and
other imaging modalities to picture archives and communications systems (PACSs), which has
greatly improved efficiency of imaging care by providing improved access to images with reduced
delays Many of these systems are derived from infrastructures implemented in hospital radiology departments and have since expanded into a wide area of networks for healthcare systems and managed care
organizations.196
NightHawk Radiology Services, founded in 1993, was the nation’s first company providing night
reads using teleradiology. By November 2006, NightHawk’s market capital value was approximately
$550 million,197 and the company reported significant profits as recently as 2008. By 2009, however,
228

V1-E-Chapter 05.indd 228

9/28/10 3:20 PM

C hap t er 5 : Technol o g y D evel opmen t

NightHawk’s earnings moved from profit to loss, due in part to physician hesitation based on potential
liability and lack of confidence in the telemedicine providers’ competence.198 Additionally, the extensive
licensing and credentialing requirements of physicians who provide services by way of large teleradiology companies provide services across the country further complicates the practice of teleradiology.199
Despite the negative effect of customer attrition in the first quarter of 2009, however, NightHawk and
others maintain that business opportunities continue to grow.200
Companies providing day reads in subspecialty areas are beginning to show market expansion.201
Full-field digital mammography makes telemammography and computer-aided detection possible, increasing facility appeal without additional burden on staff. Furthermore, digital mammography has the
potential to decrease patient anxiety because the technologist can stay in the exam room for the duration
of the screening, and this technology has proven to be useful in imaging dense breast tissue, thereby
improving quality of care.202

Regulatory and Reimbursement
Specifically with regard to PET technology, federal regulations recently were updated to ensure compliance of drug production and manufacturing practices with federal regulations regarding safety and quality of radiologic tracers used in PET procedures. New regulations require all PET production facilities to
comply with the updated requirements effective on December 12, 2011, and include updating standard
operating procedure for manufacturing of all PET drugs and PET drug product and activities related to
quality assurance; facilities; equipment; personnel; and production, process, and laboratory controls.203

Therapeutic Technology
Molecular Pharmacology
Biopharmaceuticals are drugs and biologics that treat an organism through the genetic manipulation of
foreign DNA. Biologics are therapeutic products that are developed using living sources, such as vaccines, blood and blood products, and allergenic extracts and tissues.204 The manufacturing of biopharmaceuticals, most specifically vaccines, monoclonal antibodies, recombinant proteins, and stem cells,
relies heavily on the cell culture market.205 In turn, the necessary in-depth knowledge of cell culture that
fortifies molecular pharmacology was made possible with the advent of the genomic era.
The FDA has approved drugs and biologics in eight categories of biopharmaceuticals: recombinant
blood factors, recombinant thrombolytics and anticoagulants, recombinant hormones, recombinant
growth factors, recombinant interferons and interleukins, recombinant vaccines, monoclonal antibodybased products, and miscellaneous recombinant products.206

Trends in Molecular Pharmacology
Advances in Proteomics
Therapeutic protein technology has seen developments of innumerable implications. Insulin, the first
recombinant protein to be approved, remains the prototype for biopharmaceutical development. It was
among the first biopharmaceuticals to undergo molecular engineering, a process which has since defined development and advancement in biopharmaceuticals.207 Seven faster or time releasing engineered
analogs for insulin have been approved, and with breakthroughs in drug delivery technology, Exubera inhalable recombinant insulin recently became the first biopharmaceutical to receive approval for
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nonparenteral drug delivery (namely pulmonary but also oral, nasal, transmucosal, and transdermal
delivery routes).208 With the incidence of diabetes on the rise, it is probable that the demand and market
for such products will continue to grow. 209
Nucleic Acid-Based (RNAi) Therapeutics
Recent market reports predict RNAi therapeutics to generate sales of approximately $1 billion by 2015.
These biopharmaceuticals show tremendous promise in countless areas, the most notable of which are
Hepatitis C and cancer treatment.210 MicroRNAs are believed to regulate almost one-third of the entire
genome, and they are anticipated to change therapeutic capabilities. “MicroRNAs developed as regulators over millions of years to regulate complex disease. (They) may turn out to be enormously beneficial
in terms of drug discovery.” 211 Though this area of technology has developed at a relatively slow pace,
with fifteen years of research and only two approved products, approval of the first commercial gene
therapy (molecular means of cancer treatment), Genedicine, reset the tone for nucleic acid-based RNAi
drug development.212 Approval of Genedicine by the State Food and Drug Administration of China for
treatment of head and neck squamous cell carcinoma will facilitate further developments in RNAi therapeutics and gene therapy.213

Regulatory and Reimbursement
As of 2006, 165 recombinant proteins, monoclonal antibodies, and nucleic acid-based drugs had been
approved by the United States and Europe as treatments for cancer, diabetes, growth disturbance, hemophilia, and hepatitis. 214 As of 2007, the market size was estimated to be $75 billion, and spending
is expected to continue to increase substantially through 2012.215 Although biopharmaceuticals are
nowhere near the peak of their development, they are already expensive, with some biologics costing
approximately $100,000 per year. Furthermore, research by the American Association of Retired Persons
(AARP) has shown that prices of these biopharmaceuticals are rising at a rate greater than both inflation
and the prices of other prescription drugs.216
The high-priced market for biopharmaceuticals is a result of a disparity in the approval processes
of biologic and nonbiologic drugs. To date, the majority of biologics have been regulated by the Public
Health Service Act, which prohibited generic biopharmaceuticals from being marketed.217 Biopharmaceutical companies require a substantially longer monopoly period to see a return on their investment,
which can lead to higher prices charged for their products.218
A 2008 AARP watchdog report suggests that the wholesale price of specialty drugs rose 8.7 percent
during the course of 2007, while the average market price of those drugs rose 42.9 percent between December 2003 and December 2007. In contrast, nonspecialty branded drugs rose only 7.4 percent, and the
price of generics fell 9.6 percent.219 These inflated prices have not been received well by insurers, many
of which have raised the percentage of medication costs that patients are expected to pay. Some insurers require that their patients use cheaper alternatives before approving the use of an expensive biologic
option.220
Supporting legislation to accelerate the process of developing and approving biosimilars by way
of an FDA process for biosimilar or follow-on generic drug approval could potentially save taxpayers,
insurers, and patients billions of dollars.221 Based on the Congressional Budget Office’s (CBO’s) 2008
estimates, proposed legislation made possible by presidential budget provisions could save the federal
government $6.6 billion in ten years and ensure biotech companies twelve years of market exclusivity
for new drug development.222
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Radiation Therapy
Trends in Radiation Therapy
Much like imaging technology, radiation therapies have been developed, adapted, and improved since
the discovery of the x-ray in 1895.223 Radiation therapy uses high energy light beams or charged particles to stunt the proliferation of cancer cells, which are very susceptible to damage from radiation due
to rapid proliferation and an inability to regenerate.224 However, radiation therapy also has the potential
to damage healthy cells. Most side effects of radiation therapy are short term and are usually confined
to the area being treated. Typically, treatments are administered on an outpatient basis and over the
course of multiple sessions.225 Radiation may be administered alone or simultaneously with chemotherapy either prior to, or in the absence of surgery. Approximately 50 to 60 percent of cancer patients
are treated using radiation at some point during their disease.226 The continuous development of increasingly sophisticated imaging technologies and procedures has resulted in earlier diagnoses and improved
outcomes for patients through radiation therapies.227
Devices
Technology is the leading driver of radiation therapy’s competitive market.228 The development of linear
accelerators and gamma knives has increased therapeutic capability, precision, and ease of use, all of
which enhance the quality of care. These tools are utilized in the various modalities to deliver highly advanced therapy procedures, such as intensity modulated radiation therapy and stereotactic radiosurgery.
In addition to executing treatment plans developed based on imaging scans, image guided radiotherapy
is implemented by one-third of all radiation oncology sites to date, with ultrasound, x-ray, and CT imaging technologies used most frequently.229 As radiation therapy has become one of the dominant methods
of cancer treatment, demand is likely to increase as the population ages.230
Linear Accelerators
The linear accelerator (LINAC) is the device most commonly used in external beam radiation therapy
treatments (see Procedures) for patients with cancer. 231 Linear accelerators deliver uniform doses of
high-energy x-rays to the localized area of a patient’s tumor. LINAC accelerates electrons to allow the
electrons to collide with a heavy metal target, which scatters the high energy x-rays. A portion of these
x-rays are collected and then shaped to form a beam that matches the patient’s tumor. 232 The beam
emanates from a gantry that rotates around the patient. During this process, the patient lies on a movable treatment couch.233 Lasers are utilized to ensure that the patient is properly positioned to receive
the treatment. Radiation can be delivered to the tumor from various angles by rotating the gantry and
the treatment couch. By modifying LINAC systems to include multileaf collimators, they can be used in
intensity modulated radiation therapy.234 However, without the necessary modifications, LINAC systems
simply are machines used for stereotactic radiosurgery.235 A new linear accelerator can cost anywhere
from $1.5 million to $3 million.236
Gamma Knives
Development of the gamma knife revolutionized stereotactic radiosurgery by employing computerized robotic technology to move patients at submillimeter increments during treatment. This maximizes
the procedure’s practical utility, allowing a physician to accurately target safe but high-dose radiation
treatment.237 Gamma knife treatments are administered in a single session and require CT or MRI communication with the gamma knife’s computer planning system to identify targets and normal anatomical
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structures and calculate the gamma knife treatment parameters. The gamma knife can be used for treatment of a variety of health problems, namely malignant and benign brain tumors, blood vessel defects,
and functional problems. Research is currently underway to implement gamma knife technology in
epilepsy and Parkinson’s disease treatments.238
Procedures
External beam radiation therapy (EBT) involves the administration of high-energy x-ray beams to
kill cancer cells and treat tumors.239 Often, some x-ray, ultrasound, or CT imaging is used prior to the
delivery to ensure that the path of the beam will align with the target area.240 Proton therapy is administered in a similar manner, but instead of administering x-ray beams, beams of protons are used to irradiate a variety of tumors, skull base sarcomas, and eye melanomas.241 Alternately, brachytherapy, a form
of internal radiation therapy, is used to treat a smaller area in a shorter period of time, at higher doses of
radiation by placing radiopharmaceuticals directly inside or next to the tumor.242 Brachytherapy can be
temporary or permanent, with variable administration rates and doses. During permanent brachytherapy,
also known as seed implantation, a radioactive seed is placed in or near the tumor where it gradually
decreases in radioactivity over a predetermined period of time. After the seed is rendered inactive, it
remains in the body with no lasting effect on the patient.243
Intensity-Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) is an advanced form of radiation therapy using 3D
imaging and treatment delivery. It differs from 3D conformal radiation therapy (3D CRT), which uses
linear accelerators to administer varying intensities of radiation without IMRT capabilities.244 Alternately, IMRT treatments, custom-tailored using 3D CT images alongside computer generated dose
calculations, most effectively treat the unique three-dimensional shape of a tumor. This method allows
for increased precision in the administration of high dose radiation while preserving the surrounding
tissue.245
A 2004 survey of U.S. radiation oncologists indicated that 73 percent of respondents used IMRT,
compared with 32 percent in 2002. Of those practitioners who had not used IMRT as of the 2002 survey release, 65 percent had begun using IMRT by 2004. Of all survey participants, 81 percent had used
IMRT to enable the administration of high-dose radiation to their patients.246 In recent years, market
studies have shown that EBT has fallen short of IMRT, whose market growth may be attributed to
higher dose capabilities with less damage.247
Stereotactic Radiosurgery
Stereotactic radiosurgery is a nonsurgical procedure involving the single, high-dose delivery of targeted gamma-ray or x-ray beams used to treat different parts of the body. It serves as an increasingly
preferred alternative to invasive surgery for soft tissue tumors (for example, brain tumors).248 Most frequently, stereotactic radiosurgery is administered in one session; however, physicians may recommend
fractionated stereotactic surgery (two to five treatments) or stereotactic radiotherapy (more than five
treatments) in circumstances in which tumors are larger than an inch in diameter. Linear accelerators,
proton beams or heavy-charged particle beams, and gamma knives are all used to perform stereotactic
procedures.249
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Robotics and Surgical Technology
Trends in Robotics and Surgical Technology
Historical Developments in Minimally Invasive Surgery
Laparoscopy, a form of minimally invasive surgery, involves the insertion of a slender, tubular endoscope and other surgical instruments through the abdomen wall, allowing a practitioner direct internal
visual navigation and control of a surgery.250 Laparoscopy and other forms of minimally invasive surgery have evolved from continuous improvements in surgical technology to increase ease-of-use, comfort, and accuracy. In the early 1990s, countless attempts at robotic prototyping were made, namely in
the area of laparoscopic surgical procedures, but nothing materialized.251 The U.S. military, with the intention of designing a prototype to provide remote operative care in combat regions, actually pioneered
the realm of surgical robotics. Introduced by Intuitive Surgical in 1996, this prototype came to be known
as the da Vinci system, and it was approved by the FDA in 2000. Simultaneously, Computer Motion released to the market the first laparoscopic camera holder, which it called Automated Endoscopic System
for Optimal Positioning, or AESOP.252
The da Vinci System Versus Laparoscopy
Minimally invasive procedures lessen many of the risks traditionally associated with surgery through the
use of several small incisions to guide fiber-optic cameras to the area(s) of interest.253 Some minimally
invasive instruments, such as the da Vinci System, employ robotic equipment, which serves as an added
benefit compared to laparoscopic methods due to increases in maneuverability, visibility, and precision.
Laparoscopic techniques project a mirror image onto the screen which has proven to be counterintuitive
for physicians. Robotic technology features digital correction to cater to the physician’s intuitive, natural
tendencies, and thereby increases overall accuracy.254
The da Vinci System revolutionized minimally invasive surgery by overcoming the limitations of
both traditional surgical procedures and conventionally implemented noninvasive laparoscopic technology. The procedure performed with this technology was originally limited to cardiac endoscopy, but
it has expanded to include gastrointestinal, cardiothoracic, gynecologic, urologic, and other specialty
surgical procedures.255 The da Vinci system uses small incisions for the placement of robotic appendages, which result in fewer scars that require less healing time, decrease patient discomfort, shorten postoperative hospital stays, lower hospital costs, and decrease patient morbidity and mortality.256 Further,
effective use of the da Vinci system reduces total operative time while minimizing blood loss.257
The da Vinci System revolutionized minimally invasive surgery by
overcoming the limitations of both traditional surgical procedures and
conventionally implemented noninvasive laparoscopic technology.
“Robotic Surgery,” By Joan Trombetti, DotMed News, January 7, 2009, www.dotmed.com/news/story/7463
(accessed July 6, 2009).

A keynote feature of the da Vinci system is its EndoWrist technology, which allows a surgeon to
fully rotate his or her hand, therefore giving the surgeon the capacity to reach around, beyond, or behind.
The EndoWrist technology provides the surgeon with seven degrees of freedom (that is, the number of
different rotations by the robot “hand”), more than most other surgical robots on the market.258
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A fairly recent sojourn in minimally invasive surgery, robotic-assisted laparoscopic prostatectomy,
combines da Vinci robotics with laparoscopy and “allow[s] for greater surgical precision . . . [leading] to
improvements in cancer control, potency, and urinary function.” The da Vinci system has also been used
to treat small and complex renal tumors.259
Despite its proven benefits in the field, the system has its limitations. Surgeons struggle with the lack
of tactile feedback. This would be remedied by strain sensor feedback, which is under development for
implementation in future models. Additionally, the size and complexity of robotic appendages still limit
the extent to which accurate movement can be controlled.260 Further, the system requires a significant
amount of space—something that many hospitals and facilities cannot spare.261
Demand for Robotic Surgery
Despite the difficulties associated with robotic surgery, minimally invasive technologies are replacing
traditional methods as quickly as the technology will allow. The global market was valued at an estimated $6 billion in 2005; it is expected to reach $18 billion by 2015. Laparoscopic technology represents 25 percent of the market, mainly utilized in abdominal and pelvic procedures, which accounts for
$600 million per year.262
During the past twenty years, the number of general surgical, gastrointestinal, gynecological, neurosurgical, orthopedic, pediatric, radiosurgical, and urological procedures that employ either robotically
assisted or robotically controlled capabilities has grown steadily, most frequently through adoption of
the da Vinci system.263 As of September 2008, 1,032 da Vinci units had been purchased internationally,
776 of which belong to facilities in the United States. In the third quarter of 2008 alone, ninety-one
systems were sold, and Intuitive Surgical observed a 50 percent growth in its revenue to $236 million.
Until recently, the da Vinci system was the only approved system on the market; however, in early 2009,
CUREXO Technology Corporation announced FDA clearance of its robotic orthopedic surgical device,
ROBODOC, for total hip arthroplasty.264
The CBO’s 2007 report, The Long-Term Outlook for Healthcare Spending, predicts that the United
States will see a rise in total healthcare spending from 16 percent of GDP as of March 2007 to 25 percent in 2025, 37 percent in 2050, and 49 percent in 2082.265 These projections are fueled by the perpetual
technological advancement, dynamic availability of the most accelerated technologies, fear of potential
malpractice suits, and efforts to procure economic gain that support the necessary supply factors to perpetuate this inevitable expansion. Diagnostic and therapeutic technologies continue to emerge, replacing
out-dated and risky techniques with less invasive, yet more expensive, alternatives. This ongoing development of new technologies undoubtedly contributes to the role of the United States as the global leader
in healthcare expenditures.266
According to the National Center of Health Statistics, a marked increase of inpatient elderly care has
been seen in the past forty years, and the aging demographic does not suggest that this trend is slowing
down in the near future. In 2006, 38 percent of the inpatient population was older than sixty-five, and 24
percent was older than seventy-five, as compared with 20 percent and 9 percent, respectively, in 1970.267
In addition to the rising costs are the technical demands associated with the accumulating intricacies that make noninvasive procedures desirable. The required skill sets are challenging and demand
extensive training, and improper use of these technologies can be more dangerous than the older alternatives.268 Although the da Vinci system has been used successfully in an array of surgical procedures,
many surgeons remain skeptical of its continued use in the medical profession. For example, researchers
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have found a gradual annual increase in the number of operational robots in the United States (approximately 400), with 25 percent of all cardiac surgical programs having procured a robot and performing
approximately 1,700 robotic or robotically assisted surgeries annually. However, only a handful of
institutions are performing the majority of these surgeries. Due to the excessive start-up and per procedural costs of robotic surgery, as well as the complexity of many procedures, such as cardiac and thoracic surgeries, many institutions do not use the da Vinci robot as much as was expected, often utilizing
it only for less complicated procedures (for example, urological surgery). Although minimally invasive
technology is clearly a potential asset in the future of surgery, it is uncertain at what point and to what
extent robotic surgery will become a regularly feasible procedure for many specialized and intensive
surgical programs.269
A “tortuous learning curve” paired with economic barriers to use necessarily indicate that surgeons
proficient in robotic surgical procedures are scarce; however, surgeons and other medical professionals agree that this is bound to change.270 With time, evolving criteria, perspectives, and credentials will
foster a new “breed” of surgeons, trained to take full advantage of the benefits that robotic, noninvasive
procedures provide.271 Upon approving the da Vinci robot for cardiac procedures, the FDA mandated
training of all surgical teams and professionals intending to use the product.272 Surgeons who have
pioneered the infusion of robotic technology into their programs believe that success is imminent with
the right team; dedication to administrative and clinical commitment; a properly devised curriculum
targeted at surgeons, their teams, and other members of their departments; multispecialty training; and
patience.273 As more institutions and surgical teams follow in their footsteps, a new tier of surgical competition will lead to different expectations in medical care.

Regulatory and Reimbursement
Although each insurance company differs in what procedures it reimburses, Medicare covers all laparoscopic and thorascopic procedures.274 Currently, reimbursement for procedures that use robotic technologies is limited to the agreed-upon reimbursement for the baseline procedure.275 However, as more studies
show that noninvasive cardiac technology is improving patient outcome metrics, and policymakers move
toward incentive-based programs that improve the quality of robotically assisted procedures, robotic
procedures may procure higher reimbursement.276

Home Health Technology
Home care patients represented approximately 2.5 percent of the U.S. population as of July 1, 2000.277
In 2006, 2.9 million people reportedly used home health services, an increase from 2.6 and 2.8 million
in 2003 and 2004, respectively.278 Additionally, the growing segment of older Americans will invariably
contribute to the increased use of home infusion therapies. Although the Bureau of Health Professions
predicted in 2006 that, between 2000 and 2020, the U.S. population would increase by 18 percent, the
number of Americans aged sixty-five and older is anticipated to reach 54 million (a 54 percent increase),
accounting for 16 percent of the total population.279 Approximately 69 percent of those receiving home
care services are older than age sixty-five.280 In addition, the growing baby boomer population will continue to inflate the number of candidates for home health care when they become eligible for Medicare
beginning in 2011.281
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Trends in Home Infusion Therapy
Infusion therapy, growing in popularity, involves the administration of medications, nutrients, or other
solutions intravenously, subcutaneously, enterally, or epidurally (into the bloodstream, under the
skin, into the digestive system, or into the membranes surrounding the spinal cord). Specific home infusion therapies include anti-infectives, chemotherapy, pain management, parenteral and enteral nutrition, hydration therapy, and immunotherapy.282 By 2030, it is expected that approximately 20 percent
of Americans will be older than the age of sixty-five, which will lead to an increase in the demand for
home- and community-based services.283 One of the most common services received at home is infusion
therapy, with about 4,000 regional providers reported in 2005.284
The implementation in 1983 of the Prospective Payment System (PPS) for inpatient hospital services
with its diagnosis-related group (DRG) payment system touched off a number of dramatic changes in
the healthcare field (see chapter 2, Facility-Based Reimbursement Rates for further discussion of the
PPS and DRG payment system). These changes affected not only inpatient hospital care but also virtually every aspect of the U.S. healthcare delivery system. As a result of the DRG payment methodology,
traditional indicators of inpatient hospital utilization showed substantial changes. Between 1980 and
1990, the number of hospitals and hospital beds declined, admissions and average daily census fell, and
average length of stay decreased. Combined, these indicators of inpatient utilization pointed the way to a
dramatic shift in the way healthcare services would be delivered. The types of services provided, as well
as the location of service delivery, began to shift from the inpatient to the outpatient setting. As length of
stay for Medicare patients shortened in the early 1980s, the percentage of Medicare patients discharged
to home health increased from 9.1 percent in 1981 to 17.9 percent in 1985.285
The decrease of traditional inpatient utilization led to a virtual explosion of healthcare services in
other areas, both on the hospital campus as well as in freestanding facilities located in the community.
However, the location of service delivery also moved into the most convenient location possible—the
patient’s home.286 This change in service delivery location significantly altered beneficiary access to
care. As of 2008, approximately 99 percent of beneficiaries were located in an area for which at least one
home health agency provided service, and 97 percent had access to services provided by two or more
home health agencies.287 Despite adequate patient access to home health services, the number of providers continues to grow, exceeding the growth rate in Medicare enrollees.288 As of 2007, there existed more
than 9,200 active home health agencies that participated in the Medicare payments program for home
health care.289
The home infusion therapy market is comprised of approximately 3,000 to 4,000 national, regional,
and local providers, with the majority operating primarily in either local or regional markets. Specifically, approximately one third are local or individually owned businesses, another third are hospitalbased providers, and the remaining third are national providers.290

Regulatory and Reimbursement
Medicare remains the largest single payor of home healthcare services, paying for 37 percent of all home
health expenditures in 2006, although private insurance represented a small portion of home health
payments. “Out-of-pocket” spending growth decreased from 5.2 percent in 2005 to 3.8 percent in 2006,
largely due to the introduction of Medicare Part D.291 In fact, total out-of-pocket spending declined from
14 percent in 2001292 to 10 percent in 2006.293 However, it is estimated that the rate of out-of-pocket
expenditures will increase to 6 percent by 2017. This would bring parity to the ratio of out-of-pocket
spending to private health insurance spending.294
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Although Medicare Part D covers both the ingredient costs and dispensing fees associated with home
infusion therapy, it excludes any costs associated with equipment, supplies, and professional services.295
Due to regulatory actions in 2008, home health reimbursement was cut 2.5 percent, and an anticipated
12 percent cut in spending is projected through 2012.296
Industry stakeholders and proponents of home infusion therapy continue to work with CMS to
improve coverage and payment policies.297 Pharmacy experts claim that infusion therapy is a less risky
market for reimbursement changes than other home healthcare services.298 According to a 2008 “Market
Watch: Home Infusion Therapy and Specialty Pharmacy Services” industry report published by The
Braff Group, reimbursement for home infusion therapy is expected to remain relatively stable, despite
the projected decreases in durable medical equipment and home health agency reimbursement.299
Despite the relatively stable reimbursement environment, numerous attempts have been made by
both the House of Representatives and the Senate to pass legislation for the reimbursement of equipment, supplies, and professional services. Senators proposed bills in 2007 and 2008 (S 870 and S 3505,
respectively) that were not passed.300 Additionally, in 2006 and 2007, the House of Representatives
unsuccessfully proposed HR 5791 and HR 2567.301
On January 15, 2009, Eliot Engel (D-NY) proposed The Medicare Home Infusion Therapy Coverage
Act of 2009 (HR 574). The bill proposed that Part D coverage of home infusion services include equipment, supplies, and professional services.302 Experts harbor mixed opinions on the fate of this bill based
on the current administration’s overburdened agenda, even though this economic justifications fare in
favor of passing the bill, which was still in the House Ways and Means Committee as of March 2010.303

Conclusion
Over the course of human history, healthcare trends have been driven by advances in our medical capabilities, which are largely dependent on our technological progress. With the current market demand for
both chronic and acute services undergoing continuous growth, available technologies, as well as future
technological developments, will augment the healthcare practice with the clinical and administrative
tools necessary to provide efficient, effective, and affordable healthcare services.
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6

Healthcare Reform:
Past as Prologue to
the Future
Everybody knows that the dice are loaded
Everybody rolls with their fingers crossed
Everybody knows that the war is over
Everybody knows the good guys lost
Everybody knows the fight was fixed
The poor stay poor, the rich get rich
That’s how it goes
Everybody knows
Everybody knows that the boat is leaking
Everybody knows that the captain lied
Everybody got this broken feeling
Like their father or their dog just died
Everybody talking to their pockets
Everybody wants a box of chocolates
And a long stem rose
Everybody knows
Leonard Cohen
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Overview
Motivated by the current economic conditions, trends in the reimbursement, regulatory, competitive, and
technology aspects of the healthcare environment have facilitated the emergence of a historical reform
initiative. As this Guide goes to press, sweeping changes in federal healthcare policy have been enacted,
following months of partisan controversy, political drama, and often rancorous debates. The Patient
Protection and Affordable Care Act, HR 3590, was signed into law on March 23, 2010, and one week
later, President Barack Obama signed the Health Care and Education Reconciliation Act of 2010, HR
4872, into law. As singular and perhaps as chaotic as these events may seem to have been, they may not
be unexpected within the context of the history of healthcare reform efforts.

A Historical Perspective on Healthcare Reform
Political and legislative initiatives related to U.S. healthcare reform date back to the early 1900s. President Theodore Roosevelt and the Progressive movement were among the first major political parties to
endorse the idea of health insurance, and President Franklin D. Roosevelt (FDR) continued to support
efforts for national health reform, mainly with the Social Security Act, which was passed by the United
States Congress in 1935. Healthcare reform efforts continued through the late 1930s and early to mid1940s with the establishment of the Department of Health and Human Services (HHS) in 1939 and other
national efforts to support a national health insurance plan. Early healthcare reform efforts also faced
significant opposition, however. Following his election to a full term, President Harry S. Truman attempted to pass FDR’s healthcare reform program, but it was defeated as a result of strong opposition
from the American Medical Association (AMA) and the American Hospital Association (AHA), the
latter which equated national health insurance to communism.1
Healthcare reform reached a major milestone with the creation of the Medicare and Medicaid programs, which President Lyndon B. Johnson signed into law in 1965. However, as growing healthcare
expenditures began to raise concern throughout the 1970s, cost-containment efforts replaced national
healthcare coverage initiatives as the main focus of lawmakers. This emphasis on cost savings and the
corresponding lack of support for healthcare reform initiatives continued through President William
J. Clinton’s administration. His healthcare reform initiatives, led by First Lady Hilary Clinton and Ira
Magaziner, ultimately failed to garner adequate support for passage of the Health Security Act of 1993.2
The 2010 healthcare reform legislation marks the beginning of a new era in the long history of
healthcare reform. The 2010 healthcare reform will substantially affect many, if not all, aspects of the
delivery of healthcare in the United States by affecting healthcare providers, insurers, employers, and
individual citizens.
Figure 6-1 provides an overview of key historical healthcare reform events that paved the way for
the current 2010 healthcare reform legislation.
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Teddy Roosevelt and
Progressive Party
endorse social insurance
as part of their platform.

1912
1930 – 1934

1937

President Roosevelt continued to
support national health reform
throughout his terms. His second
push for national health insurance
came after the Social Security Act
passed. However, the momentum
from FDR’s Technical Committee
on Medical Care and a National
Health Conference were not
enough to overcome a Congress
that was no longer supportive of
further government expansions.

National Health Survey conducted
under the auspices of the U.S.
Public Health Service to assess
the nation’s health and the
underlying social and economic
factors affecting health.

1935

1935 – 1936
1939

Department of Health and Human
Services born as the Federal
Security Agency bringing together
federal agencies concerned with
health, welfare, and social
insurance.

Sen. Wagner introduces National
Health Bill incorporating
recommendations from the
National Health Conference.
Proposal dies in committee.

1938

1943
1944

1945 – 1949

1951

1952

1953

1956

AFL-CIO decides
to support
government health
insurance, while
the AMA reiterates
opposition to
national health
insurance.

1957

First year that the
National Health
Interview Survey
was conducted;
survey has been
continuously
fielded ever since.

Legislation introduced in
the House (the Forand
bill) to provide health
insurance for social
security beneficiaries;
reintroduced again in
1959.

1954

Federal Security Agency made a
cabinet level agency, renamed
Department of Health Education
and Welfare (DHEW).

Federal Security Agency proposes
enactment of health insurance for
Social Security beneficiaries.

Joint Commission on the
Accreditation of Hospitals
(JCAH) formed to improve the
quality of hospital care through
the voluntary accreditation of
hospitals.

National Conference on Aging is
convened by Federal Security
Agency.

1950

Military “medicare”
program enacted,
providing government
health insurance for
dependents of those in
in the Armed Forces.

Revenue Act of 1954 excludes
employers’ contributions to
employee’s health plans from
taxable income.

President Truman picked up the mantle for a
national health program just months after the end of
World War II. His election in 1948 appeared to be a
mandate for national health insurance, but the
opposition, using fear of socialism, coupled with the
power of southern Democrats who believed a
federal role in health care might require
desegregation, effectively blocked all proposals.

Senators Wagner and Murray,
along with Representative Dingell
introduce legislation as part of
broader vision to operate health
insurance as part of social
security.

War Labor Board rules wage
freeze does not apply to fringe
benefits, including health
insurance benefits.

FDR outlines ‘economic bill of
rights.

Social Security Board calls for
compulsory national health
insurance as part of the Social
Security system.

Physicians start to organize the
first Blue Shield plans to cover the
costs of physician care.

National Health
Conference
convened in
Washington, D.C.

Technical Committee on Medical
Care established under
Interdepartmental Committee to
Coordinate Health and Welfare
Activities; publishes its report, A
National Health Program in 1938.

FDR forms Interdepartmental
Committee to Coordinate Health
and Welfare Activities.

1930 – 1934

Baylor Hospital introduces a prepaid hospital insurance plan for a
group of school teachers.

1927

1929

Committee on
the Costs of
Medical Care
forms to study
the economic
organization of
medical care.

Women reformers persuade
Congress to pass the SheppardTowner Act.

1915

1921

The All American
Association for Labor
Legislation publishes
a draft bill for
compulsory health
insurance.

National Convention of Insurance
Commissions develops first model of state
law for regulating health insurance.

Hard economic times called for social policies
to secure employment, retirement, and
medical care. President Roosevelt appointed a
committee to work on all these issues, but in
the end did not risk the passage of the Social
Security Act to advance national health
reform.

Figure 6-1: Healthcare Reform Historical Timeline—1912–1957
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1980

1981

1982

Emergency Medical Treatment
and Active Labor Act (EMTALA)
requires hospitals participating in
Medicare to screen and stabilize
all persons who use their
emergency rooms regardless of
ability to pay.

1983

1986

Federal budget
reconciliation (OBRA
86) gives states Medicaid
option to cover infants,
young children and
pregnant women up to
100% of the poverty
level.

States allowed to expand Medicaid to children
with disabilities who require institutional care but
can be cared for at home and would not
otherwise qualify for Medicaid if not
institutionalized; popularly referred to as the
Katie Beckett option for the disabled child who
garnered national attention on the issue.

In the face of stagflation and rapidly rising health costs, President
Carter prioritizes health care cost containment over expanding
coverage. Sen. Kennedy, however, drafts another national health
insurance proposal, which is then followed by Carter’s own plan that
would delay implementation until 1983. National health reform efforts
were completely stalled in the face of an economic recession and
uncontrollable health care costs.

1970 – 1974

1975 – 1979

1990 – 1994

Medicare Catastrophic
Coverage Act (MCCA)
expands Medicare coverage to
include prescription drugs and
a cap on beneficiaries’ out-ofpocket expenses.

Federal budget
reconciliation (OBRA
89) mandates
coverage for pregnant
women and children
under age 6.

1988

2003

• Maine passes the Dirigo Health Reform Act
• Medicare Drug, Improvement, and
Modernization Act
• Medicare legislation creates Health Savings
Accounts

President Bush launches
Health Center Growth
Initiative.

2000

2002

2007

2009

• President Obama establishes Office of Health
Reform
• The Children’s Health Insurance Program (CHIP) is
reauthorized
• The American Reinvestment and Recovery Act
(ARRA) makes substantial investments
• White House holds a Health Reform Summit with
key stakeholders
• President Obama releases FY 2010 budget

• Medicare Part D Drug benefit
goes into effect in January
• Massachusetts passes and
implements legislation to provide
health care coverage to nearly all
state residents.
• Vermont passes comprehensive
health care reform also aiming for
near-universal coverage.
• City of San Francisco creates the
Healthy San Francisco program

2006
2008

Mental Health
Parity Act
amended to require
full parity.

• Senators Wyden and Bennett
introduce the Healthy
Americans Act.
• Congress passes two versions
of a bill to reauthorize the State
Children’s Health Insurance
Program, but President Bush
vetoes both bills

2005

Deficit Reduction
Act of 2005

Breast and
Cervical Cancer
Treatment and
Prevention Act of
2000.

1999

Ticket to Work and Work
Incentives Improvement Act
of 1999.

Balanced Budget Act.

1996

1997

• Health Insurance
Portability and
Accountability Act
(HIPAA)
• Personal Responsibility
and Work Opportunity Act
• Mental Health Parity Act

Making national health reform a priority early in his Presidency, President
Clinton proposed a “managed competition” approach, sending a detailed
plan to Congress in 1993. It called for universal coverage, employer and
individual mandates, competition between insurers, with government
regulation to control costs. Support from key stakeholders was often limited
and conditional. The opposition was led largely by two groups: the Health
Insurance Association of America and the National Federation of
Independent Businesses, both believing reform would create hardship for
their smaller members. Congressional Democrats were divided in their
support, and further splintered by a variety of alternative proposals that were
then generated all of which blocked progress on the President’s plan.

The Family
Support Act
requires states to
extend 12 months
of transitional
Medicaid coverage
to families leaving
welfare due to
earnings from
work.

Emergency Medical
Treatment and Active Labor
Act (EMTALA) requires
hospitals participating in
Medicare to screen and
stabilize all persons who use
their emergency rooms
regardless of ability to pay.

Medicare introduces Diagnostic
Related Groups (DRGs) as a
prospective payment system for
hospital payment.

Federal budget reconciliation
(OBRA 81) requires states to
make additional Medicaid
payments to hospitals who serve a
disproportionate share of
Medicaid and low-income patients.

Department of Health,
Education, and Welfare
renamed the Department of
Health and Human Services
(DHHS).

Medicare and Medicaid were incorporated under the Social Security
Act and signed by President Johnson in 1965 with Truman by his side.
The combination of Johnson’s political skills, a large Congressional
Democratic majority, public approval, the support of the hospital and
insurance industries, and the fact that no government cost controls or
physician fee schedules were enacted contributed to the passage of
the most significant health reform of the century.

1960 – 1964

1965 – 1969

The groundwork for the enactment of
Medicare and Medicaid began in the late
1950s and early 1960s. As employer-based
health coverage grew, private plans began to
set premiums based on their experience with
health costs and the retired and disabled found
it harder to get affordable coverage. Health
reformers refocused their efforts toward the
elderly.

General inflation and unchecked health care costs were a growing
concern by the early 1970s. Sen. Kennedy’s proposal for national
health insurance was countered by President Nixon’s own
Comprehensive Health Insurance Plan (CHIP). Other Congressmen
wrote more incremental plans, all of which splintered support for any
one reform. Action on national health insurance was eventually
overshadowed by the Watergate hearings and President Nixon’s
resignation. While President Ford supported national reform in 1974
and Rep. Mills drafted yet another compromise bill, its progress
stalled without Mills’ leadership following a personal scandal.

Figure 6-1: Healthcare Reform Historical Timeline—1960–2009
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What Is Driving Healthcare Reform?
Exploding Time Bomb: Changing Patient Population
Demographic
As mentioned throughout this Guide, the changing patient population demographic is one of the major
factors driving healthcare reform. The changing age and ethnic distribution of the population substantially affects the demand for healthcare reform, and the projected growth of the U.S. elderly population
plays an important role in the anticipated demand for healthcare services. Based on the 2000 census, the
population age sixty-five and older has been projected to grow from an estimated 39.4 million in 2010 to
53.2 million in 2010, an increase from 13.2 percent to 16.5 percent of the total population.3 Additionally,
the elderly population typically has a greater per capita use of healthcare services.4
The ethnicity of the U.S. patient population is also changing, with the 2000 census figures indicating
an increasing degree of racial and ethnic diversity.5 As the minority population increases, the demand for
the services tailored to this population may also increase.6 It is estimated that by 2020, physician patientcare hours devoted to minority patients will have increased to 40 percent from an estimated 31 percent
in 2000.7 The healthcare delivery system will need to identify disparities in access to care and differences in culture that impact the provision of care in order to adjust the availability of healthcare workers
adequately trained to meet the healthcare needs of this growing segment of the U.S. population.8

Healthcare Expenditures
Rising healthcare expenditures as a percentage of gross domestic product (GDP) also significantly drove
healthcare reform efforts. In 2009, total national health expenditures (NHE) in the United States grew
to $2.5 trillion, a 5.7 percent increase from 2008.9 Concurrently, the nation’s GDP shrank by 1.1 percent, and as a result, NHE increased from 16.2 percent to 17.3 percent of the GDP—the largest one-year
increase in history.10 NHEs are predicted to continue to rise substantially in the next few years. A March
2010 study in Health Affairs estimated that NHE would increase from $2,569.6 billion in 2010 (comprising 17.3 percent of the GDP in 2010) to $4,482.7 billion in 2019 (comprising 19.3 percent of the
GDP).11 A 2009 study published in Health Affairs found that the rise in medical prices most greatly contributes to the rise in expenditures for personal healthcare, which represents a large proportion of NHE.12
Despite a growing demand for healthcare services, the patient population continues to experience
a financial strain to afford healthcare, with out-of-pocket spending for healthcare services rising faster
than the typical household income from 2001–04.13 From 2001–06, the number of Americans indicating
high financial burdens due to healthcare spending increased by approximately 1 percent a year, rising
from 16.4 percent to 19.1 percent from 2004–06 alone.14

Increased Scrutiny of Fraud and Abuse
In addition to the goals for increased and affordable healthcare coverage, the 2010 healthcare reform
legislation also responds to concerns related to fraud and abuse in the healthcare system. The legislation
includes significant initiatives aimed at reducing fraud and increasing transparency in the Medicare and
Medicaid programs, through such efforts as implementing transparency requirements for pharmaceutical and medical device manufacturers and amending various federal enforcement tools, including the
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federal antikickback statute (AKS), the False Claims Act (FCA), and the federal physician self-referral
law (Stark law).15
The healthcare reform legislation incorporates the Sunshine Act by requiring extensive reporting and
public disclosure of financial arrangements between certain provider customers and manufacturers of
drugs, medical devices, medical supplies, and biologics.16 This disclosure is intended to encourage voluntary avoidance of conflicts of interest that potentially can jeopardize the quality, integrity, and safety
of clinical care, biomedical and academic research, and medical education, as well as lead to violations
of federal fraud and abuse regulations.17
In addition to the new transparency and disclosure requirements, the healthcare reform legislation
also amends various fraud and abuse enforcement activities. One new requirement is that overpayments
made by Medicare or Medicaid must be reported within sixty days after the date the recipient identified
the overpayment. The requirement further states that failure to make a timely repayment gives rise to
liability under the FCA.18
The healthcare reform legislation also makes two changes to the intent standards relating to fraud
and abuse. First, the legislation amends the AKS by stating that a person need not have actual knowledge of or specific intent to commit a violation of the statute for the government to prove a kickback violation.19 Secondly, the healthcare reform provides that “a claim that includes items or services resulting
from a violation (of the AKS) constitutes a false or fraudulent claim for purposes,” of the FCA, which
results in a law that any violation of the AKS is sufficient to state a claim under the FCA.20
The new legislation also significantly changes the FCA by eliminating the jurisdictional bar for allegations based on publicly disclosed information and by relaxing the requirements for a qui tam action to
be eligible as an “original source.”21 These changes have the potential to increase providers’ FCA exposure by allowing for a greater number of whistleblowers to bring a claim.22 Alternatively, the healthcare
reform legislation also requires the secretary of HHS to set up a Stark law self-referral disclosure protocol, which will permit HHS to receive payment lower than the full Stark law measure of damages in
appropriate circumstances, an initiative which will potentially provide considerable monetary relief for
certain providers.23

Healthcare Provider Manpower: Supply and Demand
As discussed in several other sections in this Guide, recent reports have indicated that the United States
will face a growing physician manpower shortage, especially in primary care. This trend is driven by
several factors, including the longer life expectancy of the aging baby boomer population, which typically utilizes a greater proportion of healthcare services than the nonelderly population.24 Additionally,
the number of practicing physicians in the United States is predicted to remain fairly stagnant during the
next decade due to physician lifestyle changes, which have resulted in a reduction of the total number
of work hours, and retirement of current physicians (approximately 99,000 of which were older than
age sixty-five in 2008).25 In its November 2008 report, the Association of American Medical Colleges
(AAMC) indicated that solving the predicted physician shortage would not only depend on training
more physicians but also on reconfiguring healthcare delivery and increasing efficiency.26
The 2010 healthcare legislation responds to this projected shortage in physician manpower by (1) increasing the number of graduate medical education training positions; (2) giving priority to primary care
and general surgery fields and to those states with the lowest resident physician-to-patient population;
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(3) increasing workforce supply and support by providing health professionals with training-related
scholarships and loans; (4) promoting training in the areas of preventive medicine and public health; (5)
increasing the capacity for nurse education, the support for nurse training programs, and the number of
loan repayment and retention grants; (6) creating a career ladder to nursing; and (7) establishing a Prevention and Public Health Fund for prevention, wellness, and public health activities.27

Restructuring Reimbursement
The continuing controversy regarding physician reimbursement levels and the sustainable growth rate
(SGR) formula for determining the annual conversion factor (CF) under the Medicare physician fee
schedule are partial drivers of the efforts that have supported the progression of healthcare reform initiatives under the Obama administration. At the same time, the movement from a capitated fee reimbursement system to a fee-for-service (FFS) and managed care payment system has facilitated an increase in
NHE. This growth in NHE during the past several years has prompted recent efforts to downshift reimbursement for physician services (for example, by way of bundled payments) in an effort designed to
contain healthcare costs.

Repeal of the Sustainable Growth Rate (SGR)
The SGR method replaced the Medicare Volume Performance Standard (MVPS) provision in 1997 to
provide annual target updates to the physician fee schedule for Medicare Part B. The SGR formula is
designed to control aggregate growth in Medicare expenditures by raising or lowering the proposed payment target to reflect actual cumulative expenditures.28 The calculation of SGR relies upon four factors,
according to the Centers for Medicare & Medicaid Services (CMS):
1. “The estimated percentage change in fees for physicians’ services;
2. The estimated percentage change in the average number of Medicare fee-for-service
beneficiaries;
3. The estimated 10-year average annual percentage change in real GDP per capita; and,
4. The estimated percentage change in expenditures due to changes in law or regulations.”29
The purpose of instituting the SGR formula was two-fold: (1) to ensure patient access to physician
services; and, (2) to predictably control federal spending on Medicare part B.30 Since its enactment,
actual Medicare expenditures remained below target expenditures through 2001. Thus, the updates to
the physician fee schedule were close to the Medicare economic index (MEI), and for two consecutive
years, 2000 and 2001, the actual physician fee schedule update was more than twice the MEI.31 However, every year since 2002, actual expenditures have exceeded target expenditures, with a 65 percent increase in per-beneficiary expenditures on Medicare services between 1997 and 2005.32 Because of actual
expenditures exceeding target expenditures, the SGR formula dictated a reduction in the fee schedule.33
Despite this, Congressional action to suspend the impending cuts to payments for physician services
every year since 2003 has resulted in a widening gap between the cumulative spending and cumulative
target each year the proposed cuts were overridden.34 Table 6-1 illustrates the proposed and actual physician fee schedule conversion factor (CF) updates for the years 1997 through 2010.
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According to estimates by the CBO, under the current
SGR mechanism, the cumulative gap between target and
actual expenditures will continue to grow, perhaps increasing to a peak deficit of approximately 40 percent, until 2014,
when it is predicted that actual spending will dip below
target levels once again.35

Table 6-1: Proposed and Actual Annual Updates to the Physician Fee Schedule
Conversion Factor, 1997–2010*

Current Congressional Status
Regarding the SGR: Fix or Repeal
The 2010 healthcare reform bill did not contain language to
permanently repeal or change the SGR formula. However,
on November 19, 2009, the U.S. House of Representatives
passed a bill by a vote of 243 to 183, which would permanently repeal the SGR, replacing it with a framework that
would update the Medicare physician payment schedule by
GDP + 2 for evaluation and management services, and GDP
+ 1 for other services.36 In anticipation of the Senate vote on
this legislation, Congress temporarily postponed the 2010
cut, originally set to take effect on January 31, 2010. Upon
reconvening on April 12, 2010, the Senate decided to temporarily fix the planned 21.3 percent Medicare physician fee
cut by delaying implementation of the SGR formula until
June 1, 2010.37

Year

Formula Update

Conversion
Factor Update

1997

2.0%

0.6%

1998

2.2%

2.3%

1999

2.3%

2.3%

2000

2.4%

5.5%

2001

2.1%

5.0%

2002

–4.8%

-4.8%

2003

–4.4%

1.7%

2004

–4.5%

1.5%

2005

–3.3%

1.5%

2006

–4.4%

0.2%

2007

–5.0%

0.0%

2008

–10.1%

0.5%

2009

–15.1%

1.1%

2010

–21.3%

2.2%

*	“Estimated Sustainable Growth Rate and Conversion Factor, for
Medicare Payments to Physicians in 2010” Centers for Medicare &
Medicaid Services, November 2009, p. 7.

On May 20, 2010, text of the “American Jobs and Closing Tax Loopholes Act of 2010” was introduced by Congress. On May 28, 2010, the House of Representatives chose to separate the text regarding
the postponement of the Medicare physician payment cut from the remainder of the bill text and subsequently approved the physician payment legislation by a vote of 245 to 171. While this bill would not repeal the SGR, it would delay the scheduled June 1, 2010 cut to physician payment rates under Medicare
until 2012, providing a 2.2% increase to rates from June 1 to December 31, 2010, and a 1% increase for
2011, with the rate for 2012 to be, once again, determined depending on a targeted growth rate.38
To avoid disruption in the delivery of health care services to beneficiaries and payment of claims
for physicians, on May 27, 2010, CMS directed its contractors to hold claims for services paid under
the MPFS for the first 10 business days of June (i.e., through June 14, 2010).39 This hold only applied
to MPFS claims with dates of service of June 1, 2010, and later. With the expectation of Congressional
action in the near future, CMS extended this hold and directed its contractors to continue to hold June 1,
2010 and later claims through Thursday, June 17, 2010, with the plan to lift the hold on Friday, June 18,
2010.40
Yet, with an agreement not yet reached, and the expiration of CMS’s hold rapidly approaching, on
Wednesday, June 16, 2010, the proposed nineteen month fee fix was reduced to seven months in an attempt to gain the 60 percent supermajority needed to pass the legislation. However, even after shaving
off twelve months, the “test vote” on the measure failed to pass, with every Republican and twelve Democrats voting against the bill, in a 52-45 vote.41 Forced to restart the process, Democrats gave doctors
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even shorter relief from the impending one-fifth Medicare cuts in their payments, by giving doctors only
a 6 month reprieve in the looming cuts, and only increasing the physician reimbursement rate by 2.2%
through November 30, 2010.42
Late Thursday night, June 17, 2010, the Senate reached a deal and passed a short-term six month
physician pay cut, blocking the 21 percent reimbursement cut scheduled to go into effect on June 18,
2010, after making the physician fee fix a separate provision from the larger H.R. 4213.43 This update
came after failing earlier Thursday to pass the entire H.R. 4213, which not only would have provided
the physician payment relief, but also included provisions to extend tax and jobless benefits.44 With
Senate approval, the newly crafted compromise bill returned to the House, but the House was unable
to consider the measure before Monday, as they had already broken for the weekend.45 The House was
expected to pass the bill quickly, since in May, they approved a more expansive version of the bill that
stayed the physician fee cuts until 2012. However, because House Democrats were seeking to pass a
longer-term fix for the payment, they did not approve the bill until Thursday June 25, 2010, forced to
concede to the $6.5 billion, six-month stand-alone physician fix as a compromise.46
The House’s passage and enactment of the Senate’s bill reversed the 21.3 percent cut to Medicare
physician payments that had been in effect since the previous Friday, affecting all claims submitted and
processed after June 1, 2010, and it provided the expected 2.2 percent increase for claims dated from
June 1, 2010 to November 30, 2010.47 On Friday, June 26, 2010, President Obama signed into law The
Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act. Once the bill became
law, CMS directed its contractors to begin processing the physician and provider claims at the new increased rate.48
President Obama has pushed for an extension of the payment freeze until the end of the year,49 while
others, including the American Medical Association, have pushed for a permanent repeal. The Congressional Budget Office has estimated, however, that permanently fixing the Sustainable Growth Rate
formula, will cost $276 billion over the next decade, which is a thirty three percent increase from the
initial estimation of $207 billion.50 This projected cost of a permanent repeal has been a major issue for
Congress, which has in turn resulted in Congress choosing to postpone the date and shorten the length of
the cut.
Meanwhile, during the debate about fixing the Sustainable Growth Rate, the uncertainty about the
SGR’s future has significant present day implications. With forty-five million Americans counting on
Medicare, physicians face substantial difficulty maintaining viable practices in an environment with
such extreme financial uncertainty. Increasing numbers of doctors are simply choosing to cease accepting Medicare patients altogether,51 and the uncertainty from one month to the next ultimately threatens
patients’ access to care by undermining the ability of physicians to plan for the future.

Downshifting Reimbursement
As Medicare reimbursement has remained stagnant or has decreased for the professional component of
healthcare reimbursement since the 1990s, physicians have looked to the ancillary services and technical component (ASTC) revenue stream to supplement their income, by way of ownership investment in
ambulatory surgical centers, independent diagnostic testing facilities, and specialty or surgical hospitals.
However, legislative and regulatory opposition at the federal and state levels to limit physician ownership of or investment in ASTC revenue stream enterprises have served to restrict physicians in private
practice to receiving only professional fee component revenues. This is viewed by some as relegating
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physicians to the status of “sharecroppers” or “hired help” or compelling many physicians to acquiesce
by accepting employee status under the substantial control of hospital systems or large corporate players.
The reduction in reimbursement levels for physicians may have had more widespread effects than
adversely affecting physician revenue and income levels. An article published in the Journal of the
American Medical Association in February 2010 found that a sample of more than 40,000 physicians
reported that their hours worked have decreased an average of 7.2 percent from the periods 1996–98
through 2006–08 (from an average of 54.9 to 51 hours per week).52 Additionally, the authors found that
inflation-adjusted physician fees had decreased by approximately 25 percent between 1996 and 2006,
which coincided with the decrease in physician hours worked, suggesting that the decrease in physician
work hours may have been partially a result of decreasing incentives due to reduced levels of reimbursement.53 This trend has also become a concern to health workforce analysts, who predict an impending
physician shortage.54
The continuing two-pronged attack on niche providers pertains to both specialty physicians and physician owners of practices and specialty hospitals. It includes (1) increasing the reduction of reimbursement yield, most notably for traditionally high-reimbursement yield specialty procedures (for example,
echocardiography, nuclear imaging, etc.); and (2) the continued attack on physicians sharing in the
ownership of the ASTC revenue stream, as evidenced by the provisions restricting physician ownership
of specialty hospitals in the 2010 healthcare reform legislation.
As revenue streams available to physicians are limited by these changes, current trends, such as the
rise of hospital acquisitions of physician practices and employment of physicians, especially for more
profitable specialties that are well-suited to provide services in a hospital-based setting (for example,
cardiology, orthopedics, radiology, etc.), are likely to continue.
Experts predict that competitive pressure, as well as newly adopted and pending revenue cycle
management regulations, will force providers to assess their revenue cycle management systems. This
assessment will likely result in providers making system upgrades and purchasing new systems during
the next several years.55 Providers with older revenue cycle management systems could possibly upgrade
these systems to improve patient satisfaction and convenience and also to more efficiently manage their
revenue cycle.56 Patient satisfaction, convenience, and increased efficiency may result from a patient’s
ability to pre-register, schedule, and pay for his or her services through the provider’s website, among
other things.57 Furthermore, providers will likely benefit from new systems that improve efficiency by
easily checking payors’ rules to ensure that the services to be performed are covered, automatically
creating bills from patients’ electronic medical records, bypassing clearinghouses and submitting claims
directly to payors, enabling providers to receive electronic funds transferred directly from payors to the
provider’s bank, and allowing providers to integrate their financial and clinical data.58 Nonetheless, the
significant changes to the reimbursement landscape lay an unsteady and uncertain foundation for the
future of reimbursement for providers.

Bundling Payments
Bundling is a method of reimbursement that combines institutional and professional charges into a single
payment.59 Recently, legislators have advanced several proposals to reduce Medicare costs. The proposals employ various methods of bundling payments to hospitals and physicians for services provided
during the course of a patient’s treatment plan. The Senate Finance Committee’s “Proposals to Improve
Patient Care and Reduce Health Care Costs,” demonstrated this trend in a plan to use the bundling of
payments for inpatient and post-discharge care.60
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Proponents of bundled payments argue that the move toward bundled payments could provide higher
coordination between providers and more efficient levels of care.61 Critics, on the other hand, articulate
concern about the level of savings and patient care improvement that blanket bundling of payments actually will generate. For example, the AMA expressed concern that such bundling proposals could result
in the withholding or limiting of appropriate post-discharge or inpatient services.62 The AMA also called
for the appropriate distribution of the payments to individual providers, risk-adjustment for patients
whose care exceeds the amount accounted for in the bundled payment, and safeguards to ensure that
patient care decisions remain in the hands of the individual providers.63 Similarly, in a letter to the Senate Finance Committee, the AHA stated that the Obama administration’s approach to bundling payments
was “problematic” and would require a “paradigm shift in health service delivery,” resulting in the
revision or withdrawal of numerous regulations promulgated to manage the current healthcare delivery
and payment system.64 Finally, the AAMC, which supports the concept of care coordination provided
through bundling, criticized Medicare’s Acute Care Episode Demonstration program for not ensuring
that payments are made directly to all parties (that is, physicians) who provide the services.65
Although no actual bundling policy has been implemented, recent actions by both the Senate and
CMS have demonstrated that such initiatives are on the healthcare horizon and may soon become a part
of the healthcare reimbursement environment. For example, the 2010 healthcare reform legislation includes a provision for the creation of a new demonstration project to pay bundled payments for episodes
of care that include hospitalization (effective January 1, 2012, through December 31, 2016).
The changing patient population demographic, rising levels of healthcare expenditures, growing concern about fraud and abuse, continuing controversy about physician reimbursement, growth in NHE, and
the SGR formula for determining the annual conversion factor are all significant drivers of the efforts
that have propelled healthcare reform initiatives under the Obama administration.

Passage of the Patient Protection and Affordable
Care Act and the Health Care and Education
Reconciliation Act of 2010
Legislative Events Leading to the Passage of
Healthcare Reform
With the Obama administration in the White House, and a Democratic majority in both the Senate and
the House of Representatives, the favorable time to approach healthcare reform appeared imminent to
some. However, with the election of a Republican senator in Massachusetts and waning public approval
of the healthcare initiative driven by rising unemployment rates, a declining economy, and an increase
in the federal deficit, problems arose for those expecting a speedy legislative reform process.66 However, after long and heated debate regarding the content of potential healthcare reform initiatives to be
included in the proposed legislation, the Patient Protection and Affordable Care Act, HR 3590, and the
Health Care and Education Reconciliation Act of 2010, HR 4872, were enacted on March 23, 2010, and
March 25, 2010, respectively.
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Summary of Key Provisions
The passage of HR 3590 and HR 4872 will result in significant changes to the country’s healthcare landscape. Table 6-2 provides a brief overview of the various entities and sectors of the healthcare industry
that are affected by provisions included in the 2010 healthcare reform legislation.
Table 6-2: Chart of Key Provisions

Company

Provision

Effective Date

Insurance market rules

September 23, 2010

Grandfathered plans—eliminate pre-existing condition exclusions for children

September 23, 2010

Grandfathered plans—eliminate pre-existing condition exclusions for adults

July 6, 1905

National high-risk pool

Dissolved after 2014

Health insurance exchanges for individual states

January 1, 2014

National Association of Insurance Commissioners must establish uniform definitions
and standard methodologies

December 31, 2010

Consumer-operated and oriented plan (CO-OP)

2013

All individuals required to obtain health insurance coverage

2014

Employers with more than fifty employees that do not offer coverage

2014

Employers with fewer than fifty employees

2014

Employers that offer coverage to their employees

2014

Employers with more than 200 employees

2014

Reduce the gap between generic and brand-name drugs

2020

Restrictions on revenue spending for Medicare Advantage plans

2014

Increase payments for primary care services

2013 and 2014

Workforce training and expansion is supported, as well as support for prevention
and wellness initiatives

[2010]

Provides a refundable credit for coverage under a qualified health plan

January 1, 2014

Provides a sliding-scale tax credit to small employees

2010

Excise tax on individuals

2013

Insurance Industry

Individuals and Employers

Medicare

Medicaid

Public Health

Tax Provisions

Excise tax on businesses
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Table 6-2: Chart of Key Provisions (continued)

Company

Provision

Effective Date

Coordination of federal prevention, wellness, and public health activities

2014

Create Prevention and Public Health fund

2014

Create task forces on preventive services and community preventive services

2014

Fraud and Abuse

Streamlined Medicare prepayment medical review limitations and additional funds
for programs focusing on reducing healthcare fraud

[2010]

Funding Mechanisms

Impose tax on high-cost insurance

[?] 2013

Exemption from payment of employer’s share of Social Security employment taxes

March 18, 2010, to
January 1, 2011

Tax breaks for private-sector businesses that hire unemployed workers in 2010

February 3, 2010, to
January 1, 2011

Prevention and Wellness

Hiring Incentives to Restore
Employment Act

The various entities and sectors of the healthcare industry that are affected by provisions included in
the 2010 healthcare reform legislation include:67
1. Insurance industry. The 2010 healthcare reform legislation subjects the insurance industry to
increasing restrictions regarding expanding coverage requirements.
2. Individual states. All states are required to establish an American Health Benefit Exchange by
January 1, 2014, to facilitate the purchase of qualified health plans and a Small Business Health
Options Program (SHOP) that will assist small employers (fewer than 100 employees) in obtaining coverage for employees.
3. Individuals. Perhaps the most controversial mandate is that individuals are required to obtain or
provide some minimum level of health insurance coverage. The healthcare legislation requires all
individuals to obtain health insurance coverage or pay penalties. Exemptions will be granted for
financial hardship, religious objections, American Indians, those without coverage for less than
three months, undocumented immigrants, incarcerated individuals, those for whom the lowest
cost plan option exceeds 8 percent of individual income, and those whose individual (or household) income was below the tax filing thresholds.68
4. Employers. Although the 2010 healthcare reform legislation does not require employers to offer health coverage to employees, employers can face significant penalties if they choose not to
do so. Chapter 7 of Professional Practices discusses the legislation in detail as it pertains to the
extensive provisions for both small and large employers.
5. Medicare. The program is required to provide, among other topics, a productivity adjustment and reductions to market basket updates for many providers; make several concessions
to expand primary care, coordinated care, and delivery system reform; support quality, transparency, and fraud and abuse enforcement initiatives; provide a rebate for Medicare Part D
beneficiaries required to pay out-of-pocket for prescription drug coverage in 2010; enforce
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provisions to continuously reduce the gap between generic and brand-name drugs by 2020; add
restrictions in 2014 on revenue spending for Medicare Advantage plans; update disproportionate
share payments (DSH); address the impact of physician ownership; and control the diagnostic
imaging utilization rate.
6. Medicaid. Reform initiatives related to Medicaid will be phased in between 2010 and 2014 and
include several provisions related to expanding enrollee eligibility, prescription drug coverage,
and primary care and preventive services coverage, among others. Additionally, Medicaid will be
required to designate new matching payments for eligible individuals with and increase Medicaid
payment rates for primary care physicians.
7. Public health. The 2010 healthcare reform legislation also supports public health workforce
training and expansion, as well as support for prevention and wellness initiatives.69 Additionally,
the initial 2010 healthcare reform legislation establishes the National Prevention, Health Promotion, and Public Health Council to coordinate federal prevention, wellness, and public health
activities, as well as the creation of a Prevention and Public Health fund to expand funding for
prevention and public health programs. Further, the legislation creates task forces related to preventive services and community preventive services for the purpose of developing, updating, and
disseminating evidence-based recommendations on the use of clinical and community prevention
services.70
8. Tax provisions. The 2010 healthcare legislation contains certain tax provisions, including the
provision of a refundable credit for coverage under a qualified health plan, effective January 1,
2011, as well as a sliding-scale tax credit to small employers (those with fewer than twenty-five
employees and average annual wages of less than $50,000) that purchase health insurance for
their employees. Funding mechanisms to support the implementation of these reform initiatives
include imposing a tax on high-cost insurance (that is, insurance that exceeds a maximum premium payment level while increasing premiums for those in high-risk professions). The legislation
additionally expands the Medicare tax base for taxpayers with higher income revenue provisions.

Timeline for Implementation of HR 3590 and HR 4872
Figure 6-2 provides an overview of the implementation timeline related to certain key healthcare reform
initiatives.

Obstacles to the Implementation of Healthcare Reform
After passage of the 2010 healthcare reform legislation, there remains heated opposition from the Republican Party regarding the content and implementation of the bill’s provisions. This may be in part due
to differing perceptions with regard to quality and access to care. An April 2010 study in Health Affairs
found that respondents who identified themselves as being affiliated with the Republican Party, male, of
senior status, and wealthy were more likely than their counterparts to believe that uninsured individuals
have little or no difficulty in obtaining healthcare.71 The fundamentally different views expressed by the
Democratic Party, which supports government intervention, and the Republican Party, which supports
increased market competition to control spending in a capitalist market, regarding how to best contain
healthcare costs also suggest a division in opinion regarding the proposed reform initiatives.72
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State Balancing incentive program.

Permit enrollees with at least two chronic conditions; and,

Prohibit federal payments for health care acquired conditions;

Prohibit higher cost sharing requirements for Medicare vs. free-for-service.

10% bonus payment to primary care physicians and general surgeons in shortage areas;

2012

Increase funding to community health centers by $11 million.

2013

Expand Medicaid.

Impose an excise tax.

Limit amount of contributions to a flexible spending account
for medical expenses; and,

Increase the Medicare Part A (hospital insurance) tax rate
on wages;

Increase the threshold for the itemized deduction for
unreimbursed medical expenses;

Tax Changes

Increase Medicaid payments for primary care services.

Medicaid

Establish a national Medicare pilot program.

Begin phasing-in federal subsidies for brand-name
prescriptions; and

Medicare

Simplify health insurance administration by adopting a
single set of operating rules

Impose an excise tax on insurers of employersponsored health plans with aggregate values that
exceed $10,200.

Tax Changes

Coverage Gap eliminated by 2020.

Reduce Medicare payments to certain hospitals for
hospital-acquired conditions by 1%; and,

Medicare

Permit states to form health care choice compacts
and allow insurers to sell policies in any state
participating in the compact.

Insurance

2014

2015 and beyond

Impose fees on the health insurance sector.

Tax Changes

Create the Consumer Operated and Oriented Plan (CO-OP)
program; and,

Insurance

Require enhanced collection and reporting of data.

Medicaid

Reduce Medicare Disproportionate Share Hospital (DSH) payments;

Establish an Independent Payment Advisory Board;

Reduce rebates for Medicare Advantage plans. Program.
Create new demonstration projects in Medicaid.

Reduce the out-of-pocket amount that qualifies enrollee for catastrophic
coverage;

Medicare

Provide refundable and advanceable premium credits and cost sharing
subsidies

Premium Subsidies

Limit deductibles for health plans in the small group market

Reduce the out-of-pocket limits;

American Health Benefit Exchanges and Small Business Health Options
Program;

Insurance

U.S. citizens and legal residents to have qualifying health coverage.

Employer Requirements

Establish a hospital value-based purchasing; and

Reduce Medicare payments;

Allow ACOs share in cost savings;

Part D cost-sharing for full-benefit dual eligible
beneficiaries equal cost-sharing for institutional care;

Quality Improvements

Medicaid

Medicare

50% discount from pharma manufacturers on brand name drugs;

Grants to small employers with wellness programs.

Quality Improvement

Medicaid

Medicare

Dependent Coverage for
adult children to age 26

2011

Voluntary insurance program for long term care.

Prevention/Wellness

Insurance

• H.R. 3962

• H.R. 3950

President Obama
signs Healthcare
Reform Bill

2010

September 2010

Additional requirements on non-profit hospitals and
concurrent $50,000 fine; and,
Limit deductibility of executive compensation;

Medicaid State Plan Amendment;
Increases drug rebate percentage to 23.1%; and
Increases non-innovator multiple source drug to 13%.

Rebates; and,
Expand Coverage

High risk Pool Established;
No pre-existing condition exclusion for children;
Health plans must provide minimum coverage;
Tax Credits to small employers; and,
Reinsurance program for Medical Loss ratio reporting.

March 23, 2010

Tax Changes

Medicaid

Medicare

Insurance

Figure 6-2: A
 Brief Primer on Healthcare Reform —2010 U.S. Healthcare Reform Timeline
H.R. 3950 • H.R. 3962
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The success of the implementation timeline will depend largely on the continued political and fiscal support for the measures proposed in HR 3590, and although the current political environment on
the federal level may support the bill, individual states are responsible for much of its implementation,
leaving ample room for delays created by lack of aggressive oversight or support.73 The states’ major
implementation responsibilities include establishing the insurance exchanges for small businesses and
individuals, enforcing the new insurance requirements, and administering the new Medicaid expansion.74
Without continued support of the Obama administration, Congress, other stakeholder groups, the media,
and the public, the strides made in healthcare reform by the passage of HR 3590 and HR 4872 may be
countered, similar to when the Medicare Catastrophic Coverage Act of 1988 was repealed slightly more
than a year after its passage.75 The result of the November 2010 midterm elections may play a large
role in determining whether the current reform initiatives will maintain the majority of political support
required to successfully implement the provisions of HR 3590 and HR 4872.76
Several of the attorneys general running for political office or up for re-election in the near future
are challenging the reform bill.77 State attorneys general filed lawsuits in federal court, within minutes
of President Obama’s signing of the healthcare reform legislation into law. Each lawsuit claims that the
healthcare reform legislation violates the United States Constitution. One lawsuit, led by Florida Attorney General Bill McCollum, and joined by twelve other state attorneys general, claims that the reform
legislation exceeds Congress’s power to regulate commerce, violates the 10th Amendment protection of
state sovereignty, and imposes an unconstitutional direct tax.78 The other suit, filed by Virginia Attorney
General Kenneth T. Cuccinelli, states that Virginia is in a unique situation, as it is the only state to pass a
law that creates a conflict of interest between the state law and the federal law by “protecting its citizens
from a government-imposed mandate to buy health insurance.”79
In addition to political obstacles to the enactment of healthcare reform, some consider physicians a
potential barrier to some reform initiatives, namely, cost-containment measures.80 Some research studies
have shown that the regional variance in healthcare spending is correlated with physician recommendation of additional tests of discretionary or uncertain benefit to the patient, and that reform efforts focused
on reducing spending in high-cost regions (for example, limiting unnecessary visits, procedures, etc.)
would greatly assist in cost-containment initiatives.81

Proposed Supplemental Reform Initiatives
Despite the monumental passage of HR 3590 and HR 4872, one thing that remains clear amid the looming uncertainty regarding what this reform means is that healthcare reform must be viewed as a process
rather than an event. In the months (and years) ahead, additional healthcare reform initiatives will be
proposed and implemented. The implementation of the 2010 healthcare reform legislation will be adaptive and possibly erratic, as its implementation not only depends on what is contained within the actual
text of the legislation but also how it responds to outside factors, such as the public’s support of the
legislation; the changing political and economic landscape; the private sector’s response; the healthcare
professionals’ real-life, day-to-day application of the law; and the governors’, attorneys’ general, and
states’ response to the reform. Accordingly, consultants advising individuals and businesses in these
matters should keep abreast not only regarding the impact of the healthcare reform legislation that has
been passed to date but also forthcoming proposals and initiatives.
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Paying for Healthcare Reform
Reforming healthcare in America may cost the government an estimated $820 billion or more over ten
years,82 which may be funded in a variety of ways including (1) cutting fraud and abuse within existing government health programs, (2) removing large subsidies to insurance companies, (3) increasing
healthcare delivery efficiency through streamlining paper work and coordinating care, and (4) obtaining
various tax revenues from individuals and companies.83 The CBO projects the legislation will save $511
billion in medical spending and produce a net reduction in the federal budget deficit by $143 billion during 2010-19 as a result of changes in direct spending and raising revenues.84
Significant changes to Medicare alone are projected to result in net savings of $575 billion from
2010–19.85 Overpayments to Medicare-managed plans identified through increased pressures on fraud
and abuse through audits are projected to save more than $204 billion from 2010–19.86 Additionally,
Medicare payments to providers will be adjusted for improvements in quality and productivity. These
adjustments will apply to payments made to inpatient hospitals, long-term care facilities, inpatient
rehabilitation facilities, psychiatric hospitals, and outpatient hospitals. The CBO projects these payment
adjustments will save $160 billion from 2010–19.87 Under the new healthcare reform, the CBO projects
Medicare spending growth to be slowed from anticipated increases of 6.8 percent annually to 5.2 percent, which will extend the stability of the Medicare trust fund through 2026 and save an estimated $397
billion from 2010–19.88
CMS also estimates substantial savings in Medicare costs that can be attributed to (1) reducing Part
A and Part B payment levels and adjusting future market backset payment updates for productivity improvements ($233 billion), (2) abolishing the Medicare improvement fund ($27 billion), (3) decreasing
DSH payments ($50 billion), (4) reducing Medicare Advantage payment benchmarks and permanently
extending the ability to adjust for coding intensity ($145 billion), (5) freezing the income thresholds for
the Part B income-related premium for nine years ($8 billion), (6) implementing an independent payment advisory board to maintain strict Medicare expenditure growth rate targets ($24 billion), and (7)
increasing the hospital insurance payroll tax rate by 0.9 percent for individuals with incomes above
$200,000 and families with incomes above $250,000 ($63 billion).89
Other sources of funding for the 2010 healthcare reform legislation may include (1) new annual fees
paid by insurers, estimated to yield $60.1 billion from 2014–19; (2) new annual fees paid by pharmaceutical manufacturers, estimated to raise $27 billion from 2013–19; (3) a 2.9 percent excise tax on medical
device manufacturers, estimated to raise $20 billion from 2013–19; and (4) an excise tax on high-cost
insurance plans, estimated to raise $32 billion from 2018–19.90

Healthcare Reform Impact on the Future of U.S.
Healthcare Delivery
The CBO has estimated that the enactment of HR 3590 would reduce federal budget deficits by $118
billion from 2010–19.91 Combined with the passage HR 4872, the federal deficit was estimated to be
reduced by $143 billion.92 In addition to the budgetary benefits of bill passage, the CBO estimates that
the number of people (nonelderly) who are uninsured will be reduced by approximately 32 million, and
the percentage of nonelderly residents with insurance coverage will increase from 83 to 94 percent by
2019.93
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Impact on Individuals
The 2010 healthcare reform legislation requires U.S. citizens and legal residents to maintain minimum
amounts of health insurance coverage. Minimum essential coverage includes government-sponsored
programs, eligible employer-sponsored programs, plans in the individual market, grandfathered group
health plans, as well as some other types of coverage. To assist U.S. citizens in paying for this coverage,
the initial 2010 healthcare reform legislation provides for refundable tax credits that eligible taxpayers
may use toward health insurance premiums (for both the individual taxpayer and his or her family) for
health insurance purchased through a state health benefit exchange. Each individual enrolled in a plan
offered through an exchange will be required to report his or her income to the exchange. Based on this
information provided by the individual, the individual will receive a premium assistance credit by the
treasury paying the credit directly to the insurance plan in which the individual is enrolled. The individual will then pay the difference between the credit amount and the total premium charged.94
Individuals who fail to maintain this minimum essential coverage will be subject to the following
excise taxes: $95 in 2014, $325 in 2015, and $695 in 2016 and years beyond. This penalty also is applied to any dependents who do not maintain minimum essential coverage. Individuals who qualify for
hardship or religious exemptions are excluded.95
Significant provisions of the initial healthcare reform legislation affecting individuals are related to
the exclusion of pre-existing conditions by health plans and the extension of health insurance coverage
for dependent children. Effective September 23, 2010, all health insurance plans are prohibited from excluding children on the basis of a pre-existing condition. Effective later during the second half of 2010, a
temporary national high-risk pool will be created to permit adults with pre-existing conditions to obtain
subsidized coverage with maximum cost sharing capped at the current health savings account limit. This
high-risk pool will be dissolved after January 1, 2014, when all insurers and group health plans will be
prohibited from excluding persons with pre-existing conditions.96 Additionally, health plans beginning
on January 1, 2011, must report the proportion of premium dollars spent on clinical services and quality
improvement and other costs, and provide rebates to consumers based for any cost less than 85 percent
for large group plans and 80 percent for individual and small group plans. In addition, starting in 2010,
a process for reviewing increases in health plan premiums will be established, which will require insurance companies to justify increases.97
Also effective September 23, 2010, insurance plans will be required to provide dependent coverage
for children up to age twenty-six for all individual and group policies.98 Eligible children up to twentysix years of age who do not qualify for other coverage must be covered under their parents’ employer’s
plan.99
Healthcare reforms related to Medicaid are significant, with such expanded coverage provisions effective beginning in 2010 as (1) creation of a state option to cover childless adults through a Medicaid
State Plan Amendment; (2) creation of a state option to provide coverage for family planning services to
certain low-income individuals, up to the highest level of eligibility for pregnant women; (3) creation of
a new option for states to provide Children’s Health Insurance Program (CHIP) coverage for children of
state employees eligible for health benefits, under certain conditions; (4) an increase in the drug rebate
percentage for brand name drugs up to 23.1 percent (except the rebate for clotting factors and drugs approved exclusively for pediatric use increases to 17.1 percent); (5) an increase in the drug rebate percentage for noninnovator, multiple-source drugs up to 13 percent of the average manufacturer price; (6)
extension of the drug rebate to Medicaid managed care plans; (7) provision of additional funding for the
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Medicaid and CHIP Payment and Access Commission to include assessments of adult services (including those persons who are dually eligible for Medicare and Medicaid); and (8) issuance of regulations by
the secretary of HHS that establish a process for public notice and comment for section 1115 waivers in
Medicaid and CHIP.100
Additional Medicaid reform initiatives will be effective in 2011, including the (1) prohibition of
federal payments to states for Medicaid services related to healthcare acquired conditions; (2) creation of
a new Medicaid state plan option to permit enrollees with at least two chronic conditions, one condition
and a risk of developing another, or at least one serious and persistent mental health condition, to designate a provider as a health home (and provide states taking accepting the option with 90 percent Federal
Medical Assistance Percentage for two years for health home related services such as care management, care coordination, and health promotion); (3) creation of the State Balancing Incentive Program
in Medicaid to provide enhanced federal matching payments to increase noninstitutionally based long
term care services; and (4) establishment of the Community First Choice Option in Medicaid to provide
community-based attendant support services to certain people with disabilities.101
Such Medicaid reform initiatives for 2010 include the creation of new demonstration projects to pay
bundled payments for episodes of care that include hospitalization (effective January 1, 2012, through
December 31, 2016), as well as to make global capitated payments to safety net hospital systems (effective for the fiscal years 2010 through 2012). Providers of pediatric services will be allowed to organize
as accountable care organizations (ACOs) to share in cost-savings (effective January 1, 2010, through
December 31, 2016). Additional provisions include expanded Medicaid payments to institutions of mental disease for adult enrollees who require stabilization of an emergency condition (effective October 1,
2011, through December 31, 2015).102
Effective 2013, there will be increased Medicaid payments for primary care services provided by
primary care physicians for 2013 and 2014, with 100 percent federal funding.103 Significantly, in 2014,
Medicaid coverage will be expanded to all non-Medicare-eligible individuals under sixty-five-years of
age (that is, children, pregnant women, parents, and adults without depending children) with incomes up
to 133 percent of the federal poverty level based on a modified adjusted gross income and will provide
for enhanced federal matching funds for new eligible enrollees. Additionally, effective 2014, there will
be a reduction in states’ Medicaid DSH allotments and an increase in spending caps for territories.104
Specifically as related to Medicaid and CHIP, healthcare reform provisions require states to maintain
current income eligibility levels for children in Medicaid and CHIP until 2010 and to extend funding
levels for CHIP through 2015, with the CHIP benefit package and cost-sharing rules to continue under
current laws. Beginning in 2015, states will be given the option to receive a 23 percent increase in the
CHIP match rate up to a cap of 100 percent. Additionally, children who are eligible for CHIP but who
are unable to enroll in the program due to enrollment caps will be eligible for tax credits.105

Impact on Small and Mid-Sized Employers
The impact of the 2010 healthcare reform legislation is not limited to individuals. By January 1, 2014,
states are required to establish an American Health Benefit exchange. These exchanges will facilitate
the purchase of qualified health plans and establish a SHOP, which will assist small employers to obtain
coverage for their employees.106 Employers with 100 or fewer employees may enroll in the exchange.
Effective 2017, employers with more than 100 employees may obtain coverage through an exchange at
the discretion of the state.
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Effective for tax years beginning in 2010 or later, an “eligible small employer” that purchases health
insurance for its employees receives a tax credit for amounts spent for health insurance coverage for
employees.107 An eligible small employer meets the following conditions when (1) it has no more than
twenty-five full-time equivalent employees for the taxable year, (2) the average wages it pays during the
taxable year do not exceed $50,000, and (3) it pays at least half of the premium cost.108
Beginning in 2010 and up to 2013, small employers providing healthcare coverage for employees
are eligible to receive a tax credit up to 35 percent of the employer’s contribution toward its employees’
health insurance premiums, if the employer contributes at least 50 percent of the total premium cost of
50 percent of the benchmark premium.109 In 2014, the applicable tax credit percentage will increase to
50 percent. Employers with ten or fewer employees and average wages of less than $20,000 will receive
100 percent of the credit. Employers with fifty or fewer employees are exempt from penalties assessed
for failure to either (1) offer no health coverage to full-time employees or (2) provide coverage to fulltime employees that is not affordable.

Impact on All Larger Employers
Although the 2010 healthcare reform legislation does not require larger employers to offer healthcare
coverage to employees, employers can face significant penalties if they choose not to do so. Employers
with more than fifty employees must offer “qualified coverage” to their employees. Qualified coverage is minimum essential coverage that includes government-sponsored coverage, employer-sponsored
coverage, grandfathered health plans, and plans offered in the individual market. A qualified health plan
(1) provides the essential health benefits package, (2) limits annual cost-sharing to the high-deductible
health plan limit, (3) limits the annual deductible for small group market plans to $2,000 for individual
and $4,000 for adults, (4) and does not require cost-sharing for preventive services or immunization.110
Qualified coverage also includes the availability of catastrophic coverage for individuals under the age
of thirty.
Additionally, an “applicable large employer” (defined as an employer that employs an average of at
least fifty full-time employees during the preceding calendar year) that (1) does not provide coverage for
all of its full-time employees, (2) provides minimum essential coverage that is unaffordable, or (3) provides minimum essential coverage that consists of a plan in which the plan’s share of the total allowed
cost of benefits is less than 60 percent is required to pay a penalty if any full-time employee is certified
to the employer as having purchased health insurance through a state exchange with respect to which a
tax credit or cost-sharing reduction is allowed or paid to the employee.111 The employer penalties assessed include a $2,000 penalty for each of its full time employees, with the first thirty employees not
counted toward the penalty calculation. If an employer offers unaffordable coverage, that is, if the premium exceeds 9.5 percent of a family’s income, the employer must pay a $3,000 penalty for each fulltime employee who is given a government subsidy and purchases coverage through a health exchange.112
The 2010 healthcare reform legislation also requires employers that offer coverage to provide a free
choice voucher to employees with incomes less than 400 percent of the federal poverty level whose
share of the premium is greater than 8 percent but is less than 9.8 percent of their income and who chose
to enroll in a plan in the health insurance exchange. This amount of the voucher will equal what the
employer would have paid to provide coverage to the employee under the employer’s plan. Additionally,
employers with more than 200 employees that offer group health plans are required to automatically
enroll employees into employer-sponsored health insurance plans.113 Employers must provide employees
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with notice of automatic enrollment and give the employees the ability to opt out of coverage.114 No
effective date has been established by the secretary of Labor, who is required to issue regulations implementing this requirement. Further, through December 31, 2013, the initial legislation provides for a temporary reinsurance program for employers providing healthcare coverage to retirees over age fifty-five
but who are not yet Medicare eligible. This government-funded reinsurance program reimburses employers for 80 percent of claims with amounts between $15,000 and $90,000. The funding for this program is $5 billion for the entire period, with HHS required to establish the program by June 21, 2010.115
Effective 2013, the healthcare reform legislation eliminates the deduction for the employer subsidy for
employers that provide prescription drug coverage to employees eligible for Medicare Part D.116
It should be noted that the 2010 healthcare reform legislation provides special rules for grandfathered health plans. A grandfathered health plan is any group health plan or individual coverage that
was effective on March 23, 2010, the date of the new legislation’s enactment. The healthcare legislation
allows an employer to maintain current health coverage for individuals that are already enrolled in plans
and for subsequently enrolled family members and new hires, which will not negate the grandfathered
status as long as the plan allowed for dependent or family coverage on March 23, 2010.117 Collectively
bargained agreements are grandfathered until the date on which the last of the collective bargaining
agreements relating to the grandfathered coverage terminates.118 Grandfathered plans are generally able
to avoid many of the new legislation’s requirements, but they are still subject to the following key provisions: pre-existing conditions, dependent coverage, elimination of coverage rescissions, coverage limits,
and, in 2014, excessive waiting periods.119
Effective in 2018, a 40 percent excise tax on high-cost plans will be assessed to plans costing more
than $10,200 for individual coverage or more than $27,500 for family coverage.120 The tax percentage
will be adjusted for age, gender, and high-risk professions. Also, beginning in 2011, the healthcare legislation requires employers to report the value of employee health benefits on W-2 forms. Beginning on
or after September 23, 2010, employers with self-funded health plans or health insurers from which they
obtain employer sponsored health insurance must make the following changes to benefits. Adult children
up to age twenty-six are able to receive coverage from a parent’s plan, regardless of student status, marital status, and whether or not they are supported by or living with the parent.
Additionally, the plan may not impose annual maximum benefit limits for “essential benefits,”
except those that may be permitted by regulations at a later date. The plans cannot prohibit or limit
coverage for pre-existing conditions for children under age nineteen. Plans that are self-funded must
give covered individuals the right to seek external independent medical review of certain claims, for
example, claims that are denied based upon medical necessity. Plans cannot require prior authorization
or increased cost sharing for emergency services, even if those services are provided out-of-network.
The plans are prohibited from discriminating in favor of highly compensated employees. Employers also
are allowed to increase incentives for wellness program investments from 20 percent to 30 percent of the
cost of the insurance premium.121 By 2014, an employer may not impose a waiting period greater than
ninety days for the employee to satisfy before getting health coverage.

Impact on Professional Practice Providers
Professional practice providers, in this era of healthcare reform, will be affected both directly and indirectly by many aspects of the reform bill and reconciliation act. These include, among others, changes
and restrictions related to reimbursement, fraud and abuse regulations, and technological and compliance
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requirements. In addition, professional practices will face changes in the competitive marketplace due
to proposed restrictions on other healthcare providers, for example, by the restrictions for expansion and
growth of the specialty hospital market. Having stymied similar restrictions in several other bills during
the past decade or so, physician-owned specialty hospitals are now subject to new provisions the 2010
healthcare reform legislation, which places heavy restrictions on the growth or expansion of existing specialty hospitals with physician ownership.122 Not only does this provision reduce the beneficial
effects of healthcare provider competition and create a greater likelihood of potential for hospital and
health system monopolies, as the current regulatory and reimbursement healthcare environments facilitate trends of hospital consolidation and practice roll-up, but it further sustains the two-pronged attack
on niche providers.
In addition to the 2010 healthcare reform legislation’s affect on individuals and employers, the
recent reform efforts also will have major implications for healthcare providers. For example, primary
care physicians (including family medicine, internal medicine, geriatric, and pediatric physician providers) whose Medicare charges for office, nursing facility, and home visits comprise at least 60 percent of
their total Medicare charges will be eligible for a 10 percent bonus payment for services performed from
2011 through 2016.123 Additionally, general surgeons who conduct major procedures in a designated
health professional shortage area will be eligible for a 10 percent bonus payment for these services from
2011–16.124 Medicare also will increase payment for psychotherapy services by 5 percent125 and extend
Medicare incentive payments of 1 percent in 2011 and 0.5 percent from 2012–14 for voluntary participation in Medicare’s Physician Quality Reporting Initiative (PQRI).126 Beginning in 2015, physician
providers who do not successfully participate in the PQRI program will have their payments reduced by
1.5 percent in 2015 and 2 percent in subsequent years.
Another reimbursement change for healthcare providers is related to the establishment of an ACO,
which provides a framework for providers to work in a coordinated and efficient manner across the
patient continuum of care. Under the ACO model, both hospital and physician providers will continue to
bill Medicare under the current FFS reimbursement system, but they may be eligible to share in certain
cost savings if the patient care delivered meets CMS quality standards and the cost of delivery (including both Medicare Part A and Medicare Part B expenditures) is below a predetermined threshold.127
Although there appears to be an increase in reimbursement for some physician services, other physician providers will face a decrease in reimbursement. Beginning July 1, 2010, Medicare reimbursement
for the technical component of diagnostic imaging services will be reduced by 50 percent (currently set
at 25 percent) for subsequent procedures on consecutive body parts.128 Additionally, the market basket
update for both inpatient and outpatient hospital services will be reduced by 0.25 percent for fiscal year
(FY) 2010–11, 0.1 percent for FY 2012–13, 0.3 percent for FY 2014–15, 0.2 percent for FY 2015–6,
and 0.75 percent for FY 2017–19.129

Conclusion
Some feel that the passage of HR 3590 and HR 4872 is one of the most important fundamental changes
to federal healthcare policy, on a similar scale to the implementation of the Medicare and Medicaid
programs.130 Analyses and published opinion regarding the necessity of healthcare reform to institute
effective cost-containment measures on healthcare expenditures have been growing in number, lending
more weight to proponents of reform measures.131 However, the successful implementation and potential
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impact of the new provisions detailed in this legislation depends largely on the continued political,
financial, and public support of federal, state, and individual stakeholders during the next few years. Additionally, without a permanent “fix” or reconciliation of growing Medicare expenditures and the SGR
formula, problems regarding physician reimbursement and cost containment will continue to plague the
U.S. healthcare industry, indirectly fueling problems, such as those related to access to care, the competitive healthcare environment, and the continued attack on niche providers. As evidenced by the debate
and wide-ranging concerns and opinions regarding healthcare reform, and specifically, the provisions
contained within the recently passed reform legislation, the public and political fight regarding the U.S.
healthcare delivery system reform is far from over.
Young physicians, who are plagued by medical school debt, are seeking a more “comfortable” lifestyle and are opting out of private, independent practices and pursuing salaried employment in hospitals
and health systems. This trend has made it increasingly difficult for older independent practitioners to
recruit junior partners, a struggle which, paired with the burden of rising costs and downshifting reimbursement, has led many physician-owners to sell their practices to hospitals and enter into salaried
employment arrangements.
At the same time, the legislative and regulatory agenda at both federal and state levels to limit physician ownership of or investment in ASTC revenue stream enterprises, has restricted physicians in private
practice to receiving only professional fee component revenues. This has been viewed by some as a
circumstance akin to relegating physicians to the status of “sharecroppers” or “hired help” or compelling
many physicians to acquiesce to an untenable profitability squeeze and accept employee status under the
substantial control of hospital systems or large corporate players.
Overall, this shift from small, physician- or provider-owned, independent private practices to captive
practices within larger integrated health systems may also be viewed as the “corporatization” of healthcare professional practices, which may result in a weakening of the independent physician or providerpatient relationship, a characteristic of the “cottage industry” healthcare delivery system of old.132
As discussed in this Guide, recent efforts at regulatory and reimbursement reform and the increasing
change and complexity of healthcare reimbursement, regulatory, competitive, and technological pillars
of healthcare indicate that the current healthcare environment is one of the most dramatic and challenging times in U.S. history for healthcare professional practices.133 Given this trend in the delivery of
care by professional practices, the days of the cottage industry of medicine may be coming to end, thus
fulfilling the statement that, “Marcus Welby is dead!”
Healthcare reform is driven by complex, polar, and potentially conflicting market factors, including
increased spending; a growing and graying demographic; workforce shortages and inefficiencies; problematic chronic and acute health indicators; and shortcomings in the delivery of efficient, quality care.
The chapters in this Guide detail these issues, their implications, and the 2010 reform initiatives proposed to delicately counterbalance the U.S. healthcare delivery system on the nation’s scale of justice.
With increased regulatory scrutiny related to Stark and antitrust laws, the complete upheaval of the reimbursement landscape from new insurance industry rules and changing Medicare and Medicaid payments,
the changing competitive environment of various sectors of the healthcare industry, and the rapid advance of technological developments, the 2010 healthcare reform has set the stage for a tumultuous and
uncertain future for advisors in this era of reform. This book has addressed each of these very important
aspects of reimbursement, regulatory, competition, and technology that are now part of an ever changing
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and increasingly unpredictable landscape of new provider configurations, tactics, and strategies, particularly in light of the 2010 healthcare reform legislation.
Chapter 2, Reimbursement Environment, provides an overview of current and future trends in healthcare reimbursement. With the recent passage of healthcare reform, it is vital for providers to maintain
an applied understanding of healthcare payment sources (for example, Medicare, Medicaid, State Children’s Health Insurance Program, etc.), revenue and billing procedures (for example, the resource-based
relative value scale payment system, relative value units and their components, Current Procedural Terminology codes, etc.), payment plans (for example, FFS plans, performance-based payment plans, and
consumer driven health plans), and the new rules related to overall insurance industry practices.
The U.S. healthcare industry is governed by a network of ever-changing state and federal regulations, relating to both physician and nonphysician professionals, and is facing a completely new landscape of federal regulations in light of the 2010 healthcare reform, especially with increased scrutiny
of fraud and abuse violations. Chapter 3, Regulatory Environment, contains a detailed overview of the
general provisions that apply to the various practitioners and providers in the healthcare industry.
Changes in the healthcare competitive market may be attributed to 2010 healthcare reform, which
attempts to address access and quality issues with individual insurance mandates and extensive quality
requirements. These issues, and numerous others implicated by healthcare reform, shape the unique and
dynamic healthcare competitive environment. Chapter 4, Impact of Competitive Forces, examines these
issues in further detail within the context of Porter’s five forces of competition.
Finally, advancements in medical technology have helped to revolutionize medicine as we know it,
and they also have been significant factors in the passage of the 2010 healthcare reform legislation. The
future of healthcare may well depend on a compromise between the advancement of medical technological capabilities and the cost of supporting those technologies that allows practitioners to provide the best
quality care possible, a central issue in the 2010 healthcare reform legislation. Chapter 5, Technology
Development, contains a discussion of the impact of technology on healthcare practices.
A multitude of unresolved issues remain related to the impact of these initial healthcare reform
initiatives. In order to survive these dynamic changes, as during all times of significant upheaval and
change, providers (both small and large) will need to seek the guidance of their professional advisors
and informed managers, and consultants will need to stay knowledgeable of the changing aspects of the
U.S. healthcare delivery system in an era of reform. This Guide was written to assist these professional
advisors in meeting that objective.
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Glossary
Accreditation: A process in which private organizations assess participating institutions and programs and issue accreditation certificates to those
that meet their requirements. Ensuring the quality
and safety of services is the focus of most accreditation standards; however, many also include
documentation and other requirements.
Adverse Drug Effect (ADE): An injury caused by
drugs, typically in the form of an allergic reaction
or adverse physiological responses to a certain
combination of medications. Preventable ADEs
are injuries that are caused by human error.
Alert Fatigue: A CPOE error caused by a combination of critical medical alerts and a high volume
of marginally medically consequential alerts.
Allopathic Medicine: “A method of healing
founded on a scientific basis.”
Ambulatory Surgery Center: A Medicarecertified healthcare facility that exclusively provides surgical services to patients not requiring an
overnight stay.
Antitrust: A body of law charged with combating anticompetitive behavior that would impair the
ability of free markets to function properly. Antitrust involves the regulation of mergers and acquisitions, as well as scrutiny of behavior between
competitors which may restrain trade.
Biologics: Therapeutic products that are developed using living sources; examples of biologics
include: vaccines, blood and blood products, and
allergenic extracts and tissues.
Biopharmaceuticals: Drugs and biologics that
treat an organism through the genetic manipulation
of foreign DNA.
Biosimilar Production: Redevelopment of new
generation biologics.

BlueCross/BlueShield: BlueCross provides beneficiaries with health insurance to cover hospital
expenses, while BlueShield provides insurance to
cover expenses associated with physician services.
Together, they form BlueCross BlueShield, and
the BlueCross Blue Shield Association (works to
coordinate the nationwide plans by establishing
standards for new plans and programs; assisting
local plans with enrollment activities, national advertising, public education, professional relations,
and statistical and research activities; and serving
as the primary contractor for processing Medicare
hospital, hospice, and home health claims.
Brachytherapy: Allows for treatment at higher
doses of radiation to treat a smaller area in a
shorter time by placing radiopharmaceuticals
directly inside or next to the tumor. Brachytherapy
can be temporary or permanent, with variable administration rates and doses.
Bundling: A form of reimbursement that combines institutional and professional charges into a
single payment, including all staff for preoperative
and postoperative care. Bundled payment schemes
generally include outlier provisions for cases that
become catastrophic.
Capitation: A pre-paid reimbursement method
that pays a provider a set price for providing medical services to a defined population for a defined
set of services, regardless of service utilization.
Providers must manage the financial risk of providing adequate care by calculating the expected
volume of referrals, the average cost, and their
ability to control utilization.
Charge Capture: A process that entails the
transfer of the provider’s coding and documentation to the actual bill. Providers are tasked with
recording the appropriate procedure and diagnosis
codes on an encounter form, and the business staff
is responsible for ensuring that the encounter form
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is accurate and then using it to bill patients and
third-party insurers.
Cherry-pick or Cream-skim: To pick the best of
a group and leaving the least desirable portion; for
healthcare, choosing the most profitable patients
and leaving the rest.
Children’s Health Insurance Program: A statefederal partnership that provides assistance to
children and pregnant women in families whose
income is above the threshold for Medicaid. It was
formerly known as the State Children’s Health
Insurance Program.
Chiropractic: A form of alternative medicine
originating from the belief that vertebral aligning
would serve to remedy diseases.
Civil Monetary Penalty: Financial penalties
levied against parties found guilty of violating the
antikickback statute or submitting false claims for
government reimbursement.
Civilian Health and Medical Program of the
Department of Veteran Affairs: The Department
of Veterans Affairs’ healthcare program for the
spouses and children of veterans who meet certain
eligibility requirements.
Civilian Health and Medical Program of the
Uniformed Services: The former name for
TRICARE.
Clinical Decision Support (CDS): A technology
that provides clinicians with real-time feedback
about a wide-range of diagnostic and treatment
related information as they are entering electronic
orders.
Commercial Reasonableness: The Department of
Health and Human Services has interpreted “commercially reasonable” to mean that an arrangement
appears to be “a sensible, prudent business agreement, from the perspective of the particular parties involved, even in the absence of any potential
referrals.” The Stark II Phase II commentary also
suggests that “an arrangement will be considered

‘commercially reasonable’ in the absence of referrals if the arrangement would make commercial
sense if entered into by a reasonable entity of
similar type and size and a reasonable physician of
similar scope and specialty, even if there were no
potential DHS referrals.”
Computerized Physician Order Entry (CPOE):
A computer system that permits clinical providers
to electronically order laboratory, pharmacy, and
radiology services.
Corpus: A collection of works written by Hippocrates and his pupils. These works discuss specialties and pathologies, the practice of medicine,
and medical ethics.
Cream Skimming: In healthcare, the purposeful targeting of patients that are considered the
most profitable customers for a given provider, for
example, specialty hospitals have been accused of
cream-skimming more profitable services, such as
cardiac and orthopedic care, from general hospitals, who serve a broader patient base.
Customary Prevailing and Reasonable: The
historically implemented methodology that based
Medicare-allowed amounts on past payments for
the service.
Degrees of Freedom: The number of possible
rotations that can be made by a robotic “hand.”
Designated Health Service: One of eleven categories of healthcare entities subject to the Stark
law:
1. Clinical lab services
2. Physical therapy, occupational therapy,
and speech-language pathology services
3. Radiology and other imaging services (including nuclear medicine as of 01/01/07)
4. Radiation therapy services and supplies
5. Durable medical equipment and supplies
6. Prosthetics, orthotics and prosthetic devices and supplies
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7. Home health services
8. Outpatient prescription drugs

generated by one or more encounters in any care
delivery setting.

9. Inpatient hospital services

Enteral: Into the digestive system.

10. Outpatient hospital services
11. Parental and enteral nutrients, associated
equipment, and supplies
Diagnostic Related Groups: A classification system of patients by surgical procedure or diagnosis
into major diagnostic categories for the purpose of
Medicare reimbursement of hospitalization costs.
Disproportionate Share Hospital (DSH)
Payments: A form of additional reimbursement
under Medicaid for hospitals that care for a large
number of Medicaid and uninsured patients. DSH
payments are allotments from the federal government that augment basic Medicaid reimbursement,
and under federal law, states are required to supplement disproportionate share hospitals in order
to receive this additional Medicaid funding.
Eclectic Medicine: A school of medicine that uses
herbal medicines and remedies to treat pathologic
conditions; among less threatening therapies,
eclectics were branded for their use of arsenic and
mercury treatments.
Economic Demand: “Relationship between the
price of a healthcare item or service and the quantity demanded.”
Economic Supply: “Relationship between the
price of a healthcare good, product, or service and
the quantity provided my medical sellers.”
Electronic Health Record (EHR): A longitudinal electronic record of patient health information
generated and maintained within an institution
containing information entered by a treating physician or clinician.
Electronic Health Record (EHR): Electronically
maintained patient health information, such as
patient demographics, notes, medications, medical
history, laboratory date, or medical reports, that is

Epidural: Into the membranes surrounding the
spinal cord.
External Beam Radiation Therapy (EBT):
A procedure that involves the administration of
high-energy x-ray beams to kill cancer cells and
treat tumors. Often, some x-ray, ultrasound, or
computerized tomography imaging is used prior to
the delivery to insure that the path of the beam will
align with the target area.
Fair Market Value (FMV): As defined by Stark
II Phase I for the purpose of scrutinizing transactions between healthcare professionals, FMV is
“the value in arm’s-length transactions, consistent
with general market value,” without taking into account any ability between parties to refer business
to each other.
Fee Schedule: A payment system under which the
fees for procedures are explicitly laid out and the
physician agrees to accept those fees as full payment unless the discounted charges are less than
the fee schedule in which case the plan pays the
lesser of the two.
Fee-for-Service: A payment policy under which
providers receive a fee for each service provided
(for example, an office visit, test, procedure, etc.).
Financial Relationship: The Stark law defines
financial relationships as an ownership or investment interest in the DHS entity or a compensation arrangement between the DHS entity and the
referring physician or a member of his immediate
family. The law further describes “ownership/investment interest” to include debt, equity or other
means. The term also includes an interest in an
entity that holds an ownership or investment interest in any entity providing DHS services.
Follow-on Biologics: New generation biologics.
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Gainsharing: An arrangement “under which a
hospital gives physicians a share of the reduction
in the hospital’s costs (that is, the hospital’s cost
savings) attributable in part to the physician’s
efforts.”
Gamma Knife: Employs computerized robotic
technology to move patients at submillimeter increments during treatment.
Gene Therapy: A molecular means of cancer
treatment.
Genomics: The evaluation of the hereditary
information provided by an organism’s DNA and
the application of research findings to the fields
of genetic engineering and enhancement, cloning,
stem cell research, and eugenics.
Health Maintenance Organization (HMO): The
entity responsible for providing, or arranging for
the provision of, healthcare services (including
preventative care) for plan enrollees by way of
contractual arrangements with providers. HMO
enrollees must receive all of their care from the
plan’s participating providers except for care
provided in emergency situations or in instances in
which the plan offers a point of service option.
Health Maintenance Organization: Any organization that, through an organized system of healthcare, provides or ensures the delivery of an agreedupon set of comprehensive health maintenance and
treatment services for an enrolled group of persons
commonly under a capitation or prepaid fixed sum
arrangement.
Health Savings Accounts: Special accounts into
which employers and employees both contribute,
and from which the employee can draw funds to
pay for health services. If the employer contributes, the value of those contributions is not taxable
to the employee. Similarly, if the employee makes
contributions, they count as “above-the-line”
deductions.

Homeopathic Medicine: A school of medicine
that involves the assessment of overall health and
environment, not just symptoms.
Independent Practice Association: An association of independent physicians who maintain their
own private practices but have joined together
to enter into an agreement to treat the plan’s
enrollees.
Industrial Hygiene: “The science of keeping people safe at work and in their communities. Industrial hygienists (IHs) are professionals dedicated
to the health and well-being of workers. Originally
industrial hygienists worked primarily in factories
and other industrial settings but as our society has
changed, so has the definition of industrial hygiene. Today, IHs can be found in almost every
type of work setting. Industrial hygienists also use
the term OEHS or occupational and environmental
health and safety to refer to the work that they do.”
Intensity Modulated Radiation Therapy
(IMRT): An advanced form of radiation therapy
using three-dimensional imaging and treatment
delivery.
International Classification of Diseases, Ninth
Revision (ICD-9): A system that has codes that
supply the payor with information regarding both
the patient diagnosis and the procedures performed
in treating the diagnosis. The Health Insurance
Portability and Accountability Act (HIPAA)
requires all healthcare providers to use the ICD-9
codes when reporting diagnosis information to
payors. In addition, HIPAA requires that hospitals
use the ICD-9 procedural codes when reporting
information to payors detailing the treatment of
hospital inpatients.
International Classification of Diseases, Tenth
Revision (ICD-10): In early 2009, the United
States Department of Health and Human Services
announced a final rule that called for the replacement of the current ICD-9 code set used to report
healthcare diagnoses and procedures with the ICD10 code set by October 1, 2013. The adoption of
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the new system offers several benefits, including
the facilitation of quality data reporting, support
for pay for performance payment methodologies,
improved billing accuracy, and allowances for international comparison of the incidence and spread
of disease.
Intravenous: Through the bloodstream.
Kickback: Remuneration received in return for
referring an individual to a person for the furnishing of any item or service for which payment may
be made under a federal health care program or
remuneration received in return for purchasing,
leasing, ordering, or arranging for or recommending purchasing, leasing, or ordering any good,
facility, service, or item for which payment may be
made under a federal health care program.
Laparoscopy: Minimally invasive surgery that
involves the insertion of a slender, tubular endoscope through the abdomen wall. A laparoscopy
involves the use of surgical instruments that the
practitioner controls and fiber optic technology for
visual navigation.
Legal Medicine: Referred to as “medical jurisprudence,” involves the implementation of medical
expertise for legal and judicial purposes.
Licensure: A set of minimum qualifications an
individual must possess in order to practice a given
profession. In healthcare, almost all practitioners
are required to be licensed, and there exist state
statutes in place to penalize those who practice
without proper licensure.
Linear Accelerator (LINAC): Delivers uniform
doses of high-energy x-rays to the localized area of
the patient’s tumor although sparing the surrounding normal tissue. It is the device most commonly
used for EBT treatments for patients with cancer.
Lockboxes: Instead of handling the collection and
processing of payments themselves, providers may
decide to use a lockbox service. For a fee, lockbox
services open a provider’s mail, collect payments,
and deposit the money into the provider’s account.

Managed Care: Plans that integrate the financing
(that is, insurance) and provision of health services
under the administration of one organization in an
effort to contain costs.
Medicaid: “The expanded assistance to the states
for medical care.”
Medicaid: A means-tested, state administered
health insurance program for individuals below
certain income thresholds predetermined by the
state in which they reside. The federal government
establishes coverage requirement guidelines for the
categorically needy (for example, children, pregnant women), medically needy (for example, individuals with income above the threshold but who
have a large amount of medical bills), and special
groups. Although the federal government determines the medical services that will be covered
and paid for by the federal portion of the program,
Medicaid programs vary widely from state to state
as state governments are free to add additional services or expand eligibility to additional groups.
Medical Imaging: A “non-invasive process used
to obtain pictures of the internal anatomy or function of the anatomy using one of many different
types of imaging equipment and media for creating
the image.”
Medicare Part A: “The Democratic plan for a
compulsory hospital insurance program under
Social Security.”
Medicare Part B: “The revised Republican program of government-subsidized voluntary insurance to cover physicians’ bills.”
Medicare: An entitlement program available to individuals over the age of sixty-five and individuals
with end-stage renal disease. Medicare is divided
into four parts: (1) Part A, which covers inpatient
hospital care; (2) Part B, which covers outpatient
visits; (3) Part C, which people can choose as a
managed care replacement of Part A and B; and
(4) Part D, which covers prescription drug benefits.
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Medicare: Passed by the United States Congress
in 1964 and signed by President Lyndon B. Johnson on July 30, 1965; comprised of three layers:
Part A, Part B, and Medicaid.
Monopsony: “A single purchaser in a healthcare
market without rivals.”
National Committee on Quality Assurance
(NCQA): A nonprofit organization that works
to improve the quality of healthcare through the
accreditation of managed care plans. NCQA
performs this duty, much like other accrediting
bodies, through the setting of standards and collection of outcome and performance data.
Naturopathic Medicine: A school of medicine
that utilizes natural elements (such as water, heat,
and massage) in its therapies.
Niche Providers: Providers who focus on a section or group of buyers, a segment of a product
line, or a specific area of a geographic market.
What specific area niche providers focus on
changes based on who is creating the definition.
NightHawk Radiology Services: The nation’s
first nighthawk company.
Nonparenteral Drug Delivery: A means of drug
delivery in which the distribution is through a
means other than a digestive one.
Nonparticipating Provider: Providers who have
not agreed to accept the Medicare reimbursement
amount for every claim. Yet, nonparticipating providers are allowed to accept Medicare assignment
on a claim-by-claim basis, if they agree certain
conditions. However, it should be noted that even
though they have not accepted Medicare’s fee as
payment in full, nonparticipating providers are
subject to a “limiting charge,” that dictates what
they may charge Medicare beneficiaries for covered services.
Nurse Licensure Compact: An interstate license
for nurses created in 2000 by the National Council
of State Boards of Nursing.

Osteopathic: A school of medicine that involves
the assessment of overall health and environment,
not just symptoms.
Participating Provider: A physician who has
agreed to accept the reimbursement amount set by
the Medicare Fee Schedule as payment in full for
every claim. The physician’s office may bill the
patient for its share of the co-insurance and its deductible, but it cannot balance bill the patient, (that
is, attempt to collect the difference between its
usual fee and Medicare’s lower allowed charge).
Pasteurization: Widely used in the preservation
of perishable products, pasteurization involves the
strategic application of heat to kill microbes without injuring the quality of its media (for example,
wine, beer, etc.).
Personalized Medicine: The fusion of molecular
diagnostics and therapeutic measures for specialized screening and treatment plans.
Physician-Owned Facilities: Healthcare entities in which their practicing physicians also have
ownership investment in the facility, supplementing professional income with revenue from facility
services. Many physician-owned facilities include
limited-service facilities, such as surgical and specialty hospitals.
Physiotherapy: A term used to describe various
kinds of medical therapy, including hydrotherapy,
massage, mechanotherapy, electrotherapy, and
heat therapy.
Picture Archives and Communications Systems
(PACS): Used to connect digital x-rays and other
imaging modalities. Has become a must for efficient imaging services, as it provides improved
access to images with reduced delays.
Point-of-Care Technology: New technologies
that help to manage patient treatment plans.
Point-of-Service Plans (POS): Plans that combine many of the elements of HMOs and PPOs.
POS plans are usually an addition to an HMO
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product that allows members the benefit of seeking
care from non-participating providers. As with an
HMO, when members seek care from in-network
providers they typically pay no deductible or coinsurance. However, similar to a PPO, members are
free to seek services outside the network subject to
higher cost sharing in the form of deductibles and
coinsurance.
Preferred Provider Organization (PPO): “A
health care delivery system where providers contract with the PPO at various reimbursement levels
in return for patient steerage into their practices
and/or timely payment.”
Preferred Provider Organization (PPO): A
hybrid of an HMO and traditional health insurance
plan. It is a managed care plan that allows members to choose from an array of healthcare providers who have contracted with the plan to provide
services on a discounted basis.
Prospective Payment System: The federal medical system that reimburses hospitals for Medicare
Part A services based on diagnosis related groups.
Protected Health Information (PHI): Individually identifiable health information that is transmitted by, or maintained in, electronic media or
any other form or medium. This information must
relate to (1) the past, present, or future physical
or mental health, or condition of an individual;
(2) provision of healthcare to an individual; or
(3) payment for the provision of healthcare to an
individual.
Public Health: An area of healthcare centered
around “community health point of view,” that
considers “the means of defen(s)e against disease a
social problem.”
Purple Pill: A treatment for bleeding ulcer patients, with a proton-pump inhibitor like Prilosec (omeprazole), that stops bleeding prior to
endoscopy.
Qui Tam Action: Also known as a “whistleblower” suit, this action is filed by an individual

who alleges that a particular entity has submitted
false claims for reimbursement to the government
in violation of the False Claims Act, including
violations of the Stark law and the antikickback
statute. Qui tam actions may be brought by employees, former employees, competitors, subcontractors, state and local governments, current and
former federal employees, public interest groups,
corporations, and other private organizations.
Radiation Therapies: Procedures that use high
energy light beams or charged particles to stunt
tumor cell proliferation thereby treating cancer.
Reciprocal (Limited) Licensure: Provides an
interstate license for use with telemedicine practitioners applied for through a simple application
process and reduced licensing fees. This license is
solely used for telemedicine and may not be used
to physically practice in another state.
Reparative Medicine: Therapies that heal the
body’s natural tissue.
Resource Based Relative Value System: A
relative value scale that is based on the necessary
resources used to perform a medical service.
Revenue Cycle: The process by which a provider
practice schedules patients, diagnoses conditions,
documents diagnoses, bills payors, and collects
billable charges from the payor and the patient to
recover revenue for the services provided.
Self-Insurance: Self-insuring employers make a
conscious choice to undertake the risks associated
with the cost of healthcare and set aside money to
pay these costs as they arise. Often, a self-insurer
will hire a commercial insurer or third-party administrator to run its medical benefits program and
adjudicate claims.
Self-Referral: The practice of referring a patient
for a designated health service (DHS) to an entity
in which the referring physician (or a member of
his immediate family) has an ownership or investment interest.
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Stem Cells: Unspecialized cells capable of (1)
renewing themselves through cell division, sometimes after long periods of inactivity and (2) specializing to a certain type of tissue or organ under
the proper conditions.

The Joint Commission: An independent, nonprofit organization responsible for the certification and accreditation of health care organizations
across the United States.

Stereotactic Radiosurgery: A highly precise
procedure involving the single, high-dose delivery
of precisely-targeted gamma-ray or x-ray beams
that is used in different parts of the body, but most
frequently to treat brain tumors.

The National Center for Human Genome Research Institute (NCHGRI): Comprised of more
than fifty researchers that are each dedicated to
specific facets of genetic and genomic research and
contribute accordingly to one of seven branches of
the NCHGRI.

Store and Forward: The transfer of digital images between locations, most commonly seen in
teleradiology and telepathology.

Treble Damages: Damages equal to three times
the amount of the illegal remuneration in violation
of the antikickback statute.

Studia Generalia: Universities in the Roman Empire at which law, theology, and philosophy were
taught in addition to medicine.

TRICARE: The Department of Defense’s healthcare program for active duty military personnel;
members of the National Guard and Reserves;
retirees, their dependents, and survivors; and
certain former spouses. The program uses military
healthcare as the main provider of services, supplemented by civilian healthcare providers, facilities, pharmacies, and suppliers. TRICARE covers
approximately 9.4 million beneficiaries worldwide
through a variety of plans.

Subcutaneous: Under the skin.
Telehealth: Closely related to telemedicine and is
used to describe the broader definition of remote
healthcare that does not always involve clinical
services, although the two terms are often used
interchangeably.
Telemedicine: The transfer of electronic medical
data (high resolution images, sounds, live video,
and patient records) from one location to another
in order to enhance the quality and efficiency of
patient comfort and care.

Two-Way Interactive Television: Used telemedicine for face-to-face consultations.
Upcoding: Inflating bills by using diagnosis billing codes that suggest a more expensive illness or
treatment.

Teleradiology: Electronic transfer and storage of
electronic imaging data.
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